35 U.S.C.: Difference between revisions

From wikilawschool.net. Wiki Law School does not provide legal advice. For educational purposes only.
No edit summary
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
Appendix L Patent Laws
__TOC__


'''<big>United States Code Title 35 – Patents'''</big>


United States Code Title 35 - Patents
==PART I — UNITED STATES PATENT AND TRADEMARK OFFICE==


PART I UNITED STATES PATENT
===CHAPTER 1 ESTABLISHMENT, OFFICERS AND EMPLOYEES, FUNCTIONS===
AND TRADEMARK OFFICE


====35 U.S.C. 1 Establishment.====


CHAPTER 1 ESTABLISHMENT, OFFICERS
(a) ESTABLISHMENT.The United States
AND EMPLOYEES, FUNCTIONS
Patent and Trademark Office is established as an
agency of the United States, within the Department of
Commerce. In carrying out its functions, the United
States Patent and Trademark Office shall be subject to
the policy direction of the Secretary of Commerce,
but otherwise shall retain responsibility for decisions
regarding the management and administration of its
operations and shall exercise independent control of
its budget allocations and expenditures, personnel
decisions and processes, procurements, and other
administrative and management functions in accordance with this title and applicable provisions of law.
Those operations designed to grant and issue patents
and those operations which are designed to facilitate
the registration of trademarks shall be treated as separate operating units within the Office.
(b) OFFICES.— The United States Patent and
Trademark Office shall maintain its principal office in
the metropolitan Washington, D.C., area, for the service of process and papers and for the purpose of carrying out its functions. The United States Patent and
Trademark Office shall be deemed, for purposes of
venue in civil actions, to be a resident of the district in
which its principal office is located, except where
jurisdiction is otherwise provided by law. The United
States Patent and Trademark Office may establish satellite offices in such other places in the United States
as it considers necessary and appropriate in the conduct of its business.
(c) REFERENCE.— For purposes of this title,  
the United States Patent and Trademark Office shall
also be referred to as the “Office” and the “Patent and
Trademark Office”.


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
Stat. 1949; amended Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-572 (S. 1948 sec. 4711).)


Sec.  
====35 U.S.C. 2 Powers and duties.====


1 Establishment.
(a) IN GENERAL.— The United States Patent
2 Powers and Duties.  
and Trademark Office, subject to the policy direction
3 Officers and employees.
of the Secretary of Commerce—
4 Restrictions on officers and employees as to interest in
(1) shall be responsible for the granting and
patents.
issuing of patents and the registration of trademarks;
5 Patent and Trademark Office Public Advisory
and  
Committees.
(2) shall be responsible for disseminating to
6 Board of Patent Appeals and Interferences.
the public information with respect to patents and  
7 Library.
trademarks.  
8 Classification of patents.
(b) SPECIFIC POWERS.— The Office—
9 Certified copies of records.
10 Publications.
11 Exchange of copies of patents and applications with
foreign countries.
12 Copies of patents and applications for public libraries.
13 Annual report to Congress.
CHAPTER 2 — PROCEEDINGS IN THE
PATENT AND TRADEMARK OFFICE
21 Filing date and day for taking action.
22 Printing of papers filed.
23 Testimony in Patent and Trademark Office cases.
24 Subpoenas, witnesses.  
25 Declaration in lieu of oath.  
26 Effect of defective execution.
CHAPTER 11 APPLICATION FOR PATENT


(1) shall adopt and use a seal of the Office,
which shall be judicially noticed and with which letters patent, certificates of trademark registrations, and
papers issued by the Office shall be authenticated;
(2) may establish regulations, not inconsistent with law, which—
(A) shall govern the conduct of proceedings in the Office;
(B) shall be made in accordance with section 553 of title 5;
(C) shall facilitate and expedite the processing of patent applications, particularly those
which can be filed, stored, processed, searched, and
retrieved electronically, subject to the provisions of
section 122 relating to the confidential status of applications;
(D) may govern the recognition and conduct of agents, attorneys, or other persons representing applicants or other parties before the Office, and
may require them, before being recognized as representatives of applicants or other persons, to show that
they are of good moral character and reputation and
are possessed of the necessary qualifications to render
to applicants or other persons valuable service,
advice, and assistance in the presentation or prosecution of their applications or other business before the
Office;
(E) shall recognize the public interest in
continuing to safeguard broad access to the United
States patent system through the reduced fee structure
for small entities under section 41(h)(1) of this title;
and
(F) provide for the development of a performance-based process that includes quantitative and
qualitative measures and standards for evaluating
cost-effectiveness and is consistent with the principles
of impartiality and competitiveness;
(3) may acquire, construct, purchase, lease,
hold, manage, operate, improve, alter, and renovate
any real, personal, or mixed property, or any interest
therein, as it considers necessary to carry out its functions;
(4)(A) may make such purchases, contracts
for the construction, or management and operation of
facilities, and contracts for supplies or services, without regard to the provisions of subtitle I and chapter
33 of title 40, title III of the Federal Property and
Administrative Services Act of 1949 (41 U.S.C. 251
et seq.), and the McKinney-Vento Homeless Assistance Act (42 U.S.C. 11301 et seq.);




CHAPTER 3 — PRACTICE BEFORE PATENT
(B) may enter into and perform such purchases and contracts for printing services, including
AND TRADEMARK OFFICE
the process of composition, platemaking, presswork,
 
silk screen processes, binding, microform, and the
31 [Repealed].
products of such processes, as it considers necessary
32 Suspension or exclusion from practice.
to carry out the functions of the Office, without regard
33 Unauthorized representation as practitioner.
to sections 501 through 517 and 1101 through 1123 of
 
title 44;
 
(5) may use, with their consent, services,
CHAPTER 4 — PATENT FEES; FUNDING;  
equipment, personnel, and facilities of other departments, agencies, and instrumentalities of the Federal
SEARCH SYSTEMS
Government, on a reimbursable basis, and cooperate
 
with such other departments, agencies, and instrumentalities in the establishment and use of services, equipment, and facilities of the Office;  
41 Patent fees; patent and trademark search systems.
(6) may, when the Director determines that it
42 Patent and Trademark Office funding.
is practicable, efficient, and cost-effective to do so,
 
use, with the consent of the United States and the
PART II — PATENTABILITY OF
agency, instrumentality, Patent and Trademark Office,
INVENTIONS AND GRANT OF PATENTS
or international organization concerned, the services,
records, facilities, or personnel of any State or local
government agency or instrumentality or foreign
patent and trademark office or international organization to perform functions on its behalf;
(7) may retain and use all of its revenues and  
receipts, including revenues from the sale, lease, or
disposal of any real, personal, or mixed property, or
any interest therein, of the Office;




CHAPTER 10 — PATENTABILITY
(8) shall advise the President, through the
OF INVENTIONS
Secretary of Commerce, on national and certain international intellectual property policy issues;
(9) shall advise Federal departments and
agencies on matters of intellectual property policy in
the United States and intellectual property protection
in other countries;
(10) shall provide guidance, as appropriate,
with respect to proposals by agencies to assist foreign
governments and international intergovernmental
organizations on matters of intellectual property protection;
(11) may conduct programs, studies, or
exchanges of items or services regarding domestic
and international intellectual property law and the
effectiveness of intellectual property protection
domestically and throughout the world;
(12)(A) shall advise the Secretary of Commerce on programs and studies relating to intellectual
property policy that are conducted, or authorized to be
conducted, cooperatively with foreign intellectual
property offices and international intergovernmental
organizations; and




100 Definitions.
(B) may conduct programs and studies
described in subparagraph (A); and
(13)(A) in coordination with the Department of
State, may conduct programs and studies cooperatively with foreign intellectual property offices and
international intergovernmental organizations; and


101 Inventions patentable.


102 Conditions for patentability; novelty and loss of right
(B) with the concurrence of the Secretary
to patent.  
of State, may authorize the transfer of not to exceed
$100,000 in any year to the Department of State for
the purpose of making special payments to international intergovernmental organizations for studies and
programs for advancing international cooperation
concerning patents, trademarks, and other matters.
(c) CLARIFICATION OF SPECIFIC POWERS.—
(1) The special payments under subsection
(b)(13)(B) shall be in addition to any other payments
or contributions to international organizations
described in subsection (b)(13)(B) and shall not be
subject to any limitations imposed by law on the
amounts of such other payments or contributions by
the United States Government.  


103 Conditions for patentability; non-obvious subject
matter.


104 Invention made abroad.


105 Inventions in outer space.  
(2) Nothing in subsection (b) shall derogate
from the duties of the Secretary of State or from the
duties of the United States Trade Representative as set
forth in section 141 of the Trade Act of 1974 (19 U.S.C. 2171).  


111 Application.  
(3) Nothing in subsection (b) shall derogate
 
from the duties and functions of the Register of Copyrights or otherwise alter current authorities relating to
112 Specification.  
copyright matters.  
 
(4) In exercising the Director’s powers under
113 Drawings.  
paragraphs (3) and (4)(A) of subsection (b), the Director shall consult with the Administrator of General
Services.  
(5) In exercising the Director’s powers and
duties under this section, the Director shall consult
with the Register of Copyrights on all copyright and
related matters.
(d) CONSTRUCTION.— Nothing in this section shall be construed to nullify, void, cancel, or
interrupt any pending request-for-proposal let or contract issued by the General Services Administration
for the specific purpose of relocating or leasing space
to the United States Patent and Trademark Office.  


114 Models, specimens.


115 Oath of applicant.  
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
Stat. 1949; amended Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-572 (S. 1948 sec. 4712);
subsection (b)(4)(A) amended Oct. 30, 2000, Public Law
106-400, sec. 2, 114 Stat. 1675; subsections (b)(2)(B) and
(b)(4)(B) amended Nov. 2, 2002, Public Law 107-273, sec.
13206, 116 Stat. 1904; subsection (b)(4)(A) amended Dec.
15, 2003, Public Law 108-178, sec. 4(g), 117 Stat. 2641.)


116 Inventors.  
====35 U.S.C. 3 Officers and employees.====


117 Death or incapacity of inventor.  
(a) UNDER SECRETARY AND DIRECTOR.—
(1) IN GENERAL.— The powers and duties
of the United States Patent and Trademark Office
shall be vested in an Under Secretary of Commerce
for Intellectual Property and Director of the United
States Patent and Trademark Office (in this title
referred to as the “Director”), who shall be a citizen of
the United States and who shall be appointed by the
President, by and with the advice and consent of the
Senate. The Director shall be a person who has a professional background and experience in patent or  
trademark law.
(2) DUTIES.


118 Filing by other than inventor.  
(A) IN GENERAL.— The Director shall
be responsible for providing policy direction and
management supervision for the Office and for the
issuance of patents and the registration of trademarks.
The Director shall perform these duties in a fair,
impartial, and equitable manner.  


119 Benefit of earlier filing date; right of priority.  
(B) CONSULTING WITH THE PUBLIC
 
ADVISORY COMMITTEES.— The Director shall
120 Benefit of earlier filing date in the United States.  
consult with the Patent Public Advisory Committee
 
established in section 5 on a regular basis on matters
121 Divisional applications.  
relating to the patent operations of the Office, shall
 
consult with the Trademark Public Advisory Committee established in section 5 on a regular basis on matters relating to the trademark operations of the Office,
122 Confidential status of applications; publication of  
and shall consult with the respective Public Advisory
patent applications.  
Committee before submitting budgetary proposals to
 
the Office of Management and Budget or changing or
CHAPTER 12 EXAMINATION
proposing to change patent or trademark user fees or
OF APPLICATION
patent or trademark regulations which are subject to
the requirement to provide notice and opportunity for
public comment under section 553 of title 5, as the
case may be.  
(3) OATH.— The Director shall, before taking office, take an oath to discharge faithfully the
duties of the Office.
(4) REMOVAL.— The Director may be
removed from office by the President. The President
shall provide notification of any such removal to both
Houses of Congress.  
(b) OFFICERS AND EMPLOYEES OF THE
OFFICE.
(1) DEPUTY UNDER SECRETARY AND
DEPUTY DIRECTOR.— The Secretary of Commerce, upon nomination by the Director, shall appoint
a Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the United States
Patent and Trademark Office who shall be vested with
the authority to act in the capacity of the Director in
the event of the absence or incapacity of the Director.
The Deputy Director shall be a citizen of the United
States who has a professional background and experience in patent or trademark law.  
(2) COMMISSIONERS.—  


(A) APPOINTMENT AND DUTIES.—
The Secretary of Commerce shall appoint a Commissioner for Patents and a Commissioner for Trademarks, without regard to chapter 33, 51, or 53 of title
5. The Commissioner for Patents shall be a citizen of
the United States with demonstrated management
ability and professional background and experience in
patent law and serve for a term of 5 years. The Commissioner for Trademarks shall be a citizen of the
United States with demonstrated management ability
and professional background and experience in trademark law and serve for a term of 5 years. The Commissioner for Patents and the Commissioner for
Trademarks shall serve as the chief operating officers
for the operations of the Office relating to patents and
trademarks, respectively, and shall be responsible for
the management and direction of all aspects of the
activities of the Office that affect the administration of
patent and trademark operations, respectively. The
Secretary may reappoint a Commissioner to subsequent terms of 5 years as long as the performance of
the Commissioner as set forth in the performance
agreement in subparagraph (B) is satisfactory.


131 Examination of application.  
(B) SALARY AND PERFORMANCE
 
AGREEMENT.— The Commissioners shall be paid
132 Notice of rejection; reexamination.  
an annual rate of basic pay not to exceed the maximum rate of basic pay for the Senior Executive Service established under section 5382 of title 5,
 
including any applicable locality-based comparability
133 Time for prosecuting application.  
payment that may be authorized under section
 
5304(h)(2)(C) of title 5. The compensation of the
134 Appeal to the Board of Patent Appeals and
Commissioners shall be considered, for purposes of
Interferences.  
section 207(c)(2)(A) of title 18, to be the equivalent of
 
that described under clause (ii) of section
135 Interferences.  
207(c)(2)(A) of title 18. In addition, the Commissioners may receive a bonus in an amount of up to, but not
in excess of, 50 percent of the Commissioners’ annual
rate of basic pay, based upon an evaluation by the
Secretary of Commerce, acting through the Director,
of the Commissioners’ performance as defined in an
annual performance agreement between the Commissioners and the Secretary. The annual performance
agreements shall incorporate measurable organization
and individual goals in key operational areas as delineated in an annual performance plan agreed to by the
Commissioners and the Secretary. Payment of a bonus
under this subparagraph may be made to the Commissioners only to the extent that such payment does not
cause the Commissioners’ total aggregate compensation in a calendar year to equal or exceed the amount
of the salary of the Vice President under section 104
of title 3.
(C) REMOVAL.— The Commissioners
may be removed from office by the Secretary for misconduct or nonsatisfactory performance under the performance
agreement described in subparagraph (B),
without regard to the provisions of title 5. The Secretary shall provide notification of any such removal to
both Houses of Congress.  


CHAPTER 13 REVIEW OF PATENT AND
(3) OTHER OFFICERS AND EMPLOYEES.The Director shall—
TRADEMARK OFFICE DECISION
(A) appoint such officers, employees
(including attorneys), and agents of the Office as the
Director considers necessary to carry out the functions
of the Office; and
(B) define the title, authority, and duties of
such officers and employees and delegate to them
such of the powers vested in the Office as the Director
may determine.
The Office shall not be subject to any
administratively or statutorily imposed limitation on
positions or personnel, and no positions or personnel
of the Office shall be taken into account for purposes
of applying any such limitation


(4) TRAINING OF EXAMINERS.— The
Office shall submit to the Congress a proposal to provide an incentive program to retain as employees
patent and trademark examiners of the primary examiner grade or higher who are eligible for retirement,
for the sole purpose of training patent and trademark
examiners.
(5) NATIONAL SECURITY POSITIONS.— The Director, in consultation with the
Director of the Office of Personnel Management,
shall maintain a program for identifying national
security positions and providing for appropriate security clearances, in order to maintain the secrecy of certain inventions, as described in section 181, and to
prevent disclosure of sensitive and strategic information in the interest of national security.
(c) CONTINUED APPLICABILITY OF
TITLE 5. — Officers and employees of the Office
shall be subject to the provisions of title 5, relating to
Federal employees.
(d) ADOPTION OF EXISTING LABOR
AGREEMENTS.— The Office shall adopt all labor
agreements which are in effect, as of the day before
the effective date of the Patent and Trademark Office
Efficiency Act, with respect to such Office (as then in
effect).
(e) CARRYOVER OF PERSONNEL.—


141 Appeal to Court of Appeals for the Federal Circuit.
(1) FROM PTO.— Effective as of the effective date of the Patent and Trademark Office Efficiency
142 Notice of appeal.
Act, all officers and employees of the Patent
143 Proceedings on appeal.
and Trademark Office on the day before such effective date shall become officers and employees of the
144 Decision on appeal.
Office, without a break in service.  
145 Civil action to obtain patent.
146 Civil action in case of interference.  


(2) OTHER PERSONNEL.— Any individual who, on the day before the effective date of the
Patent and Trademark Office Efficiency Act, is an
officer or employee of the Department of Commerce
(other than an officer or employee under paragraph
(1)) shall be transferred to the Office, as necessary to
carry out the purposes of this Act, if—
(A) such individual serves in a position for
which a major function is the performance of work
reimbursed by the Patent and Trademark Office, as
determined by the Secretary of Commerce;
(B) such individual serves in a position that
performed work in support of the Patent and Trademark Office during at least half of the incumbent’s
work time, as determined by the Secretary of Commerce; or
(C) such transfer would be in the interest of
the Office, as determined by the Secretary of Commerce in consultation with the Director.


Any transfer under this paragraph shall be
effective as of the same effective date as referred to in
paragraph (1), and shall be made without a break in
service.


CHAPTER 14 ISSUE OF PATENT
(f) TRANSITION PROVISIONS.—  


151 Issue of patent.
(1) INTERIM APPOINTMENT OF DIRECTOR.— On or after the effective date of the Patent
152 Issue of patent to assignee.  
and Trademark Office Efficiency Act, the President
153 How issued.  
shall appoint an individual to serve as the Director
154 Contents and term of patent; provisional rights.  
until the date on which a Director qualifies under subsection (a). The President shall not make more than
155 Patent term extension.  
one such appointment under this subsection.  
155A Patent term restoration.
(2) CONTINUATION IN OFFICE OF CERTAIN OFFICERS.
156 Extension of patent term.
(A) The individual serving as the Assistant
157 Statutory invention registration.
Commissioner for Patents on the day before the effective date of the Patent and Trademark Office Efficiency Act may serve as the Commissioner for
Patents until the date on which a Commissioner for
Patents is appointed under subsection (b).  
(B) The individual serving as the Assistant
Commissioner for Trademarks on the day before the
effective date of the Patent and Trademark Office
Efficiency Act may serve as the Commissioner for




CHAPTER 15 — PLANT PATENTS
Trademarks until the date on which a Commissioner
for Trademarks is appointed under subsection (b).


161 Patents for plants.  
(Amended Sept. 6, 1958, Public Law 85-933, sec. 1,
162 Description, claim.
72 Stat. 1793; Sept. 23, 1959, Public Law 86-370, sec. 1(a),
163 Grant.
73 Stat. 650; Aug. 14, 1964, Public Law 88-426, sec.  
164 Assistance of the Department of Agriculture.
305(26), 78 Stat. 425; Jan. 2, 1975, Public Law 93-596, sec.  
 
1, 88 Stat. 1949; Jan. 2, 1975, Public Law 93-601, sec. 1,
 
88 Stat. 1956; Aug. 27, 1982, Public Law 97-247, sec. 4, 96
CHAPTER 16 — DESIGNS
Stat. 319; Oct. 25, 1982, Public Law 97-366, sec. 4, 96 Stat.
 
1760; Nov. 8, 1984, Public Law 98-622, sec. 405, 98 Stat.
171 Patents for designs.  
3392; Oct. 28, 1998, Public Law 105-304, sec. 401(a)(1),
172 Right of priority.  
112 Stat. 2887; Nov. 29, 1999, Public Law 106-113, sec.  
173 Term of design patent.  
1000(a)(9), 113 Stat. 1501A-575 (S. 1948 sec. 4713); subsections (a)(2)(B), (b)(2), and (c) amended Nov. 2, 2002,
Public Law 107-273, sec. 13206, 116 Stat. 1904.)


CHAPTER 17 — SECRECY OF CERTAIN
====35 U.S.C. 4 Restrictions on officers and employees as to interest in patents. ====
INVENTIONS AND FILING APPLICATIONS
IN FOREIGN COUNTRIES


Officers and employees of the Patent and Trademark Office shall be incapable, during the period of
their appointments and for one year thereafter, of
applying for a patent and of acquiring, directly or
indirectly, except by inheritance or bequest, any
patent or any right or interest in any patent, issued or
to be issued by the Office. In patents applied for thereafter they shall not be entitled to any priority date earlier than one year after the termination of their
appointment.


181 Secrecy of certain inventions and withholding of
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
patent.  
Stat. 1949.)


182 Abandonment of invention for unauthorized
====35 U.S.C. 5 Patent and Trademark Office Public Advisory Committees.====
disclosure.  


183 Right to compensation.  
(a) ESTABLISHMENT OF PUBLIC ADVISORY COMMITTEES.—
(1) APPOINTMENT.— The United States
Patent and Trademark Office shall have a Patent Public Advisory Committee and a Trademark Public
Advisory Committee, each of which shall have nine
voting members who shall be appointed by the Secretary of Commerce and serve at the pleasure of the
Secretary of Commerce. Members of each Public
Advisory Committee shall be appointed for a term of
3 years, except that of the members first appointed,
three shall be appointed for a term of 1 year, and three
shall be appointed for a term of 2 years. In making
appointments to each Committee, the Secretary of
Commerce shall consider the risk of loss of competitive advantage in international commerce or other
harm to United States companies as a result of such
appointments.  


184 Filing of application in foreign country.  
(2) CHAIR.— The Secretary shall designate
 
a chair of each Advisory Committee, whose term as
185 Patent barred for filing without license.  
chair shall be for 3 years.
 
(3) TIMING OF APPOINTMENTS.— Initial appointments to each Advisory Committee shall
186 Penalty.
be made within 3 months after the effective date of the
 
Patent and Trademark Office Efficiency Act. Vacancies shall be filled within 3 months after they occur.
187 Nonapplicability to certain persons.  
(b) BASIS FOR APPOINTMENTS.— Members of each Advisory Committee—
 
(1) shall be citizens of the United States who
188 Rules and regulations, delegation of power.  
shall be chosen so as to represent the interests of
 
diverse users of the United States Patent and Trademark Office with respect to patents, in the case of the
CHAPTER 18 PATENT RIGHTS
Patent Public Advisory Committee, and with respect
IN INVENTIONS MADE WITH
to trademarks, in the case of the Trademark Public
FEDERAL ASSISTANCE
Advisory Committee;
(2) shall include members who represent
small and large entity applicants located in the United
States in proportion to the number of applications
filed by such applicants, but in no case shall members
who represent small entity patent applicants, including small business concerns, independent inventors,
and nonprofit organizations, constitute less than 25
percent of the members of the Patent Public Advisory
Committee, and such members shall include at least
one independent inventor; and
(3) shall include individuals with substantial
background and achievement in finance, management, labor relations, science, technology, and office
automation. In addition to the voting members, each
Advisory Committee shall include a representative of
each labor organization recognized by the United
States Patent and Trademark Office. Such representatives shall be nonvoting members of the Advisory
Committee to which they are appointed.
(c) MEETINGS.— Each Advisory Committee
shall meet at the call of the chair to consider an
agenda set by the chair.
(d) DUTIES.Each Advisory Committee
shall—
(1) review the policies, goals, performance,
budget, and user fees of the United States Patent and
Trademark Office with respect to patents, in the case
of the Patent Public Advisory Committee, and with
respect to Trademarks, in the case of the Trademark
Public Advisory Committee, and advise the Director
on these matters;


(2) within 60 days after the end of each fiscal
year—
(A) prepare an annual report on the matters
referred to in paragraph (1);
(B) transmit the report to the Secretary of
Commerce, the President, and the Committees on the
Judiciary of the Senate and the House of Representatives; and
(C) publish the report in the Official
Gazette of the United States Patent and Trademark
Office.
(e) COMPENSATION.— Each member of
each Advisory Committee shall be compensated for
each day (including travel time) during which such
member is attending meetings or conferences of that
Advisory Committee or otherwise engaged in the
business of that Advisory Committee, at the rate
which is the daily equivalent of the annual rate of
basic pay in effect for level III of the Executive
Schedule under section 5314 of title 5. While away
from such member’s home or regular place of business such member shall be allowed travel expenses,
including per diem in lieu of subsistence, as authorized by section 5703 of title 5.
(f) ACCESS TO INFORMATION.— Members
of each Advisory Committee shall be provided access
to records and information in the United States Patent
and Trademark Office, except for personnel or other
privileged information and information concerning
patent applications required to be kept in confidence
by section 122.
(g) APPLICABILITY OF CERTAIN ETHICS
LAWS.— Members of each Advisory Committee
shall be special Government employees within the
meaning of section 202 of title 18.
(h) INAPPLICABILITY OF FEDERAL
ADVISORY COMMITTEE ACT.— The Federal
Advisory Committee Act (5 U.S.C. App.) shall not
apply to each Advisory Committee.
(i) OPEN MEETINGS.— The meetings of
each Advisory Committee shall be open to the public,
except that each Advisory Committee may by majority vote meet in executive session when considering
personnel, privileged, or other confidential information.
(j) INAPPLICABILITY OF PATENT PROHIBITION.— Section 4 shall not apply to voting members of the Advisory Committees.


200 Policy and objective.  
(Added Nov. 29, 1999, Public Law 106-113, sec.  
 
1000(a)(9), 113 Stat. 1501A-578 (S. 1948 sec. 4714); subsections (e) and (g) amended Nov. 2, 2002, Public Law
201 Definitions.  
107-273, sec. 13206, 116 Stat. 1904; subsection (i)
202 Disposition of rights.  
amended and subsection (j) added Nov. 2, 2002, Public
203 March-in rights.
Law 107-273, sec. 13203, 116 Stat. 1902.)
204 Preference for United States industry.  
205 Confidentiality.  
206 Uniform clauses and regulations.  
207 Domestic and foreign protection of federally owned
 
 
inventions.  
 
208 Regulations governing Federal licensing.  
 
209 Licensing federally owned inventions.  
 
210 Precedence of chapter.  
 
211 Relationship to antitrust laws.  
 
212 Disposition of rights in educational awards.  


PART III — PATENTS AND PROTECTION
====35 U.S.C. 6 Board of Patent Appeals and Interferences.====
OF PATENT RIGHTS


CHAPTER 25 AMENDMENT AND
(a) ESTABLISHMENT AND COMPOSITION.— There shall be in the United States Patent
CORRECTION OF PATENTS
and Trademark Office a Board of Patent Appeals and
Interferences. The Director, the Deputy Commissioner, the Commissioner for Patents, the Commissioner for Trademarks, and the administrative patent
judges shall constitute the Board. The administrative
patent judges shall be persons of competent legal
knowledge and scientific ability who are appointed by
the Director.
(b) DUTIES.The Board of Patent Appeals
and Interferences shall, on written appeal of an applicant, review adverse decisions of examiners upon
applications for patents and shall determine priority
and patentability of invention in interferences
declared under section 135(a). Each appeal and interference shall be heard by at least three members of the
Board, who shall be designated by the Director. Only
the Board of Patent Appeals and Interferences may
grant rehearings.




251 Reissue of defective patents.  
(Repealed by Public Law 106-113, sec. 1000(a)(9),
113 Stat. 1501A-580 (S. 1948 sec. 4715(a).)


252 Effect of reissue.  
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4717(2)).)


253 Disclaimer.  
(Subsection (a) amended Nov. 2, 2002, Public Law
107-273, sec. 13203, 116 Stat. 1902.)


254 Certificate of correction of Patent and Trademark
====35 U.S.C. 7 Library.====
Office mistake.  


255 Certificate of correction of applicant’s mistake.  
The Director shall maintain a library of scientific
and other works and periodicals, both foreign and
domestic, in the Patent and Trademark Office to aid
the officers in the discharge of their duties.  


256 Correction of named inventor.  
(Repealed Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4717(1)).)


CHAPTER 26 — OWNERSHIP AND
(Transferred from 35 U.S.C. 8 Nov. 29, 1999, Public
ASSIGNMENT
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S.


1948 sec. 4717(1)); amended Jan. 2, 1975, Public Law 93596, sec. 1, 88 Stat. 1949.)


261 Ownership; assignment.  
(Amended Nov. 29, 1999, Public Law 106-113, sec.
262 Joint owners.  
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
4732(a)(10)(A)).)


CHAPTER 27 — GOVERNMENT
====35 U.S.C. 8 Classification of patents.====
INTERESTS IN PATENTS


The Director may revise and maintain the classification by subject matter of United States letters
patent, and such other patents and printed publications
as may be necessary or practicable, for the purpose of
determining with readiness and accuracy the novelty
of inventions for which applications for patent are
filed.


266 [Repealed.]
(Transferred to 35 U.S.C. 7 Nov. 29, 1999, Public Law
267 Time for taking action in Government applications.  
106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948
sec. 4717(1)).)


(Transferred from 35 U.S.C. 9 Nov. 29, 1999, Public
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S.
1948 sec. 4717(1)).)


CHAPTER 28 — INFRINGEMENT OF PATENTS
(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


271 Infringement of patent.  
====35 U.S.C. 9 Certified copies of records.====
272 Temporary presence in the United States.
273 Defense to infringement based on earlier inventor.  


The Director may furnish certified copies of specifications and drawings of patents issued by the Patent
and Trademark Office, and of other records available
either to the public or to the person applying therefor.


(Transferred to 35 U.S.C. 8 Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948
sec. 4717(1)).)


CHAPTER 29 — REMEDIES FOR
(Transferred from 35 U.S.C. 10 Nov. 29, 1999, Public
INFRINGEMENT OF PATENT, AND
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S.
OTHER ACTIONS
1948 sec. 4717(1)); amended Jan. 2, 1975, Public Law 93596, sec. 1, 88 Stat. 1949.)


(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


281 Remedy for infringement of patent.  
====35 U.S.C. 10 Publications.====


282 Presumption of validity; defenses.  
(a) The Director may publish in printed, typewritten, or electronic form, the following:
 
(1) Patents and published applications for
283 Injunction.  
patents, including specifications and drawings,
 
together with copies of the same. The Patent and
284 Damages.  
Trademark Office may print the headings of the drawings for patents for the purpose of photolithography.
 
(2) Certificates of trademark registrations,
285 Attorney fees.  
including statements and drawings, together with copies of the same.
 
(3) The Official Gazette of the United States
286 Time limitation on damages.  
Patent and Trademark Office.  
(4) Annual indexes of patents and patentees,
and of trademarks and registrants.  
(5) Annual volumes of decisions in patent
and trademark cases.  
(6) Pamphlet copies of the patent laws and
rules of practice, laws and rules relating to trademarks, and circulars or other publications relating to
the business of the Office.  
(b) The Director may exchange any of the publications specified in items 3, 4, 5, and 6 of subsection
(a) of this section for publications desirable for the
use of the Patent and Trademark Office.  


287 Limitation on damages and other remedies; marking
and notice.


288 Action for infringement of a patent containing an
(Transferred to 35 U.S.C. 9 Nov. 29, 1999, Public Law
invalid claim.  
106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948
sec. 4717(1)).)


289 Additional remedy for infringement of design patent.  
(Transferred from 35 U.S.C. 11 Nov. 29, 1999, Public
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580
(S 1948 sec. 4717(1)); amended Jan. 2, 1975, Public Law
93-596, sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-589 (S. 1948
sec. 4804(b)).)


290 Notice of patent suits.  
(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-565, 582 (S. 1948 secs.
4507(1) and 4732(a)(10)(A)).)


291 Interfering patents.  
====35 U.S.C. 11 Exchange of copies of patents and applications with foreign countries.====


292 False marking.  
The Director may exchange copies of specifications
and drawings of United States patents and published
applications for patents for those of foreign countries.


293 Nonresident patentee; service and notice.  
The Director shall not enter into an agreement to
provide such copies of specifications and drawings of
United States patents and applications to a foreign
country, other than a NAFTA country or a WTO
member country, without the express authorization of
the Secretary of Commerce. For purposes of this section, the terms “NAFTA country” and “WTO member
country” have the meanings given those terms in section 104(b).  


294 Voluntary arbitration.  
(Transferred to 35 U.S.C. 10 Nov. 29, 1999, Public
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580
(S 1948 sec. 4717(1)).)


295 Presumptions: Product made by patented process.  
(Transferred from 35 U.S.C. 12 Nov. 29, 1999, Public
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580
(S 1948 sec. 4717(1)); amended Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-591 (S. 1948
sec. 4808).)


296 Liability of States, instrumentalities of States, and  
(Amended Nov. 29, 1999, Public Law 106-113, sec.
State officials for infringement of patents.  
1000(a)(9), 113 Stat. 1501A-565, 582 (S. 1948 secs.
4507(2)(A), 4507(2)(B), and 4732(a)(10)(A)).)


297 Improper and deceptive invention promotion.  
====35 U.S.C. 12 Copies of patents and applications for public libraries.====
 
CHAPTER 30 — PRIOR ART CITATIONS TO
OFFICE AND EX PARTE REEXAMINATION
OF PATENTS


The Director may supply copies of specifications
and drawings of patents and published applications
for patents in printed or electronic form to public
libraries in the United States which shall maintain
such copies for the use of the public, at the rate for
each year’s issue established for this purpose in section 41(d) of this title.


301 Citation of prior art.  
(Transferred to 35 U.S.C. 11 Nov. 29, 1999, Public
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S.
1948 sec. 4717(1)).)


302 Request for reexamination.  
(Transferred from 35 U.S.C. 13 Nov. 29, 1999, Public
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580
(S 1948 sec. 4717(1)); amended Aug. 27, 1982, Public Law
97-247, sec. 15, 96 Stat. 321; Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-589 (S. 1948
sec. 4804(c)).)


303 Determination of issue by Director.  
(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-565, 566, 582 (S. 1948 secs.
4507(3)(A), 4507(3)(B), 4507(4), and 4732(a)(10)(A)).)


304 Reexamination order by Director.  
====35 U.S.C. 13 Annual report to Congress.====


305 Conduct of reexamination proceedings.  
The Director shall report to the Congress, not later
than 180 days after the end of each fiscal year, the
moneys received and expended by the Office, the purposes for which the moneys were spent, the quality
and quantity of the work of the Office, the nature of
training provided to examiners, the evaluation of the
Commissioner of Patents and the Commissioner of
Trademarks by the Secretary of Commerce, the compensation of the Commissioners, and other information relating to the Office.  


306 Appeal.  
(Transferred to 35 U.S.C. 12 Nov. 29, 1999, Public
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580
(S 1948 sec. 4717(1)).)


307 Certificate of patentability, unpatentability, and claim
(Transferred from 35 U.S.C. 14 Nov. 29, 1999, Public
cancellation.  
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580
(S 1948 sec. 4717(1)).)


CHAPTER 31 — OPTIONAL INTER PARTES
(Amended Nov. 29, 1999, Public Law 106-113, sec.
REEXAMINATION PROCEDURES
1000(a)(9), 113 Stat. 1501A-565, 581 (S. 1948 secs.
4507(2), 4718).)


===CHAPTER 2 — PROCEEDINGS IN THE PATENT AND TRADEMARK OFFICE===


311 Request for inter partes reexamination.  
====35 U.S.C. 21 Filing date and day for taking action.====


312 Determination of issue by Director.  
(a) The Director may by rule prescribe that any
paper or fee required to be filed in the Patent and
Trademark Office will be considered filed in the
Office on the date on which it was deposited with the
United States Postal Service or would have been
deposited with the United States Postal Service but for
postal service interruptions or emergencies designated
by the Director.
(b) When the day, or the last day, for taking any
action or paying any fee in the United States Patent
and Trademark Office falls on Saturday, Sunday, or a
Federal holiday within the District of Columbia, the
action may be taken, or fee paid, on the next succeeding secular or business day.  


313 Inter partes reexamination order by Director.


314 Conduct of inter partes reexamination proceedings.  
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
88 Stat. 1949; Aug. 27, 1982, Public Law 97-247, sec. 12,
96 Stat. 321; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


315 Appeal.  
====35 U.S.C. 22 Printing of papers filed.====


316 Certificate of patentability, unpatentability, and claim
The Director may require papers filed in the Patent
cancellation.  
and Trademark Office to be printed, typewritten, or on
an electronic medium.  


317 Inter partes reexamination prohibited.  
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
318 Stay of litigation.  
Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582, 589 (S. 1948 secs.  
4732(a)(10)(A), 4804(a)).)


PART IV — PATENT
35 U.S.C. 23 Testimony in Patent and Trademark Office cases.
COOPERATION TREATY


The Director may establish rules for taking affidavits and depositions required in cases in the Patent
and Trademark Office. Any officer authorized by law
to take depositions to be used in the courts of the
United States, or of the State where he resides, may
take such affidavits and depositions.


CHAPTER 35 — DEFINITIONS
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


351 Definitions.  
====35 U.S.C. 24 Subpoenas, witnesses.====


CHAPTER 36 — INTERNATIONAL STAGE
The clerk of any United States court for the district
wherein testimony is to be taken for use in any contested case in the Patent and Trademark Office, shall,
upon the application of any party thereto, issue a subpoena for any witness residing or being within such
district, commanding him to appear and testify before
an officer in such district authorized to take depositions and affidavits, at the time and place stated in the
subpoena. The provisions of the Federal Rules of
Civil Procedure relating to the attendance of witnesses and to the production of documents and things
shall apply to contested cases in the Patent and Trademark Office.


361 Receiving Office.  
Every witness subpoenaed and in attendance shall
be allowed the fees and traveling expenses allowed to
witnesses attending the United States district courts.  


362 International Searching Authority and International
A judge of a court whose clerk issued a subpoena
Preliminary Examining Authority.  
may enforce obedience to the process or punish disobedience as in other like cases, on proof that a witness, served with such subpoena, neglected or refused
to appear or to testify. No witness shall be deemed
guilty of contempt for disobeying such subpoena
unless his fees and traveling expenses in going to, and
returning from, and one day’s attendance at the place
of examination, are paid or tendered him at the time of
the service of the subpoena; nor for refusing to disclose any secret matter except upon appropriate order
of the court which issued the subpoena.  


363 International application designating the United
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
States: Effect.  
88 Stat. 1949.)


364 International stage: Procedure.  
====35 U.S.C. 25 Declaration in lieu of oath.====


365 Right of priority; benefit of the filing date of a prior
(a) The Director may by rule prescribe that any
application.  
document to be filed in the Patent and Trademark
Office and which is required by any law, rule, or other
regulation to be under oath may be subscribed to by a
written declaration in such form as the Director may
prescribe, such declaration to be in lieu of the oath
otherwise required.  


366 Withdrawn international application.


367 Actions of other authorities: Review.  
(b) Whenever such written declaration is used,
the document must warn the declarant that willful
false statements and the like are punishable by fine or
imprisonment, or both (18 U.S.C. 1001).  


368 Secrecy of certain inventions; filing international
(Added Mar. 26, 1964, Public Law 88-292, sec. 1,
applications in foreign countries.  
78 Stat. 171; amended Jan. 2, 1975, Public Law 93-596,
sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


CHAPTER 37 — NATIONAL STAGE
====35 U.S.C. 26 Effect of defective execution.====


371 National stage: Commencement.
Any document to be filed in the Patent and Trademark Office and which is required by any law, rule, or
372 National stage: Requirements and procedure.
other regulation to be executed in a specified manner
373 Improper applicant.
may be provisionally accepted by the Director despite
374 Publication of international application.
a defective execution, provided a properly executed
375 Patent issued on international application: Effect.
document is submitted within such time as may be
376 Fees.
prescribed.  


(Added Mar. 26, 1964, Public Law 88-292, sec. 1,
78 Stat. 171; amended Jan. 2, 1975, Public Law 93-596,
sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


PART I UNITED STATES PATENT  
===CHAPTER 3 PRACTICE BEFORE PATENT===
AND TRADEMARK OFFICE


====35 U.S.C. 31 [Repealed].====


CHAPTER 1 — ESTABLISHMENT,  
(Repealed Nov. 29, 1999, Public Law 106-113, sec.
OFFICERS AND EMPLOYEES, FUNCTIONS
1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4715(b)).)


====35 U.S.C. 32 Suspension or exclusion from practice.====


Sec.  
The Director may, after notice and opportunity for a
hearing, suspend or exclude, either generally or in any
particular case, from further practice before the Patent
and Trademark Office, any person, agent, or attorney
shown to be incompetent or disreputable, or guilty of
gross misconduct, or who does not comply with the
regulations established under section 2(b)(2)(D) of
this title, or who shall, by word, circular, letter, or
advertising, with intent to defraud in any manner,
deceive, mislead, or threaten any applicant or prospective applicant, or other person having immediate
or prospective business before the Office. The reasons
for any such suspension or exclusion shall be duly
recorded. The Director shall have the discretion to
designate any attorney who is an officer or employee
of the United States Patent and Trademark Office to
conduct the hearing required by this section. The
United States District Court for the District of Columbia, under such conditions and upon such proceedings
as it by its rules determines, may review the action of
the Director upon the petition of the person so refused
recognition or so suspended or excluded.  


1 Establishment.  
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
 
88 Stat.1949; Nov. 29, 1999, Public Law 106-113, sec.  
2 Powers and duties.  
1000(a)(9), 113 Stat. 1501A-580, 581, 582 (S. 1948 secs.
4715(c), 4719, 4732(a)(10)(A)).)


3 Officers and employees.  
====35 U.S.C. 33 Unauthorized representation as practitioner.====


4 Restrictions on officers and employees as to  
Whoever, not being recognized to practice before
interest in patents.  
the Patent and Trademark Office, holds himself out or
permits himself to be held out as so recognized, or as
being qualified to prepare or prosecute applications
for patent, shall be fined not more than $1,000 for
each offense.  


5 Patent and Trademark Office Public Advisory
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
Committees.  
88 Stat. 1949.)


===CHAPTER 4 — PATENT FEES; FUNDING; SEARCH SYSTEMS===


6 Board of Patent and Appeals and Interferences.
====35 U.S.C. 41 Patent fees; patent and trademark search systems.====
7 Library.
8 Classification of patents.
9 Certified copies of records.
10 Publications.
11 Exchange of copies of patents and applications


*Editor’s Note: During fiscal years 2005 and
2006, subsections (a) and (b) of section 41 of title
35, United States Code, shall be administered as
though subsections (a) and (b) read as follows:


with foreign countries.  
(a) GENERAL FEES. — The Director shall
charge the following fees:
(1) FILING AND BASIC NATIONAL
FEES. —
(A) On filing each application for an original patent, except for design, plant, or provisional
applications, $300.
(B) On filing each application for an original design patent, $200.
(C) On filing each application for an original plant patent, $200.
(D) On filing each provisional application
for an original patent, $200.
(E) On filing each application for the reissue of a patent, $300.
(F) The basic national fee for each international application filed under the treaty defined in section 351(a) of this title entering the national stage
under section 371 of this title, $300.
(G) In addition, excluding any sequence
listing or computer program listing filed in electronic
medium as prescribed by the Director, for any application the specification and drawings of which exceed
100 sheets of paper (or equivalent as prescribed by the
Director if filed in an electronic medium), $250 for
each additional 50 sheets of paper (or equivalent as
prescribed by the Director if filed in an electronic
medium) or fraction thereof.
(2) EXCESS CLAIMS FEES. — In addition
to the fee specified in paragraph (1) —
(A) on filing or on presentation at any other
time, $200 for each claim in independent form in
excess of 3;
(B) on filing or on presentation at any other
time, $50 for each claim (whether dependent or independent) in excess of 20; and
(C) for each application containing a multiple dependent claim, $360.  


12 Copies of patents and applications for public
libraries.


13 Annual report to Congress.  
For the purpose of computing fees under this
paragraph, a multiple dependent claim referred to in
section 112 of this title or any claim depending therefrom shall be considered as separate dependent claims
in accordance with the number of claims to which reference is made. The Director may by regulation provide for a refund of any part of the fee specified in this
paragraph for any claim that is canceled before an
examination on the merits, as prescribed by the Director, has been made of the application under section
131 of this title. Errors in payment of the additional
fees under this paragraph may be rectified in accordance with regulations prescribed by the Director.  


35 U.S.C. 1 Establishment.  
(3) EXAMINATION FEES.


(a) ESTABLISHMENT.— The United States
(A) For examination of each application
Patent and Trademark Office is established as an  
for an original patent, except for design, plant, provisional, or international applications, $200.  
agency of the United States, within the Department of
(B) For examination of each application
Commerce. In carrying out its functions, the United
for an original design patent, $130.  
States Patent and Trademark Office shall be subject to
the policy direction of the Secretary of Commerce,  
but otherwise shall retain responsibility for decisions
regarding the management and administration of its
operations and shall exercise independent control of
its budget allocations and expenditures, personnel
decisions and processes, procurements, and other
administrative and management functions in accordance with this title and applicable provisions of law.
Those operations designed to grant and issue patents
and those operations which are designed to facilitate
the registration of trademarks shall be treated as separate operating units within the Office.  
(b) OFFICES.— The United States Patent and
Trademark Office shall maintain its principal office in
the metropolitan Washington, D.C., area, for the service of process and papers and for the purpose of carrying out its functions. The United States Patent and
Trademark Office shall be deemed, for purposes of
venue in civil actions, to be a resident of the district in
which its principal office is located, except where
jurisdiction is otherwise provided by law. The United
States Patent and Trademark Office may establish satellite offices in such other places in the United States
as it considers necessary and appropriate in the conduct of its business.
(c) REFERENCE.— For purposes of this title,
the United States Patent and Trademark Office shall
also be referred to as the “Office” and the “Patent and
Trademark Office”.  




(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
(C) For examination of each application
Stat. 1949; amended Nov. 29, 1999, Public Law 106-113,
for an original plant patent, $160.  
sec. 1000(a)(9), 113 Stat. 1501A-572 (S. 1948 sec. 4711).)
(D) For examination of the national stage
of each international application, $200.  
(E) For examination of each application
for the reissue of a patent, $600.


35 U.S.C. 2 Powers and duties.


(a) IN GENERAL.— The United States Patent
The provisions of section 111(a) of this title
and Trademark Office, subject to the policy direction
relating to the payment of the fee for filing the application shall apply to the payment of the fee specified
of the Secretary of Commerce—
in this paragraph with respect to an application filed
(1) shall be responsible for the granting and
under section 111(a) of this title. The provisions of
issuing of patents and the registration of trademarks;
section 371(d) of this title relating to the payment of  
and
the national fee shall apply to the payment of the fee
(2) shall be responsible for disseminating to  
specified in this paragraph with respect to an international application.  
the public information with respect to patents and
trademarks.  
(b) SPECIFIC POWERS.— The Office—


(4) ISSUE FEES. —


(1) shall adopt and use a seal of the Office,  
(A) For issuing each original patent, except
which shall be judicially noticed and with which letters patent, certificates of trademark registrations, and
for design or plant patents, $1,400.
papers issued by the Office shall be authenticated;
(B) For issuing each original design patent,  
(2) may establish regulations, not inconsistent with law, which—
$800.
(A) shall govern the conduct of proceedings in the Office;
(C) For issuing each original plant patent,  
(B) shall be made in accordance with section 553 of title 5;
$1,100.
(C) shall facilitate and expedite the processing of patent applications, particularly those
(D) For issuing each reissue patent, $1,400.
which can be filed, stored, processed, searched, and
retrieved electronically, subject to the provisions of
section 122 relating to the confidential status of applications;
(D) may govern the recognition and conduct of agents, attorneys, or other persons representing applicants or other parties before the Office, and
may require them, before being recognized as representatives of applicants or other persons, to show that
they are of good moral character and reputation and
are possessed of the necessary qualifications to render
to applicants or other persons valuable service,
advice, and assistance in the presentation or prosecution of their applications or other business before the
Office;
(E) shall recognize the public interest in
continuing to safeguard broad access to the United
States patent system through the reduced fee structure
for small entities under section 41(h)(1) of this title;
and




(5) DISCLAIMER FEE. — On filing each
disclaimer, $130.
(6) APPEAL FEES. —


(F) provide for the development of a performance-based process that includes quantitative and
qualitative measures and standards for evaluating
cost-effectiveness and is consistent with the principles
of impartiality and competitiveness;
(3) may acquire, construct, purchase, lease,
hold, manage, operate, improve, alter, and renovate
any real, personal, or mixed property, or any interest
therein, as it considers necessary to carry out its functions;
(4)(A) may make such purchases, contracts
for the construction, or management and operation of
facilities, and contracts for supplies or services, without regard to the provisions of subtitle I and chapter
33 of title 40, title III of the Federal Property and
Administrative Services Act of 1949 (41 U.S.C. 251
et seq.), and the McKinney-Vento Homeless Assistance Act (42 U.S.C. 11301 et seq.);


(A) On filing an appeal from the examiner
to the Board of Patent Appeals and Interferences,
$500.
(B) In addition, on filing a brief in support
of the appeal, $500, and on requesting an oral hearing
in the appeal before the Board of Patent Appeals and
Interferences, $1,000.
(7) REVIVAL FEES. — On filing each petition for the revival of an unintentionally abandoned
application for a patent, for the unintentionally
delayed payment of the fee for issuing each patent, or
for an unintentionally delayed response by the patent
owner in any reexamination proceeding, $1,500,
unless the petition is filed under section 133 or 151 of
this title, in which case the fee shall be $500.
(8) EXTENSION FEES. — For petitions for
1-month extensions of time to take actions required
by the Director in an application —
(A) on filing a first petition, $120;
(B) on filing a second petition, $330; and
(C) on filing a third or subsequent petition,
$570.
(b) MAINTENANCE FEES. — The Director
shall charge the following fees for maintaining in
force all patents based on applications filed on or after
December 12, 1980:
(1) 3 years and 6 months after grant, $900.
(2) 7 years and 6 months after grant, $2,300.
(3) 11 years and 6 months after grant, $3,800.
Unless payment of the applicable maintenance fee is
received in the United States Patent and Trademark
Office on or before the date the fee is due or within a
grace period of 6 months thereafter, the patent will
expire as of the end of such grace period. The Director
may require the payment of a surcharge as a condition
of accepting within such 6-month grace period the
payment of an applicable maintenance fee. No fee
may be established for maintaining a design or plant
patent in force.
(Dec. 8, 2004, Public Law 108-447, sec. 801, 118
Stat. 2809.)


(B) may enter into and perform such purchases and contracts for printing services, including
The bracketed text below is the unamended text
the process of composition, platemaking, presswork,
of 35 U.S.C. 41(a) and (b), which may continue to  
silk screen processes, binding, microform, and the
have effect following fiscal year 2006:
products of such processes, as it considers necessary
to carry out the functions of the Office, without regard
to sections 501 through 517 and 1101 through 1123 of  
title 44;
(5) may use, with their consent, services,
equipment, personnel, and facilities of other departments, agencies, and instrumentalities of the Federal
Government, on a reimbursable basis, and cooperate
with such other departments, agencies, and instrumentalities in the establishment and use of services, equipment, and facilities of the Office;
(6) may, when the Director determines that it
is practicable, efficient, and cost-effective to do so,
use, with the consent of the United States and the
agency, instrumentality, Patent and Trademark Office,
or international organization concerned, the services,
records, facilities, or personnel of any State or local
government agency or instrumentality or foreign
patent and trademark office or international organization to perform functions on its behalf;
(7) may retain and use all of its revenues and
receipts, including revenues from the sale, lease, or
disposal of any real, personal, or mixed property, or
any interest therein, of the Office;
 
 
(8) shall advise the President, through the
Secretary of Commerce, on national and certain international intellectual property policy issues;
(9) shall advise Federal departments and
agencies on matters of intellectual property policy in
the United States and intellectual property protection
in other countries;
(10) shall provide guidance, as appropriate,
with respect to proposals by agencies to assist foreign
governments and international intergovernmental
organizations on matters of intellectual property protection;
(11) may conduct programs, studies, or
exchanges of items or services regarding domestic
and international intellectual property law and the
effectiveness of intellectual property protection
domestically and throughout the world;
(12)(A) shall advise the Secretary of Commerce on programs and studies relating to intellectual
property policy that are conducted, or authorized to be
conducted, cooperatively with foreign intellectual
property offices and international intergovernmental
organizations; and
 


(B) may conduct programs and studies
[(a) The Director shall charge the following
described in subparagraph (A); and
fees:
(13)(A) in coordination with the Department of
(1)(A) On filing each application for an original patent, except in design or plant cases, $690.
State, may conduct programs and studies cooperatively with foreign intellectual property offices and
international intergovernmental organizations; and


(B) In addition, on filing or on presentation
at any other time, $78 for each claim in independent
form which is in excess of 3, $18 for each claim
(whether independent or dependent) which is in
excess of 20, and $260 for each application containing
a multiple dependent claim.


(B) with the concurrence of the Secretary
(C) On filing each provisional application
of State, may authorize the transfer of not to exceed
for an original patent, $150.  
$100,000 in any year to the Department of State for
the purpose of making special payments to international intergovernmental organizations for studies and
programs for advancing international cooperation
concerning patents, trademarks, and other matters.
(c) CLARIFICATION OF SPECIFIC POWERS.—
(1) The special payments under subsection
(b)(13)(B) shall be in addition to any other payments
or contributions to international organizations
described in subsection (b)(13)(B) and shall not be
subject to any limitations imposed by law on the
amounts of such other payments or contributions by
the United States Government.  


(2) For issuing each original or reissue
patent, except in design or plant cases, $1,210.


(3) In design and plant cases


(2) Nothing in subsection (b) shall derogate
(A) on filing each design application, $310;
from the duties of the Secretary of State or from the
duties of the United States Trade Representative as set
forth in section 141 of the Trade Act of 1974 (19


U.S.C. 2171).
(B) on filing each plant application, $480;


(3) Nothing in subsection (b) shall derogate
(C) on issuing each design patent, $430;
from the duties and functions of the Register of Copyrights or otherwise alter current authorities relating to
and  
copyright matters.
(4) In exercising the Director’s powers under
paragraphs (3) and (4)(A) of subsection (b), the Director shall consult with the Administrator of General
Services.
(5) In exercising the Director’s powers and
duties under this section, the Director shall consult
with the Register of Copyrights on all copyright and
related matters.
(d) CONSTRUCTION.— Nothing in this section shall be construed to nullify, void, cancel, or
interrupt any pending request-for-proposal let or contract issued by the General Services Administration
for the specific purpose of relocating or leasing space
to the United States Patent and Trademark Office.




(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
(D) on issuing each plant patent, $580.  
Stat. 1949; amended Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-572 (S. 1948 sec. 4712);
subsection (b)(4)(A) amended Oct. 30, 2000, Public Law
106-400, sec. 2, 114 Stat. 1675; subsections (b)(2)(B) and
(b)(4)(B) amended Nov. 2, 2002, Public Law 107-273, sec.
13206, 116 Stat. 1904; subsection (b)(4)(A) amended Dec.
15, 2003, Public Law 108-178, sec. 4(g), 117 Stat. 2641.)


35 U.S.C. 3 Officers and employees.  
(4)(A)On filing each application for the reissue
of a patent, $690.  


(a) UNDER SECRETARY AND DIRECTOR.—
(B) In addition, on filing or on presentation
(1) IN GENERAL.— The powers and duties
at any other time, $78 for each claim in independent
of the United States Patent and Trademark Office
form which is in excess of the number of independent
shall be vested in an Under Secretary of Commerce
claims of the original patent, and $18 for each claim
for Intellectual Property and Director of the United
(whether independent or dependent) which is in
States Patent and Trademark Office (in this title
excess of 20 and also in excess of the number of  
referred to as the “Director”), who shall be a citizen of  
claims of the original patent.
the United States and who shall be appointed by the  
 
President, by and with the advice and consent of the  
(5) On filing each disclaimer, $110.
Senate. The Director shall be a person who has a professional background and experience in patent or  
(6)(A) On filing an appeal from the examiner
trademark law.
 
(2) DUTIES.
to the Board of Patent Appeals and Interferences,
$300.
 
(B) In addition, on filing a brief in support
of the appeal, $300, and on requesting an oral hearing
in the appeal before the Board of Patent Appeals and  
Interferences, $260.
(7) On filing each petition for the revival of
an unintentionally abandoned application for a patent,  
for the unintentionally delayed payment of the fee for
issuing each patent, or for an unintentionally delayed
response by the patent owner in any reexamination
proceeding, $1,210, unless the petition is filed under
section 133 or 151 of this title, in which case the fee
shall be $110.  


(8) For petitions for 1-month extensions of
time to take actions required by the Director in an
application


(A) IN GENERAL.— The Director shall
(A) on filing a first petition, $110;
be responsible for providing policy direction and


(B) on filing a second petition, $270; and


management supervision for the Office and for the
(C) on filing a third or subsequent petition,  
issuance of patents and the registration of trademarks.
$490.  
The Director shall perform these duties in a fair,  
impartial, and equitable manner.  


(B) CONSULTING WITH THE PUBLIC
(9) Basic national fee for an international
ADVISORY COMMITTEES.— The Director shall
application where the Patent and Trademark Office  
consult with the Patent Public Advisory Committee
was the International Preliminary Examining Authority and the International Searching Authority, $670.  
established in section 5 on a regular basis on matters
(10) Basic national fee for an international
relating to the patent operations of the Office, shall
application where the Patent and Trademark Office  
consult with the Trademark Public Advisory Committee established in section 5 on a regular basis on matters relating to the trademark operations of the Office,
was the International Searching Authority but not the  
and shall consult with the respective Public Advisory
International Preliminary Examining Authority, $690.  
Committee before submitting budgetary proposals to
(11) Basic national fee for an international
the Office of Management and Budget or changing or
application where the Patent and Trademark Office  
proposing to change patent or trademark user fees or
was neither the International Searching Authority nor
patent or trademark regulations which are subject to
the International Preliminary Examining Authority,
the requirement to provide notice and opportunity for
$970.  
public comment under section 553 of title 5, as the
case may be.  
(3) OATH.— The Director shall, before taking office, take an oath to discharge faithfully the
duties of the Office.
(4) REMOVAL.— The Director may be
removed from office by the President. The President
shall provide notification of any such removal to both
Houses of Congress.  
(b) OFFICERS AND EMPLOYEES OF THE
OFFICE.—
(1) DEPUTY UNDER SECRETARY AND
DEPUTY DIRECTOR.— The Secretary of Commerce, upon nomination by the Director, shall appoint
a Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the United States
Patent and Trademark Office who shall be vested with
the authority to act in the capacity of the Director in
the event of the absence or incapacity of the Director.
The Deputy Director shall be a citizen of the United
States who has a professional background and experience in patent or trademark law.
(2) COMMISSIONERS.


(12) Basic national fee for an international
application where the international preliminary examination has been paid to the Patent and Trademark
Office, and the international preliminary examination
report states that the provisions of Article 33 (2), (3),
and (4) of the Patent Cooperation Treaty have been
satisfied for all claims in the application entering the
national stage, $96.


(A) APPOINTMENT AND DUTIES.
(13) For filing or later presentation of each
The Secretary of Commerce shall appoint a Commissioner for Patents and a Commissioner for Trademarks, without regard to chapter 33, 51, or 53 of title  
independent claim in the national stage of an international application in excess of 3, $78.  
 
(14) For filing or later presentation of each
 
claim (whether independent or dependent) in a  
5. The Commissioner for Patents shall be a citizen of  
national stage of an international application in excess
the United States with demonstrated management
of 20, $18.
ability and professional background and experience in
(15) For each national stage of an international
application containing a multiple dependent claim,  
$260.
For the purpose of computing fees, a multiple
dependent claim as referred to in section 112 of this
title or any claim depending therefrom shall be considered as separate dependent claims in accordance
with the number of claims to which reference is made.
Errors in payment of the additional fees may be rectified in accordance with regulations of the Director.


(b) The Director shall charge the following fees
for maintaining in force all patents based on applications filed on or after December 12, 1980:


patent law and serve for a term of 5 years. The Commissioner for Trademarks shall be a citizen of the
(1) 3 years and 6 months after grant, $830.  
United States with demonstrated management ability
and professional background and experience in trademark law and serve for a term of 5 years. The Commissioner for Patents and the Commissioner for
Trademarks shall serve as the chief operating officers
for the operations of the Office relating to patents and
trademarks, respectively, and shall be responsible for
the management and direction of all aspects of the
activities of the Office that affect the administration of
patent and trademark operations, respectively. The
Secretary may reappoint a Commissioner to subsequent terms of 5 years as long as the performance of
the Commissioner as set forth in the performance
agreement in subparagraph (B) is satisfactory.  


(B) SALARY AND PERFORMANCE
(2) 7 years and 6 months after grant, $1,900.  
AGREEMENT.— The Commissioners shall be paid
an annual rate of basic pay not to exceed the maximum rate of basic pay for the Senior Executive Service established under section 5382 of title 5,
including any applicable locality-based comparability
payment that may be authorized under section
5304(h)(2)(C) of title 5. The compensation of the
Commissioners shall be considered, for purposes of
section 207(c)(2)(A) of title 18, to be the equivalent of
that described under clause (ii) of section
207(c)(2)(A) of title 18. In addition, the Commissioners may receive a bonus in an amount of up to, but not
in excess of, 50 percent of the Commissioners’ annual
rate of basic pay, based upon an evaluation by the
Secretary of Commerce, acting through the Director,
of the Commissioners’ performance as defined in an
annual performance agreement between the Commissioners and the Secretary. The annual performance
agreements shall incorporate measurable organization
and individual goals in key operational areas as delineated in an annual performance plan agreed to by the
Commissioners and the Secretary. Payment of a bonus
under this subparagraph may be made to the Commissioners only to the extent that such payment does not
cause the Commissioners’ total aggregate compensation in a calendar year to equal or exceed the amount
of the salary of the Vice President under section 104
of title 3.
(C) REMOVAL.— The Commissioners
may be removed from office by the Secretary for misconduct or nonsatisfactory performance under the per


(3) 11 years and 6 months after grant, $2,910.


formance agreement described in subparagraph (B),
Unless payment of the applicable maintenance fee is received in the Patent and Trademark
without regard to the provisions of title 5. The Secretary shall provide notification of any such removal to
Office on or before the date the fee is due or within a
both Houses of Congress.
grace period of six months thereafter, the patent will
 
expire as of the end of such grace period. The Director
(3) OTHER OFFICERS AND EMPLOYEES.— The Director shall—
may require the payment of a surcharge as a condition
(A) appoint such officers, employees
of accepting within such 6-month grace period the  
(including attorneys), and agents of the Office as the  
payment of an applicable maintenance fee. No fee
Director considers necessary to carry out the functions
may be established for maintaining a design or plant
of the Office; and
patent in force.]
(B) define the title, authority, and duties of  
such officers and employees and delegate to them
such of the powers vested in the Office as the Director
may determine.  
The Office shall not be subject to any
administratively or statutorily imposed limitation on
positions or personnel, and no positions or personnel
of the Office shall be taken into account for purposes
of applying any such limitation


(c)(1) The Director may accept the payment of
any maintenance fee required by subsection (b) of this
section which is made within twenty-four months
after the six-month grace period if the delay is shown
to the satisfaction of the Director to have been unintentional, or at any time after the six-month grace
period if the delay is shown to the satisfaction of the
Director to have been unavoidable. The Director may
require the payment of a surcharge as a condition of
accepting payment of any maintenance fee after the
six-month grace period. If the Director accepts payment of a maintenance fee after the six-month grace
period, the patent shall be considered as not having
expired at the end of the grace period.


(4) TRAINING OF EXAMINERS.— The
(2) A patent, the term of which has been
Office shall submit to the Congress a proposal to provide an incentive program to retain as employees
maintained as a result of the acceptance of a payment
patent and trademark examiners of the primary examiner grade or higher who are eligible for retirement,  
of a maintenance fee under this subsection, shall not
for the sole purpose of training patent and trademark
abridge or affect the right of any person or that person’s successors in business who made, purchased,
examiners.
offered to sell, or used anything protected by the
(5) NATIONAL SECURITY POSITIONS.— The Director, in consultation with the  
patent within the United States, or imported anything
Director of the Office of Personnel Management,  
protected by the patent into the United States after the
shall maintain a program for identifying national
6-month grace period but prior to the acceptance of a
security positions and providing for appropriate security clearances, in order to maintain the secrecy of certain inventions, as described in section 181, and to
maintenance fee under this subsection, to continue the  
prevent disclosure of sensitive and strategic information in the interest of national security.
use of, to offer for sale, or to sell to others to be used,  
(c) CONTINUED APPLICABILITY OF
offered for sale, or sold, the specific thing so made,
TITLE 5. — Officers and employees of the Office
purchased, offered for sale, used, or imported. The
shall be subject to the provisions of title 5, relating to
court before which such matter is in question may
Federal employees.
provide for the continued manufacture, use, offer for
(d) ADOPTION OF EXISTING LABOR
sale, or sale of the thing made, purchased, offered for
AGREEMENTS.— The Office shall adopt all labor
sale, or used within the United States, or imported into
agreements which are in effect, as of the day before  
the United States, as specified, or for the manufacture,  
the effective date of the Patent and Trademark Office
use, offer for sale, or sale in the United States of  
Efficiency Act, with respect to such Office (as then in
which substantial preparation was made after the 6month grace period but before the acceptance of a
effect).
maintenance fee under this subsection, and the court
(e) CARRYOVER OF PERSONNEL.
may also provide for the continued practice of any
process that is practiced, or for the practice of which
substantial preparation was made, after the 6-month
grace period but before the acceptance of a maintenance fee under this subsection, to the extent and  
under such terms as the court deems equitable for the
protection of investments made or business commenced after the 6-month grace period but before the
acceptance of a maintenance fee under this subsection.  


*Editor’s Note: During fiscal years 2005 and
2006, subsection (d) of section 41 of title 35, United
States Code, shall be administered as though subsection (d) reads as follows:


(1) FROM PTO.— Effective as of the effective date of the Patent and Trademark Office Effi-
(d) PATENT SEARCH AND OTHER FEES. —  


(1) PATENT SEARCH FEES. —


(A) The Director shall charge a fee for the
search of each application for a patent, except for provisional applications. The Director shall establish the
fees charged under this paragraph to recover an
amount not to exceed the estimated average cost to
the Office of searching applications for patent either
by acquiring a search report from a qualified search
authority, or by causing a search by Office personnel
to be made, of each application for patent. For the 3year period beginning on the date of enactment of this


ciency Act, all officers and employees of the Patent
Act, the fee for a search by a qualified search authority of a patent application described in clause (i), (iv),
and Trademark Office on the day before such effective date shall become officers and employees of the  
or (v) of subparagraph (B) may not exceed $500, of a
Office, without a break in service.  
patent application described in clause (ii) of subparagraph (B) may not exceed $100, and of a patent application described in clause (iii) of subparagraph (B)
may not exceed $300. The Director may not increase
any such fee by more than 20 percent in each of the  
next three 1-year periods, and the Director may not
increase any such fee thereafter.  


(2) OTHER PERSONNEL.— Any individual who, on the day before the effective date of the  
(B) For purposes of determining the fees to
Patent and Trademark Office Efficiency Act, is an
be established under this paragraph, the cost to the  
officer or employee of the Department of Commerce
Office of causing a search of an application to be
(other than an officer or employee under paragraph
made by Office personnel shall be deemed to be —
(1)) shall be transferred to the Office, as necessary to  
(i) $500 for each application for an
carry out the purposes of this Act, if—
original patent, except for design, plant, provisional,  
(A) such individual serves in a position for  
or international applications;  
which a major function is the performance of work
(ii) $100 for each application for an
reimbursed by the Patent and Trademark Office, as
original design patent;  
determined by the Secretary of Commerce;  
(B) such individual serves in a position that
performed work in support of the Patent and Trademark Office during at least half of the incumbent’s
work time, as determined by the Secretary of Commerce; or
(C) such transfer would be in the interest of
the Office, as determined by the Secretary of Commerce in consultation with the Director.


(iii) $300 for each application for an
original plant patent;


Any transfer under this paragraph shall be
(iv) $500 for the national stage of each
effective as of the same effective date as referred to in  
international application; and
paragraph (1), and shall be made without a break in  
(v) $500 for each application for the
service.
reissue of a patent.
(C) The provisions of section 111 (a)(3) of
this title relating to the payment of the fee for filing
the application shall apply to the payment of the fee
specified in this paragraph with respect to an application filed under section 111(a) of this title. The provisions of section 371(d) of this title relating to the
payment of the national fee shall apply to the payment
of the fee specified in this paragraph with respect to  
an international application.
(D) The Director may by regulation provide for a refund of any part of the fee specified in this
paragraph for any applicant who files a written declaration of express abandonment as prescribed by the
Director before an examination has been made of the
application under section 131 of this title, and for any
applicant who provides a search report that meets the
conditions prescribed by the Director.
(E) For purposes of subparagraph (A), a
“qualified search authority” may not include a commercial entity unless —
(i) the Director conducts a pilot program of limited scope, conducted over a period of not
more than 18 months, which demonstrates that
searches by commercial entities of the available prior
art relating to the subject matter of inventions claimed
in patent applications —


(f) TRANSITION PROVISIONS.—
(I) are accurate; and


(1) INTERIM APPOINTMENT OF DIRECTOR.— On or after the effective date of the Patent  
(II) meet or exceed the standards of  
and Trademark Office Efficiency Act, the President
searches conducted by and used by the Patent and
shall appoint an individual to serve as the Director  
Trademark Office during the patent examination process;
until the date on which a Director qualifies under subsection (a). The President shall not make more than
(ii) the Director submits a report on the
one such appointment under this subsection.
results of the pilot program to Congress and the Patent
(2) CONTINUATION IN OFFICE OF CERTAIN OFFICERS.—  
Public Advisory Committee that includes —  
(A) The individual serving as the Assistant
(I) a description of the scope and  
Commissioner for Patents on the day before the effective date of the Patent and Trademark Office Efficiency Act may serve as the Commissioner for
duration o f the pilot program;
Patents until the date on which a Commissioner for
(II) the identity of each commercial
Patents is appointed under subsection (b).
entity participating in the pilot program;
(B) The individual serving as the Assistant
Commissioner for Trademarks on the day before the  
effective date of the Patent and Trademark Office
Efficiency Act may serve as the Commissioner for


(III) an explanation of the methodology used to evaluate the accuracy and quality of the
search reports; and


Trademarks until the date on which a Commissioner
(IV) an assessment of the effects that
for Trademarks is appointed under subsection (b).
the pilot program, as compared to searches conducted
by the Patent and Trademark Office, had and will
have on


(Amended Sept. 6, 1958, Public Law 85-933, sec. 1,
(aa) patentability determinations;  
72 Stat. 1793; Sept. 23, 1959, Public Law 86-370, sec. 1(a),
(bb) productivity of the Patent and
73 Stat. 650; Aug. 14, 1964, Public Law 88-426, sec.
Trademark Office;  
305(26), 78 Stat. 425; Jan. 2, 1975, Public Law 93-596, sec.
1, 88 Stat. 1949; Jan. 2, 1975, Public Law 93-601, sec. 1,
88 Stat. 1956; Aug. 27, 1982, Public Law 97-247, sec. 4, 96
Stat. 319; Oct. 25, 1982, Public Law 97-366, sec. 4, 96 Stat.
1760; Nov. 8, 1984, Public Law 98-622, sec. 405, 98 Stat.
3392; Oct. 28, 1998, Public Law 105-304, sec. 401(a)(1),
112 Stat. 2887; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-575 (S. 1948 sec. 4713); subsections (a)(2)(B), (b)(2), and (c) amended Nov. 2, 2002,
Public Law 107-273, sec. 13206, 116 Stat. 1904.)


35 U.S.C. 4 Restrictions on officers and employees as to interest in patents.
(cc) costs to the Patent and Trade


Officers and employees of the Patent and Trademark Office shall be incapable, during the period of
mark Office;
their appointments and for one year thereafter, of
(dd) costs to patent applicants; and  
applying for a patent and of acquiring, directly or
(ee) other relevant factors;
indirectly, except by inheritance or bequest, any
patent or any right or interest in any patent, issued or
to be issued by the Office. In patents applied for thereafter they shall not be entitled to any priority date earlier than one year after the termination of their
appointment.


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
(iii) the Patent Public Advisory Committee reviews and analyzes the Director’s report under
Stat. 1949.)  
clause (ii) and the results of the pilot program and
submits a separate report on its analysis to the Director and the Congress that includes —


35 U.S.C. 5 Patent and Trademark Office Public Advisory Committees.  
(I) an independent evaluation of the
effects that the pilot program, as compared to searches
conducted by the Patent and Trademark Office, had
and will have on the factors set forth in clause
(ii)(IV); and
(II) an analysis of the reasonableness,
appropriateness, and effectiveness of the methods
used in the pilot program to make the evaluations
required under clause (ii)(IV); and
(iv) Congress does not, during the 1year period beginning on the date on which the Patent
Public Advisory Committee submits its report to the
Congress under clause (iii), enact a law prohibiting
searches by commercial entities of the available prior
art relating to the subject matter of inventions claimed
in patent applications.  


(a) ESTABLISHMENT OF PUBLIC ADVISORY COMMITTEES.—
(F) The Director shall require that any
(1) APPOINTMENT.— The United States
search by a qualified search authority that is a commercial entity is conducted in the United States by
Patent and Trademark Office shall have a Patent Public Advisory Committee and a Trademark Public
persons that —
Advisory Committee, each of which shall have nine
voting members who shall be appointed by the Secretary of Commerce and serve at the pleasure of the
Secretary of Commerce. Members of each Public
Advisory Committee shall be appointed for a term of
3 years, except that of the members first appointed,
three shall be appointed for a term of 1 year, and three
shall be appointed for a term of 2 years. In making
appointments to each Committee, the Secretary of
Commerce shall consider the risk of loss of competitive advantage in international commerce or other


(i) if individuals, are United States citizens; and


(ii) if business concerns, are organized
under the laws of the United States or any State and
employ United States citizens to perform the searches.


harm to United States companies as a result of such
(G) A search of an application that is the
appointments.  
subject of a secrecy order under section 181 or otherwise involves classified information may only be conducted by Office personnel.  


(2) CHAIR.— The Secretary shall designate
(H) A qualified search authority that is a
a chair of each Advisory Committee, whose term as
commercial entity may not conduct a search of a
chair shall be for 3 years.
patent application if the entity has any direct or indirect financial interest in any patent or in any pending
(3) TIMING OF APPOINTMENTS.— Initial appointments to each Advisory Committee shall
or imminent application for patent filed or to be filed
be made within 3 months after the effective date of the
in the Patent and Trademark Office.  
Patent and Trademark Office Efficiency Act. Vacancies shall be filled within 3 months after they occur.  
 
(b) BASIS FOR APPOINTMENTS.— Members of each Advisory Committee—
(2) OTHER FEES. — The Director shall  
(1) shall be citizens of the United States who
establish fees for all other processing, services, or
shall be chosen so as to represent the interests of
materials relating to patents not specified in this section to recover the estimated average cost to the  
diverse users of the United States Patent and Trademark Office with respect to patents, in the case of the
Office of such processing, services; or materials,  
Patent Public Advisory Committee, and with respect
except that the Director shall charge the following
to trademarks, in the case of the Trademark Public
fees for the following services:
Advisory Committee;
(2) shall include members who represent
small and large entity applicants located in the United
States in proportion to the number of applications
filed by such applicants, but in no case shall members
who represent small entity patent applicants, including small business concerns, independent inventors,
and nonprofit organizations, constitute less than 25
percent of the members of the Patent Public Advisory
Committee, and such members shall include at least
one independent inventor; and
(3) shall include individuals with substantial
background and achievement in finance, management, labor relations, science, technology, and office
automation. In addition to the voting members, each
Advisory Committee shall include a representative of
each labor organization recognized by the United
States Patent and Trademark Office. Such representatives shall be nonvoting members of the Advisory
Committee to which they are appointed.
(c) MEETINGS.— Each Advisory Committee
shall meet at the call of the chair to consider an
agenda set by the chair.
(d) DUTIES.— Each Advisory Committee
shall—
(1) review the policies, goals, performance,
budget, and user fees of the United States Patent and
Trademark Office with respect to patents, in the case
of the Patent Public Advisory Committee, and with
respect to Trademarks, in the case of the Trademark


(A) For recording a document affecting
title, $40 per property.


Public Advisory Committee, and advise the Director
(B) For each photocopy, $.25 per page.
on these matters;


(2) within 60 days after the end of each fiscal
(C) For each black and white copy of a
year—
patent, $3. The yearly fee for providing a library specified in section 12 of this title with uncertified printed
(A) prepare an annual report on the matters
copies of the specifications and drawings for all patents in that year shall be $50.  
referred to in paragraph (1);
(B) transmit the report to the Secretary of  
Commerce, the President, and the Committees on the
Judiciary of the Senate and the House of Representatives; and
(C) publish the report in the Official
Gazette of the United States Patent and Trademark
Office.  
(e) COMPENSATION.— Each member of
each Advisory Committee shall be compensated for
each day (including travel time) during which such
member is attending meetings or conferences of that
Advisory Committee or otherwise engaged in the
business of that Advisory Committee, at the rate
which is the daily equivalent of the annual rate of
basic pay in effect for level III of the Executive
Schedule under section 5314 of title 5. While away
from such member’s home or regular place of business such member shall be allowed travel expenses,
including per diem in lieu of subsistence, as authorized by section 5703 of title 5.
(f) ACCESS TO INFORMATION.— Members
of each Advisory Committee shall be provided access
to records and information in the United States Patent
and Trademark Office, except for personnel or other
privileged information and information concerning
patent applications required to be kept in confidence
by section 122.
(g) APPLICABILITY OF CERTAIN ETHICS
LAWS.— Members of each Advisory Committee
shall be special Government employees within the
meaning of section 202 of title 18.
(h) INAPPLICABILITY OF FEDERAL
ADVISORY COMMITTEE ACT.— The Federal
Advisory Committee Act (5 U.S.C. App.) shall not
apply to each Advisory Committee.
(i) OPEN MEETINGS.— The meetings of
each Advisory Committee shall be open to the public,
except that each Advisory Committee may by majority vote meet in executive session when considering
personnel, privileged, or other confidential information.  


(Dec. 8, 2004, Public Law 108-447, sec. 801, 118
Stat. 2809.)


The bracketed text below is the unamended text
of 35 U.S.C. 41(d), which may continue to have
effect following fiscal year 2006:


(j) INAPPLICABILITY OF PATENT PROHIBITION.— Section 4 shall not apply to voting members of the Advisory Committees.
(d) The Director shall establish fees for all other
processing, services, or materials relating to patents
not specified in this section to recover the estimated
average cost to the Office of such processing, services, or materials, except that the Director shall
charge the following fees for the following services:


(Added Nov. 29, 1999, Public Law 106-113, sec.
(1) For recording a document affecting title, $40 per property.
1000(a)(9), 113 Stat. 1501A-578 (S. 1948 sec. 4714); subsections (e) and (g) amended Nov. 2, 2002, Public Law
107-273, sec. 13206, 116 Stat. 1904; subsection (i)
amended and subsection (j) added Nov. 2, 2002, Public
Law 107-273, sec. 13203, 116 Stat. 1902.)


35 U.S.C. 6 Board of Patent Appeals and Interferences.  
(2) For each photocopy, $.25 per page.  


(a) ESTABLISHMENT AND COMPOSITION.— There shall be in the United States Patent
(3) For each black and white copy of a  
and Trademark Office a Board of Patent Appeals and
patent, $3.  
Interferences. The Director, the Deputy Commissioner, the Commissioner for Patents, the Commissioner for Trademarks, and the administrative patent
The yearly fee for providing a library specified in section 13 of this title with uncertified printed
judges shall constitute the Board. The administrative
copies of the specifications and drawings for all patents issued in that year shall be $50.]
patent judges shall be persons of competent legal
knowledge and scientific ability who are appointed by
the Director.
(b) DUTIES.— The Board of Patent Appeals
and Interferences shall, on written appeal of an applicant, review adverse decisions of examiners upon
applications for patents and shall determine priority
and patentability of invention in interferences
declared under section 135(a). Each appeal and interference shall be heard by at least three members of the
Board, who shall be designated by the Director. Only
the Board of Patent Appeals and Interferences may
grant rehearings.




(Repealed by Public Law 106-113, sec. 1000(a)(9),
(e) The Director may waive the payment of any
113 Stat. 1501A-580 (S. 1948 sec. 4715(a).)
fee for any service or material related to patents in
connection with an occasional or incidental request
made by a department or agency of the Government,  
or any officer thereof. The Director may provide any
applicant issued a notice under section 132 of this title
with a copy of the specifications and drawings for all
patents referred to in that notice without charge.  
(f) The fees established in subsections (a) and


(Added Nov. 29, 1999, Public Law 106-113, sec.
(b) of this section may be adjusted by the Director on
1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4717(2)).)
October 1, 1992, and every year thereafter, to reflect
any fluctuations occurring during the previous 12
months in the Consumer Price Index, as determined
by the Secretary of Labor. Changes of less than 1 per
centum may be ignored.  


(Subsection (a) amended Nov. 2, 2002, Public Law
107-273, sec. 13203, 116 Stat. 1902.)


35 U.S.C. 7 Library.  
*Editor’s Note: During fiscal years 2005 and
2006, subsection (f) of section 41 of title 35, United
States Code applies to the fees established under
section 801 of Public Law 108-447. (Dec. 8, 2004,
Public Law 108-447, sec. 801, 118 Stat. 2809.)


The Director shall maintain a library of scientific
(g) No fee established by the Director under
and other works and periodicals, both foreign and
this section shall take effect until at least 30 days after
domestic, in the Patent and Trademark Office to aid
notice of the fee has been published in the Federal
the officers in the discharge of their duties.  
Register and in the Official Gazette of the Patent and  
Trademark Office.  


(Repealed Nov. 29, 1999, Public Law 106-113, sec.
*Editor’s Note: During fiscal years 2005 and
1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4717(1)).)  
2006, subsection (h) of section 41 of title 35, United
States Code, shall be administered as though subsection (h) reads as follows:


(Transferred from 35 U.S.C. 8 Nov. 29, 1999, Public
(h)(1) Subject to paragraph (3), fees charged
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S.  
under subsections (a), (b) and (d)(1) shall be reduced
by 50 percent with respect to their application to any
small business concern as defined under section 3 of
the Small Business Act, and to any independent
inventor or nonprofit organization as defined in regulations issued by the Director.  


1948 sec. 4717(1)); amended Jan. 2, 1975, Public Law 93596, sec. 1, 88 Stat. 1949.)
(2) With respect to its application to any
entity described in paragraph (1), any surcharge or fee
charged under subsection (c) or (d) shall not be higher
than the surcharge or fee required of any other entity
under the same or substantially similar circumstances.  


(Amended Nov. 29, 1999, Public Law 106-113, sec.
(3) The fee charged under subsection
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
(a)(l)(A) shall be reduced by 75 percent with respect
4732(a)(10)(A)).)
to its application to any entity to which paragraph (1)  
applies, if the application is filed by electronic means
as prescribed by the Director.  


35 U.S.C. 8 Classification of patents.  
(Dec. 8, 2004, Public Law 108-447, sec. 801, 118
Stat. 2809.)


The Director may revise and maintain the classification by subject matter of United States letters
The bracketed text below is the unamended text
patent, and such other patents and printed publications
of 35 U.S.C. 41(h), which may continue to have
as may be necessary or practicable, for the purpose of
effect following fiscal year 2006:
determining with readiness and accuracy the novelty
of inventions for which applications for patent are
filed.


(Transferred to 35 U.S.C. 7 Nov. 29, 1999, Public Law
[(h)(1) Fees charged under subsection (a) or (b)  
106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948
shall be reduced by 50 percent with respect to their
sec. 4717(1)).)
application to any small business concern as defined
under section 3 of the Small Business Act, and to any
independent inventor or nonprofit organization as
defined in regulations issued by the Director.  


(Transferred from 35 U.S.C. 9 Nov. 29, 1999, Public
(2) With respect to its application to any
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S.
entity described in paragraph (1), any surcharge or fee
1948 sec. 4717(1)).)
charged under subsection (c) or (d) shall not be higher
 
than the surcharge or fee required of any other entity
(Amended Nov. 29, 1999, Public Law 106-113, sec.  
under the same or substantially similar circumstances.]
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
(i)(1) The Director shall maintain, for use by the
4732(a)(10)(A)).)
public, paper, microform or electronic collections of
United States patents, foreign patent documents, and
United States trademark registrations arranged to permit search for and retrieval of information. The Director may not impose fees directly for the use of such
collections, or for the use of the public patent and
trademark search rooms or libraries.  


35 U.S.C. 9 Certified copies of records.


The Director may furnish certified copies of specifications and drawings of patents issued by the Patent  
(2) The Director shall provide for the full
and Trademark Office, and of other records available  
deployment of the automated search systems of the
either to the public or to the person applying therefor.  
Patent and Trademark Office so that such systems are
available for use by the public, and shall assure full
access by the public to, and dissemination of, patent
and trademark information, using a variety of automated methods, including electronic bulletin boards
and remote access by users to mass storage and
retrieval systems.
(3) The Director may establish reasonable
fees for access by the public to the automated search
systems of the Patent and Trademark Office. If such
fees are established, a limited amount of free access
shall be made available to users of the systems for
purposes of education and training. The Director may
waive the payment by an individual of fees authorized
by this subsection upon a showing of need or hardship, and if such waiver is in the public interest.  


(Transferred to 35 U.S.C. 8 Nov. 29, 1999, Public Law
(4) The Director shall submit to the Congress
106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948
an annual report on the automated search systems of
sec. 4717(1)).)
the Patent and Trademark Office and the access by the
public to such systems. The Director shall also publish such report in the Federal Register. The Director
shall provide an opportunity for the submission of
comments by interested persons on each such report.


(Transferred from 35 U.S.C. 10 Nov. 29, 1999, Public  
(Amended July 24, 1965, Public Law 89-83, sec. 1, 2,  
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S.
79 Stat. 259; Jan. 2, 1975, Public Law 93-596, sec. 1, Jan.  
1948 sec. 4717(1)); amended Jan. 2, 1975, Public Law 93596, sec. 1, 88 Stat. 1949.)  
2, 1975, 88 Stat. 1949; Nov. 14, 1975, Public Law 94-131,  
sec. 3, 89 Stat. 690.)  


(Amended Nov. 29, 1999, Public Law 106-113, sec.  
(Subsection (g) amended Dec. 12, 1980, Public Law  
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
96-517, sec. 2, 94 Stat. 3017; Aug. 27, 1982, Public Law
4732(a)(10)(A)).)  
97-247, sec. 3(a)-(e), 96 Stat. 317.)  


35 U.S.C. 10 Publications.  
(Subsections (a)-(d) amended Sept. 8, 1982, Public
Law 97-256, sec. 101, 96 Stat. 816.)


(a) The Director may publish in printed, typewritten, or electronic form, the following:
(Subsection (a)(6) amended Nov. 8, 1984, Public Law
(1) Patents and published applications for
98-622, sec. 204(a), 98 Stat. 3388.)
patents, including specifications and drawings,
 
together with copies of the same. The Patent and
(Subsection (h) added Nov. 6, 1986, Public Law 99607, sec. 1(b)(2), 100 Stat. 3470.)
Trademark Office may print the headings of the drawings for patents for the purpose of photolithography.  


(Subsections (a), (b), (d), (f), and (g) amended Dec. 10,
1991, Public Law 102-204, sec. 5, 105 Stat. 1637.)


(Subsections (a)(9) - (15) and (i) added Dec. 10, 1991,
Public Law 102-204, sec. 5, 105 Stat. 1637.)


(2) Certificates of trademark registrations,
(Subsection (c)(1) amended Oct. 23, 1992, Public Law
including statements and drawings, together with copies of the same.
102-444, sec. 1, 106 Stat. 2245.)  
(3) The Official Gazette of the United States
Patent and Trademark Office.
(4) Annual indexes of patents and patentees,
and of trademarks and registrants.
(5) Annual volumes of decisions in patent
and trademark cases.  
(6) Pamphlet copies of the patent laws and
rules of practice, laws and rules relating to trademarks, and circulars or other publications relating to
the business of the Office.  
(b) The Director may exchange any of the publications specified in items 3, 4, 5, and 6 of subsection
(a) of this section for publications desirable for the
use of the Patent and Trademark Office.


(Subsection (a)(1)(C) added Dec. 8, 1994, Public Law
103-465, sec. 532(b)(2), 108 Stat. 4986.)


(Transferred to 35 U.S.C. 9 Nov. 29, 1999, Public Law  
(Subsection (c)(2) amended, Dec. 8, 1994, Public Law  
106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948
103-465, sec. 533(b)(1), 108 Stat. 4988.)  
sec. 4717(1)).)  


(Transferred from 35 U.S.C. 11 Nov. 29, 1999, Public
(Subsections (a)-(b) revised Nov. 10, 1998, Public Law  
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580
105-358, sec. 3, 112 Stat. 3272.)  
(S 1948 sec. 4717(1)); amended Jan. 2, 1975, Public Law
93-596, sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law  
106-113, sec. 1000(a)(9), 113 Stat. 1501A-589 (S. 1948
sec. 4804(b)).)  


(Amended Nov. 29, 1999, Public Law 106-113, sec.  
(Amended Nov. 29, 1999, Public Law 106-113, sec.  
1000(a)(9), 113 Stat. 1501A-565, 582 (S. 1948 secs.  
1000(a)(9), 113 Stat. 1501A-554, 570, 582, 589 (S. 1948  
4507(1) and 4732(a)(10)(A)).)  
secs. 4202, 4605(a), 4732(a)(5), 4732(a)(10)(A)) and
4804(d)).)  


35 U.S.C. 11 Exchange of copies of patents and  
35 U.S.C. 42 Patent and Trademark Office funding.  
applications with foreign countries.  


The Director may exchange copies of specifications
(a) All fees for services performed by or materials furnished by the Patent and Trademark Office
and drawings of United States patents and published
will be payable to the Director.
applications for patents for those of foreign countries.


The Director shall not enter into an agreement to
(b) All fees paid to the Director and all appropriations for defraying the costs of the activities of the
provide such copies of specifications and drawings of  
Patent and Trademark Office will be credited to the
United States patents and applications to a foreign
Patent and Trademark Office Appropriation Account
country, other than a NAFTA country or a WTO
in the Treasury of the United States.  
member country, without the express authorization of  
the Secretary of Commerce. For purposes of this section, the terms “NAFTA country” and “WTO member
country” have the meanings given those terms in section 104(b).  


(Transferred to 35 U.S.C. 10 Nov. 29, 1999, Public
(c) To the extent and in the amounts provided in
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580
advance in appropriations Acts, fees authorized in this
(S 1948 sec. 4717(1)).)
title or any other Act to be charged or established by
the Director shall be collected by and shall be available to the Director to carry out the activities of the
Patent and Trademark Office. All fees available to the
Director under section 31 of the Trademark Act of
1946 shall be used only for the processing of trademark registrations and for other activities, services
and materials relating to trademarks and to cover a  
proportionate share of the administrative costs of the
Patent and Trademark Office.  


(Transferred from 35 U.S.C. 12 Nov. 29, 1999, Public
(d) The Director may refund any fee paid by
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580
mistake or any amount paid in excess of that required.  
(S 1948 sec. 4717(1)); amended Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-591 (S. 1948
sec. 4808).)


(Amended Nov. 29, 1999, Public Law 106-113, sec.
(e) The Secretary of Commerce shall, on the
1000(a)(9), 113 Stat. 1501A-565, 582 (S. 1948 secs.
day each year on which the President submits the
4507(2)(A), 4507(2)(B), and 4732(a)(10)(A)).)
annual budget to the Congress, provide to the Committees on the Judiciary of the Senate and the House
of Representatives:


35 U.S.C. 12 Copies of patents and applications
(1) a list of patent and trademark fee collections by the Patent and Trademark Office during the
for public libraries.
preceding fiscal year;


The Director may supply copies of specifications
(2) a list of activities of the Patent and Trademark Office during the preceding fiscal year which  
and drawings of patents and published applications
were supported by patent fee expenditures, trademark
for patents in printed or electronic form to public
fee expenditures, and appropriations;
libraries in the United States which shall maintain
such copies for the use of the public, at the rate for
each year’s issue established for this purpose in section 41(d) of this title.


(Transferred to 35 U.S.C. 11 Nov. 29, 1999, Public
(3) budget plans for significant programs,  
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S.
projects, and activities of the Office, including out-
1948 sec. 4717(1)).)
year funding estimates;


(Transferred from 35 U.S.C. 13 Nov. 29, 1999, Public
(4) any proposed disposition of surplus fees
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580
by the Office; and
(S 1948 sec. 4717(1)); amended Aug. 27, 1982, Public Law
97-247, sec. 15, 96 Stat. 321; Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-589 (S. 1948
sec. 4804(c)).)


(Amended Nov. 29, 1999, Public Law 106-113, sec.
(5) such other information as the committees
1000(a)(9), 113 Stat. 1501A-565, 566, 582 (S. 1948 secs.
consider necessary.  
4507(3)(A), 4507(3)(B), 4507(4), and 4732(a)(10)(A)).)


35 U.S.C. 13 Annual report to Congress.


The Director shall report to the Congress, not later
(Amended Nov. 14, 1975, Public Law 94-131, sec. 4,  
than 180 days after the end of each fiscal year, the
89 Stat. 690; Dec. 12, 1980, Public Law 96-517, sec. 3, 94
moneys received and expended by the Office, the purposes for which the moneys were spent, the quality
Stat. 3018; Aug. 27, 1982, Public Law 97-247, sec. 3(g), 96
and quantity of the work of the Office, the nature of
Stat. 319; Sept. 13, 1982, Public Law 97-258, sec. 3(i), 96
training provided to examiners, the evaluation of the
Stat. 1065.)
Commissioner of Patents and the Commissioner of
Trademarks by the Secretary of Commerce, the compensation of the Commissioners, and other information relating to the Office.  


(Transferred to 35 U.S.C. 12 Nov. 29, 1999, Public  
(Subsection (c) amended Dec. 10, 1991, Public Law
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580
102-204, sec. 5(e), 105 Stat. 1640.)  
(S 1948 sec. 4717(1)).)  


(Transferred from 35 U.S.C. 14 Nov. 29, 1999, Public  
(Subsection (e) added Dec. 10, 1991, Public Law 102204, sec. 4, 105 Stat. 1637.)  
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580
(S 1948 sec. 4717(1)).)  


(Subsection (c) revised Nov. 10, 1998, Public Law
105-358, sec. 4, 112 Stat. 3274.)


(Amended Nov. 29, 1999, Public Law 106-113, sec.  
(Amended Nov. 29, 1999, Public Law 106-113, sec.  
1000(a)(9), 113 Stat. 1501A-565, 581 (S. 1948 secs.  
1000(a)(9), 113 Stat. 1501A-555, 582 (S. 1948 secs. 4205
4507(2), 4718).)  
and 4732(a)(10)(A)).)  


CHAPTER 2 PROCEEDINGS IN THE
==PART II PATENTABILITY OF INVENTIONS AND GRANT OF PATENTS==
PATENT AND TRADEMARK OFFICE


===CHAPTER 10 — PATENTABILITY OF INVENTIONS===


Sec.
Sec.
21 Filing date and day for taking action.
22 Printing of papers filed.
23 Testimony in Patent and Trademark Office


100 Definitions.


cases.
101 Inventions patentable.  
24 Subpoenas, witnesses.
25 Declaration in lieu of oath.
26 Effect of defective execution.  


35 U.S.C. 21 Filing date and day for taking
102 Conditions for patentability; novelty and loss of
action.  
right to patent.  


(a) The Director may by rule prescribe that any
103 Conditions for patentability; non-obvious sub
paper or fee required to be filed in the Patent and
ject matter.
Trademark Office will be considered filed in the
 
Office on the date on which it was deposited with the
104 Invention made abroad.  
United States Postal Service or would have been
 
deposited with the United States Postal Service but for
105 Inventions in outer space.  
postal service interruptions or emergencies designated
by the Director.  
(b) When the day, or the last day, for taking any
action or paying any fee in the United States Patent
and Trademark Office falls on Saturday, Sunday, or a
Federal holiday within the District of Columbia, the
action may be taken, or fee paid, on the next succeeding secular or business day.  


====35 U.S.C. 100 Definitions.====


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
When used in this title unless the context otherwise
88 Stat. 1949; Aug. 27, 1982, Public Law 97-247, sec. 12,
indicates
96 Stat. 321; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


35 U.S.C. 22 Printing of papers filed.  
(a) The term “invention” means invention or
discovery.  


The Director may require papers filed in the Patent
(b) The term “process” means process, art, or
and Trademark Office to be printed, typewritten, or on
method, and includes a new use of a known process,
an electronic medium.  
machine, manufacture, composition of matter, or  
material.  


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
(c) The terms “United States” and “this country” mean the United States of America, its territories
Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.
and possessions.  
1000(a)(9), 113 Stat. 1501A-582, 589 (S. 1948 secs.
4732(a)(10)(A), 4804(a)).)


35 U.S.C. 23 Testimony in Patent and Trademark Office cases.  
(d) The word “patentee” includes not only the
patentee to whom the patent was issued but also the
successors in title to the patentee.  


The Director may establish rules for taking affidavits and depositions required in cases in the Patent
(e) The term “third-party requester” means a
and Trademark Office. Any officer authorized by law
person requesting ex parte reexamination under section 302 or inter partes reexamination under section
to take depositions to be used in the courts of the  
311 who is not the patent owner.
United States, or of the State where he resides, may
take such affidavits and depositions.  


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
(Subsection (e) added Nov. 29, 1999, Public Law  
88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.  
106-113, sec. 1000(a)(9), 113 Stat. 1501A-567 (S. 1948  
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
sec. 4603).)  
4732(a)(10)(A)).)  


35 U.S.C. 24 Subpoenas, witnesses.  
====35 U.S.C. 101 Inventions patentable.====


The clerk of any United States court for the district
Whoever invents or discovers any new and useful
wherein testimony is to be taken for use in any contested case in the Patent and Trademark Office, shall,  
process, machine, manufacture, or composition of
upon the application of any party thereto, issue a subpoena for any witness residing or being within such
matter, or any new and useful improvement thereof,
district, commanding him to appear and testify before
may obtain a patent therefor, subject to the conditions
an officer in such district authorized to take depositions and affidavits, at the time and place stated in the  
and requirements of this title.  
subpoena. The provisions of the Federal Rules of
Civil Procedure relating to the attendance of witnesses and to the production of documents and things
shall apply to contested cases in the Patent and Trademark Office.  


Every witness subpoenaed and in attendance shall
====35 U.S.C. 102 Conditions for patentability; novelty and loss of right to patent.====
be allowed the fees and traveling expenses allowed to  
witnesses attending the United States district courts.  


A judge of a court whose clerk issued a subpoena
A person shall be entitled to a patent unless
may enforce obedience to the process or punish disobedience as in other like cases, on proof that a witness, served with such subpoena, neglected or refused
to appear or to testify. No witness shall be deemed
guilty of contempt for disobeying such subpoena
unless his fees and traveling expenses in going to, and
returning from, and one day’s attendance at the place
of examination, are paid or tendered him at the time of
the service of the subpoena; nor for refusing to disclose any secret matter except upon appropriate order
of the court which issued the subpoena.


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
(a) the invention was known or used by others
88 Stat. 1949.)
in this country, or patented or described in a printed
publication in this or a foreign country, before the
invention thereof by the applicant for patent, or


35 U.S.C. 25 Declaration in lieu of oath.
(b) the invention was patented or described in a
printed publication in this or a foreign country or in
public use or on sale in this country, more than one
year prior to the date of the application for patent in
the United States, or


(a) The Director may by rule prescribe that any
(c) he has abandoned the invention, or  
document to be filed in the Patent and Trademark
Office and which is required by any law, rule, or other
regulation to be under oath may be subscribed to by a
written declaration in such form as the Director may
prescribe, such declaration to be in lieu of the oath
otherwise required.


(d) the invention was first patented or caused to
be patented, or was the subject of an inventor’s certificate, by the applicant or his legal representatives or
assigns in a foreign country prior to the date of the
application for patent in this country on an application
for patent or inventor’s certificate filed more than
twelve months before the filing of the application in
the United States, or


(b) Whenever such written declaration is used,  
(e) the invention was described in — (1) an
the document must warn the declarant that willful
application for patent, published under section 122(b),  
false statements and the like are punishable by fine or
by another filed in the United States before the invention by the applicant for patent or (2) a patent granted
imprisonment, or both (18 U.S.C. 1001).
on an application for patent by another filed in the  
United States before the invention by the applicant for
patent, except that an international application filed
under the treaty defined in section 351(a) shall have
the effects for the purposes of this subsection of an
application filed in the United States only if the international application designated the United States and
was published under Article 21(2) of such treaty in
the English language; or


(Added Mar. 26, 1964, Public Law 88-292, sec. 1,
(f) he did not himself invent the subject matter
78 Stat. 171; amended Jan. 2, 1975, Public Law 93-596,
sought to be patented, or
sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


35 U.S.C. 26 Effect of defective execution.  
(g)(1) during the course of an interference conducted under section 135 or section 291, another
inventor involved therein establishes, to the extent
permitted in section 104, that before such person’s
invention thereof the invention was made by such
other inventor and not abandoned, suppressed, or concealed, or (2) before such person’s invention thereof,
the invention was made in this country by another
inventor who had not abandoned, suppressed, or concealed it. In determining priority of invention under
this subsection, there shall be considered not only the
respective dates of conception and reduction to practice of the invention, but also the reasonable diligence
of one who was first to conceive and last to reduce to
practice, from a time prior to conception by the other.  


Any document to be filed in the Patent and Trademark Office and which is required by any law, rule, or
(Amended July 28, 1972, Public Law 92-358, sec. 2,  
other regulation to be executed in a specified manner
86 Stat. 501; Nov. 14, 1975, Public Law 94-131, sec. 5, 89
may be provisionally accepted by the Director despite
Stat. 691.)
a defective execution, provided a properly executed
document is submitted within such time as may be
prescribed.  


(Added Mar. 26, 1964, Public Law 88-292, sec. 1,
(Subsection (e) amended Nov. 29, 1999, Public Law  
78 Stat. 171; amended Jan. 2, 1975, Public Law 93-596,
106-113, sec. 1000(a)(9), 113 Stat. 1501A-565 (S. 1948  
sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113,  
sec. 4505).)  
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
4732(a)(10)(A)).)  


CHAPTER 3 — PRACTICE BEFORE PATENT
(Subsection (g) amended Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-590 (S. 1948
sec. 4806).)


AND TRADEMARK OFFICE
(Subsection (e) amended Nov. 2, 2002, Public Law
Sec.  
107-273, sec. 13205, 116 Stat. 1903.)
31 [Repealed]
32 Suspension or exclusion from practice.  
33 Unauthorized representation as practitioner.  


35 U.S.C. 31 [Repealed].  
====35 U.S.C. 103 Conditions for patentability; non-obvious subject matter.====


(Repealed Nov. 29, 1999, Public Law 106-113, sec.  
(a) A patent may not be obtained though the
1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4715(b)).)  
invention is not identically disclosed or described as
set forth in section 102 of this title, if the differences
between the subject matter sought to be patented and
the prior art are such that the subject matter as a whole
would have been obvious at the time the invention
was made to a person having ordinary skill in the art
to which said subject matter pertains. Patentability
shall not be negatived by the manner in which the
invention was made.  
 
(b)(1) Notwithstanding subsection (a), and upon
timely election by the applicant for patent to proceed
under this subsection, a biotechnological process
using or resulting in a composition of matter that is
novel under section 102 and nonobvious under subsection (a) of this section shall be considered nonobvious if


35 U.S.C. 32 Suspension or exclusion from practice.
(A) claims to the process and the composition of matter are contained in either the same application for patent or in separate applications having the
same effective filing date; and


The Director may, after notice and opportunity for a
(B) the composition of matter, and the process at the time it was invented, were owned by the
hearing, suspend or exclude, either generally or in any
same person or subject to an obligation of assignment
particular case, from further practice before the Patent
to the same person.  
and Trademark Office, any person, agent, or attorney
shown to be incompetent or disreputable, or guilty of
gross misconduct, or who does not comply with the  
regulations established under section 2(b)(2)(D) of
this title, or who shall, by word, circular, letter, or
advertising, with intent to defraud in any manner,
deceive, mislead, or threaten any applicant or prospective applicant, or other person having immediate
or prospective business before the Office. The reasons
for any such suspension or exclusion shall be duly
recorded. The Director shall have the discretion to  
designate any attorney who is an officer or employee
of the United States Patent and Trademark Office to  
conduct the hearing required by this section. The
United States District Court for the District of Columbia, under such conditions and upon such proceedings
as it by its rules determines, may review the action of
the Director upon the petition of the person so refused
recognition or so suspended or excluded.  


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
(2) A patent issued on a process under paragraph (1)
88 Stat.1949; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-580, 581, 582 (S. 1948 secs.
4715(c), 4719, 4732(a)(10)(A)).)  


===35 U.S.C. 33 Unauthorized representation as practitioner.===
(A) shall also contain the claims to the
composition of matter used in or made by that process, or
 
(B) shall, if such composition of matter is
claimed in another patent, be set to expire on the same
date as such other patent, notwithstanding section
 
154.  
 
(3) For purposes of paragraph (1), the term
“biotechnological process” means
(A) a process of genetically altering or otherwise inducing a single- or multi-celled organism to
(i) express an exogenous nucleotide
sequence,
(ii) inhibit, eliminate, augment, or alter
expression of an endogenous nucleotide sequence, or


Whoever, not being recognized to practice before
the Patent and Trademark Office, holds himself out or
permits himself to be held out as so recognized, or as
being qualified to prepare or prosecute applications
for patent, shall be fined not more than $1,000 for
each offense.


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
(iii) express a specific physiological
88 Stat. 1949.)
characteristic not naturally associated with said organism;


CHAPTER 4 — PATENT FEES; FUNDING;  
(B) cell fusion procedures yielding a cell
line that expresses a specific protein, such as a monoclonal antibody; and
(C) a method of using a product produced
by a process defined by subparagraph (A) or (B), or a
combination of subparagraphs (A) and (B).
(c)(1) Subject matter developed by another person, which qualifies as prior art only under one or
more of subsections (e), (f), and (g) of section 102 of
this title, shall not preclude patentability under this
section where the subject matter and the claimed
invention were, at the time the claimed invention was
made, owned by the same person or subject to an obligation of assignment to the same person.


SEARCH SYSTEMS
Sec.
41 Patent fees; patent and trademark search systems.
42 Patent and Trademark Office funding.


35 U.S.C. 41 Patent fees; patent and trademark
(2) For purposes of this subsection, subject
search systems.
matter developed by another person and a claimed
invention shall be deemed to have been owned by the
same person or subject to an obligation of assignment
to the same person if —


*Editor’s Note: During fiscal years 2005 and
(A) the claimed invention was made by or
2006, subsections (a) and (b) of section 41 of title
on behalf of parties to a joint research agreement that
35, United States Code, shall be administered as
was in effect on or before the date the claimed invention was made;
though subsections (a) and (b) read as follows:


(a) GENERAL FEES. — The Director shall
(B) the claimed invention was made as a  
charge the following fees:
result of activities undertaken within the scope of the  
(1) FILING AND BASIC NATIONAL
joint research agreement; and
FEES. —
 
(A) On filing each application for an original patent, except for design, plant, or provisional
(C) the application for patent for the  
applications, $300.
claimed invention discloses or is amended to disclose
(B) On filing each application for an original design patent, $200.
the names of the parties to the joint research agreement.  
(C) On filing each application for an original plant patent, $200.
(D) On filing each provisional application
for an original patent, $200.
(E) On filing each application for the reissue of a patent, $300.
(F) The basic national fee for each international application filed under the treaty defined in section 351(a) of this title entering the national stage
under section 371 of this title, $300.
(G) In addition, excluding any sequence
listing or computer program listing filed in electronic
medium as prescribed by the Director, for any application the specification and drawings of which exceed
100 sheets of paper (or equivalent as prescribed by the
Director if filed in an electronic medium), $250 for
each additional 50 sheets of paper (or equivalent as
prescribed by the Director if filed in an electronic
medium) or fraction thereof.
(2) EXCESS CLAIMS FEES. — In addition
to the fee specified in paragraph (1) —
(A) on filing or on presentation at any other
time, $200 for each claim in independent form in
excess of 3;
(B) on filing or on presentation at any other
time, $50 for each claim (whether dependent or independent) in excess of 20; and
(C) for each application containing a multiple dependent claim, $360.  


(3) For purposes of paragraph (2), the term
“joint research agreement” means a written contract,
grant, or cooperative agreement entered into by two or
more persons or entities for the performance of experimental, developmental, or research work in the field
of the claimed invention.


For the purpose of computing fees under this
(Amended Nov. 8, 1984, Public Law 98-622, sec. 103,  
paragraph, a multiple dependent claim referred to in
98 Stat. 3384; Nov. 1, 1995, Public Law 104-41, sec.1, 109
section 112 of this title or any claim depending therefrom shall be considered as separate dependent claims
Stat. 3511.)
in accordance with the number of claims to which reference is made. The Director may by regulation provide for a refund of any part of the fee specified in this
paragraph for any claim that is canceled before an
examination on the merits, as prescribed by the Director, has been made of the application under section
131 of this title. Errors in payment of the additional
fees under this paragraph may be rectified in accordance with regulations prescribed by the Director.  


(3) EXAMINATION FEES.
(Subsection (c) amended Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-591 (S. 1948
sec. 4807).)


(A) For examination of each application
(Subsection (c) amended Dec. 10, 2004, Public Law
for an original patent, except for design, plant, provisional, or international applications, $200.  
108-453 , sec. 2, 118 Stat. 3596.)  
(B) For examination of each application
for an original design patent, $130.


====35 U.S.C. 104 Invention made abroad.====


(C) For examination of each application
(a) IN GENERAL.
for an original plant patent, $160.
(D) For examination of the national stage
of each international application, $200.
(E) For examination of each application
for the reissue of a patent, $600.


(1) PROCEEDINGS.—In proceedings in the
Patent and Trademark Office, in the courts, and before
any other competent authority, an applicant for a
patent, or a patentee, may not establish a date of
invention by reference to knowledge or use thereof, or
other activity with respect thereto, in a foreign country other than a NAFTA country or a WTO member
country, except as provided in sections 119 and 365 of
this title.
(2) RIGHTS.—If an invention was made by
a person, civil or military—
(A) while domiciled in the United States,
and serving in any other country in connection with
operations by or on behalf of the United States,
(B) while domiciled in a NAFTA country
and serving in another country in connection with
operations by or on behalf of that NAFTA country, or
(C) while domiciled in a WTO member
country and serving in another country in connection
with operations by or on behalf of that WTO member
country, that person shall be entitled to the same rights
of priority in the United States with respect to such
invention as if such invention had been made in the
United States, that NAFTA country, or that WTO
member country, as the case may be.
(3) USE OF INFORMATION.—To the
extent that any information in a NAFTA country or a
WTO member country concerning knowledge, use, or
other activity relevant to proving or disproving a date
of invention has not been made available for use in a
proceeding in the Patent and Trademark Office, a
court, or any other competent authority to the same
extent as such information could be made available in
the United States, the Director, court, or such other
authority shall draw appropriate inferences, or take
other action permitted by statute, rule, or regulation,
in favor of the party that requested the information in
the proceeding.


The provisions of section 111(a) of this title
(b) DEFINITIONS.—As used in this section—
relating to the payment of the fee for filing the application shall apply to the payment of the fee specified
in this paragraph with respect to an application filed
under section 111(a) of this title. The provisions of
section 371(d) of this title relating to the payment of
the national fee shall apply to the payment of the fee
specified in this paragraph with respect to an international application.


(4) ISSUE FEES. —
(1) The term “NAFTA country” has the
 
meaning given that term in section 2(4) of the North
(A) For issuing each original patent, except
American Free Trade Agreement Implementation
for design or plant patents, $1,400.
Act; and
(B) For issuing each original design patent,
(2) The term “WTO member country” has
$800.
the meaning given that term in section 2(10) of the
(C) For issuing each original plant patent,
Uruguay Round Agreements Act.  
$1,100.
(D) For issuing each reissue patent, $1,400.  




(5) DISCLAIMER FEE. — On filing each
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
disclaimer, $130.  
88 Stat. 1949; Nov. 14, 1975, Public Law 94-131, sec. 6,
(6) APPEAL FEES.
89 Stat. 691; Nov. 8, 1984, Public Law 98-622, sec. 403(a),
98 Stat. 3392; Dec. 8, 1993, Public Law 103-182, sec. 331,
107 Stat. 2113; Dec. 8, 1994, Public Law 103-465, sec.
531(a), 108 Stat. 4982; Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
4732(a)(10)(A)).)


====35 U.S.C. 105 Inventions in outer space.====
(a) Any invention made, used, or sold in outer
space on a space object or component thereof under
the jurisdiction or control of the United States shall be
considered to be made, used or sold within the United
States for the purposes of this title, except with
respect to any space object or component thereof that
is specifically identified and otherwise provided for
by an international agreement to which the United
States is a party, or with respect to any space object or
component thereof that is carried on the registry of a
foreign state in accordance with the Convention on
Registration of Objects Launched into Outer Space.
(b) Any invention made, used, or sold in outer
space on a space object or component thereof that is
carried on the registry of a foreign state in accordance
with the Convention on Registration of Objects
Launched into Outer Space, shall be considered to be
made, used, or sold within the United States for the
purposes of this title if specifically so agreed in an
international agreement between the United States
and the state of registry.


(A) On filing an appeal from the examiner
to the Board of Patent Appeals and Interferences,
$500.
(B) In addition, on filing a brief in support
of the appeal, $500, and on requesting an oral hearing
in the appeal before the Board of Patent Appeals and
Interferences, $1,000.
(7) REVIVAL FEES. — On filing each petition for the revival of an unintentionally abandoned
application for a patent, for the unintentionally
delayed payment of the fee for issuing each patent, or
for an unintentionally delayed response by the patent
owner in any reexamination proceeding, $1,500,
unless the petition is filed under section 133 or 151 of
this title, in which case the fee shall be $500.
(8) EXTENSION FEES. — For petitions for
1-month extensions of time to take actions required
by the Director in an application —
(A) on filing a first petition, $120;
(B) on filing a second petition, $330; and


(Added Nov. 15, 1990, Public Law 101-580, sec. 1(a),
104 Stat. 2863.)


===CHAPTER 11 — APPLICATION FOR PATENT===


Sec.


(C) on filing a third or subsequent petition,
111 Application.  
$570.  


112 Specification.


113 Drawings.


(b) MAINTENANCE FEES. — The Director
114 Models, specimens.  
shall charge the following fees for maintaining in
force all patents based on applications filed on or after
December 12, 1980:
(1) 3 years and 6 months after grant, $900.
(2) 7 years and 6 months after grant, $2,300.  


115 Oath of applicant.


116 Inventors.


117 Death or incapacity of inventor.


(3) 11 years and 6 months after grant, $3,800.
118 Filing by other than inventor.  
Unless payment of the applicable maintenance fee is
received in the United States Patent and Trademark
Office on or before the date the fee is due or within a
grace period of 6 months thereafter, the patent will
expire as of the end of such grace period. The Director
may require the payment of a surcharge as a condition
of accepting within such 6-month grace period the
payment of an applicable maintenance fee. No fee
may be established for maintaining a design or plant
patent in force.  


(Dec. 8, 2004, Public Law 108-447, sec. 801, 118
119 Benefit of earlier filing date; right of priority.  
Stat. 2809.)


The bracketed text below is the unamended text
120 Benefit of earlier filing date in the United
of 35 U.S.C. 41(a) and (b), which may continue to
States.  
have effect following fiscal year 2006:


[(a) The Director shall charge the following
121 Divisional applications.  
fees:
(1)(A) On filing each application for an original patent, except in design or plant cases, $690.  


(B) In addition, on filing or on presentation
122 Confidential status of applications; publication
at any other time, $78 for each claim in independent
 
form which is in excess of 3, $18 for each claim
of patent applications.
(whether independent or dependent) which is in
 
excess of 20, and $260 for each application containing
====35 U.S.C. 111 Application.====
a multiple dependent claim.  


(C) On filing each provisional application
(a) IN GENERAL.
for an original patent, $150.  


(2) For issuing each original or reissue
{{tab1}}(1) WRITTEN APPLICATION.—An application for patent shall be made, or authorized to be made, by the inventor, except as otherwise provided in this title, in writing to the Director.</p>
patent, except in design or plant cases, $1,210.  


(3) In design and plant cases
{{tab1}}(2) CONTENTS.—Such application shall include— </p>


(A) on filing each design application, $310;  
{{tab2}}(A) a specification as prescribed by section 112 of this title; </p>


(B) on filing each plant application, $480;  
{{tab2}}(B) a drawing as prescribed by section 113 of this title; and </p>


(C) on issuing each design patent, $430;
{{tab2}}(C) an oath by the applicant as prescribed by section 115 of this title. </p>
and


{{tab1}}(3) FEE AND OATH.—The application must be accompanied by the fee required by law. The fee and oath may be submitted after the specification and any required drawing are submitted, within such period and under such conditions, including the payment of a surcharge, as may be prescribed by the Director. </p>


(D) on issuing each plant patent, $580.  
{{tab1}}(4) FAILURE TO SUBMIT.—Upon failure to submit the fee and oath within such prescribed period, the application shall be regarded as abandoned, unless it is shown to the satisfaction of the Director that the delay in submitting the fee and oath was unavoidable or unintentional. The filing date of an application shall be the date on which the specification and any required drawing are received in the Patent and Trademark Office. </p>


(4)(A)On filing each application for the reissue
(b) PROVISIONAL APPLICATION.
of a patent, $690.  


(B) In addition, on filing or on presentation
{{tab1}}(1) AUTHORIZATION.—A provisional application for patent shall be made or authorized to be made by the inventor, except as otherwise provided in this title, in writing to the Director. Such application shall include— </p>
at any other time, $78 for each claim in independent
form which is in excess of the number of independent
claims of the original patent, and $18 for each claim
(whether independent or dependent) which is in
excess of 20 and also in excess of the number of
claims of the original patent.  


(5) On filing each disclaimer, $110.
{{tab2}}(A) a specification as prescribed by the first paragraph of section 112 of this title; and </p>
(6)(A) On filing an appeal from the examiner


to the Board of Patent Appeals and Interferences,
{{tab2}}(B) a drawing as prescribed by section 113 of this title. </p>
$300.  


(B) In addition, on filing a brief in support
{{tab1}}(2) CLAIM.—A claim, as required by the second through fifth paragraphs of section 112, shall not be required in a provisional application.</p>
of the appeal, $300, and on requesting an oral hearing
in the appeal before the Board of Patent Appeals and
Interferences, $260.  
(7) On filing each petition for the revival of
an unintentionally abandoned application for a patent,  
for the unintentionally delayed payment of the fee for
issuing each patent, or for an unintentionally delayed
response by the patent owner in any reexamination
proceeding, $1,210, unless the petition is filed under
section 133 or 151 of this title, in which case the fee
shall be $110.  


(8) For petitions for 1-month extensions of
{{tab1}}(3) FEE.— </p>
time to take actions required by the Director in an
application


(A) on filing a first petition, $110;
{{tab2}}(A) The application must be accompanied by the fee required by law. </p>


(B) on filing a second petition, $270; and
{{tab2}}(B) The fee may be submitted after the specification and any required drawing are submitted, within such period and under such conditions, including the payment of a surcharge, as may be prescribed by the Director.</p>


(C) on filing a third or subsequent petition,
{{tab2}}(C) Upon failure to submit the fee within such prescribed period, the application shall be regarded as abandoned, unless it is shown to the satisfaction of the Director that the delay in submitting the fee was unavoidable or unintentional.</p>
$490.  


(9) Basic national fee for an international
{{tab1}}(4) FILING DATE.—The filing date of a provisional application shall be the date on which the specification and any required drawing are received in the Patent and Trademark Office.</p>
application where the Patent and Trademark Office  
 
was the International Preliminary Examining Authority and the International Searching Authority, $670.
{{tab1}}(5) ABANDONMENT.—Notwithstanding the absence of a claim, upon timely request and as prescribed by the Director, a provisional application may be treated as an application filed under subsection (a). Subject to section 119(e)(3) of this title, if no such request is made, the provisional application shall be regarded as abandoned 12 months after the filing date of such application and shall not be subject to revival after such 12-month period.</p>
(10) Basic national fee for an international
application where the Patent and Trademark Office
was the International Searching Authority but not the  
International Preliminary Examining Authority, $690.  
(11) Basic national fee for an international
application where the Patent and Trademark Office
was neither the International Searching Authority nor
the International Preliminary Examining Authority,
$970.  


(12) Basic national fee for an international
{{tab1}}(6) OTHER BASIS FOR PROVISIONAL APPLICATION.—Subject to all the conditions in this subsection and section 119(e) of this title, and as prescribed by the Director, an application for patent filed under subsection (a) may be treated as a provisional application for patent.</p>
application where the international preliminary examination has been paid to the Patent and Trademark
Office, and the international preliminary examination
report states that the provisions of Article 33 (2), (3),
and (4) of the Patent Cooperation Treaty have been
satisfied for all claims in the application entering the
national stage, $96.  


(13) For filing or later presentation of each
{{tab1}}(7) NO RIGHT OF PRIORITY OR BENEFIT OF EARLIEST FILING DATE.—A provisional application shall not be entitled to the right of priority of any other application under section 119 or 365(a) of this title or to the benefit of an earlier filing date in the United States under section 120, 121, or 365(c) of this title. </p>
independent claim in the national stage of an international application in excess of 3, $78.
(14) For filing or later presentation of each
claim (whether independent or dependent) in a
national stage of an international application in excess
of 20, $18.
(15) For each national stage of an international
application containing a multiple dependent claim,
$260.
For the purpose of computing fees, a multiple
dependent claim as referred to in section 112 of this  
title or any claim depending therefrom shall be considered as separate dependent claims in accordance
with the number of claims to which reference is made.
Errors in payment of the additional fees may be rectified in accordance with regulations of the Director.  


(b) The Director shall charge the following fees
{{tab1}}(8) APPLICABLE PROVISIONS.—The provisions of this title relating to applications for patent shall apply to provisional applications for patent, except as otherwise provided, and except that provisional applications for patent shall not be subject to sections 115, 131, 135, and 157 of this title.</p>
for maintaining in force all patents based on applications filed on or after December 12, 1980:


(1) 3 years and 6 months after grant, $830.  
====35 U.S.C. 112 Specification.====


(2) 7 years and 6 months after grant, $1,900.  
The specification shall contain a written description
of the invention, and of the manner and process of
making and using it, in such full, clear, concise, and
exact terms as to enable any person skilled in the art
to which it pertains, or with which it is most nearly
connected, to make and use the same, and shall set
forth the best mode contemplated by the inventor of
carrying out his invention.  


(3) 11 years and 6 months after grant, $2,910.  
The specification shall conclude with one or more
claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as
his invention.  


Unless payment of the applicable maintenance fee is received in the Patent and Trademark
A claim may be written in independent or, if the
Office on or before the date the fee is due or within a  
nature of the case admits, in dependent or multiple
grace period of six months thereafter, the patent will
dependent form.
expire as of the end of such grace period. The Director
 
may require the payment of a surcharge as a condition
Subject to the following paragraph, a claim in
of accepting within such 6-month grace period the
dependent form shall contain a reference to a claim
payment of an applicable maintenance fee. No fee
previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it
may be established for maintaining a design or plant
refers.
patent in force.]
 
A claim in multiple dependent form shall contain a  
reference, in the alternative only, to more than one
claim previously set forth and then specify a further
limitation of the subject matter claimed. A multiple
dependent claim shall not serve as a basis for any
other multiple dependent claim. A multiple dependent
claim shall be construed to incorporate by reference
all the limitations of the particular claim in relation to
which it is being considered.  


(c)(1) The Director may accept the payment of
An element in a claim for a combination may be
any maintenance fee required by subsection (b) of this
expressed as a means or step for performing a specified function without the recital of structure, material,
section which is made within twenty-four months
or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material,
after the six-month grace period if the delay is shown
or acts described in the specification and equivalents
to the satisfaction of the Director to have been unintentional, or at any time after the six-month grace
thereof.  
period if the delay is shown to the satisfaction of the
Director to have been unavoidable. The Director may
require the payment of a surcharge as a condition of
accepting payment of any maintenance fee after the  
six-month grace period. If the Director accepts payment of a maintenance fee after the six-month grace
period, the patent shall be considered as not having
expired at the end of the grace period.  


(2) A patent, the term of which has been
(Amended July 24, 1965, Public Law 89-83, sec. 9,  
maintained as a result of the acceptance of a payment
79 Stat. 261; Nov. 14, 1975, Public Law 94-131, sec. 7,  
of a maintenance fee under this subsection, shall not
89 Stat. 691.)
abridge or affect the right of any person or that person’s successors in business who made, purchased,  
offered to sell, or used anything protected by the
patent within the United States, or imported anything
protected by the patent into the United States after the
6-month grace period but prior to the acceptance of a
maintenance fee under this subsection, to continue the
use of, to offer for sale, or to sell to others to be used,  
offered for sale, or sold, the specific thing so made,
purchased, offered for sale, used, or imported. The
court before which such matter is in question may
provide for the continued manufacture, use, offer for
sale, or sale of the thing made, purchased, offered for
sale, or used within the United States, or imported into
the United States, as specified, or for the manufacture,
use, offer for sale, or sale in the United States of
which substantial preparation was made after the 6month grace period but before the acceptance of a
maintenance fee under this subsection, and the court
may also provide for the continued practice of any
process that is practiced, or for the practice of which
substantial preparation was made, after the 6-month
grace period but before the acceptance of a maintenance fee under this subsection, to the extent and
under such terms as the court deems equitable for the
protection of investments made or business commenced after the 6-month grace period but before the
acceptance of a maintenance fee under this subsection.  


*Editor’s Note: During fiscal years 2005 and
====35 U.S.C. 113 Drawings.====
2006, subsection (d) of section 41 of title 35, United
States Code, shall be administered as though subsection (d) reads as follows:


(d) PATENT SEARCH AND OTHER FEES.
The applicant shall furnish a drawing where necessary for the understanding of the subject matter
sought to be patented. When the nature of such subject matter admits of illustration by a drawing and the
applicant has not furnished such a drawing, the Director may require its submission within a time period of
not less than two months from the sending of a notice
thereof. Drawings submitted after the filing date of
the application may not be used (i) to overcome any
insufficiency of the specification due to lack of an
enabling disclosure or otherwise inadequate disclosure therein, or (ii) to supplement the original disclosure thereof for the purpose of interpretation of the
scope of any claim.  


(1) PATENT SEARCH FEES.
(Amended Nov. 14, 1975, Public Law 94-131, sec. 8,
89 Stat. 691; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


(A) The Director shall charge a fee for the
====35 U.S.C. 114 Models, specimens.====
search of each application for a patent, except for provisional applications. The Director shall establish the
fees charged under this paragraph to recover an
amount not to exceed the estimated average cost to
the Office of searching applications for patent either
by acquiring a search report from a qualified search
authority, or by causing a search by Office personnel
to be made, of each application for patent. For the 3year period beginning on the date of enactment of this


Act, the fee for a search by a qualified search authority of a patent application described in clause (i), (iv),
The Director may require the applicant to furnish a
or (v) of subparagraph (B) may not exceed $500, of a
model of convenient size to exhibit advantageously
patent application described in clause (ii) of subparagraph (B) may not exceed $100, and of a patent application described in clause (iii) of subparagraph (B)
the several parts of his invention.  
may not exceed $300. The Director may not increase
any such fee by more than 20 percent in each of the
next three 1-year periods, and the Director may not
increase any such fee thereafter.  


(B) For purposes of determining the fees to  
When the invention relates to a composition of matter, the Director may require the applicant to furnish
be established under this paragraph, the cost to the  
specimens or ingredients for the purpose of inspection
Office of causing a search of an application to be
or experiment.
made by Office personnel shall be deemed to be —
(i) $500 for each application for an
original patent, except for design, plant, provisional,
or international applications;
(ii) $100 for each application for an
original design patent;


(iii) $300 for each application for an
(Amended Nov. 29, 1999, Public Law 106-113, sec.  
original plant patent;
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
 
4732(a)(10)(A)).)
(iv) $500 for the national stage of each
international application; and
(v) $500 for each application for the
reissue of a patent.  
(C) The provisions of section 111 (a)(3) of
this title relating to the payment of the fee for filing
the application shall apply to the payment of the fee
specified in this paragraph with respect to an application filed under section 111(a) of this title. The provisions of section 371(d) of this title relating to the
payment of the national fee shall apply to the payment
of the fee specified in this paragraph with respect to
an international application.  
(D) The Director may by regulation provide for a refund of any part of the fee specified in this
paragraph for any applicant who files a written declaration of express abandonment as prescribed by the
Director before an examination has been made of the
application under section 131 of this title, and for any
applicant who provides a search report that meets the
conditions prescribed by the Director.
(E) For purposes of subparagraph (A), a
“qualified search authority” may not include a commercial entity unless —
(i) the Director conducts a pilot program of limited scope, conducted over a period of not
more than 18 months, which demonstrates that
searches by commercial entities of the available prior
art relating to the subject matter of inventions claimed
in patent applications —


(I) are accurate; and
====35 U.S.C. 115 Oath of applicant.====


(II) meet or exceed the standards of  
The applicant shall make oath that he believes himself to be the original and first inventor of the process,
searches conducted by and used by the Patent and
machine, manufacture, or composition of matter, or
Trademark Office during the patent examination process;  
improvement thereof, for which he solicits a patent;  
(ii) the Director submits a report on the  
and shall state of what country he is a citizen. Such
results of the pilot program to Congress and the Patent
oath may be made before any person within the  
Public Advisory Committee that includes —
United States authorized by law to administer oaths,
(I) a description of the scope and
or, when made in a foreign country, before any diplomatic or consular officer of the United States authorized to administer oaths, or before any officer having
duration o f the pilot program;
an official seal and authorized to administer oaths in
(II) the identity of each commercial
the foreign country in which the applicant may be,
entity participating in the pilot program;
whose authority is proved by certificate of a diplomatic or consular officer of the United States, or apostille of an official designated by a foreign country
which, by treaty or convention, accords like effect to
apostilles of designated officials in the United States.
Such oath is valid if it complies with the laws of the
state or country where made. When the application is
made as provided in this title by a person other than
the inventor, the oath may be so varied in form that it
can be made by him. For purposes of this section, a
consular officer shall include any United States citizen serving overseas, authorized to perform notarial
functions pursuant to section 1750 of the Revised
Statutes, as amended (22 U.S.C. 4221).


(Amended Aug. 27, 1982, Public Law 97-247, sec.
14(a), 96 Stat. 321; Oct. 21, 1998, Pub. L. 105-277, sec.
2222(d), 112 Stat. 2681-818.)


(III) an explanation of the methodology used to evaluate the accuracy and quality of the
====35 U.S.C. 116 Inventors.====
search reports; and


(IV) an assessment of the effects that
When an invention is made by two or more persons
the pilot program, as compared to searches conducted
jointly, they shall apply for patent jointly and each
by the Patent and Trademark Office, had and will
make the required oath, except as otherwise provided
have on —
in this title. Inventors may apply for a patent jointly
even though (1) they did not physically work together
or at the same time, (2) each did not make the same
type or amount of contribution, or (3) each did not
make a contribution to the subject matter of every
claim of the patent.


(aa) patentability determinations;
If a joint inventor refuses to join in an application
(bb) productivity of the Patent and  
for patent or cannot be found or reached after diligent
Trademark Office;
effort, the application may be made by the other
inventor on behalf of himself and the omitted inventor. The Director, on proof of the pertinent facts and  
after such notice to the omitted inventor as he prescribes, may grant a patent to the inventor making the
application, subject to the same rights which the omitted inventor would have had if he had been joined.
The omitted inventor may subsequently join in the
application.


(cc) costs to the Patent and Trade
Whenever through error a person is named in an
application for patent as the inventor, or through an
error an inventor is not named in an application, and  


mark Office;
(dd) costs to patent applicants; and
(ee) other relevant factors;


(iii) the Patent Public Advisory Committee reviews and analyzes the Director’s report under
such error arose without any deceptive intention on
clause (ii) and the results of the pilot program and
his part, the Director may permit the application to be
submits a separate report on its analysis to the Director and the Congress that includes —
amended accordingly, under such terms as he prescribes.


(I) an independent evaluation of the
(Amended Aug. 27, 1982, Public Law 97-247, sec.
effects that the pilot program, as compared to searches
6(a), 96 Stat. 320; Nov. 8, 1984, Public Law 98-622, sec.
conducted by the Patent and Trademark Office, had
104(a), 98 Stat. 3384; Nov. 29, 1999, Public Law 106-113,  
and will have on the factors set forth in clause
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
(ii)(IV); and
4732(a)(10)(A)).)
(II) an analysis of the reasonableness,  
appropriateness, and effectiveness of the methods
used in the pilot program to make the evaluations
required under clause (ii)(IV); and
(iv) Congress does not, during the 1year period beginning on the date on which the Patent
Public Advisory Committee submits its report to the
Congress under clause (iii), enact a law prohibiting
searches by commercial entities of the available prior
art relating to the subject matter of inventions claimed
in patent applications.  


(F) The Director shall require that any
====35 U.S.C. 117 Death or incapacity of inventor.====
search by a qualified search authority that is a commercial entity is conducted in the United States by
persons that —


(i) if individuals, are United States citizens; and  
Legal representatives of deceased inventors and of
those under legal incapacity may make application for
patent upon compliance with the requirements and on
the same terms and conditions applicable to the inventor.


(ii) if business concerns, are organized
====35 U.S.C. 118 Filing by other than inventor.====
under the laws of the United States or any State and
employ United States citizens to perform the searches.  


(G) A search of an application that is the  
Whenever an inventor refuses to execute an application for patent, or cannot be found or reached after
subject of a secrecy order under section 181 or otherwise involves classified information may only be conducted by Office personnel.  
diligent effort, a person to whom the inventor has
assigned or agreed in writing to assign the invention
or who otherwise shows sufficient proprietary interest
in the matter justifying such action, may make application for patent on behalf of and as agent for the
inventor on proof of the pertinent facts and a showing
that such action is necessary to preserve the rights of
the parties or to prevent irreparable damage; and the
Director may grant a patent to such inventor upon
such notice to him as the Director deems sufficient,
and on compliance with such regulations as he prescribes.  


(H) A qualified search authority that is a
(Amended Nov. 29, 1999, Public Law 106-113, sec.
commercial entity may not conduct a search of a
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
patent application if the entity has any direct or indirect financial interest in any patent or in any pending
4732(a)(10)(A)).)
or imminent application for patent filed or to be filed
in the Patent and Trademark Office.  


(2) OTHER FEES. — The Director shall
====35 U.S.C. 119 Benefit of earlier filing date; right of priority.====
establish fees for all other processing, services, or
materials relating to patents not specified in this section to recover the estimated average cost to the
Office of such processing, services; or materials,
except that the Director shall charge the following
fees for the following services:


(A) For recording a document affecting
(a) An application for patent for an invention
title, $40 per property.  
filed in this country by any person who has, or whose
legal representatives or assigns have, previously regularly filed an application for a patent for the same
invention in a foreign country which affords similar
privileges in the case of applications filed in the
United States or to citizens of the United States, or in
a WTO member country, shall have the same effect as
the same application would have if filed in this country on the date on which the application for patent for
the same invention was first filed in such foreign
country, if the application in this country is filed
within twelve months from the earliest date on which
such foreign application was filed; but no patent shall
be granted on any application for patent for an invention which had been patented or described in a printed
publication in any country more than one year before
the date of the actual filing of the application in this
country, or which had been in public use or on sale in
this country more than one year prior to such filing.  


(B) For each photocopy, $.25 per page.  
(b)(1)No application for patent shall be entitled to
this right of priority unless a claim is filed in the
Patent and Trademark Office, identifying the foreign
application by specifying the application number on
that foreign application, the intellectual property
authority or country in or for which the application
was filed, and the date of filing the application, at
such time during the pendency of the application as
required by the Director.  


(C) For each black and white copy of a  
(2) The Director may consider the failure of  
patent, $3. The yearly fee for providing a library specified in section 12 of this title with uncertified printed
the applicant to file a timely claim for priority as a  
copies of the specifications and drawings for all patents in that year shall be $50.  
waiver of any such claim. The Director may establish
 
procedures, including the payment of a surcharge, to
(Dec. 8, 2004, Public Law 108-447, sec. 801, 118
accept an unintentionally delayed claim under this
Stat. 2809.)  
section.
 
(3) The Director may require a certified copy
The bracketed text below is the unamended text
of the original foreign application, specification, and  
of 35 U.S.C. 41(d), which may continue to have
drawings upon which it is based, a translation if not in  
effect following fiscal year 2006:
the English language, and such other information as
the Director considers necessary. Any such certification shall be made by the foreign intellectual property
authority in which the foreign application was filed
and show the date of the application and of the filing
of the specification and other papers.  
(c) In like manner and subject to the same conditions and requirements, the right provided in this
section may be based upon a subsequent regularly
filed application in the same foreign country instead
of the first filed foreign application, provided that any
foreign application filed prior to such subsequent
application has been withdrawn, abandoned, or otherwise disposed of, without having been laid open to
public inspection and without leaving any rights outstanding, and has not served, nor thereafter shall
serve, as a basis for claiming a right of priority.  
(d) Applications for inventors’ certificates filed
in a foreign country in which applicants have a right
to apply, at their discretion, either for a patent or for
an inventor’s certificate shall be treated in this country
in the same manner and have the same effect for purpose of the right of priority under this section as applications for patents, subject to the same conditions and
requirements of this section as apply to applications
for patents, provided such applicants are entitled to  
the benefits of the Stockholm Revision of the Paris
Convention at the time of such filing.


(d) The Director shall establish fees for all other
(e)(1)An application for patent filed under section
processing, services, or materials relating to patents
111(a) or section 363 of this title for an invention disclosed in the manner provided by the first paragraph
not specified in this section to recover the estimated
of section 112 of this title in a provisional application
average cost to the Office of such processing, services, or materials, except that the Director shall
filed under section 111(b) of this title, by an inventor
charge the following fees for the following services:
or inventors named in the provisional application,  
shall have the same effect, as to such invention, as
though filed on the date of the provisional application
filed under section 111(b) of this title, if the application for patent filed under section 111(a) or section
363 of this title is filed not later than 12 months after
the date on which the provisional application was
filed and if it contains or is amended to contain a specific reference to the provisional application. No
application shall be entitled to the benefit of an earlier
filed provisional application under this subsection
unless an amendment containing the specific reference to the earlier filed provisional application is submitted at such time during the pendency of the
application as required by the Director. The Director
may consider the failure to submit such an amendment within that time period as a waiver of any benefit under this subsection. The Director may establish
procedures, including the payment of a surcharge, to
accept an unintentionally delayed submission of an
amendment under this subsection during the pendency
of the application


(1) For recording a document affecting title, $40 per property.
(2) A provisional application filed under section 111(b) of this title may not be relied upon in any
 
proceeding in the Patent and Trademark Office unless
(2) For each photocopy, $.25 per page.
the fee set forth in subparagraph (A) or (C) of section
41(a)(1) of this title has been paid.
(3) If the day that is 12 months after the filing
date of a provisional application falls on a Saturday,
Sunday, or Federal holiday within the District of
Columbia, the period of pendency of the provisional
application shall be extended to the next succeeding
secular or business day.  
(f) Applications for plant breeder’s rights filed
in a WTO member country (or in a foreign UPOV
Contracting Party) shall have the same effect for the
purpose of the right of priority under subsections (a)  


(3) For each black and white copy of a
patent, $3.
The yearly fee for providing a library specified in section 13 of this title with uncertified printed
copies of the specifications and drawings for all patents issued in that year shall be $50.]


through (c) of this section as applications for patents,
subject to the same conditions and requirements of
this section as apply to applications for patents.


(e) The Director may waive the payment of any
(g) As used in this section—
fee for any service or material related to patents in  
connection with an occasional or incidental request
made by a department or agency of the Government,
or any officer thereof. The Director may provide any
applicant issued a notice under section 132 of this title
with a copy of the specifications and drawings for all
patents referred to in that notice without charge.
(f) The fees established in subsections (a) and


(1) the term “WTO member country” has the
same meaning as the term is defined in section
104(b)(2) of this title; and
(2) the term “UPOV Contracting Party”
means a member of the International Convention for
the Protection of New Varieties of Plants.


(b) of this section may be adjusted by the Director on
October 1, 1992, and every year thereafter, to reflect
any fluctuations occurring during the previous 12
months in the Consumer Price Index, as determined
by the Secretary of Labor. Changes of less than 1 per
centum may be ignored.


(Amended Oct. 3, 1961, Public Law 87-333, sec. 1, 75
Stat. 748; July 28, 1972, Public Law 92-358, sec. 1, 86 Stat.
501; Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949;
Dec. 8, 1994, Public Law 103-465, sec. 532(b)(1), 108 Stat.
4985.)


*Editor’s Note: During fiscal years 2005 and
(Subsection (b) amended Nov. 29, 1999, Public Law  
2006, subsection (f) of section 41 of title 35, United
106-113, sec. 1000(a)(9), 113 Stat. 1501A-563 (S. 1948
States Code applies to the fees established under
sec.4503(a)).)  
section 801 of Public Law 108-447. (Dec. 8, 2004,  
Public Law 108-447, sec. 801, 118 Stat. 2809.)  


(g) No fee established by the Director under
(Subsection (e) amended Nov. 29, 1999, Public Law
this section shall take effect until at least 30 days after
106-113, sec. 1000(a)(9), 113 Stat. 1501A-564, 588, 589
notice of the fee has been published in the Federal
Register and in the Official Gazette of the Patent and
Trademark Office.  


*Editor’s Note: During fiscal years 2005 and  
(S. 1948 secs. 4503(b)(2), 4801 and 4802).)
2006, subsection (h) of section 41 of title 35, United
(Subsections (f) and (g) added Nov. 29, 1999, Public
States Code, shall be administered as though subsection (h) reads as follows:
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-589


(h)(1) Subject to paragraph (3), fees charged
(S. 1948 sec. 4802).)
under subsections (a), (b) and (d)(1) shall be reduced
by 50 percent with respect to their application to any
small business concern as defined under section 3 of
the Small Business Act, and to any independent
inventor or nonprofit organization as defined in regulations issued by the Director.


(2) With respect to its application to any
====35 U.S.C. 120 Benefit of earlier filing date in the United States.====
entity described in paragraph (1), any surcharge or fee
charged under subsection (c) or (d) shall not be higher


An application for patent for an invention disclosed
in the manner provided by the first paragraph of section 112 of this title in an application previously filed
in the United States, or as provided by section 363 of
this title, which is filed by an inventor or inventors
named in the previously filed application shall have
the same effect, as to such invention, as though filed
on the date of the prior application, if filed before the
patenting or abandonment of or termination of proceedings on the first application or on an application
similarly entitled to the benefit of the filing date of the
first application and if it contains or is amended to
contain a specific reference to the earlier filed application. No application shall be entitled to the benefit of
an earlier filed application under this section unless an
amendment containing the specific reference to the
earlier filed application is submitted at such time during the pendency of the application as required by the
Director. The Director may consider the failure to
submit such an amendment within that time period as
a waiver of any benefit under this section. The Director may establish procedures, including the payment
of a surcharge, to accept an unintentionally delayed
submission of an amendment under this section.


than the surcharge or fee required of any other entity
(Amended Nov. 14, 1975, Public Law 94-131, sec. 9,
under the same or substantially similar circumstances.  
89 Stat. 691; Nov. 8, 1984, Public Law 98-622, sec. 104(b),
98 Stat. 3385; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-563 (S. 1948 sec.
4503(b)(1)).)


(3) The fee charged under subsection
====35 U.S.C. 121 Divisional applications.====
(a)(l)(A) shall be reduced by 75 percent with respect
to its application to any entity to which paragraph (1)
applies, if the application is filed by electronic means
as prescribed by the Director.  


(Dec. 8, 2004, Public Law 108-447, sec. 801, 118
If two or more independent and distinct inventions
Stat. 2809.)
are claimed in one application, the Director may
require the application to be restricted to one of the
inventions. If the other invention is made the subject
of a divisional application which complies with the
requirements of section 120 of this title it shall be
entitled to the benefit of the filing date of the original
application. A patent issuing on an application with
respect to which a requirement for restriction under
this section has been made, or on an application filed
as a result of such a requirement, shall not be used as a
reference either in the Patent and Trademark Office or
in the courts against a divisional application or against
the original application or any patent issued on either
of them, if the divisional application is filed before the
issuance of the patent on the other application. If a
divisional application is directed solely to subject
matter described and claimed in the original application as filed, the Director may dispense with signing
and execution by the inventor. The validity of a patent
shall not be questioned for failure of the Director to
require the application to be restricted to one invention.  


The bracketed text below is the unamended text
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
of 35 U.S.C. 41(h), which may continue to have
88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.  
effect following fiscal year 2006:
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


[(h)(1) Fees charged under subsection (a) or (b)
====35 U.S.C. 122 Confidential status of applications; publication of patent applications.====
shall be reduced by 50 percent with respect to their
application to any small business concern as defined
under section 3 of the Small Business Act, and to any
independent inventor or nonprofit organization as
defined in regulations issued by the Director.  


(2) With respect to its application to any
(a) CONFIDENTIALITY.— Except as provided in subsection (b), applications for patents shall
entity described in paragraph (1), any surcharge or fee
be kept in confidence by the Patent and Trademark
charged under subsection (c) or (d) shall not be higher
Office and no information concerning the same given
than the surcharge or fee required of any other entity
without authority of the applicant or owner unless
under the same or substantially similar circumstances.]
necessary to carry out the provisions of an Act of  
(i)(1) The Director shall maintain, for use by the  
Congress or in such special circumstances as may be
public, paper, microform or electronic collections of
determined by the Director.  
United States patents, foreign patent documents, and
United States trademark registrations arranged to permit search for and retrieval of information. The Director may not impose fees directly for the use of such  
collections, or for the use of the public patent and
trademark search rooms or libraries.  


(b) PUBLICATION.—


(2) The Director shall provide for the full
(1) IN GENERAL.
deployment of the automated search systems of the
Patent and Trademark Office so that such systems are
available for use by the public, and shall assure full
access by the public to, and dissemination of, patent
and trademark information, using a variety of automated methods, including electronic bulletin boards
and remote access by users to mass storage and
retrieval systems.  
(3) The Director may establish reasonable
fees for access by the public to the automated search
systems of the Patent and Trademark Office. If such
fees are established, a limited amount of free access
shall be made available to users of the systems for
purposes of education and training. The Director may
waive the payment by an individual of fees authorized


(A) Subject to paragraph (2), each application for a patent shall be published, in accordance
with procedures determined by the Director, promptly
after the expiration of a period of 18 months from the
earliest filing date for which a benefit is sought under
this title. At the request of the applicant, an application may be published earlier than the end of such 18month period.
(B) No information concerning published
patent applications shall be made available to the public except as the Director determines.
(C) Notwithstanding any other provision of
law, a determination by the Director to release or not
to release information concerning a published patent
application shall be final and nonreviewable.
(2) EXCEPTIONS.—


by this subsection upon a showing of need or hardship, and if such waiver is in the public interest.
(A) An application shall not be published if  
that application is—
(i) no longer pending;


(4) The Director shall submit to the Congress
(ii) subject to a secrecy order under section 181 of this title;
an annual report on the automated search systems of  
the Patent and Trademark Office and the access by the
public to such systems. The Director shall also publish such report in the Federal Register. The Director
shall provide an opportunity for the submission of
comments by interested persons on each such report.


(Amended July 24, 1965, Public Law 89-83, sec. 1, 2,
(iii) a provisional application filed under
79 Stat. 259; Jan. 2, 1975, Public Law 93-596, sec. 1, Jan.
section 111(b) of this title; or
2, 1975, 88 Stat. 1949; Nov. 14, 1975, Public Law 94-131,
sec. 3, 89 Stat. 690.)


(Subsection (g) amended Dec. 12, 1980, Public Law
(iv) an application for a design patent
96-517, sec. 2, 94 Stat. 3017; Aug. 27, 1982, Public Law
filed under chapter 16 of this title.
97-247, sec. 3(a)-(e), 96 Stat. 317.)
(B)(i) If an applicant makes a request upon
filing, certifying that the invention disclosed in the
application has not and will not be the subject of an
application filed in another country, or under a multilateral international agreement, that requires publication of applications 18 months after filing, the
application shall not be published as provided in paragraph (1).  


(Subsections (a)-(d) amended Sept. 8, 1982, Public
(ii) An applicant may rescind a request
Law 97-256, sec. 101, 96 Stat. 816.)
made under clause (i) at any time.  


(Subsection (a)(6) amended Nov. 8, 1984, Public Law
(iii) An applicant who has made a
98-622, sec. 204(a), 98 Stat. 3388.)
request under clause (i) but who subsequently files, in
a foreign country or under a multilateral international
agreement specified in clause (i), an application
directed to the invention disclosed in the application
filed in the Patent and Trademark Office, shall notify
the Director of such filing not later than 45 days after
the date of the filing of such foreign or international
application. A failure of the applicant to provide such
notice within the prescribed period shall result in the
application being regarded as abandoned, unless it is
shown to the satisfaction of the Director that the delay
in submitting the notice was unintentional.  


(Subsection (h) added Nov. 6, 1986, Public Law 99607, sec. 1(b)(2), 100 Stat. 3470.)  
(iv) If an applicant rescinds a request
 
made under clause (i) or notifies the Director that an
(Subsections (a), (b), (d), (f), and (g) amended Dec. 10,
application was filed in a foreign country or under a
1991, Public Law 102-204, sec. 5, 105 Stat. 1637.)
multilateral international agreement specified in
 
clause (i), the application shall be published in accordance with the provisions of paragraph (1) on or as
(Subsections (a)(9) - (15) and (i) added Dec. 10, 1991,
soon as is practical after the date that is specified in
Public Law 102-204, sec. 5, 105 Stat. 1637.)
clause (i).
 
(v) If an applicant has filed applications
(Subsection (c)(1) amended Oct. 23, 1992, Public Law  
in one or more foreign countries, directly or through a
102-444, sec. 1, 106 Stat. 2245.)
multilateral international agreement, and such foreign
 
filed applications corresponding to an application
(Subsection (a)(1)(C) added Dec. 8, 1994, Public Law  
filed in the Patent and Trademark Office or the
103-465, sec. 532(b)(2), 108 Stat. 4986.)
description of the invention in such foreign filed
 
applications is less extensive than the application or
(Subsection (c)(2) amended, Dec. 8, 1994, Public Law
description of the invention in the application filed in
103-465, sec. 533(b)(1), 108 Stat. 4988.)
the Patent and Trademark Office, the applicant may
 
submit a redacted copy of the application filed in the
(Subsections (a)-(b) revised Nov. 10, 1998, Public Law
Patent and Trademark Office eliminating any part or
105-358, sec. 3, 112 Stat. 3272.)  
description of the invention in such application that is
not also contained in any of the corresponding applications filed in a foreign country. The Director may
only publish the redacted copy of the application
unless the redacted copy of the application is not
received within 16 months after the earliest effective
filing date for which a benefit is sought under this
title. The provisions of section 154(d) shall not apply
to a claim if the description of the invention published
in the redacted application filed under this clause with
respect to the claim does not enable a person skilled in
the art to make and use the subject matter of the claim.  
(c) PROTEST AND PRE-ISSUANCE OPPOSITION.— The Director shall establish appropriate
procedures to ensure that no protest or other form of
pre-issuance opposition to the grant of a patent on an
application may be initiated after publication of the
application without the express written consent of the
applicant.
(d) NATIONAL SECURITY.— No application
for patent shall be published under subsection (b)(1) if
the publication or disclosure of such invention would
be detrimental to the national security. The Director
shall establish appropriate procedures to ensure that
such applications are promptly identified and the
secrecy of such inventions is maintained in accordance with chapter 17 of this title.  
 
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.  
1000(a)(9), 113 Stat. 1501A-563 (S. 1948 sec.  
4503(b)(1)).)  


(Amended Nov. 29, 1999, Public Law 106-113, sec.
===CHAPTER 12 — EXAMINATION OF APPLICATION===
1000(a)(9), 113 Stat. 1501A-554, 570, 582, 589 (S. 1948
secs. 4202, 4605(a), 4732(a)(5), 4732(a)(10)(A)) and
4804(d)).)


35 U.S.C. 42 Patent and Trademark Office funding.
Sec.
131 Examination of application.  
132 Notice of rejection; reexamination.
133 Time for prosecuting application.
134 Appeal to the Board of Patent Appeals and


(a) All fees for services performed by or materials furnished by the Patent and Trademark Office
Interferences.
will be payable to the Director.
135 Interferences.  


(b) All fees paid to the Director and all appropriations for defraying the costs of the activities of the
====35 U.S.C. 131 Examination of application.====
Patent and Trademark Office will be credited to the
Patent and Trademark Office Appropriation Account
in the Treasury of the United States.  


(c) To the extent and in the amounts provided in
The Director shall cause an examination to be made
advance in appropriations Acts, fees authorized in this
of the application and the alleged new invention; and  
title or any other Act to be charged or established by
if on such examination it appears that the applicant is
the Director shall be collected by and shall be available to the Director to carry out the activities of the
entitled to a patent under the law, the Director shall
Patent and Trademark Office. All fees available to the
issue a patent therefor.  
Director under section 31 of the Trademark Act of
1946 shall be used only for the processing of trademark registrations and for other activities, services
and materials relating to trademarks and to cover a  
proportionate share of the administrative costs of the  
Patent and Trademark Office.  


(d) The Director may refund any fee paid by
(Amended Nov. 29, 1999, Public Law 106-113, sec.
mistake or any amount paid in excess of that required.  
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


(e) The Secretary of Commerce shall, on the
====35 U.S.C. 132 Notice of rejection; reexamination.====
day each year on which the President submits the
annual budget to the Congress, provide to the Committees on the Judiciary of the Senate and the House
of Representatives:


(1) a list of patent and trademark fee collections by the Patent and Trademark Office during the  
(a) Whenever, on examination, any claim for a  
preceding fiscal year;
patent is rejected, or any objection or requirement
made, the Director shall notify the applicant thereof,
stating the reasons for such rejection, or objection or
requirement, together with such information and references as may be useful in judging of the propriety of
continuing the prosecution of his application; and if
after receiving such notice, the applicant persists in
his claim for a patent, with or without amendment, the
application shall be reexamined. No amendment shall
introduce new matter into the disclosure of the invention.
(b) The Director shall prescribe regulations to
provide for the continued examination of applications
for patent at the request of the applicant. The Director
may establish appropriate fees for such continued
examination and shall provide a 50 percent reduction
in such fees for small entities that qualify for reduced
fees under section 41(h)(1) of this title.


(2) a list of activities of the Patent and Trademark Office during the preceding fiscal year which
were supported by patent fee expenditures, trademark
fee expenditures, and appropriations;


(3) budget plans for significant programs,  
(Amended Nov. 29, 1999, Public Law 106-113, sec.
projects, and activities of the Office, including out-
1000(a)(9), 113 Stat. 1501A-560, 582 (S. 1948 secs. 4403
year funding estimates;
and 4732(a)(10)(A)).)


(4) any proposed disposition of surplus fees
====35 U.S.C. 133 Time for prosecuting application.====
by the Office; and


(5) such other information as the committees
Upon failure of the applicant to prosecute the application within six months after any action therein, of
consider necessary.
which notice has been given or mailed to the applicant, or within such shorter time, not less than thirty
 
days, as fixed by the Director in such action, the
 
application shall be regarded as abandoned by the parties thereto, unless it be shown to the satisfaction of
(Amended Nov. 14, 1975, Public Law 94-131, sec. 4,  
the Director that such delay was unavoidable.  
89 Stat. 690; Dec. 12, 1980, Public Law 96-517, sec. 3, 94
Stat. 3018; Aug. 27, 1982, Public Law 97-247, sec. 3(g), 96
Stat. 319; Sept. 13, 1982, Public Law 97-258, sec. 3(i), 96
Stat. 1065.)
 
(Subsection (c) amended Dec. 10, 1991, Public Law
102-204, sec. 5(e), 105 Stat. 1640.)
 
(Subsection (e) added Dec. 10, 1991, Public Law 102204, sec. 4, 105 Stat. 1637.)
 
(Subsection (c) revised Nov. 10, 1998, Public Law
105-358, sec. 4, 112 Stat. 3274.)


(Amended Nov. 29, 1999, Public Law 106-113, sec.  
(Amended Nov. 29, 1999, Public Law 106-113, sec.  
1000(a)(9), 113 Stat. 1501A-555, 582 (S. 1948 secs. 4205
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
and 4732(a)(10)(A)).)  
4732(a)(10)(A)).)  


PART II — PATENTABILITY OF
====35 U.S.C. 134 Appeal to the Board of Patent Appeals and Interferences.====
INVENTIONS AND GRANT OF
PATENTS


CHAPTER 10 PATENTABILITY OF
(a) PATENT APPLICANT.An applicant for
INVENTIONS
a patent, any of whose claims has been twice rejected,
may appeal from the decision of the primary examiner
to the Board of Patent Appeals and Interferences, having once paid the fee for such appeal.
(b) PATENT OWNER.— A patent owner in
any reexamination proceeding may appeal from the
final rejection of any claim by the primary examiner
to the Board of Patent Appeals and Interferences, having once paid the fee for such appeal.
(c) THIRD-PARTY.— A third-party requester
in an inter partes proceeding may appeal to the Board
of Patent Appeals and Interferences from the final
decision of the primary examiner favorable to the patentability of any original or proposed amended or new
claim of a patent, having once paid the fee for such
appeal.


Sec.
(Amended Nov. 8, 1984, Public Law 98-622, sec.
204(b)(1), 98 Stat. 3388; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec.
4605(b)); subsections (a)-(c) amended Nov. 2, 2002, Public
Law 107-273, secs. 13106 and 13202, 116 Stat. 1901.)


100 Definitions.
====35 U.S.C. 135 Interferences.====


101 Inventions patentable.  
(a) Whenever an application is made for a
 
patent which, in the opinion of the Director, would
102 Conditions for patentability; novelty and loss of
interfere with any pending application, or with any
right to patent.  
unexpired patent, an interference may be declared and
 
the Director shall give notice of such declaration to
103 Conditions for patentability; non-obvious sub
the applicants, or applicant and patentee, as the case
ject matter.  
may be. The Board of Patent Appeals and Interferences shall determine questions of priority of the
inventions and may determine questions of patentability. Any final decision, if adverse to the claim of an
applicant, shall constitute the final refusal by the
Patent and Trademark Office of the claims involved,
and the Director may issue a patent to the applicant
who is adjudged the prior inventor. A final judgment
adverse to a patentee from which no appeal or other
review has been or can be taken or had shall constitute
cancellation of the claims involved in the patent, and
notice of such cancellation shall be endorsed on copies of the patent distributed after such cancellation by
the Patent and Trademark Office.  


104 Invention made abroad.  
(b)(1)A claim which is the same as, or for the
same or substantially the same subject matter as, a
claim of an issued patent may not be made in any
application unless such a claim is made prior to one
year from the date on which the patent was granted.  


105 Inventions in outer space.  
(2) A claim which is the same as, or for the
same or substantially the same subject matter as, a
claim of an application published under section
122(b) of this title may be made in an application filed
after the application is published only if the claim is
made before 1 year after the date on which the application is published.
(c) Any agreement or understanding between
parties to an interference, including any collateral
agreements referred to therein, made in connection
with or in contemplation of the termination of the
interference, shall be in writing and a true copy
thereof filed in the Patent and Trademark Office
before the termination of the interference as between
the said parties to the agreement or understanding. If
any party filing the same so requests, the copy shall be
kept separate from the file of the interference, and
made available only to Government agencies on written request, or to any person on a showing of good
cause. Failure to file the copy of such agreement or
understanding shall render permanently unenforceable such agreement or understanding and any patent
of such parties involved in the interference or any
patent subsequently issued on any application of such
parties so involved. The Director may, however, on a
showing of good cause for failure to file within the
time prescribed, permit the filing of the agreement or
understanding during the six-month period subsequent to the termination of the interference as
between the parties to the agreement or understanding.  


===35 U.S.C. 100 Definitions.===
The Director shall give notice to the parties or
their attorneys of record, a reasonable time prior to
said termination, of the filing requirement of this section. If the Director gives such notice at a later time,
irrespective of the right to file such agreement or
understanding within the six-month period on a showing of good cause, the parties may file such agreement
or understanding within sixty days of the receipt of
such notice.  


When used in this title unless the context otherwise
Any discretionary action of the Director under
indicates
this subsection shall be reviewable under section 10
of the Administrative Procedure Act.
 
(d) Parties to a patent interference, within such
time as may be specified by the Director by regulation, may determine such contest or any aspect thereof
by arbitration. Such arbitration shall be governed by
the provisions of title 9 to the extent such title is not
inconsistent with this section. The parties shall give
notice of any arbitration award to the Director, and
such award shall, as between the parties to the arbitration, be dispositive of the issues to which it relates.
The arbitration award shall be unenforceable until
such notice is given. Nothing in this subsection shall
preclude the Director from determining patentability
of the invention involved in the interference.


(a) The term “invention” means invention or
(Subsection (c) added Oct. 15, 1962, Public Law 87831, 76 Stat. 958.)
discovery.  


(b) The term “process” means process, art, or
(Subsections (a) and (c) amended, Jan. 2, 1975, Public
method, and includes a new use of a known process,  
Law 93-596, sec. 1, 88 Stat. 1949.)
machine, manufacture, composition of matter, or
material.  


(c) The terms “United States” and “this country” mean the United States of America, its territories
(Subsection (a) amended Nov. 8, 1984, Public Law 98622, sec. 202, 98 Stat. 3386.)
and possessions.  


(d) The word “patentee” includes not only the
(Subsection (d) added Nov. 8, 1984, Public Law 98622, sec. 105, 98 Stat. 3385.)
patentee to whom the patent was issued but also the
successors in title to the patentee.  


(e) The term “third-party requester” means a  
(Amended Nov. 29, 1999, Public Law 106-113, sec.
person requesting ex parte reexamination under section 302 or inter partes reexamination under section
1000(a)(9), 113 Stat. 1501A-566, 582 (S. 1948 secs.
311 who is not the patent owner.
4507(11) and 4732(a)(10)(A)).)


(Subsection (e) added Nov. 29, 1999, Public Law
===CHAPTER 13 — REVIEW OF PATENT AND TRADEMARK OFFICE DECISION===
106-113, sec. 1000(a)(9), 113 Stat. 1501A-567 (S. 1948
sec. 4603).)


===35 U.S.C. 101 Inventions patentable.===
Sec.
141 Appeal to Court of Appeals for the Federal Cir


Whoever invents or discovers any new and useful
process, machine, manufacture, or composition of
matter, or any new and useful improvement thereof,
may obtain a patent therefor, subject to the conditions
and requirements of this title.


===35 U.S.C. 102 Conditions for patentability; novelty and loss of right to patent.===
cuit.  
142 Notice of appeal.  
143 Proceedings on appeal.  
144 Decision on appeal.
145 Civil action to obtain patent.  
146 Civil action in case of interference.


A person shall be entitled to a patent unless —
====35 U.S.C. 141 Appeal to the Court of Appeals for the Federal Circuit.====


(a) the invention was known or used by others
An applicant dissatisfied with the decision in an
in this country, or patented or described in a printed
appeal to the Board of Patent Appeals and Interferences under section 134 of this title may appeal the
publication in this or a foreign country, before the  
decision to the United States Court of Appeals for the
invention thereof by the applicant for patent, or
Federal Circuit. By filing such an appeal the applicant
waives his or her right to proceed under section 145 of
this title. A patent owner, or a third-party requester in
an inter partes reexamination proceeding, who is in
any reexamination proceeding dissatisfied with the
final decision in an appeal to the Board of Patent
Appeals and Interferences under section 134 may
appeal the decision only to the United States Court of
Appeals for the Federal Circuit. A party to an interference dissatisfied with the decision of the Board of
Patent Appeals and Interferences on the interference
may appeal the decision to the United States Court of
Appeals for the Federal Circuit, but such appeal shall
be dismissed if any adverse party to such interference,
within twenty days after the appellant has filed notice
of appeal in accordance with section 142 of this title,  
files notice with the Director that the party elects to
have all further proceedings conducted as provided in
section 146 of this title. If the appellant does not,
within thirty days after filing of such notice by the  
adverse party, file a civil action under section 146, the
decision appealed from shall govern the further proceedings in the case.


(b) the invention was patented or described in a  
(Amended Apr. 2, 1982, Public Law 97-164, sec.
printed publication in this or a foreign country or in
163(a)(7), (b)(2), 96 Stat. 49, 50; Nov. 8, 1984, Public Law
public use or on sale in this country, more than one
98-622, sec. 203(a), 98 Stat. 3387; Nov. 29, 1999, Public
year prior to the date of the application for patent in
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-571, 582
the United States, or


(c) he has abandoned the invention, or
(S. 1948 secs. 4605(c) and 4732(a)(10)(A)); Nov. 2, 2002,
Public Law 107-273, sec. 13106, 116 Stat. 1901.)


(d) the invention was first patented or caused to
====35 U.S.C. 142 Notice of appeal.====
be patented, or was the subject of an inventor’s certificate, by the applicant or his legal representatives or
assigns in a foreign country prior to the date of the
application for patent in this country on an application
for patent or inventor’s certificate filed more than
twelve months before the filing of the application in
the United States, or


(e) the invention was described in — (1) an
When an appeal is taken to the United States Court
application for patent, published under section 122(b),  
of Appeals for the Federal Circuit, the appellant shall
by another filed in the United States before the invention by the applicant for patent or (2) a patent granted
file in the Patent and Trademark Office a written
on an application for patent by another filed in the  
notice of appeal directed to the Director, within such
United States before the invention by the applicant for
time after the date of the decision from which the  
patent, except that an international application filed
appeal is taken as the Director prescribes, but in no
under the treaty defined in section 351(a) shall have
case less than 60 days after that date.
the effects for the purposes of this subsection of an
 
application filed in the United States only if the international application designated the United States and
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
was published under Article 21(2) of such treaty in
Stat. 1949; Apr. 2, 1982, Public Law 97-164, sec.
the English language; or
163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-620,
sec. 414(a), 98 Stat. 3363; Nov. 29, 1999, Public Law 106
113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)  


(f) he did not himself invent the subject matter
====35 U.S.C. 143 Proceedings on appeal.====
sought to be patented, or


(g)(1) during the course of an interference conducted under section 135 or section 291, another
With respect to an appeal described in section 142
inventor involved therein establishes, to the extent
of this title, the Director shall transmit to the United
permitted in section 104, that before such person’s
States Court of Appeals for the Federal Circuit a certified list of the documents comprising the record in the
invention thereof the invention was made by such
Patent and Trademark Office. The court may request
other inventor and not abandoned, suppressed, or concealed, or (2) before such person’s invention thereof,  
that the Director forward the original or certified copies of such documents during the pendency of the  
the invention was made in this country by another
appeal. In an ex parte case or any reexamination case,  
inventor who had not abandoned, suppressed, or concealed it. In determining priority of invention under
the Director shall submit to the court in writing the
this subsection, there shall be considered not only the
grounds for the decision of the Patent and Trademark
respective dates of conception and reduction to practice of the invention, but also the reasonable diligence
Office, addressing all the issues involved in the
of one who was first to conceive and last to reduce to
appeal. The court shall, before hearing an appeal, give
practice, from a time prior to conception by the other.  
notice of the time and place of the hearing to the  
Director and the parties in the appeal.  


(Amended July 28, 1972, Public Law 92-358, sec. 2,  
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
86 Stat. 501; Nov. 14, 1975, Public Law 94-131, sec. 5, 89
88 Stat. 1949; Apr. 2, 1982, Public Law 97-164, sec.
Stat. 691.)  
163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-620,
sec. 414(a), 98 Stat. 3363; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-571, 582 (S. 1948
secs. 4605(d) and 4732(a)(10)(A)); Nov. 2, 2002, Public
Law 107-273, sec. 13202, 116 Stat. 1901.)  


(Subsection (e) amended Nov. 29, 1999, Public Law
====35 U.S.C. 144 Decision on appeal.====
106-113, sec. 1000(a)(9), 113 Stat. 1501A-565 (S. 1948
sec. 4505).)


(Subsection (g) amended Nov. 29, 1999, Public Law
The United States Court of Appeals for the Federal
106-113, sec. 1000(a)(9), 113 Stat. 1501A-590 (S. 1948
Circuit shall review the decision from which an
sec. 4806).)
appeal is taken on the record before the Patent and
Trademark Office. Upon its determination the court
shall issue to the Director its mandate and opinion,  
which shall be entered of record in the Patent and
Trademark Office and shall govern the further proceedings in the case.  


(Subsection (e) amended Nov. 2, 2002, Public Law  
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
107-273, sec. 13205, 116 Stat. 1903.)  
Stat. 1949; Apr. 2, 1982, Public Law 97-164, sec.
163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-620,
sec. 414(a), 98 Stat. 3363; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)  


===35 U.S.C. 103 Conditions for patentability; non-
====35 U.S.C. 145 Civil action to obtain patent.====
obvious subject matter.===


(a) A patent may not be obtained though the  
An applicant dissatisfied with the decision of the  
invention is not identically disclosed or described as
Board of Patent Appeals and Interferences in an
set forth in section 102 of this title, if the differences
appeal under section 134(a) of this title may, unless
between the subject matter sought to be patented and
appeal has been taken to the United States Court of
the prior art are such that the subject matter as a whole
Appeals for the Federal Circuit, have remedy by civil
would have been obvious at the time the invention
action against the Director in the United States District Court for the District of Columbia if commenced
was made to a person having ordinary skill in the art
within such time after such decision, not less than
to which said subject matter pertains. Patentability
sixty days, as the Director appoints. The court may
shall not be negatived by the manner in which the
adjudge that such applicant is entitled to receive a
invention was made.  
patent for his invention, as specified in any of his
claims involved in the decision of the Board of Patent
Appeals and Interferences, as the facts in the case may
appear, and such adjudication shall authorize the
Director to issue such patent on compliance with the
requirements of law. All the expenses of the proceedings shall be paid by the applicant.  


(b)(1) Notwithstanding subsection (a), and upon
(Amended Apr. 2, 1982, Public Law 97-164, sec.
timely election by the applicant for patent to proceed
163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-622,
under this subsection, a biotechnological process
sec. 203(b), 98 Stat. 3387; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-571, 582 (S. 1948
using or resulting in a composition of matter that is
secs. 4605(e) and 4732(a)(10)(A).)
novel under section 102 and nonobvious under subsection (a) of this section shall be considered nonobvious if


(A) claims to the process and the composition of matter are contained in either the same application for patent or in separate applications having the
====35 U.S.C. 146 Civil action in case of interference.====
same effective filing date; and


(B) the composition of matter, and the process at the time it was invented, were owned by the  
Any party to an interference dissatisfied with the
same person or subject to an obligation of assignment
decision of the Board of Patent Appeals and Interferences may have remedy by civil action, if commenced
to the same person.  
within such time after such decision, not less than
sixty days, as the Director appoints or as provided in
section 141 of this title, unless he has appealed to the  
United States Court of Appeals for the Federal Circuit, and such appeal is pending or has been decided.
In such suits the record in the Patent and Trademark
Office shall be admitted on motion of either party
upon the terms and conditions as to costs, expenses,  
and the further cross-examination of the witnesses as
the court imposes, without prejudice to the right of the
parties to take further testimony. The testimony and
exhibits of the record in the Patent and Trademark
Office when admitted shall have the same effect as if
originally taken and produced in the suit.  


(2) A patent issued on a process under paragraph (1)
Such suit may be instituted against the party in
interest as shown by the records of the Patent and
Trademark Office at the time of the decision complained of, but any party in interest may become a
party to the action. If there be adverse parties residing
in a plurality of districts not embraced within the
same state, or an adverse party residing in a foreign
country, the United States District Court for the District of Columbia shall have jurisdiction and may
issue summons against the adverse parties directed to
the marshal of any district in which any adverse party
resides. Summons against adverse parties residing in
foreign countries may be served by publication or otherwise as the court directs. The Director shall not be a
necessary party but he shall be notified of the filing of
the suit by the clerk of the court in which it is filed
and shall have the right to intervene. Judgment of the
court in favor of the right of an applicant to a patent
shall authorize the Director to issue such patent on the
filing in the Patent and Trademark Office of a certified copy of the judgment and on compliance with the
requirements of law.


(A) shall also contain the claims to the
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
composition of matter used in or made by that process, or
88 Stat. 1949; Apr. 2, 1982, Public Law 97-164, sec.
163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-622,
sec. 203(c), 98 Stat. 3387; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


(B) shall, if such composition of matter is
===CHAPTER 14 — ISSUE OF PATENT===
claimed in another patent, be set to expire on the same
date as such other patent, notwithstanding section


154.  
Sec.
 
151 Issue of patent.
(3) For purposes of paragraph (1), the term
152 Issue of patent to assignee.
“biotechnological process” means
153 How issued.
(A) a process of genetically altering or otherwise inducing a single- or multi-celled organism to
154 Contents and term of patent; provisional rights.
(i) express an exogenous nucleotide
155 Patent term extension.
sequence,
155A Patent term restoration.
(ii) inhibit, eliminate, augment, or alter
156 Extension of patent term.
expression of an endogenous nucleotide sequence, or
157 Statutory invention registration.




(iii) express a specific physiological
====35 U.S.C. 151 Issue of patent.====
characteristic not naturally associated with said organism;


(B) cell fusion procedures yielding a cell
If it appears that applicant is entitled to a patent
line that expresses a specific protein, such as a monoclonal antibody; and
under the law, a written notice of allowance of the
(C) a method of using a product produced
application shall be given or mailed to the applicant.
by a process defined by subparagraph (A) or (B), or a  
The notice shall specify a sum, constituting the issue
combination of subparagraphs (A) and (B).
fee or a portion thereof, which shall be paid within
(c)(1) Subject matter developed by another person, which qualifies as prior art only under one or
three months thereafter.  
more of subsections (e), (f), and (g) of section 102 of  
this title, shall not preclude patentability under this
section where the subject matter and the claimed
invention were, at the time the claimed invention was
made, owned by the same person or subject to an obligation of assignment to the same person.  


Upon payment of this sum the patent shall issue,
but if payment is not timely made, the application
shall be regarded as abandoned.


(2) For purposes of this subsection, subject
Any remaining balance of the issue fee shall be
matter developed by another person and a claimed
paid within three months from the sending of a notice
invention shall be deemed to have been owned by the  
thereof, and, if not paid, the patent shall lapse at the  
same person or subject to an obligation of assignment
termination of this three-month period. In calculating
to the same person if —
the amount of a remaining balance, charges for a page
or less may be disregarded.


(A) the claimed invention was made by or
If any payment required by this section is not
on behalf of parties to a joint research agreement that
timely made, but is submitted with the fee for delayed
was in effect on or before the date the claimed invention was made;
payment and the delay in payment is shown to have
been unavoidable, it may be accepted by the Director
as though no abandonment or lapse had ever occurred.


(B) the claimed invention was made as a  
(Amended July 24, 1965, Public Law 89-83, sec. 4,
result of activities undertaken within the scope of the
79 Stat. 260; Jan. 2, 1975, Public Law 93-601, sec. 3, 88
joint research agreement; and
Stat. 1956; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)); Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)
 
====35 U.S.C. 152 Issue of patent to assignee.====


(C) the application for patent for the  
Patents may be granted to the assignee of the inventor of record in the Patent and Trademark Office, upon
claimed invention discloses or is amended to disclose
the application made and the specification sworn to  
the names of the parties to the joint research agreement.  
by the inventor, except as otherwise provided in this
title.  


(3) For purposes of paragraph (2), the term
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,  
“joint research agreement” means a written contract,  
88 Stat. 1949.)
grant, or cooperative agreement entered into by two or
more persons or entities for the performance of experimental, developmental, or research work in the field
of the claimed invention.  


(Amended Nov. 8, 1984, Public Law 98-622, sec. 103,
====35 U.S.C. 153 How issued.====
98 Stat. 3384; Nov. 1, 1995, Public Law 104-41, sec.1, 109
Stat. 3511.)


(Subsection (c) amended Nov. 29, 1999, Public Law
Patents shall be issued in the name of the United
106-113, sec. 1000(a)(9), 113 Stat. 1501A-591 (S. 1948
States of America, under the seal of the Patent and
sec. 4807).)
Trademark Office, and shall be signed by the Director
or have his signature placed thereon and shall be
recorded in the Patent and Trademark Office.  


(Subsection (c) amended Dec. 10, 2004, Public Law  
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
108-453 , sec. 2, 118 Stat. 3596.)  
88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
4732(a)(10)(A)); Nov. 2, 2002, Public Law 107-273, sec.  
13203, 116 Stat. 1902.)  


===35 U.S.C. 104 Invention made abroad.===
====35 U.S.C. 154 Contents and term of patent; provisional rights.====


(a) IN GENERAL.—  
(a) IN GENERAL.—  


(1) PROCEEDINGS.—In proceedings in the  
(1) CONTENTS.—Every patent shall contain a short title of the invention and a grant to the patentee, his heirs or assigns, of the right to exclude
Patent and Trademark Office, in the courts, and before
others from making, using, offering for sale, or selling
any other competent authority, an applicant for a
the invention throughout the United States or importing the invention into the United States, and, if the
patent, or a patentee, may not establish a date of  
invention is a process, of the right to exclude others
invention by reference to knowledge or use thereof, or
from using, offering for sale or selling throughout the  
other activity with respect thereto, in a foreign country other than a NAFTA country or a WTO member
United States, or importing into the United States,  
country, except as provided in sections 119 and 365 of
products made by that process, referring to the specification for the particulars thereof.  
this title.
(2) TERM.—Subject to the payment of fees
(2) RIGHTS.—If an invention was made by
under this title, such grant shall be for a term beginning on the date on which the patent issues and ending
a person, civil or military—
20 years from the date on which the application for
(A) while domiciled in the United States,
the patent was filed in the United States or, if the  
and serving in any other country in connection with
application contains a specific reference to an earlier
operations by or on behalf of the United States,  
filed application or applications under section 120,  
(B) while domiciled in a NAFTA country
121, or 365(c) of this title, from the date on which the
and serving in another country in connection with
earliest such application was filed.
operations by or on behalf of that NAFTA country, or
(C) while domiciled in a WTO member
country and serving in another country in connection
with operations by or on behalf of that WTO member
country, that person shall be entitled to the same rights
of priority in the United States with respect to such
invention as if such invention had been made in the  
United States, that NAFTA country, or that WTO
member country, as the case may be.  
(3) USE OF INFORMATION.—To the  
extent that any information in a NAFTA country or a
WTO member country concerning knowledge, use, or
other activity relevant to proving or disproving a date  
of invention has not been made available for use in a
proceeding in the Patent and Trademark Office, a
court, or any other competent authority to the same
extent as such information could be made available in  
the United States, the Director, court, or such other


(3) PRIORITY.—Priority under section 119,
365(a), or 365(b) of this title shall not be taken into
account in determining the term of a patent.
(4) SPECIFICATION AND DRAWING.—A
copy of the specification and drawing shall be
annexed to the patent and be a part of such patent.
(b) ADJUSTMENT OF PATENT TERM.—
(1) PATENT TERM GUARANTEES.—


(A) GUARANTEE OF PROMPT PATENT
 
AND TRADEMARK OFFICE RESPONSES.— Subject to the limitations under paragraph (2), if the issue
authority shall draw appropriate inferences, or take
of an original patent is delayed due to the failure of
other action permitted by statute, rule, or regulation,  
the Patent and Trademark Office to—
in favor of the party that requested the information in
(i) provide at least one of the notifications under section 132 of this title or a notice of
the proceeding.
allowance under section 151 of this title not later than
14 months after—
(I) the date on which an application
was filed under section 111(a) of this title; or  
(II) the date on which an international
application fulfilled the requirements of section 371
of this title;
(ii) respond to a reply under section 132,  
or to an appeal taken under section 134, within
4 months after the date on which the reply was filed or
the appeal was taken;


(b) DEFINITIONS.—As used in this section—
(iii) act on an application within
4 months after the date of a decision by the Board of
Patent Appeals and Interferences under section 134 or
135 or a decision by a Federal court under section
141, 145, or 146 in a case in which allowable claims
remain in the application; or
 
(iv) issue a patent within 4 months after
the date on which the issue fee was paid under section
151 and all outstanding requirements were satisfied,
the term of the patent shall be extended 1 day for each
day after the end of the period specified in clause (i),
(ii), (iii), or (iv), as the case may be, until the action
described in such clause is taken.
(B) GUARANTEE OF NO MORE THAN
3-YEAR APPLICATION PENDENCY.— Subject to
the limitations under paragraph (2), if the issue of an
original patent is delayed due to the failure of the
United States Patent and Trademark Office to issue a
patent within 3 years after the actual filing date of the
application in the United States, not including—


(1) The term “NAFTA country” has the  
(i) any time consumed by continued
meaning given that term in section 2(4) of the North
examination of the application requested by the applicant under section 132(b);  
American Free Trade Agreement Implementation
(ii) any time consumed by a proceeding
Act; and
under section 135(a), any time consumed by the
(2) The term “WTO member country” has
imposition of an order under section 181, or any time
the meaning given that term in section 2(10) of the  
consumed by appellate review by the Board of Patent
Uruguay Round Agreements Act.
Appeals and Interferences or by a Federal court; or


(iii) any delay in the processing of the
application by the United States Patent and Trademark Office requested by the applicant except as permitted by paragraph (3)(C), the term of the patent
shall be extended 1 day for each day after the end of
that 3-year period until the patent is issued.


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,  
(C) GUARANTEE OR ADJUSTMENTS
88 Stat. 1949; Nov. 14, 1975, Public Law 94-131, sec. 6,
FOR DELAYS DUE TO INTERFERENCES,  
89 Stat. 691; Nov. 8, 1984, Public Law 98-622, sec. 403(a),  
SECRECY ORDERS, AND APPEALS.— Subject to
98 Stat. 3392; Dec. 8, 1993, Public Law 103-182, sec. 331,
the limitations under paragraph (2), if the issue of an
107 Stat. 2113; Dec. 8, 1994, Public Law 103-465, sec.
original patent is delayed due to—
531(a), 108 Stat. 4982; Nov. 29, 1999, Public Law 106-113,
(i) a proceeding under section 135(a);
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


35 U.S.C. 105 Inventions in outer space.
(ii) the imposition of an order under section 181; or


(a) Any invention made, used, or sold in outer
(iii) appellate review by the Board of  
space on a space object or component thereof under
Patent Appeals and Interferences or by a Federal court
the jurisdiction or control of the United States shall be
in a case in which the patent was issued under a decision in the review reversing an adverse determination
considered to be made, used or sold within the United
of patentability, the term of the patent shall be  
States for the purposes of this title, except with
extended 1 day for each day of the pendency of the  
respect to any space object or component thereof that
proceeding, order, or review, as the case may be.  
is specifically identified and otherwise provided for
by an international agreement to which the United
States is a party, or with respect to any space object or
component thereof that is carried on the registry of a  
foreign state in accordance with the Convention on
Registration of Objects Launched into Outer Space.
(b) Any invention made, used, or sold in outer
space on a space object or component thereof that is
carried on the registry of a foreign state in accordance
with the Convention on Registration of Objects
Launched into Outer Space, shall be considered to be  
made, used, or sold within the United States for the  
purposes of this title if specifically so agreed in an
international agreement between the United States
and the state of registry.  


(2) LIMITATIONS.—


(Added Nov. 15, 1990, Public Law 101-580, sec. 1(a),
(A) IN GENERAL.— To the extent that
104 Stat. 2863.)  
periods of delay attributable to grounds specified in
 
paragraph (1) overlap, the period of any adjustment
CHAPTER 11 APPLICATION FOR PATENT
granted under this subsection shall not exceed the
 
actual number of days the issuance of the patent was
Sec.
delayed.  
 
(B) DISCLAIMED TERM.— No patent
111 Application.  
the term of which has been disclaimed beyond a specified date may be adjusted under this section beyond
the expiration date specified in the disclaimer.  
(C) REDUCTION OF PERIOD OF
ADJUSTMENT.—  
(i) The period of adjustment of the term
of a patent under paragraph (1) shall be reduced by a
period equal to the period of time during which the
applicant failed to engage in reasonable efforts to conclude prosecution of the application.  


112 Specification.  
(ii) With respect to adjustments to patent
term made under the authority of paragraph (1)(B), an
applicant shall be deemed to have failed to engage in
reasonable efforts to conclude processing or examination of an application for the cumulative total of any
periods of time in excess of 3 months that are taken to
respond to a notice from the Office making any rejection, objection, argument, or other request, measuring
such 3-month period from the date the notice was
given or mailed to the applicant.  


113 Drawings.  
(iii) The Director shall prescribe regulations establishing the circumstances that constitute a
failure of an applicant to engage in reasonable efforts
to conclude processing or examination of an application.  


114 Models, specimens.  
(3) PROCEDURES FOR PATENT TERM
ADJUSTMENT DETERMINATION.—
(A) The Director shall prescribe regulations establishing procedures for the application for
and determination of patent term adjustments under
this subsection.
(B) Under the procedures established
under subparagraph (A), the Director shall—
(i) make a determination of the period
of any patent term adjustment under this subsection,
and shall transmit a notice of that determination with
the written notice of allowance of the application
under section 151; and
(ii) provide the applicant one opportunity to request reconsideration of any patent term
adjustment determination made by the Director.
(C) The Director shall reinstate all or part
of the cumulative period of time of an adjustment
under paragraph (2)(C) if the applicant, prior to the
issuance of the patent, makes a showing that, in spite
of all due care, the applicant was unable to respond
within the 3-month period, but in no case shall more
than three additional months for each such response
beyond the original 3-month period be reinstated.
(D) The Director shall proceed to grant the
patent after completion of the Director’s determination of a patent term adjustment under the procedures
established under this subsection, notwithstanding
any appeal taken by the applicant of such determination.  


115 Oath of applicant.


116 Inventors.  
(4) APPEAL OF PATENT TERM ADJUSTMENT DETERMINATION.
 
(A) An applicant dissatisfied with a determination made by the Director under paragraph (3)
117 Death or incapacity of inventor.  
shall have remedy by a civil action against the Director filed in the United States District Court for the
District of Columbia within 180 days after the grant
of the patent. Chapter 7 of title 5 shall apply to such
action. Any final judgment resulting in a change to the
period of adjustment of the patent term shall be served
on the Director, and the Director shall thereafter alter
the term of the patent to reflect such change.
(B) The determination of a patent term
adjustment under this subsection shall not be subject
to appeal or challenge by a third party prior to the
grant of the patent.
(c) CONTINUATION.


118 Filing by other than inventor.


119 Benefit of earlier filing date; right of priority.  
(1) DETERMINATION.—The term of a
patent that is in force on or that results from an application filed before the date that is 6 months after the
date of the enactment of the Uruguay Round Agreements Act shall be the greater of the 20-year term as
provided in subsection (a), or 17 years from grant,
subject to any terminal disclaimers.
(2) REMEDIES.—The remedies of sections
283, 284, and 285 of this title shall not apply to acts
which —
(A) were commenced or for which substantial investment was made before the date that is 6
months after the date of the enactment of the Uruguay
Round Agreements Act; and
(B) became infringing by reason of paragraph (1).
(3) REMUNERATION.—The acts referred
to in paragraph (2) may be continued only upon the
payment of an equitable remuneration to the patentee
that is determined in an action brought under chapter
28 and chapter 29 (other than those provisions
excluded by paragraph (2)) of this title.
(d) PROVISIONAL RIGHTS.


120 Benefit of earlier filing date in the United
States.


121 Divisional applications.  
(1) IN GENERAL.— In addition to other
rights provided by this section, a patent shall include
the right to obtain a reasonable royalty from any person who, during the period beginning on the date of
publication of the application for such patent under
section 122(b), or in the case of an international application filed under the treaty defined in section 351(a)
designating the United States under Article 21(2)(a)
of such treaty, the date of publication of the application, and ending on the date the patent is issued—


122 Confidential status of applications; publication
(A) (i) makes, uses, offers for sale, or sells
 
in the United States the invention as claimed in the
of patent applications.  
published patent application or imports such an invention into the United States; or
 
(ii) if the invention as claimed in the
35 U.S.C. 111 Application.  
published patent application is a process, uses, offers
 
for sale, or sells in the United States or imports into
(a) IN GENERAL.
the United States products made by that process as
claimed in the published patent application; and
(B) had actual notice of the published
patent application and, in a case in which the right
arising under this paragraph is based upon an international application designating the United States that is
published in a language other than English, had a
translation of the international application into the
English language.
(2) RIGHT BASED ON SUBSTANTIALLY
IDENTICAL INVENTIONS.— The right under paragraph (1) to obtain a reasonable royalty shall not be
available under this subsection unless the invention as
claimed in the patent is substantially identical to the
invention as claimed in the published patent application.  
(3) TIME LIMITATION ON OBTAINING A
REASONABLE ROYALTY.— The right under paragraph (1) to obtain a reasonable royalty shall be available only in an action brought not later than 6 years
after the patent is issued. The right under paragraph
(1) to obtain a reasonable royalty shall not be affected
by the duration of the period described in paragraph
(1).  
(4) REQUIREMENTS FOR INTERNATIONAL APPLICATIONS—
(A) EFFECTIVE DATE.— The right under
paragraph (1) to obtain a reasonable royalty based
upon the publication under the treaty defined in section 351(a) of an international application designating
the United States shall commence on the date of publication under the treaty of the international application, or, if the publication under the treaty of the
international application is in a language other than
English, on the date on which the Patent and Trademark Office receives a translation of the publication
in the English language.  


(1) WRITTEN APPLICATION.—An application for patent shall be made, or authorized to be
(B) COPIES.The Director may require
made, by the inventor, except as otherwise provided
the applicant to provide a copy of the international
in this title, in writing to the Director.
application and a translation thereof.  
(2) CONTENTS.—Such application shall
include—
(A) a specification as prescribed by section
112 of this title;
(B) a drawing as prescribed by section 113
of this title; and
(C) an oath by the applicant as prescribed
by section 115 of this title.
(3) FEE AND OATH.—The application must
be accompanied by the fee required by law. The fee
and oath may be submitted after the specification and
any required drawing are submitted, within such
period and under such conditions, including the payment of a surcharge, as may be prescribed by the
Director.
(4) FAILURE TO SUBMIT.—Upon failure
to submit the fee and oath within such prescribed
period, the application shall be regarded as abandoned, unless it is shown to the satisfaction of the  
Director that the delay in submitting the fee and oath
was unavoidable or unintentional. The filing date of
an application shall be the date on which the specification and any required drawing are received in the
Patent and Trademark Office.  


(Amended July 24, 1965, Public Law 89-83, sec. 5, 79
Stat. 261; Dec. 12, 1980, Public Law 96-517, sec. 4, 94
Stat. 3018; Aug. 23, 1988, Public Law 100-418, sec. 9002,
102 Stat. 1563; Dec. 8, 1994, Public Law 103-465, sec. 532
(a)(1), 108 Stat. 4983; Oct. 11, 1996, Public Law 104-295,
sec. 20(e)(1), 110 Stat. 3529.)


(Subsection (b) amended Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-557 (S. 1948
sec. 4402(a)).)


(b) PROVISIONAL APPLICATION.
(Subsection (d) added Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-564 (S. 1948 sec.
4504).)


(1) AUTHORIZATION.—A provisional
(Subsection (b)(4) amended Nov. 2, 2002, Public Law
application for patent shall be made or authorized to
107-273, sec. 13206, 116 Stat. 1904; subsection (d)(4)(A)  
be made by the inventor, except as otherwise provided
amended Nov. 2, 2002, Public Law 107-273, sec. 13204,  
in this title, in writing to the Director. Such application shall include—
116 Stat. 1902.)  
(A) a specification as prescribed by the
first paragraph of section 112 of this title; and
(B) a drawing as prescribed by section 113
of this title.  
(2) CLAIM.—A claim, as required by the
second through fifth paragraphs of section 112, shall
not be required in a provisional application.  
(3) FEE.—


====35 U.S.C. 155 Patent term extension.====


(A) The application must be accompanied
Notwithstanding the provisions of section 154, the  
by the fee required by law.
term of a patent which encompasses within its scope a
(B) The fee may be submitted after the  
composition of matter or a process for using such
specification and any required drawing are submitted,
composition shall be extended if such composition or
within such period and under such conditions, including the payment of a surcharge, as may be prescribed
process has been subjected to a regulatory review by  
by the Director.
the Federal Food and Drug Administration pursuant
(C) Upon failure to submit the fee within
to the Federal Food, Drug and Cosmetic Act leading
such prescribed period, the application shall be
to the publication of regulation permitting the interstate distribution and sale of such composition or process and for which there has thereafter been a stay of
regarded as abandoned, unless it is shown to the satisfaction of the Director that the delay in submitting the  
regulation of approval imposed pursuant to section
fee was unavoidable or unintentional.
409 of the Federal Food, Drug and Cosmetic Act,
(4) FILING DATE.—The filing date of a
which stay was in effect on January 1, 1981, by a
provisional application shall be the date on which the  
length of time to be measured from the date such stay
specification and any required drawing are received in
of regulation of approval was imposed until such proceedings are finally resolved and commercial marketing permitted. The patentee, his heirs, successors, or  
the Patent and Trademark Office.  
assigns shall notify the Director within 90 days of the
(5) ABANDONMENT.—Notwithstanding
date of enactment of this section or the date the stay of
the absence of a claim, upon timely request and as
regulation of approval has been removed, whichever
prescribed by the Director, a provisional application
is later, of the number of the patent to be extended and  
may be treated as an application filed under subsection (a). Subject to section 119(e)(3) of this title, if no
the date the stay was imposed and the date commercial marketing was permitted. On receipt of such
such request is made, the provisional application shall
notice, the Director shall promptly issue to the owner
be regarded as abandoned 12 months after the filing
of record of the patent a certificate of extension, under
date of such application and shall not be subject to  
seal, stating the fact and length of the extension and
revival after such 12-month period.
identifying the composition of matter or process for
(6) OTHER BASIS FOR PROVISIONAL
using such composition to which such extension is
APPLICATION.—Subject to all the conditions in this
applicable. Such certificate shall be recorded in the  
subsection and section 119(e) of this title, and as prescribed by the Director, an application for patent filed
official file of each patent extended and such certificate shall be considered as part of the original patent,  
under subsection (a) may be treated as a provisional
and an appropriate notice shall be published in the  
application for patent.
Official Gazette of the Patent and Trademark Office.
(7) NO RIGHT OF PRIORITY OR BENEFIT OF EARLIEST FILING DATE.—A provisional
application shall not be entitled to the right of priority


(Added Jan. 4, 1983, Public Law 97-414, sec. 11(a),
96 Stat. 2065; amended Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 secs.
4732(a)(6) and 4732(a)(10)(A)).)


of any other application under section 119 or 365(a)
====35 U.S.C. 155A Patent term restoration.====
of this title or to the benefit of an earlier filing date in
the United States under section 120, 121, or 365(c) of
this title.  


(8) APPLICABLE PROVISIONS.—The
(a) Notwithstanding section 154 of this title, the
provisions of this title relating to applications for
term of each of the following patents shall be
patent shall apply to provisional applications for
extended in accordance with this section:
patent, except as otherwise provided, and except that
(1) Any patent which encompasses within its
provisional applications for patent shall not be subject
scope a composition of matter which is a new drug
to sections 115, 131, 135, and 157 of this title.
product, if during the regulatory review of the product
 
by the Federal Food and Drug Administration —
(Amended Aug. 27, 1982, Public Law 97-247, sec. 5,  
(A) the Federal Food and Drug Administration notified the patentee, by letter dated February
96 Stat. 319; Dec. 8, 1994, Public Law 103-465, sec.
20, 1976, that such product’s new drug application
532(b)(3), 108 Stat. 4986; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582, 588 (S. 1948
was not approvable under section 505(b)(1) of the
secs. 4732(a)(10)(A), 4801(a)).)
Federal Food, Drug and Cosmetic Act;
 
(B) in 1977 the patentee submitted to the
35 U.S.C. 112 Specification.
Federal Food and Drug Administration the results of a
 
health effects test to evaluate the carcinogenic potential of such product;  
The specification shall contain a written description
(C) the Federal Food and Drug Administration approved, by letter dated December 18, 1979,  
of the invention, and of the manner and process of
the new drug application for such application; and
making and using it, in such full, clear, concise, and  
(D) the Federal Food and Drug Administration approved, by letter dated May 26, 1981, a supplementary application covering the facility for the
exact terms as to enable any person skilled in the art
production of such product.  
to which it pertains, or with which it is most nearly
(2) Any patent which encompasses within its
connected, to make and use the same, and shall set
scope a process for using the composition described
forth the best mode contemplated by the inventor of  
in paragraph (1).
carrying out his invention.  
(b) The term of any patent described in subsection (a) shall be extended for a period equal to the
 
period beginning February 20, 1976, and ending May
The specification shall conclude with one or more
26, 1981, and such patent shall have the effect as if
claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as
originally issued with such extended term.
his invention.  
(c) The patentee of any patent described in subsection (a) of this section shall, within ninety days
after the date of enactment of this section, notify the  
Director of the number of any patent so extended. On
receipt of such notice, the Director shall confirm such
extension by placing a notice thereof in the official
file of such patent and publishing an appropriate
notice of such extension in the Official Gazette of the  
Patent and Trademark Office.  


A claim may be written in independent or, if the
(Added Oct. 13, 1983, Public Law 98-127, sec. 4(a),
nature of the case admits, in dependent or multiple
97 Stat. 832; amended Nov. 29, 1999, Public Law 106-113,  
dependent form.  
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 secs.
4732(a)(7) and 4732(a)(10)(A)).)


Subject to the following paragraph, a claim in
====35 U.S.C. 156 Extension of patent term.====
dependent form shall contain a reference to a claim
previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by
reference all the limitations of the claim to which it
refers.  


A claim in multiple dependent form shall contain a  
(a) The term of a patent which claims a product, a method of using a product, or a method of manufacturing a product shall be extended in accordance
reference, in the alternative only, to more than one
with this section from the original expiration date of
claim previously set forth and then specify a further
the patent, which shall include any patent term adjustment granted under section 154(b) if —
limitation of the subject matter claimed. A multiple
(1) the term of the patent has not expired
dependent claim shall not serve as a basis for any
before an application is submitted under subsection
other multiple dependent claim. A multiple dependent
(d)(1) for its extension;
claim shall be construed to incorporate by reference
(2) the term of the patent has never been
all the limitations of the particular claim in relation to
extended under subsection (e)(1) of this section;
which it is being considered.
(3) an application for extension is submitted
 
by the owner of record of the patent or its agent and in
accordance with the requirements of paragraphs (1)
through (4) of subsection (d);
(4) the product has been subject to a regulatory review period before its commercial marketing or
use;
(5)(A) except as provided in subparagraph (B)
or (C), the permission for the commercial marketing
or use of the product after such regulatory review
period is the first permitted commercial marketing or
use of the product under the provision of law under
which such regulatory review period occurred;


An element in a claim for a combination may be
(B) in the case of a patent which claims a  
expressed as a means or step for performing a specified function without the recital of structure, material,
method of manufacturing the product which primarily
or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material,
uses recombinant DNA technology in the manufacture of the product, the permission for the commercial
or acts described in the specification and equivalents
marketing or use of the product after such regulatory
thereof.
period is the first permitted commercial marketing or
use of a product manufactured under the process
claimed in the patent; or  
(C) for purposes of subparagraph (A), in
the case of a patent which —
(i) claims a new animal drug or a veterinary biological product which (I) is not covered by
the claims in any other patent which has been
extended, and (II) has received permission for the  
commercial marketing or use in non-food-producing
animals and in food-producing animals, and  


(Amended July 24, 1965, Public Law 89-83, sec. 9,
(ii) was not extended on the basis of the
79 Stat. 261; Nov. 14, 1975, Public Law 94-131, sec. 7,
regulatory review period for use in non-food-producing animals, the permission for the commercial marketing or use of the drug or product after the
89 Stat. 691.)
regulatory review period for use in food-producing
animals is the first permitted commercial marketing
or use of the drug or product for administration to a
food-producing animal.  
The product referred to in paragraphs


35 U.S.C. 113 Drawings.  
(4) and (5) is hereinafter in this section referred to as
 
the “approved product.
The applicant shall furnish a drawing where necessary for the understanding of the subject matter
(b) Except as provided in subsection (d)(5)(F),
sought to be patented. When the nature of such subject matter admits of illustration by a drawing and the  
the rights derived from any patent the term of which is
applicant has not furnished such a drawing, the Director may require its submission within a time period of  
extended under this section shall during the period
not less than two months from the sending of a notice
during which the term of the patent is extended —
thereof. Drawings submitted after the filing date of  
(1) in the case of a patent which claims a
the application may not be used (i) to overcome any  
product, be limited to any use approved for the product —
insufficiency of the specification due to lack of an
(A) before the expiration of the term of the
enabling disclosure or otherwise inadequate disclosure therein, or (ii) to supplement the original disclosure thereof for the purpose of interpretation of the  
patent —
scope of any claim.
(i) under the provision of law under
which the applicable regulatory review occurred, or
(ii) under the provision of law under
which any regulatory review described in paragraph
(1), (4), or (5) of subsection (g) occurred, and  
(B) on or after the expiration of the regulatory review period upon which the extension of the
patent was based;
(2) in the case of a patent which claims a
method of using a product, be limited to any use
claimed by the patent and approved for the product —
(A) before the expiration of the term of the
patent —
(i) under any provision of law under
which an applicable regulatory review occurred, and
(ii) under the provision of law under
which any regulatory review described in paragraph
(1), (4), or (5) of subsection (g) occurred, and
(B) on or after the expiration of the regulatory review period upon which the extension of the
patent was based; and
(3) in the case of a patent which claims a
method of manufacturing a product, be limited to the  
method of manufacturing as used to make —
(A) the approved product, or


(Amended Nov. 14, 1975, Public Law 94-131, sec. 8,
(B) the product if it has been subject to a
89 Stat. 691; Nov. 29, 1999, Public Law 106-113, sec.
regulatory review period described in paragraph (1),  
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
(4), or (5) of subsection (g).  
4732(a)(10)(A)).)


35 U.S.C. 114 Models, specimens.  
As used in this subsection, the term “product” includes an approved product.  


The Director may require the applicant to furnish a
(c) The term of a patent eligible for extension
model of convenient size to exhibit advantageously
under subsection (a) shall be extended by the time
the several parts of his invention.
equal to the regulatory review period for the approved
 
product which period occurs after the date the patent
When the invention relates to a composition of matter, the Director may require the applicant to furnish
is issued, except that—
specimens or ingredients for the purpose of inspection
(1) each period of the regulatory review
or experiment.
period shall be reduced by any period determined
 
under subsection (d)(2)(B) during which the applicant  
(Amended Nov. 29, 1999, Public Law 106-113, sec.
for the patent extension did not act with due diligence
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
during such period of the regulatory review period;
4732(a)(10)(A)).)  
(2) after any reduction required by paragraph
(1), the period of extension shall include only one-half
of the time remaining in the periods described in paragraphs (1)(B)(i), (2)(B)(i), (3)(B)(i), (4)(B)(i), and
(5)(B)(i) of subsection (g);
(3) if the period remaining in the term of a  
patent after the date of the approval of the approved
product under the provision of law under which such
regulatory review occurred when added to the regulatory review period as revised under paragraphs (1)  
and (2) exceeds fourteen years, the period of extension shall be reduced so that the total of both such
periods does not exceed fourteen years, and
(4) in no event shall more than one patent be
extended under subsection (e)(i) for the same regulatory review period for any product.
(d)(1) To obtain an extension of the term of a
patent under this section, the owner of record of the
patent or its agent shall submit an application to the
Director. Except as provided in paragraph (5), such an
application may only be submitted within the sixty-
day period beginning on the date the product received
permission under the provision of law under which
the applicable regulatory review period occurred for
commercial marketing or use. The application shall
contain —


35 U.S.C. 115 Oath of applicant.
(A) the identity of the approved product
and the Federal statute under which regulatory review
occurred;
(B) the identity of the patent for which an
extension is being sought and the identity of each
claim of such patent;
(C) information to enable the Director to
determine under subsections (a) and (b) the eligibility
of a patent for extension and the rights that will be
derived from the extension and information to enable
the Director and the Secretary of Health and Human
Services or the Secretary of Agriculture to determine
the period of the extension under subsection (g);


The applicant shall make oath that he believes himself to be the original and first inventor of the process,
(D) a brief description of the activities
machine, manufacture, or composition of matter, or
undertaken by the applicant during the applicable regulatory review period with respect to the approved
improvement thereof, for which he solicits a patent;
product and the significant dates applicable to such
and shall state of what country he is a citizen. Such
activities; and  
oath may be made before any person within the  
(E) such patent or other information as the  
United States authorized by law to administer oaths,
Director may require.
or, when made in a foreign country, before any diplomatic or consular officer of the United States authorized to administer oaths, or before any officer having
(2)(A) Within 60 days of the submittal of an  
an official seal and authorized to administer oaths in
application for extension of the term of a patent under
the foreign country in which the applicant may be,
paragraph (1), the Director shall notify —
whose authority is proved by certificate of a diplomatic or consular officer of the United States, or apostille of an official designated by a foreign country
which, by treaty or convention, accords like effect to
apostilles of designated officials in the United States.
Such oath is valid if it complies with the laws of the
state or country where made. When the application is
made as provided in this title by a person other than
the inventor, the oath may be so varied in form that it
can be made by him. For purposes of this section, a
consular officer shall include any United States citizen serving overseas, authorized to perform notarial
functions pursuant to section 1750 of the Revised
Statutes, as amended (22 U.S.C. 4221).


(Amended Aug. 27, 1982, Public Law 97-247, sec.
(i) the Secretary of Agriculture if the
14(a), 96 Stat. 321; Oct. 21, 1998, Pub. L. 105-277, sec.
patent claims a drug product or a method of using or
2222(d), 112 Stat. 2681-818.)
manufacturing a drug product and the drug product is
subject to the Virus-Serum-Toxin Act, and
(ii) the Secretary of Health and Human
Services if the patent claims any other drug product, a
medical device, or a food additive or color additive or
a method of using or manufacturing such a product,
device, or additive and if the product, device, and
additive are subject to the Federal Food, Drug and
Cosmetic Act, of the extension application and shall
submit to the Secretary who is so notified a copy of
the application. Not later than 30 days after the receipt
of an application from the Director, the Secretary
reviewing the application shall review the dates contained in the application pursuant to paragraph (1)(C)  
and determine the applicable regulatory review
period, shall notify the Director of the determination,  
and shall publish in the Federal Register a notice of
such determination.  


35 U.S.C. 116 Inventors.


When an invention is made by two or more persons
(B)(i) If a petition is submitted to the Secretary making the determination under subparagraph
jointly, they shall apply for patent jointly and each
(A), not later than 180 days after the publication of the
make the required oath, except as otherwise provided
determination under subparagraph (A), upon which it
in this title. Inventors may apply for a patent jointly
may reasonably be determined that the applicant did
even though (1) they did not physically work together
not act with due diligence during the applicable regulatory review period, the Secretary making the determination shall, in accordance with regulations
or at the same time, (2) each did not make the same
promulgated by the Secretary, determine if the applicant acted with due diligence during the applicable
type or amount of contribution, or (3) each did not
regulatory review period. The Secretary making the
make a contribution to the subject matter of every
determination shall make such determination not later
claim of the patent.  
than 90 days after the receipt of such a petition. For a
drug product, device, or additive subject to the Federal Food, Drug, and Cosmetic Act or the Public
Health Service Act, the Secretary may not delegate
the authority to make the determination prescribed by
this clause to an office below the Office of the Commissioner of Food and Drugs. For a product subject to
the Virus-Serum-Toxin Act, the Secretary of Agriculture may not delegate the authority to make the determination prescribed by this clause to an office below
the Office of the Assistant Secretary for Marketing
and Inspection Services.
 
(ii) The Secretary making a determination under clause (i) shall notify the Director of the
determination and shall publish in the Federal Register a notice of such determination together with the
factual and legal basis for such determination. Any
interested person may request, within the 60-day
period beginning on the publication of a determination, the Secretary making the determination to hold
an informal hearing on the determination. If such a
request is made within such period, such Secretary
shall hold such hearing not later than 30 days after the
date of the request, or at the request of the person
making the request, not later than 60 days after such
date. The Secretary who is holding the hearing shall
provide notice of the hearing to the owner of
the patent involved and to any interested person and
provide the owner and any interested person an
opportunity to participate in the hearing. Within
30 days after the completion of the hearing, such Secretary shall affirm or revise the determination which
was the subject of the hearing and notify the Director
of any revision of the determination and shall publish
any such revision in the Federal Register.
(3) For the purposes of paragraph (2)(B), the
term “due diligence” means that degree of attention,
continuous directed effort, and timeliness as may reasonably be expected from, and are ordinarily exercised by, a person during a regulatory review period.
(4) An application for the extension of the
term of a patent is subject to the disclosure requirements prescribed by the Director.  


If a joint inventor refuses to join in an application
for patent or cannot be found or reached after diligent
effort, the application may be made by the other
inventor on behalf of himself and the omitted inventor. The Director, on proof of the pertinent facts and
after such notice to the omitted inventor as he prescribes, may grant a patent to the inventor making the
application, subject to the same rights which the omitted inventor would have had if he had been joined.
The omitted inventor may subsequently join in the
application.


Whenever through error a person is named in an
(5)(A) If the owner of record of the patent or
application for patent as the inventor, or through an
its agent reasonably expects that the applicable regulatory review period described in paragraphs
error an inventor is not named in an application, and
(1)(B)(ii), (2)(B)(ii), (3)(B)(ii), (4)(B)(ii), or (5)(B)(ii)
of subsection (g) that began for a product that is the
subject of such patent may extend beyond the expiration of the patent term in effect, the owner or its agent
may submit an application to the Director for an  


   
   


such error arose without any deceptive intention on
interim extension during the period beginning 6
his part, the Director may permit the application to be
months, and ending 15 days before such term is due to  
amended accordingly, under such terms as he prescribes.  
expire. The application shall contain—


(Amended Aug. 27, 1982, Public Law 97-247, sec.
(i) the identity of the product subject to
6(a), 96 Stat. 320; Nov. 8, 1984, Public Law 98-622, sec.
regulating review and the Federal statute under which
104(a), 98 Stat. 3384; Nov. 29, 1999, Public Law 106-113,
such review is occurring;  
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
(ii) the identity of the patent for which
4732(a)(10)(A)).)
interim extension is being sought and the identity of
each claim of such patent which claims the product
under regulatory review or a method of using or manufacturing the product;


35 U.S.C. 117 Death or incapacity of inventor.


Legal representatives of deceased inventors and of  
(iii) information to enable the Director to
those under legal incapacity may make application for  
determine under subsection (a)(1), (2), and (3) the eligibility of a patent for extension;
patent upon compliance with the requirements and on
 
the same terms and conditions applicable to the inventor.  
(iv) a brief description of the activities
undertaken by the applicant during the applicable regulatory review period to date with respect to the product under review and the significant dates applicable
to such activities; and
(v) such patent or other information as
the Director may require.
(B) If the Director determines that, except
for permission to market or use the product commercially, the patent would be eligible for an extension of  
the patent term under this section, the Director shall
publish in the Federal Register a notice of such determination, including the identity of the product under
regulatory review, and shall issue to the applicant a
certificate of interim extension for a period of not
more than 1 year.
(C) The owner of record of a patent, or its
agent, for which an interim extension has been
granted under subparagraph (B), may apply for not
more than 4 subsequent interim extensions under this
paragraph, except that, in the case of a patent subject
to subsection (g)(6)(C), the owner of record of the
patent, or its agent, may apply for only 1 subsequent
interim extension under this paragraph. Each such
subsequent application shall be made during the  
period beginning 60 days before, and ending 30 days
before, the expiration of the preceding interim extension.
(D) Each certificate of interim extension
under this paragraph shall be recorded in the official
file of the patent and shall be considered part of the  
original patent.  
(E) Any interim extension granted under
this paragraph shall terminate at the end of the 60-day


35 U.S.C. 118 Filing by other than inventor.


Whenever an inventor refuses to execute an application for patent, or cannot be found or reached after
period beginning on the day on which the product
diligent effort, a person to whom the inventor has
involved receives permission for commercial marketing or use, except that, if within that 60-day period,  
assigned or agreed in writing to assign the invention
the applicant notifies the Director of such permission
or who otherwise shows sufficient proprietary interest
and submits any additional information under paragraph (1) of this subsection not previously contained
in the matter justifying such action, may make application for patent on behalf of and as agent for the
in the application for interim extension, the patent  
inventor on proof of the pertinent facts and a showing
shall be further extended, in accordance with the provisions of this section—
that such action is necessary to preserve the rights of  
the parties or to prevent irreparable damage; and the  
Director may grant a patent to such inventor upon
such notice to him as the Director deems sufficient,  
and on compliance with such regulations as he prescribes.


(Amended Nov. 29, 1999, Public Law 106-113, sec.
(i) for not to exceed 5 years from the
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
date of expiration of the original patent term; or
4732(a)(10)(A)).)  
(ii) if the patent is subject to subsection
(g)(6)(C), from the date on which the product
involved receives approval for commercial marketing
or use.  
(F) The rights derived from any patent the
term of which is extended under this paragraph shall,
during the period of interim extension—
(i) in the case of a patent which claims a
product, be limited to any use then under regulatory
review;
(ii) in the case of a patent which claims a
method of using a product, be limited to any use
claimed by the patent then under regulatory review;
and


35 U.S.C. 119 Benefit of earlier filing date; right
of priority.


(a) An application for patent for an invention
(iii) in the case of a patent which claims a  
filed in this country by any person who has, or whose
method of manufacturing a product, be limited to the  
legal representatives or assigns have, previously regularly filed an application for a patent for the same
method of manufacturing as used to make the product
invention in a foreign country which affords similar
then under regulatory review.  
privileges in the case of applications filed in the
United States or to citizens of the United States, or in
a WTO member country, shall have the same effect as
the same application would have if filed in this country on the date on which the application for patent for
the same invention was first filed in such foreign
country, if the application in this country is filed
within twelve months from the earliest date on which  
such foreign application was filed; but no patent shall
be granted on any application for patent for an invention which had been patented or described in a printed
publication in any country more than one year before
the date of the actual filing of the application in this
country, or which had been in public use or on sale in
this country more than one year prior to such filing.  


(b)(1)No application for patent shall be entitled to
(e)(1) A determination that a patent is eligible
this right of priority unless a claim is filed in the
for extension may be made by the Director solely on  
Patent and Trademark Office, identifying the foreign
the basis of the representations contained in the application for the extension. If the Director determines
application by specifying the application number on  
that a patent is eligible for extension under subsection
that foreign application, the intellectual property
authority or country in or for which the application  
was filed, and the date of filing the application, at
such time during the pendency of the application as
required by the Director.


(2) The Director may consider the failure of  
(a) and that the requirements of paragraphs (1)
the applicant to file a timely claim for priority as a
through (4) of subsection (d) have been complied
waiver of any such claim. The Director may establish
with, the Director shall issue to the applicant for the
procedures, including the payment of a surcharge, to
extension of the term of the patent a certificate of
accept an unintentionally delayed claim under this
extension, under seal, for the period prescribed by
section.
subsection (c). Such certificate shall be recorded in  
(3) The Director may require a certified copy
the official file of the patent and shall be considered as
of the original foreign application, specification, and
part of the original patent.  
drawings upon which it is based, a translation if not in
(2) If the term of a patent for which an application has been submitted under subsection (d)(1)
the English language, and such other information as
would expire before a certificate of extension is
the Director considers necessary. Any such certification shall be made by the foreign intellectual property
issued or denied under paragraph (1) respecting the
authority in which the foreign application was filed
application, the Director shall extend, until such
and show the date of the application and of the filing
determination is made, the term of the patent for peri-
of the specification and other papers.  
(c) In like manner and subject to the same conditions and requirements, the right provided in this
section may be based upon a subsequent regularly
filed application in the same foreign country instead
of the first filed foreign application, provided that any
foreign application filed prior to such subsequent
application has been withdrawn, abandoned, or otherwise disposed of, without having been laid open to
public inspection and without leaving any rights outstanding, and has not served, nor thereafter shall
serve, as a basis for claiming a right of priority.
(d) Applications for inventors’ certificates filed
in a foreign country in which applicants have a right
to apply, at their discretion, either for a patent or for
an inventor’s certificate shall be treated in this country
in the same manner and have the same effect for pur-




   
   


pose of the right of priority under this section as applications for patents, subject to the same conditions and
ods of up to one year if he determines that the patent
requirements of this section as apply to applications
is eligible for extension.
for patents, provided such applicants are entitled to
 
the benefits of the Stockholm Revision of the Paris
(f) For purposes of this section:
Convention at the time of such filing.


(e)(1)An application for patent filed under section
(1) The term “product” means:
111(a) or section 363 of this title for an invention disclosed in the manner provided by the first paragraph
of section 112 of this title in a provisional application
filed under section 111(b) of this title, by an inventor
or inventors named in the provisional application,
shall have the same effect, as to such invention, as
though filed on the date of the provisional application
filed under section 111(b) of this title, if the application for patent filed under section 111(a) or section
363 of this title is filed not later than 12 months after
the date on which the provisional application was
filed and if it contains or is amended to contain a specific reference to the provisional application. No
application shall be entitled to the benefit of an earlier
filed provisional application under this subsection
unless an amendment containing the specific reference to the earlier filed provisional application is submitted at such time during the pendency of the
application as required by the Director. The Director
may consider the failure to submit such an amendment within that time period as a waiver of any benefit under this subsection. The Director may establish
procedures, including the payment of a surcharge, to
accept an unintentionally delayed submission of an
amendment under this subsection during the pendency
of the application


(2) A provisional application filed under section 111(b) of this title may not be relied upon in any
(A) A drug product.  
proceeding in the Patent and Trademark Office unless
the fee set forth in subparagraph (A) or (C) of section
41(a)(1) of this title has been paid.
(3) If the day that is 12 months after the filing
date of a provisional application falls on a Saturday,
Sunday, or Federal holiday within the District of
Columbia, the period of pendency of the provisional
application shall be extended to the next succeeding
secular or business day.  
(f) Applications for plant breeder’s rights filed
in a WTO member country (or in a foreign UPOV
Contracting Party) shall have the same effect for the
purpose of the right of priority under subsections (a)


 
(B) Any medical device, food additive, or
through (c) of this section as applications for patents,  
color additive subject to regulation under the Federal
subject to the same conditions and requirements of
Food, Drug, and Cosmetic Act.
this section as apply to applications for patents.
(2) The term “drug product” means the active
 
ingredient of—
(g) As used in this section—
(A) a new drug, antibiotic drug, or human
 
biological product (as those terms are used in the Federal Food, Drug, and Cosmetic Act and the Public
(1) the term “WTO member country” has the  
Health Service Act) or
same meaning as the term is defined in section
(B) a new animal drug or veterinary biological product (as those terms are used in the Federal
104(b)(2) of this title; and
Food, Drug, and Cosmetic Act and the Virus-Serum-
(2) the term “UPOV Contracting Party”
Toxin Act) which is not primarily manufactured using
means a member of the International Convention for  
recombinant DNA, recombinant RNA, hybridoma
the Protection of New Varieties of Plants.  
technology, or other processes involving site specific
genetic manipulation techniques, including any salt or
ester of the active ingredient, as a single entity or in  
combination with another active ingredient.
(3) The term “major health or environmental
effects test” means a test which is reasonably related
to the evaluation of the health or environmental
effects of a product, which requires at least six months
to conduct, and the data from which is submitted to
receive permission for commercial marketing or use.
Periods of analysis or evaluation of test results are not
to be included in determining if the conduct of a test
required at least six months.
(4)(A) Any reference to section 351 is a reference to section 351 of the Public Health Service Act.  




(Amended Oct. 3, 1961, Public Law 87-333, sec. 1, 75
(B) Any reference to section 503, 505, 512,  
Stat. 748; July 28, 1972, Public Law 92-358, sec. 1, 86 Stat.  
or 515 is a reference to section 503, 505, 512, or 515
501; Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949;
of the Federal Food, Drug and Cosmetic Act.  
Dec. 8, 1994, Public Law 103-465, sec. 532(b)(1), 108 Stat.  
(C) Any reference to the Virus-Serum-
4985.)  
Toxin Act is a reference to the Act of March 4, 1913
(21 U.S.C. 151 - 158).  
(5) The term “informal hearing” has the
meaning prescribed for such term by section 201(y) of
the Federal Food, Drug and Cosmetic Act.  
(6) The term “patent” means a patent issued
by the United States Patent and Trademark Office.  
(7) The term “date of enactment” as used in
this section means September 24, 1984, for human


(Subsection (b) amended Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-563 (S. 1948
sec.4503(a)).)


(Subsection (e) amended Nov. 29, 1999, Public Law
drug product, a medical device, food additive, or color
106-113, sec. 1000(a)(9), 113 Stat. 1501A-564, 588, 589
additive.  


(S. 1948 secs. 4503(b)(2), 4801 and 4802).)  
(8) The term “date of enactment” as used in
(Subsections (f) and (g) added Nov. 29, 1999, Public
this section means the date of enactment of the
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-589
Generic Animal Drug and Patent Term Restoration
Act for an animal drug or a veterinary biological
product.  
(g) For purposes of this section, the term “regulatory review period” has the following meanings:
(1)(A)In the case of a product which is a new
drug, antibiotic drug, or human biological product, the
term means the period described in subparagraph (B)
to which the limitation described in paragraph (6)  
applies.  
 
 
(B) The regulatory review period for a new
drug, antibiotic drug, or human biological product is
the sum of —
(i) the period beginning on the date an
exemption under subsection (i) of section 505 or subsection (d) of section 507 became effective for the
approved product and ending on the date an application was initially submitted for such drug product
under section 351, 505, or 507, and
(ii) the period beginning on the date the
application was initially submitted for the approved
product under section 351, subsection (b) of section
505, or section 507 and ending on the date such application was approved under such section.  
(2)(A) In the case of a product which is a food
additive or color additive, the term means the period
described in subparagraph (B) to which the limitation
described in paragraph (6) applies.  




(S. 1948 sec. 4802).)  
(B) The regulatory review period for a
food or color additive is the sum of —
(i) the period beginning on the date a
major health or environmental effects test on the additive was initiated and ending on the date a petition
was initially submitted with respect to the product
under the Federal Food, Drug, and Cosmetic Act
requesting the issuance of a regulation for use of the
product, and
(ii) the period beginning on the date a
petition was initially submitted with respect to the
product under the Federal Food, Drug, and Cosmetic
Act requesting the issuance of a regulation for use of
the product, and ending on the date such regulation
became effective or, if objections were filed to such
regulation, ending on the date such objections were




35 U.S.C. 120 Benefit of earlier filing date in the
United States.


An application for patent for an invention disclosed
resolved and commercial marketing was permitted or,
in the manner provided by the first paragraph of section 112 of this title in an application previously filed
if commercial marketing was permitted and later
in the United States, or as provided by section 363 of  
revoked pending further proceedings as a result of  
this title, which is filed by an inventor or inventors
such objections, ending on the date such proceedings  
named in the previously filed application shall have
were finally resolved and commercial marketing was
the same effect, as to such invention, as though filed
permitted.  
on the date of the prior application, if filed before the
patenting or abandonment of or termination of proceedings on the first application or on an application
similarly entitled to the benefit of the filing date of the
first application and if it contains or is amended to
contain a specific reference to the earlier filed application. No application shall be entitled to the benefit of
an earlier filed application under this section unless an
amendment containing the specific reference to the
earlier filed application is submitted at such time during the pendency of the application as required by the
Director. The Director may consider the failure to
submit such an amendment within that time period as
a waiver of any benefit under this section. The Direc-


(3)(A) In the case of a product which is a
medical device, the term means the period described
in subparagraph (B) to which the limitation described
in paragraph (6) applies.


tor may establish procedures, including the payment
(B) The regulatory review period for a
of a surcharge, to accept an unintentionally delayed
medical device is the sum of —
submission of an amendment under this section.  
(i) the period beginning on the date a  
clinical investigation on humans involving the device
was begun and ending on the date an application was
initially submitted with respect to the device under
section 515, and
(ii) the period beginning on the date an
application was initially submitted with respect to the
device under section 515 and ending on the date such
application was approved under such Act or the
period beginning on the date a notice of completion of
a product development protocol was initially submitted under section 515(f)(5) and ending on the date the
protocol was declared completed under section  
515(f)(6).
(4)(A) In the case of a product which is a new
animal drug, the term means the period described in
subparagraph (B) to which the limitation described in
paragraph (6) applies.  


(Amended Nov. 14, 1975, Public Law 94-131, sec. 9,
89 Stat. 691; Nov. 8, 1984, Public Law 98-622, sec. 104(b),
98 Stat. 3385; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-563 (S. 1948 sec.
4503(b)(1)).)


35 U.S.C. 121 Divisional applications.
(B) The regulatory review period for a new
 
animal drug product is the sum of —
If two or more independent and distinct inventions
(i) the period beginning on the earlier of  
are claimed in one application, the Director may
the date a major health or environmental effects test
require the application to be restricted to one of the  
on the drug was initiated or the date an exemption
inventions. If the other invention is made the subject
under subsection (j) of section 512 became effective
of a divisional application which complies with the
for the approved new animal drug product and ending
requirements of section 120 of this title it shall be
on the date an application was initially submitted for
entitled to the benefit of the filing date of the original
such animal drug product under section 512, and  
application. A patent issuing on an application with
(ii) the period beginning on the date the  
respect to which a requirement for restriction under  
application was initially submitted for the approved
this section has been made, or on an application filed
animal drug product under subsection (b) of section
as a result of such a requirement, shall not be used as a
512 and ending on the date such application was
reference either in the Patent and Trademark Office or
approved under such section.  
in the courts against a divisional application or against
the original application or any patent issued on either
of them, if the divisional application is filed before the
issuance of the patent on the other application. If a
divisional application is directed solely to subject
matter described and claimed in the original application as filed, the Director may dispense with signing
and execution by the inventor. The validity of a patent
shall not be questioned for failure of the Director to
require the application to be restricted to one invention.
 
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.  
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


35 U.S.C. 122 Confidential status of applications;
publication of patent applications.


(a) CONFIDENTIALITY.— Except as provided in subsection (b), applications for patents shall
(5)(A) In the case of a product which is a veterinary biological product, the term means the period
be kept in confidence by the Patent and Trademark
described in subparagraph (B) to which the limitation
Office and no information concerning the same given
described in paragraph (6) applies.  
without authority of the applicant or owner unless
necessary to carry out the provisions of an Act of
Congress or in such special circumstances as may be
determined by the Director.  


(b) PUBLICATION.—  
(B) The regulatory period for a veterinary
 
biological product is the sum of —
(1) IN GENERAL.—
(i) the period beginning on the date the
authority to prepare an experimental biological product under the Virus- Serum-Toxin Act became effective and ending on the date an application for a license
was submitted under the Virus-Serum-Toxin Act, and
(ii) the period beginning on the date an
application for a license was initially submitted for
approval under the Virus-Serum-Toxin Act and ending on the date such license was issued.  
(6) A period determined under any of the
preceding paragraphs is subject to the following limitations:
(A) If the patent involved was issued after
the date of the enactment of this section, the period of
extension determined on the basis of the regulatory
review period determined under any such paragraph
may not exceed five years.
(B) If the patent involved was issued
before the date of the enactment of this section and —  
(i) no request for an exemption
described in paragraph (1)(B) or (4)(B) was submitted
and no request for the authority described in paragraph (5)(B) was submitted,
(ii) no major health or environment
effects test described in paragraph (2)(B) or (4)(B)
was initiated and no petition for a regulation or application for registration described in such paragraph
was submitted, or


(A) Subject to paragraph (2), each application for a patent shall be published, in accordance
with procedures determined by the Director, promptly
after the expiration of a period of 18 months from the
earliest filing date for which a benefit is sought under
this title. At the request of the applicant, an application may be published earlier than the end of such 18month period.
(B) No information concerning published
patent applications shall be made available to the public except as the Director determines.
(C) Notwithstanding any other provision of
law, a determination by the Director to release or not
to release information concerning a published patent
application shall be final and nonreviewable.
(2) EXCEPTIONS.—


(iii) no clinical investigation described in
paragraph (3) was begun or product development protocol described in such paragraph was submitted,
before such date for the approved product the period
of extension determined on the basis of the regulatory
review period determined under any such paragraph
may not exceed five years.


(A) An application shall not be published if
(C) If the patent involved was issued
that application is—
before the date of the enactment of this section and if
(i) no longer pending;
an action described in subparagraph (B) was taken
before the date of enactment of this section with
respect to the approved product and the commercial
marketing or use of the product has not been approved
before such date, the period of extension determined
on the basis of the regulatory review period determined under such paragraph may not exceed two
years or in the case of an approved product which is a
new animal drug or veterinary biological product (as




(ii) subject to a secrecy order under section 181 of this title;
those terms are used in the Federal Food, Drug, and
Cosmetic Act or the Virus-Serum-Toxin Act), three
years.


(h) The Director may establish such fees as the
Director determines appropriate to cover the costs to
the Office of receiving and acting upon applications
under this section.


(iii) a provisional application filed under
(Added Sept. 24, 1984, Public Law 98-417, sec.
section 111(b) of this title; or
201(a), 98 Stat. 1598; amended Nov. 16, 1988, Public Law
100-670, sec. 201(a)-(h), 102 Stat. 3984; Dec. 3, 1993,
Public Law 103-179, secs. 5, 6, 107 Stat. 2040, 2042; Dec.
8, 1994, Public Law 103-465, sec. 532(c)(1), 108 Stat.
4987.)  


(iv) an application for a design patent
(Subsection (f) amended Nov. 21, 1997, Public Law
filed under chapter 16 of this title.  
105-115, sec. 125(b)(2)(P), 111 Stat. 2326.)
(B)(i) If an applicant makes a request upon
filing, certifying that the invention disclosed in the
application has not and will not be the subject of an
application filed in another country, or under a multilateral international agreement, that requires publication of applications 18 months after filing, the
application shall not be published as provided in paragraph (1).  


(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-560, 582 (S. 1948 secs. 4404
and 4732(a)(10)(A)).)


(ii) An applicant may rescind a request
(Subsections (b)(3)(B), (d)(2)(B)(i), and (g)(6)(B)(iii)
made under clause (i) at any time.  
amended Nov. 2, 2002, Public Law 107-273, sec. 13206,
116 Stat. 1904.)


35 U.S.C. 157 Statutory invention registration.


(iii) An applicant who has made a
(a) Notwithstanding any other provision of this
request under clause (i) but who subsequently files, in
title, the Director is authorized to publish a statutory
a foreign country or under a multilateral international
invention registration containing the specification and
agreement specified in clause (i), an application
drawings of a regularly filed application for a patent
directed to the invention disclosed in the application
without examination if the applicant
filed in the Patent and Trademark Office, shall notify
(1) meets the requirements of section 112 of
the Director of such filing not later than 45 days after
this title;
the date of the filing of such foreign or international
(2) has complied with the requirements for
application. A failure of the applicant to provide such
printing, as set forth in regulations of the Director;
notice within the prescribed period shall result in the
(3) waives the right to receive a patent on the  
application being regarded as abandoned, unless it is
invention within such period as may be prescribed by
the Director; and  
(4) pays application, publication, and other
processing fees established by the Director.
If an interference is declared with respect to
such an application, a statutory invention registration
may not be published unless the issue of priority of  
invention is finally determined in favor of the applicant.




shown to the satisfaction of the Director that the delay
(b) The waiver under subsection (a)(3) of this
in submitting the notice was unintentional.
section by an applicant shall take effect upon publication of the statutory invention registration.  
 
(c) A statutory invention registration published  
(iv) If an applicant rescinds a request
pursuant to this section shall have all of the attributes
made under clause (i) or notifies the Director that an
specified for patents in this title except those specified
application was filed in a foreign country or under a
multilateral international agreement specified in
clause (i), the application shall be published in accordance with the provisions of paragraph (1) on or as
soon as is practical after the date that is specified in
clause (i).
(v) If an applicant has filed applications
in one or more foreign countries, directly or through a
multilateral international agreement, and such foreign
filed applications corresponding to an application
filed in the Patent and Trademark Office or the
description of the invention in such foreign filed
applications is less extensive than the application or
description of the invention in the application filed in
the Patent and Trademark Office, the applicant may
submit a redacted copy of the application filed in the
Patent and Trademark Office eliminating any part or
description of the invention in such application that is
not also contained in any of the corresponding applications filed in a foreign country. The Director may
only publish the redacted copy of the application
unless the redacted copy of the application is not
received within 16 months after the earliest effective
filing date for which a benefit is sought under this
title. The provisions of section 154(d) shall not apply
to a claim if the description of the invention published  
in the redacted application filed under this clause with
respect to the claim does not enable a person skilled in
the art to make and use the subject matter of the claim.
(c) PROTEST AND PRE-ISSUANCE OPPOSITION.— The Director shall establish appropriate
procedures to ensure that no protest or other form of  
pre-issuance opposition to the grant of a patent on an
application may be initiated after publication of the
application without the express written consent of the
applicant.
(d) NATIONAL SECURITY.— No application
for patent shall be published under subsection (b)(1) if
the publication or disclosure of such invention would
be detrimental to the national security. The Director
shall establish appropriate procedures to ensure that
such applications are promptly identified and the
secrecy of such inventions is maintained in accordance with chapter 17 of this title.




(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
in section 183 and sections 271 through 289 of this
Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.  
title. A statutory invention registration shall not have
1000(a)(9), 113 Stat. 1501A-563 (S. 1948 sec.
any of the attributes specified for patents in any other
4503(b)(1)).)
provision of law other than this title. A statutory
invention registration published pursuant to this section shall give appropriate notice to the public, pursuant to regulations which the Director shall issue, of
the preceding provisions of this subsection. The
invention with respect to which a statutory invention
certificate is published is not a patented invention for
purposes of section 292 of this title.
 
(d) The Director shall report to the Congress
annually on the use of statutory invention registrations. Such report shall include an assessment of the
degree to which agencies of the federal government
are making use of the statutory invention registration
system, the degree to which it aids the management of
federally developed technology, and an assessment of
the cost savings to the Federal Government of the
uses of such procedures.  


CHAPTER 12 — EXAMINATION OF
(Added Nov. 8, 1984, Public Law 98-622, sec. 102(a),
APPLICATION
98 Stat. 3383; amended Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582, 583 (S. 1948
secs. 4732(a)(10)(A) and 4732(a)(11)).)


===CHAPTER 15 — PLANT PATENTS===


Sec.
Sec.
131 Examination of application.  
161 Patents for plants.
132 Notice of rejection; reexamination.
162 Description, claim.  
133 Time for prosecuting application.
163 Grant.
134 Appeal to the Board of Patent Appeals and
164 Assistance of the Department of Agriculture.
 


35 U.S.C. 161 Patents for plants.


Interferences.
Whoever invents or discovers and asexually reproduces any distinct and new variety of plant, including
135 Interferences.  
cultivated sports, mutants, hybrids, and newly found
seedlings, other than a tuber propagated plant or a
plant found in an uncultivated state, may obtain a
patent therefor, subject to the conditions and requirements of this title.  


35 U.S.C. 131 Examination of application.  
The provisions of this title relating to patents for
inventions shall apply to patents for plants, except as
otherwise provided.  


The Director shall cause an examination to be made
(Amended Sept. 3, 1954, 68 Stat. 1190.)
of the application and the alleged new invention; and
if on such examination it appears that the applicant is
entitled to a patent under the law, the Director shall
issue a patent therefor.  


(Amended Nov. 29, 1999, Public Law 106-113, sec.
35 U.S.C. 162 Description, claim.  
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
4732(a)(10)(A)).)


35 U.S.C. 132 Notice of rejection; reexamination.  
No plant patent shall be declared invalid for noncompliance with section 112 of this title if the description is as complete as is reasonably possible.  


(a) Whenever, on examination, any claim for a
patent is rejected, or any objection or requirement
 
made, the Director shall notify the applicant thereof,
The claim in the specification shall be in formal
stating the reasons for such rejection, or objection or
terms to the plant shown and described.  
requirement, together with such information and references as may be useful in judging of the propriety of
continuing the prosecution of his application; and if
after receiving such notice, the applicant persists in  
his claim for a patent, with or without amendment, the
application shall be reexamined. No amendment shall
introduce new matter into the disclosure of the invention.
(b) The Director shall prescribe regulations to  
provide for the continued examination of applications
for patent at the request of the applicant. The Director
may establish appropriate fees for such continued
examination and shall provide a 50 percent reduction
in such fees for small entities that qualify for reduced
fees under section 41(h)(1) of this title.  


35 U.S.C. 163 Grant.


(Amended Nov. 29, 1999, Public Law 106-113, sec.
In the case of a plant patent, the grant shall include
1000(a)(9), 113 Stat. 1501A-560, 582 (S. 1948 secs. 4403
the right to exclude others from asexually reproducing
and 4732(a)(10)(A)).)
the plant, and from using, offering for sale, or selling
the plant so reproduced, or any of its parts, throughout
the United States, or from importing the plant so
reproduced, or any parts thereof, into the United
States.  


(Amended Oct. 27, 1998, Public Law 105-289, sec. 3,
112 Stat. 2781.)


35 U.S.C. 133 Time for prosecuting application.  
35 U.S.C. 164 Assistance of the Department of
Agriculture.  


Upon failure of the applicant to prosecute the application within six months after any action therein, of  
The President may by Executive order direct the
which notice has been given or mailed to the applicant, or within such shorter time, not less than thirty
Secretary of Agriculture, in accordance with the  
days, as fixed by the Director in such action, the  
requests of the Director, for the purpose of carrying
application shall be regarded as abandoned by the parties thereto, unless it be shown to the satisfaction of  
into effect the provisions of this title with respect to
the Director that such delay was unavoidable.  
plants (1) to furnish available information of the  
Department of Agriculture, (2) to conduct through the  
appropriate bureau or division of the Department
research upon special problems, or (3) to detail to the  
Director officers and employees of the Department.  


(Amended Nov. 29, 1999, Public Law 106-113, sec.  
(Amended Nov. 29, 1999, Public Law 106-113, sec.  
Line 3,048: Line 3,807:
4732(a)(10)(A)).)  
4732(a)(10)(A)).)  


35 U.S.C. 134 Appeal to the Board of Patent
===CHAPTER 16 — DESIGNS===
Appeals and Interferences.


(a) PATENT APPLICANT.— An applicant for
Sec.
a patent, any of whose claims has been twice rejected,
171 Patents for designs.
may appeal from the decision of the primary examiner
172 Right of priority.
to the Board of Patent Appeals and Interferences, having once paid the fee for such appeal.
173 Term of design patent.
(b) PATENT OWNER.— A patent owner in
any reexamination proceeding may appeal from the
final rejection of any claim by the primary examiner
to the Board of Patent Appeals and Interferences, having once paid the fee for such appeal.
(c) THIRD-PARTY.— A third-party requester
in an inter partes proceeding may appeal to the Board
of Patent Appeals and Interferences from the final
decision of the primary examiner favorable to the patentability of any original or proposed amended or new
claim of a patent, having once paid the fee for such
appeal.  




(Amended Nov. 8, 1984, Public Law 98-622, sec.
35 U.S.C. 171 Patents for designs.  
204(b)(1), 98 Stat. 3388; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec.
4605(b)); subsections (a)-(c) amended Nov. 2, 2002, Public
Law 107-273, secs. 13106 and 13202, 116 Stat. 1901.)


35 U.S.C. 135 Interferences.  
Whoever invents any new, original, and ornamental
design for an article of manufacture may obtain a
patent therefor, subject to the conditions and requirements of this title.  


(a) Whenever an application is made for a
The provisions of this title relating to patents for
patent which, in the opinion of the Director, would
inventions shall apply to patents for designs, except as
interfere with any pending application, or with any
otherwise provided.  
unexpired patent, an interference may be declared and
the Director shall give notice of such declaration to  
the applicants, or applicant and patentee, as the case
may be. The Board of Patent Appeals and Interferences shall determine questions of priority of the
inventions and may determine questions of patentability. Any final decision, if adverse to the claim of an
applicant, shall constitute the final refusal by the
Patent and Trademark Office of the claims involved,
and the Director may issue a patent to the applicant
who is adjudged the prior inventor. A final judgment
adverse to a patentee from which no appeal or other
review has been or can be taken or had shall constitute
cancellation of the claims involved in the patent, and
notice of such cancellation shall be endorsed on copies of the patent distributed after such cancellation by
the Patent and Trademark Office.  


(b)(1)A claim which is the same as, or for the
35 U.S.C. 172 Right of priority.  
same or substantially the same subject matter as, a
claim of an issued patent may not be made in any
application unless such a claim is made prior to one
year from the date on which the patent was granted.  


(2) A claim which is the same as, or for the
The right of priority provided for by subsections (a)  
same or substantially the same subject matter as, a
through (d) of section 119 of this title and the time
claim of an application published under section  
specified in section 102(d) shall be six months in the  
122(b) of this title may be made in an application filed
case of designs. The right of priority provided for by
after the application is published only if the claim is
section 119(e) of this title shall not apply to designs.  
made before 1 year after the date on which the application is published.
(c) Any agreement or understanding between
parties to an interference, including any collateral
agreements referred to therein, made in connection
with or in contemplation of the termination of the
interference, shall be in writing and a true copy
thereof filed in the Patent and Trademark Office
before the termination of the interference as between
the said parties to the agreement or understanding. If
any party filing the same so requests, the copy shall be
kept separate from the file of the interference, and
made available only to Government agencies on written request, or to any person on a showing of good
cause. Failure to file the copy of such agreement or
understanding shall render permanently unenforceable such agreement or understanding and any patent
of such parties involved in the interference or any
patent subsequently issued on any application of such
parties so involved. The Director may, however, on a
showing of good cause for failure to file within the
time prescribed, permit the filing of the agreement or
understanding during the six-month period subsequent to the termination of the interference as
between the parties to the agreement or understanding.  


(Amended Dec. 8, 1994, Public Law 103-465, sec.
532(c)(2), 108 Stat. 4987.)


The Director shall give notice to the parties or
35 U.S.C. 173 Term of design patent.
their attorneys of record, a reasonable time prior to


Patents for designs shall be granted for the term of
fourteen years from the date of grant.


said termination, of the filing requirement of this section. If the Director gives such notice at a later time,  
(Amended Aug. 27, 1982, Public Law 97-247, sec. 16,  
irrespective of the right to file such agreement or
96 Stat. 321; Dec. 8, 1994, Public Law 103-465, sec.
understanding within the six-month period on a showing of good cause, the parties may file such agreement
532(c)(3), 108 Stat. 4987.)
or understanding within sixty days of the receipt of
such notice.  


Any discretionary action of the Director under
===CHAPTER 17 — SECRECY OF CERTAIN INVENTIONS AND FILING APPLICATIONS IN FOREIGN COUNTRIES===
this subsection shall be reviewable under section 10
of the Administrative Procedure Act.


(d) Parties to a patent interference, within such
time as may be specified by the Director by regulation, may determine such contest or any aspect thereof
by arbitration. Such arbitration shall be governed by
the provisions of title 9 to the extent such title is not
inconsistent with this section. The parties shall give
notice of any arbitration award to the Director, and
such award shall, as between the parties to the arbitration, be dispositive of the issues to which it relates.
The arbitration award shall be unenforceable until
such notice is given. Nothing in this subsection shall
preclude the Director from determining patentability
of the invention involved in the interference.


(Subsection (c) added Oct. 15, 1962, Public Law 87831, 76 Stat. 958.)
Sec.
181 Secrecy of certain inventions and withholding


(Subsections (a) and (c) amended, Jan. 2, 1975, Public
Law 93-596, sec. 1, 88 Stat. 1949.)


(Subsection (a) amended Nov. 8, 1984, Public Law 98622, sec. 202, 98 Stat. 3386.)
of patent.  
182 Abandonment of invention for unauthorized


(Subsection (d) added Nov. 8, 1984, Public Law 98622, sec. 105, 98 Stat. 3385.)
disclosure.  
183 Right to compensation.
184 Filing of application in foreign country.
185 Patent barred for filing without license.
186 Penalty.
187 Nonapplicability to certain persons.  
188 Rules and regulations, delegation of power.  


(Amended Nov. 29, 1999, Public Law 106-113, sec.
35 U.S.C. 181 Secrecy of certain inventions and
1000(a)(9), 113 Stat. 1501A-566, 582 (S. 1948 secs.  
withholding of patent.  
4507(11) and 4732(a)(10)(A)).)


CHAPTER 13 — REVIEW OF PATENT AND
Whenever publication or disclosure by the publication of an application or by the grant of a patent on an
TRADEMARK OFFICE DECISION
invention in which the Government has a property
interest might, in the opinion of the head of the interested Government agency, be detrimental to the
national security, the Commissioner of Patents upon
being so notified shall order that the invention be kept
secret and shall withhold the publication of an application or the grant of a patent therefor under the conditions set forth hereinafter.


Sec.
Whenever the publication or disclosure of an invention by the publication of an application or by the
141 Appeal to Court of Appeals for the Federal Cir
granting of a patent, in which the Government does
not have a property interest, might, in the opinion of
the Commissioner of Patents, be detrimental to the
national security, he shall make the application for
patent in which such invention is disclosed available
for inspection to the Atomic Energy Commission, the
Secretary of Defense, and the chief officer of any
other department or agency of the Government desig-




cuit.
nated by the President as a defense agency of the
142 Notice of appeal.
United States.  
143 Proceedings on appeal.
144 Decision on appeal.
145 Civil action to obtain patent.
146 Civil action in case of interference.  


35 U.S.C. 141 Appeal to the Court of Appeals for
Each individual to whom the application is disclosed shall sign a dated acknowledgment thereof,
the Federal Circuit.  
which acknowledgment shall be entered in the file of  
 
the application. If, in the opinion of the Atomic
An applicant dissatisfied with the decision in an
Energy Commission, the Secretary of a Defense
appeal to the Board of Patent Appeals and Interferences under section 134 of this title may appeal the  
Department, or the chief officer of another department
decision to the United States Court of Appeals for the
or agency so designated, the publication or disclosure
Federal Circuit. By filing such an appeal the applicant
of the invention by the publication of an application
waives his or her right to proceed under section 145 of
or by the granting of a patent therefor would be detrimental to the national security, the Atomic Energy
this title. A patent owner, or a third-party requester in
Commission, the Secretary of a Defense Department,  
an inter partes reexamination proceeding, who is in
or such other chief officer shall notify the Commissioner of Patents and the Commissioner of Patents
any reexamination proceeding dissatisfied with the  
shall order that the invention be kept secret and shall
final decision in an appeal to the Board of Patent
withhold the publication of the application or the  
Appeals and Interferences under section 134 may
grant of a patent for such period as the national interest requires, and notify the applicant thereof. Upon
appeal the decision only to the United States Court of  
proper showing by the head of the department or
Appeals for the Federal Circuit. A party to an interference dissatisfied with the decision of the Board of
agency who caused the secrecy order to be issued that
Patent Appeals and Interferences on the interference
the examination of the application might jeopardize
may appeal the decision to the United States Court of
the national interest, the Commissioner of Patents
Appeals for the Federal Circuit, but such appeal shall
shall thereupon maintain the application in a sealed
be dismissed if any adverse party to such interference,  
condition and notify the applicant thereof. The owner
within twenty days after the appellant has filed notice
of an application which has been placed under a
of appeal in accordance with section 142 of this title,
secrecy order shall have a right to appeal from the  
files notice with the Director that the party elects to
order to the Secretary of Commerce under rules prescribed by him.  
have all further proceedings conducted as provided in  
section 146 of this title. If the appellant does not,
within thirty days after filing of such notice by the
adverse party, file a civil action under section 146, the  
decision appealed from shall govern the further proceedings in the case.  


(Amended Apr. 2, 1982, Public Law 97-164, sec.
An invention shall not be ordered kept secret and
163(a)(7), (b)(2), 96 Stat. 49, 50; Nov. 8, 1984, Public Law
the publication of an application or the grant of a
98-622, sec. 203(a), 98 Stat. 3387; Nov. 29, 1999, Public
patent withheld for a period of more than one year.  
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-571, 582
The Commissioner of Patents shall renew the order at
 
the end thereof, or at the end of any renewal period,  
(S. 1948 secs. 4605(c) and 4732(a)(10)(A)); Nov. 2, 2002,
for additional periods of one year upon notification by
Public Law 107-273, sec. 13106, 116 Stat. 1901.)
the head of the department or the chief officer of the
agency who caused the order to be issued that an affirmative determination has been made that the national
interest continues to so require. An order in effect, or
issued, during a time when the United States is at war,  
shall remain in effect for the duration of hostilities and
one year following cessation of hostilities. An order in
effect, or issued, during a national emergency
declared by the President shall remain in effect for the
duration of the national emergency and six months
thereafter. The Commissioner of Patents may rescind
any order upon notification by the heads of the departments and the chief officers of the agencies who
caused the order to be issued that the publication or
disclosure of the invention is no longer deemed detrimental to the national security.  


35 U.S.C. 142 Notice of appeal.  
(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-566, 582 (S. 1948 secs.  
4507(7) and 4732(a)(10)(B)).)


When an appeal is taken to the United States Court
35 U.S.C. 182 Abandonment of invention for  
of Appeals for the Federal Circuit, the appellant shall
unauthorized disclosure.  
file in the Patent and Trademark Office a written
notice of appeal directed to the Director, within such
time after the date of the decision from which the
appeal is taken as the Director prescribes, but in no
case less than 60 days after that date.  


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
The invention disclosed in an application for patent
Stat. 1949; Apr. 2, 1982, Public Law 97-164, sec.  
subject to an order made pursuant to section 181 of
163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-620,  
this title may be held abandoned upon its being established by the Commissioner of Patents that in violation of said order the invention has been published or
sec. 414(a), 98 Stat. 3363; Nov. 29, 1999, Public Law 106
disclosed or that an application for a patent therefor
has been filed in a foreign country by the inventor, his
successors, assigns, or legal representatives, or anyone in privity with him or them, without the consent
of the Commissioner of Patents. The abandonment
shall be held to have occurred as of the time of violation. The consent of the Commissioner of Patents
shall not be given without the concurrence of the
heads of the departments and the chief officers of the
agencies who caused the order to be issued. A holding
of abandonment shall constitute forfeiture by the
applicant, his successors, assigns, or legal representatives, or anyone in privity with him or them, of all
claims against the United States based upon such
invention.  


(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(B)).)


113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
35 U.S.C. 183 Right to compensation.  
4732(a)(10)(A)).)


35 U.S.C. 143 Proceedings on appeal.
An applicant, his successors, assigns, or legal representatives, whose patent is withheld as herein provided, shall have the right, beginning at the date the  
 
applicant is notified that, except for such order, his
With respect to an appeal described in section 142
application is otherwise in condition for allowance, or  
of this title, the Director shall transmit to the United
February 1, 1952, whichever is later, and ending six
States Court of Appeals for the Federal Circuit a certified list of the documents comprising the record in the
years after a patent is issued thereon, to apply to the  
Patent and Trademark Office. The court may request
head of any department or agency who caused the  
that the Director forward the original or certified copies of such documents during the pendency of the
order to be issued for compensation for the damage
appeal. In an ex parte case or any reexamination case,  
caused by the order of secrecy and/or for the use of
the Director shall submit to the court in writing the  
the invention by the Government, resulting from his
grounds for the decision of the Patent and Trademark
disclosure. The right to compensation for use shall  
Office, addressing all the issues involved in the  
begin on the date of the first use of the invention by
appeal. The court shall, before hearing an appeal, give
the Government. The head of the department or
notice of the time and place of the hearing to the  
agency is authorized, upon the presentation of a
Director and the parties in the appeal.


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
88 Stat. 1949; Apr. 2, 1982, Public Law 97-164, sec.
163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-620,
sec. 414(a), 98 Stat. 3363; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-571, 582 (S. 1948
secs. 4605(d) and 4732(a)(10)(A)); Nov. 2, 2002, Public
Law 107-273, sec. 13202, 116 Stat. 1901.)


35 U.S.C. 144 Decision on appeal.
claim, to enter into an agreement with the applicant,
 
his successors, assigns, or legal representatives, in full
The United States Court of Appeals for the Federal
settlement for the damage and/or use. This settlement
Circuit shall review the decision from which an
agreement shall be conclusive for all purposes notwithstanding any other provision of law to the contrary. If full settlement of the claim cannot be effected,  
appeal is taken on the record before the Patent and  
the head of the department or agency may award and  
Trademark Office. Upon its determination the court
pay to such applicant, his successors, assigns, or legal
shall issue to the Director its mandate and opinion,  
representatives, a sum not exceeding 75 per centum of
which shall be entered of record in the Patent and  
the sum which the head of the department or agency
Trademark Office and shall govern the further proceedings in the case.
considers just compensation for the damage and/or
 
use. A claimant may bring suit against the United
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
States in the United States Court of Federal Claims or
Stat. 1949; Apr. 2, 1982, Public Law 97-164, sec.
in the District Court of the United States for the district in which such claimant is a resident for an
163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-620,
amount which when added to the award shall constitute just compensation for the damage and/or use of
sec. 414(a), 98 Stat. 3363; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
the invention by the Government. The owner of any
4732(a)(10)(A)).)
patent issued upon an application that was subject to a
 
secrecy order issued pursuant to section 181 of this  
35 U.S.C. 145 Civil action to obtain patent.  
title, who did not apply for compensation as above
 
provided, shall have the right, after the date of issuance of such patent, to bring suit in the United States  
An applicant dissatisfied with the decision of the  
Court of Federal Claims for just compensation for the  
Board of Patent Appeals and Interferences in an  
damage caused by reason of the order of secrecy and/
appeal under section 134(a) of this title may, unless
or use by the Government of the invention resulting
appeal has been taken to the United States Court of  
from his disclosure. The right to compensation for use
Appeals for the Federal Circuit, have remedy by civil
shall begin on the date of the first use of the invention
action against the Director in the United States District Court for the District of Columbia if commenced
by the Government. In a suit under the provisions of
within such time after such decision, not less than
this section the United States may avail itself of all
sixty days, as the Director appoints. The court may  
defenses it may plead in an action under section 1498
adjudge that such applicant is entitled to receive a  
of title 28. This section shall not confer a right of
patent for his invention, as specified in any of his
action on anyone or his successors, assigns, or legal
claims involved in the decision of the Board of Patent
representatives who, while in the full-time employment or service of the United States, discovered,  
Appeals and Interferences, as the facts in the case may
invented, or developed the invention on which the  
appear, and such adjudication shall authorize the  
claim is based.  
Director to issue such patent on compliance with the  
requirements of law. All the expenses of the proceedings shall be paid by the applicant.  


(Amended Apr. 2, 1982, Public Law 97-164, sec.  
(Amended Apr. 2, 1982, Public Law 97-164, sec.  
163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-622,  
160(a)(12), 96 Stat. 48; Oct. 29, 1992, Public Law 102-572,  
sec. 203(b), 98 Stat. 3387; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-571, 582 (S. 1948
sec. 902 (b)(1), 106 Stat. 4516.)  
secs. 4605(e) and 4732(a)(10)(A).)  


35 U.S.C. 146 Civil action in case of interference.  
35 U.S.C. 184 Filing of application in foreign
country.  


Any party to an interference dissatisfied with the
Except when authorized by a license obtained from
decision of the Board of Patent Appeals and Interferences may have remedy by civil action, if commenced
the Commissioner of Patents a person shall not file or
within such time after such decision, not less than
cause or authorize to be filed in any foreign country
sixty days, as the Director appoints or as provided in  
prior to six months after filing in the United States an
section 141 of this title, unless he has appealed to the  
application for patent or for the registration of a utility
United States Court of Appeals for the Federal Circuit, and such appeal is pending or has been decided.
model, industrial design, or model in respect of an
In such suits the record in the Patent and Trademark
invention made in this country. A license shall not be  
Office shall be admitted on motion of either party
granted with respect to an invention subject to an
upon the terms and conditions as to costs, expenses,
order issued by the Commissioner of Patents pursuant
and the further cross-examination of the witnesses as
to section 181 of this title without the concurrence of
the court imposes, without prejudice to the right of the  
the head of the departments and the chief officers of  
parties to take further testimony. The testimony and  
the agencies who caused the order to be issued.  
exhibits of the record in the Patent and Trademark
The license may be granted retroactively where an
Office when admitted shall have the same effect as if
application has been filed abroad through error and  
originally taken and produced in the suit.  
without deceptive intent and the application does not
disclose an invention within the scope of section 181
of this title.  


Such suit may be instituted against the party in  
The term “application” when used in this chapter
interest as shown by the records of the Patent and  
includes applications and any modifications, amendments, or supplements thereto, or divisions thereof.  
Trademark Office at the time of the decision complained of, but any party in interest may become a
party to the action. If there be adverse parties residing
in a plurality of districts not embraced within the
same state, or an adverse party residing in a foreign
country, the United States District Court for the District of Columbia shall have jurisdiction and may
issue summons against the adverse parties directed to
the marshal of any district in which any adverse party
resides. Summons against adverse parties residing in
foreign countries may be served by publication or otherwise as the court directs. The Director shall not be a
necessary party but he shall be notified of the filing of


The scope of a license shall permit subsequent
modifications, amendments, and supplements containing additional subject matter if the application
upon which the request for the license is based is not,
or was not, required to be made available for inspection under section 181 of this title and if such modifications, amendments, and supplements do not change
the general nature of the invention in a manner which
would require such application to be made available
for inspection under such section 181. In any case in
which a license is not, or was not, required in order to
file an application in any foreign country, such subsequent modifications, amendments, and supplements
may be made, without a license, to the application
filed in the foreign country if the United States application was not required to be made available for
inspection under section 181 and if such modifications, amendments, and supplements do not, or did
not, change the general nature of the invention in a
manner which would require the United States application to have been made available for inspection
under such section 181.


the suit by the clerk of the court in which it is filed
(Amended Aug. 23, 1988, Public Law 100-418, sec.
and shall have the right to intervene. Judgment of the
9101(b)(1), 102 Stat. 1567; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
court in favor of the right of an applicant to a patent
4732(a)(10)(B)).)
shall authorize the Director to issue such patent on the
filing in the Patent and Trademark Office of a certified copy of the judgment and on compliance with the
requirements of law.  


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
35 U.S.C. 185 Patent barred for filing without
88 Stat. 1949; Apr. 2, 1982, Public Law 97-164, sec.
license.  
163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-622,
sec. 203(c), 98 Stat. 3387; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
4732(a)(10)(A)).)


CHAPTER 14 — ISSUE OF PATENT
Notwithstanding any other provisions of law any
person, and his successors, assigns, or legal representatives, shall not receive a United States patent for an
invention if that person, or his successors, assigns, or
legal representatives shall, without procuring the
license prescribed in section 184 of this title, have


Sec.
151 Issue of patent.
152 Issue of patent to assignee.
153 How issued.
154 Contents and term of patent; provisional rights.
155 Patent term extension.
155A Patent term restoration.
156 Extension of patent term.
157 Statutory invention registration.


made, or consented to or assisted another’s making,
application in a foreign country for a patent or for the
registration of a utility model, industrial design, or
model in respect of the invention. A United States
patent issued to such person, his successors, assigns,
or legal representatives shall be invalid, unless the
failure to procure such license was through error and
without deceptive intent, and the patent does not disclose subject matter within the scope of section 181 of
this title.


35 U.S.C. 151 Issue of patent.  
(Amended Aug. 23, 1988, Public Law 100-418, sec.  
9101(b)(2), 102 Stat. 1568; Nov. 2, 2002, Public Law 107273, sec. 13206, 116 Stat. 1904.)


If it appears that applicant is entitled to a patent
35 U.S.C. 186 Penalty.  
under the law, a written notice of allowance of the
application shall be given or mailed to the applicant.  
The notice shall specify a sum, constituting the issue
fee or a portion thereof, which shall be paid within
three months thereafter.  


Upon payment of this sum the patent shall issue,  
Whoever, during the period or periods of time an
but if payment is not timely made, the application  
invention has been ordered to be kept secret and the  
shall be regarded as abandoned.  
grant of a patent thereon withheld pursuant to section
181 of this title, shall, with knowledge of such order
and without due authorization, willfully publish or
disclose or authorize or cause to be published or disclosed the invention, or material information with
respect thereto, or whoever willfully, in violation of
the provisions of section 184 of this title, shall file or
cause or authorize to be filed in any foreign country
an application for patent or for the registration of a
utility model, industrial design, or model in respect of
any invention made in the United States, shall, upon
conviction, be fined not more than $10,000 or imprisoned for not more than two years, or both.  


Any remaining balance of the issue fee shall be
(Amended Aug. 23, 1988, Public Law 100-418, sec.  
paid within three months from the sending of a notice
9101(b)(3), 102 Stat. 1568.)
thereof, and, if not paid, the patent shall lapse at the
termination of this three-month period. In calculating
the amount of a remaining balance, charges for a page
or less may be disregarded.  


If any payment required by this section is not
35 U.S.C. 187 Nonapplicability to certain persons.  
timely made, but is submitted with the fee for delayed
payment and the delay in payment is shown to have
been unavoidable, it may be accepted by the Director
as though no abandonment or lapse had ever occurred.  


(Amended July 24, 1965, Public Law 89-83, sec. 4,
The prohibitions and penalties of this chapter shall
79 Stat. 260; Jan. 2, 1975, Public Law 93-601, sec. 3, 88
not apply to any officer or agent of the United States
Stat. 1956; Nov. 29, 1999, Public Law 106-113, sec.
acting within the scope of his authority, nor to any
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
person acting upon his written instructions or permission.  
4732(a)(10)(A)); Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


35 U.S.C. 152 Issue of patent to assignee.  
35 U.S.C. 188 Rules and regulations, delegation of  
power.  


Patents may be granted to the assignee of the inventor of record in the Patent and Trademark Office, upon
The Atomic Energy Commission, the Secretary of a
the application made and the specification sworn to  
defense department, the chief officer of any other
by the inventor, except as otherwise provided in this  
department or agency of the Government designated
title.  
by the President as a defense agency of the United
States, and the Secretary of Commerce, may separately issue rules and regulations to enable the respective department or agency to carry out the provisions
of this chapter, and may delegate any power conferred
by this chapter.  


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
===CHAPTER 18 — PATENT RIGHTS IN INVENTIONS MADE WITH FEDERAL ASSISTANCE===
88 Stat. 1949.)


35 U.S.C. 153 How issued.


Patents shall be issued in the name of the United  
Sec.
States of America, under the seal of the Patent and
200 Policy and objective.
Trademark Office, and shall be signed by the Director
201 Definitions.
or have his signature placed thereon and shall be
202 Disposition of rights.
recorded in the Patent and Trademark Office.
203 March-in rights.
204 Preference for United States industry.
205 Confidentiality.
206 Uniform clauses and regulations.
207 Domestic and foreign protection of federally


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)); Nov. 2, 2002, Public Law 107-273, sec.
13203, 116 Stat. 1902.)


35 U.S.C. 154 Contents and term of patent; provisional rights.  
owned inventions.  
208 Regulations governing Federal licensing.  
209 Licensing federally owned inventions.  
210 Precedence of chapter.
211 Relationship to antitrust laws.
212 Disposition of rights in educational awards.  


(a) IN GENERAL.
35 U.S.C. 200 Policy and objective.  


(1) CONTENTS.—Every patent shall contain a short title of the invention and a grant to the patentee, his heirs or assigns, of the right to exclude
It is the policy and objective of the Congress to use
others from making, using, offering for sale, or selling
the patent system to promote the utilization of inventions arising from federally supported research or  
the invention throughout the United States or importing the invention into the United States, and, if the
development; to encourage maximum participation of
invention is a process, of the right to exclude others
small business firms in federally supported research
from using, offering for sale or selling throughout the  
and development efforts; to promote collaboration
United States, or importing into the United States,
between commercial concerns and nonprofit organizations, including universities; to ensure that inventions made by nonprofit organizations and small
products made by that process, referring to the specification for the particulars thereof.
business firms are used in a manner to promote free
(2) TERM.—Subject to the payment of fees
competition and enterprise without unduly encumbering future research and discovery; to promote the  
under this title, such grant shall be for a term beginning on the date on which the patent issues and ending
commercialization and public availability of inventions made in the United States by United States  
20 years from the date on which the application for
industry and labor; to ensure that the Government
the patent was filed in the United States or, if the
obtains sufficient rights in federally supported inventions to meet the needs of the Government and protect
application contains a specific reference to an earlier
the public against nonuse or unreasonable use of
filed application or applications under section 120,
inventions; and to minimize the costs of administering
121, or 365(c) of this title, from the date on which the
policies in this area.  
earliest such application was filed.  


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
94 Stat. 3018; amended Nov. 1, 2000, Public Law 106-404,
sec. 5, 114 Stat. 1745.)


   
   


(3) PRIORITY.—Priority under section 119,
35 U.S.C. 201 Definitions.  
365(a), or 365(b) of this title shall not be taken into
 
account in determining the term of a patent.  
As used in this chapter —  
(4) SPECIFICATION AND DRAWING.—A
copy of the specification and drawing shall be
annexed to the patent and be a part of such patent.  
(b) ADJUSTMENT OF PATENT TERM.—
(1) PATENT TERM GUARANTEES.—  


(a) The term “Federal agency” means any executive agency as defined in section 105 of title 5, and
the military departments as defined by section 102 of
title 5.
(b) The term “funding agreement” means any
contract, grant, or cooperative agreement entered into
between any Federal agency, other than the Tennessee
Valley Authority, and any contractor for the performance of experimental, developmental, or research
work funded in whole or in part by the Federal Government. Such term includes any assignment, substitution of parties, or subcontract of any type entered
into for the performance of experimental, developmental, or research work under a funding agreement
as herein defined.
(c) The term “contractor” means any person,
small business firm, or nonprofit organization that is a
party to a funding agreement.
(d) The term “invention” means any invention
or discovery which is or may be patentable or otherwise protectable under this title or any novel variety
of plant which is or may be protectable under the
Plant Variety Protection Act (7 U.S.C. 2321, et seq.).
(e) The term “subject invention” means any
invention of the contractor conceived or first actually
reduced to practice in the performance of work under
a funding agreement: Provided, That in the case of a
variety of plant, the date of determination (as defined
in section 41(d) of the Plant Variety Protection Act (7


(A) GUARANTEE OF PROMPT PATENT
AND TRADEMARK OFFICE RESPONSES.— Subject to the limitations under paragraph (2), if the issue
of an original patent is delayed due to the failure of
the Patent and Trademark Office to—
(i) provide at least one of the notifications under section 132 of this title or a notice of
allowance under section 151 of this title not later than
14 months after—
(I) the date on which an application
was filed under section 111(a) of this title; or
(II) the date on which an international
application fulfilled the requirements of section 371
of this title;
(ii) respond to a reply under section 132,
or to an appeal taken under section 134, within
4 months after the date on which the reply was filed or
the appeal was taken;


U.S.C. 2401(d)) must also occur during the period of
contract performance.
(f) The term “practical application” means to
manufacture in the case of a composition or product,
to practice in the case of a process or method, or to
operate in the case of a machine or system; and, in
each case, under such conditions as to establish that
the invention is being utilized and that its benefits are
to the extent permitted by law or Government regulations available to the public on reasonable terms.
(g) The term “made” when used in relation to
any invention means the conception or first actual
reduction to practice of such invention.
(h) The term “small business firm” means a
small business concern as defined at section 2 of Public Law 85-536 (15 U.S.C. 632) and implementing


(iii) act on an application within
4 months after the date of a decision by the Board of
Patent Appeals and Interferences under section 134 or
135 or a decision by a Federal court under section
141, 145, or 146 in a case in which allowable claims
remain in the application; or


(iv) issue a patent within 4 months after
regulations of the Administrator of the Small Business Administration.  
the date on which the issue fee was paid under section
151 and all outstanding requirements were satisfied,
the term of the patent shall be extended 1 day for each
day after the end of the period specified in clause (i),
(ii), (iii), or (iv), as the case may be, until the action
described in such clause is taken.
(B) GUARANTEE OF NO MORE THAN
3-YEAR APPLICATION PENDENCY.— Subject to
the limitations under paragraph (2), if the issue of an
original patent is delayed due to the failure of the
United States Patent and Trademark Office to issue a
patent within 3 years after the actual filing date of the
application in the United States, not including—


(i) The term “nonprofit organization” means
universities and other institutions of higher education
or an organization of the type described in section
501(c)(3) of the Internal Revenue Code of 1986 (26


(i) any time consumed by continued
U.S.C. 501(c)) and exempt from taxation under section 501(a) of the Internal Revenue Code (26 U.S.C.
examination of the application requested by the applicant under section 132(b);
501(a)) or any nonprofit scientific or educational
(ii) any time consumed by a proceeding
organization qualified under a State nonprofit organization statute.
under section 135(a), any time consumed by the
imposition of an order under section 181, or any time
consumed by appellate review by the Board of Patent
Appeals and Interferences or by a Federal court; or


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
94 Stat. 3019.)


(iii) any delay in the processing of the
(Subsection (d) amended Nov. 8, 1984, Public Law 98620, sec. 501(1), 98 Stat. 3364.)
application by the United States Patent and Trademark Office requested by the applicant except as permitted by paragraph (3)(C), the term of the patent
shall be extended 1 day for each day after the end of
that 3-year period until the patent is issued.  


(C) GUARANTEE OR ADJUSTMENTS
(Subsection (e) amended Nov. 8, 1984, Public Law 98620, sec. 501(2), 98 Stat. 3364.)  
FOR DELAYS DUE TO INTERFERENCES,  
SECRECY ORDERS, AND APPEALS.— Subject to
the limitations under paragraph (2), if the issue of an
original patent is delayed due to—
(i) a proceeding under section 135(a);


(Subsection (i) amended Oct. 22, 1986, Public Law 99514, sec. 2, 100 Stat. 2095.)


(ii) the imposition of an order under section 181; or
(Subsection (a) amended Nov. 2, 2002, Public Law
107-273, sec. 13206, 116 Stat. 1904.)  


35 U.S.C. 202 Disposition of rights.


(iii) appellate review by the Board of  
(a) Each nonprofit organization or small business firm may, within a reasonable time after disclosure as required by paragraph (c)(1) of this section,
Patent Appeals and Interferences or by a Federal court
elect to retain title to any subject invention: Provided,
in a case in which the patent was issued under a decision in the review reversing an adverse determination
however, That a funding agreement may provide otherwise (i) when the contractor is not located in the  
of patentability, the term of the patent shall be
United States or does not have a place of business
extended 1 day for each day of the pendency of the
located in the United States or is subject to the control
proceeding, order, or review, as the case may be.
of a foreign government, (ii) in exceptional circumstances when it is determined by the agency that  
 
restriction or elimination of the right to retain title to  
(2) LIMITATIONS.—
any subject invention will better promote the policy
 
and objectives of this chapter, (iii) when it is determined by a Government authority which is authorized
(A) IN GENERAL.— To the extent that  
by statute or Executive order to conduct foreign intelligence or counterintelligence activities that the  
periods of delay attributable to grounds specified in
restriction or elimination of the right to retain title to
paragraph (1) overlap, the period of any adjustment
any subject invention is necessary to protect the security of such activities, or (iv) when the funding agreement includes the operation of a Government-owned,
granted under this subsection shall not exceed the  
contractor-operated facility of the Department of  
actual number of days the issuance of the patent was
Energy primarily dedicated to that Department’s naval
delayed.
nuclear propulsion or weapons related programs and
(B) DISCLAIMED TERM.— No patent
all funding agreement limitations under this subparagraph on the contractor’s right to elect title to a sub-
the term of which has been disclaimed beyond a specified date may be adjusted under this section beyond
the expiration date specified in the disclaimer.
(C) REDUCTION OF PERIOD OF
ADJUSTMENT.—
(i) The period of adjustment of the term
of a patent under paragraph (1) shall be reduced by a  
period equal to the period of time during which the  
applicant failed to engage in reasonable efforts to conclude prosecution of the application.
 


   
   


(ii) With respect to adjustments to patent
ject invention are limited to inventions occurring
term made under the authority of paragraph (1)(B), an
under the above two programs of the Department of  
applicant shall be deemed to have failed to engage in
Energy. The rights of the nonprofit organization or
reasonable efforts to conclude processing or examination of an application for the cumulative total of any
small business firm shall be subject to the provisions
periods of time in excess of 3 months that are taken to
of paragraph (c) of this section and the other provisions of this chapter.  
respond to a notice from the Office making any rejection, objection, argument, or other request, measuring
such 3-month period from the date the notice was
given or mailed to the applicant.  


(iii) The Director shall prescribe regulations establishing the circumstances that constitute a  
(b)(1) The rights of the Government under subsection (a) shall not be exercised by a Federal agency
failure of an applicant to engage in reasonable efforts
unless it first determines that at least one of the conditions identified in clauses (i) through (iii) of subsection (a) exists. Except in the case of subsection
to conclude processing or examination of an application.  
(a)(iii), the agency shall file with the Secretary of
Commerce, within thirty days after the award of the
applicable funding agreement, a copy of such determination. In the case of a determination under subsection (a)(ii), the statement shall include an analysis
justifying the determination. In the case of determinations applicable to funding agreements with small
business firms, copies shall also be sent to the Chief
Counsel for Advocacy of the Small Business Administration. If the Secretary of Commerce believes that
any individual determination or pattern of determinations is contrary to the policies and objectives of this
chapter or otherwise not in conformance with this
chapter, the Secretary shall so advise the head of the
agency concerned and the Administrator of the Office
of Federal Procurement Policy, and recommend corrective actions.  


(3) PROCEDURES FOR PATENT TERM
(2) Whenever the Administrator of the Office
ADJUSTMENT DETERMINATION.—
of Federal Procurement Policy has determined that
(A) The Director shall prescribe regulations establishing procedures for the application for
one or more Federal agencies are utilizing the authority of clause (i) or (ii) of subsection (a) of this section
and determination of patent term adjustments under
in a manner that is contrary to the policies and objectives of this chapter the Administrator is authorized to
this subsection.
issue regulations describing classes of situations in
(B) Under the procedures established
which agencies may not exercise the authorities of  
under subparagraph (A), the Director shall—
those clauses.  
(i) make a determination of the period
(3) At least once every 5 years, the Comptroller General shall transmit a report to the Committees on the Judiciary of the Senate and House of  
of any patent term adjustment under this subsection,
Representatives on the manner in which this chapter
and shall transmit a notice of that determination with
is being implemented by the agencies and on such
the written notice of allowance of the application
other aspects of Government patent policies and practices with respect to federally funded inventions as the  
under section 151; and
Comptroller General believes appropriate.  
(ii) provide the applicant one opportunity to request reconsideration of any patent term
(4) If the contractor believes that a determination is contrary to the policies and objectives of this  
adjustment determination made by the Director.  
chapter or constitutes an abuse of discretion by the  
(C) The Director shall reinstate all or part
of the cumulative period of time of an adjustment
under paragraph (2)(C) if the applicant, prior to the  
issuance of the patent, makes a showing that, in spite
of all due care, the applicant was unable to respond
within the 3-month period, but in no case shall more
than three additional months for each such response
beyond the original 3-month period be reinstated.  
(D) The Director shall proceed to grant the  
patent after completion of the Director’s determination of a patent term adjustment under the procedures
established under this subsection, notwithstanding
any appeal taken by the applicant of such determination.




(4) APPEAL OF PATENT TERM ADJUSTMENT DETERMINATION.—
agency, the determination shall be subject to the section 203(b).  
(A) An applicant dissatisfied with a determination made by the Director under paragraph (3)
shall have remedy by a civil action against the Director filed in the United States District Court for the
District of Columbia within 180 days after the grant
of the patent. Chapter 7 of title 5 shall apply to such
action. Any final judgment resulting in a change to the
period of adjustment of the patent term shall be served
on the Director, and the Director shall thereafter alter
the term of the patent to reflect such change.
(B) The determination of a patent term
adjustment under this subsection shall not be subject  
to appeal or challenge by a third party prior to the  
grant of the patent.
(c) CONTINUATION.


 
(c) Each funding agreement with a small business firm or nonprofit organization shall contain
(1) DETERMINATION.—The term of a  
appropriate provisions to effectuate the following:
patent that is in force on or that results from an application filed before the date that is 6 months after the  
(1) That the contractor disclose each subject
date of the enactment of the Uruguay Round Agreements Act shall be the greater of the 20-year term as
invention to the Federal agency within a reasonable
provided in subsection (a), or 17 years from grant,  
time after it becomes known to contractor personnel
subject to any terminal disclaimers.
responsible for the administration of patent matters,
(2) REMEDIES.—The remedies of sections
and that the Federal Government may receive title to
283, 284, and 285 of this title shall not apply to acts
any subject invention not disclosed to it within such
which
time.
(A) were commenced or for which substantial investment was made before the date that is 6
(2) That the contractor make a written election within two years after disclosure to the Federal
months after the date of the enactment of the Uruguay
agency (or such additional time as may be approved
Round Agreements Act; and
by the Federal agency) whether the contractor will
(B) became infringing by reason of paragraph (1).  
retain title to a subject invention: Provided, That in
(3) REMUNERATION.—The acts referred
any case where publication, on sale, or public use, has
to in paragraph (2) may be continued only upon the
initiated the one year statutory period in which valid
payment of an equitable remuneration to the patentee
patent protection can still be obtained in the United
that is determined in an action brought under chapter
States, the period for election may be shortened by the  
28 and chapter 29 (other than those provisions
Federal agency to a date that is not more than sixty
excluded by paragraph (2)) of this title.
days prior to the end of the statutory period: And provided further, That the Federal Government may
(d) PROVISIONAL RIGHTS.
receive title to any subject invention in which the contractor does not elect to retain rights or fails to elect
 
rights within such times.  
 
(3) That a contractor electing rights in a subject invention agrees to file a patent application prior
(1) IN GENERAL.— In addition to other
to any statutory bar date that may occur under this
rights provided by this section, a patent shall include
title due to publication, on sale, or public use, and
the right to obtain a reasonable royalty from any person who, during the period beginning on the date of
shall thereafter file corresponding patent applications
publication of the application for such patent under
in other countries in which it wishes to retain title
section 122(b), or in the case of an international application filed under the treaty defined in section 351(a)
within reasonable times, and that the Federal Government may receive title to any subject inventions in the
designating the United States under Article 21(2)(a)
United States or other countries in which the contractor has not filed patent applications on the subject
invention within such times.  
(4) With respect to any invention in which
the contractor elects rights, the Federal agency shall  
have a nonexclusive, nontransferable, irrevocable,  
paid-up license to practice or have practiced for or on  
behalf of the United States any subject invention
throughout the world: Provided, That the funding
agreement may provide for such additional rights,
including the right to assign or have assigned foreign
patent rights in the subject invention, as are determined by the agency as necessary for meeting the  




   
   


of such treaty, the date of publication of the application, and ending on the date the patent is issued—
obligations of the United States under any treaty,  
international agreement, arrangement of cooperation,
memorandum of understanding, or similar arrangement, including military agreements relating to weapons development and production.


(A) (i) makes, uses, offers for sale, or sells
(5) The right of the Federal agency to require
in the United States the invention as claimed in the  
periodic reporting on the utilization or efforts at
published patent application or imports such an invention into the United States; or  
obtaining utilization that are being made by the contractor or his licensees or assignees: Provided, That
(ii) if the invention as claimed in the  
any such information, as well as any information on
published patent application is a process, uses, offers
utilization or efforts at obtaining utilization obtained
for sale, or sells in the United States or imports into
as part of a proceeding under section 203 of this chapter shall be treated by the Federal agency as commercial and financial information obtained from a person
the United States products made by that process as  
and privileged and confidential and not subject to disclosure under section 552 of title 5.  
claimed in the published patent application; and
(6) An obligation on the part of the contractor, in the event a United States patent application is
(B) had actual notice of the published
filed by or on its behalf or by any assignee of the contractor, to include within the specification of such
patent application and, in a case in which the right
application and any patent issuing thereon, a statement specifying that the invention was made with
arising under this paragraph is based upon an international application designating the United States that is
Government support and that the Government has certain rights in the invention.  
published in a language other than English, had a
(7) In the case of a nonprofit organization,
translation of the international application into the
English language.
(2) RIGHT BASED ON SUBSTANTIALLY
IDENTICAL INVENTIONS.— The right under paragraph (1) to obtain a reasonable royalty shall not be  
available under this subsection unless the invention as  
claimed in the patent is substantially identical to the
invention as claimed in the published patent application.  
(3) TIME LIMITATION ON OBTAINING A
REASONABLE ROYALTY.— The right under paragraph (1) to obtain a reasonable royalty shall be available only in an action brought not later than 6 years
after the patent is issued. The right under paragraph
(1) to obtain a reasonable royalty shall not be affected
by the duration of the period described in paragraph
(1).
(4) REQUIREMENTS FOR INTERNATIONAL APPLICATIONS—
(A) EFFECTIVE DATE.— The right under
paragraph (1) to obtain a reasonable royalty based
upon the publication under the treaty defined in section 351(a) of an international application designating
the United States shall commence on the date of publication under the treaty of the international application, or, if the publication under the treaty of the
international application is in a language other than
English, on the date on which the Patent and Trademark Office receives a translation of the publication
in the English language.  




(B) COPIES.— The Director may require
(A) a prohibition upon the assignment of rights to a
the applicant to provide a copy of the international
subject invention in the United States without the
application and a translation thereof.
approval of the Federal agency, except where such
 
assignment is made to an organization which has as
(Amended July 24, 1965, Public Law 89-83, sec. 5, 79
one of its primary functions the management of
Stat. 261; Dec. 12, 1980, Public Law 96-517, sec. 4, 94
inventions (provided that such assignee shall be subject to the same provisions as the contractor); (B) a  
Stat. 3018; Aug. 23, 1988, Public Law 100-418, sec. 9002,  
requirement that the contractor share royalties with
102 Stat. 1563; Dec. 8, 1994, Public Law 103-465, sec. 532
the inventor; (C) except with respect to a funding
(a)(1), 108 Stat. 4983; Oct. 11, 1996, Public Law 104-295,  
agreement for the operation of a Government-ownedcontractor-operated facility, a requirement that the
sec. 20(e)(1), 110 Stat. 3529.)
balance of any royalties or income earned by the contractor with respect to subject inventions, after payment of expenses (including payments to inventors)
incidental to the administration of subject inventions,  
be utilized for the support of scientific research, or
education; (D) a requirement that, except where it
proves infeasible after a reasonable inquiry, in the
licensing of subject inventions shall be given to small
business firms; and (E) with respect to a funding
agreement for the operation of a Government-ownedcontractor-operator facility, requirements (i) that after
payment of patenting costs, licensing costs, payments


(Subsection (b) amended Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-557 (S. 1948
sec. 4402(a)).)


(Subsection (d) added Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-564 (S. 1948 sec.
to inventors, and other expenses incidental to the
4504).)
administration of subject inventions, 100 percent of
the balance of any royalties or income earned and
retained by the contractor during any fiscal year, up to
an amount equal to 5 percent of the annual budget of
the facility, shall be used by the contractor for scientific research, development, and education consistent
with the research and development mission and objectives of the facility, including activities that increase
the licensing potential of other inventions of the facility provided that if said balance exceeds 5 percent of
the annual budget of the facility, that 75 percent of
such excess shall be paid to the Treasury of the United
States and the remaining 25 percent shall be used for
the same purposes as described above in this clause
(D); and (ii) that, to the extent it provides the most
effective technology transfer, the licensing of subject
inventions shall be administered by contractor
employees on location at the facility.  


(Subsection (b)(4) amended Nov. 2, 2002, Public Law
(8) The requirements of sections 203 and 204
107-273, sec. 13206, 116 Stat. 1904; subsection (d)(4)(A)
of this chapter.  
amended Nov. 2, 2002, Public Law 107-273, sec. 13204,  
(d) If a contractor does not elect to retain title to
116 Stat. 1902.)
a subject invention in cases subject to this section, the
 
Federal agency may consider and after consultation
35 U.S.C. 155 Patent term extension.
with the contractor grant requests for retention of
 
rights by the inventor subject to the provisions of this
Notwithstanding the provisions of section 154, the
Act and regulations promulgated hereunder.
term of a patent which encompasses within its scope a  
(e) In any case when a Federal employee is a  
composition of matter or a process for using such
coinventor of any invention made with a nonprofit
composition shall be extended if such composition or  
organization, a small business firm, or a non-Federal  
process has been subjected to a regulatory review by
inventor, the Federal agency employing such coinventor may, for the purpose of consolidating rights in the  
the Federal Food and Drug Administration pursuant
invention and if it finds that it would expedite the
to the Federal Food, Drug and Cosmetic Act leading
development of the invention—
to the publication of regulation permitting the interstate distribution and sale of such composition or process and for which there has thereafter been a stay of
(1) license or assign whatever rights it may
regulation of approval imposed pursuant to section
acquire in the subject invention to the nonprofit organization, small business firm, or non-Federal inventor
409 of the Federal Food, Drug and Cosmetic Act,
in accordance with the provisions of this chapter; or  
which stay was in effect on January 1, 1981, by a
(2) acquire any rights in the subject invention
length of time to be measured from the date such stay
from the nonprofit organization, small business firm,  
of regulation of approval was imposed until such proceedings are finally resolved and commercial marketing permitted. The patentee, his heirs, successors, or  
or non-Federal inventor, but only to the extent the  
assigns shall notify the Director within 90 days of the
party from whom the rights are acquired voluntarily
date of enactment of this section or the date the stay of
enters into the transaction and no other transaction
regulation of approval has been removed, whichever
under this chapter is conditioned on such acquisition.
is later, of the number of the patent to be extended and
the date the stay was imposed and the date commercial marketing was permitted. On receipt of such
notice, the Director shall promptly issue to the owner
of record of the patent a certificate of extension, under
seal, stating the fact and length of the extension and  
identifying the composition of matter or process for
using such composition to which such extension is




applicable. Such certificate shall be recorded in the
(f)(1) No funding agreement with a small business firm or nonprofit organization shall contain a
official file of each patent extended and such certificate shall be considered as part of the original patent,
provision allowing a Federal agency to require the  
and an appropriate notice shall be published in the  
licensing to third parties of inventions owned by the  
Official Gazette of the Patent and Trademark Office.


(Added Jan. 4, 1983, Public Law 97-414, sec. 11(a),
96 Stat. 2065; amended Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 secs.
4732(a)(6) and 4732(a)(10)(A)).)


35 U.S.C. 155A Patent term restoration.  
contractor that are not subject inventions unless such
provision has been approved by the head of the
agency and a written justification has been signed by
the head of the agency. Any such provision shall
clearly state whether the licensing may be required in
connection with the practice of a subject invention, a
specifically identified work object, or both. The head
of the agency may not delegate the authority to
approve provisions or sign justifications required by
this paragraph.  


(a) Notwithstanding section 154 of this title, the  
(2) A Federal agency shall not require the  
term of each of the following patents shall be
licensing of third parties under any such provision
extended in accordance with this section:
unless the head of the agency determines that the use
(1) Any patent which encompasses within its
of the invention by others is necessary for the practice
scope a composition of matter which is a new drug
of a subject invention or for the use of a work object
product, if during the regulatory review of the product
of the funding agreement and that such action is necessary to achieve the practical application of the subject invention or work object. Any such determination
by the Federal Food and Drug Administration —
shall be on the record after an opportunity for an
(A) the Federal Food and Drug Administration notified the patentee, by letter dated February
agency hearing. Any action commenced for judicial
20, 1976, that such product’s new drug application
review of such determination shall be brought within  
was not approvable under section 505(b)(1) of the  
sixty days after notification of such determination.  
Federal Food, Drug and Cosmetic Act;
(B) in 1977 the patentee submitted to the
Federal Food and Drug Administration the results of a  
health effects test to evaluate the carcinogenic potential of such product;
(C) the Federal Food and Drug Administration approved, by letter dated December 18, 1979,
the new drug application for such application; and
(D) the Federal Food and Drug Administration approved, by letter dated May 26, 1981, a supplementary application covering the facility for the  
production of such product.  
(2) Any patent which encompasses within its
scope a process for using the composition described
in paragraph (1).
(b) The term of any patent described in subsection (a) shall be extended for a period equal to the
period beginning February 20, 1976, and ending May
26, 1981, and such patent shall have the effect as if
originally issued with such extended term.  
(c) The patentee of any patent described in subsection (a) of this section shall, within ninety days  
after the date of enactment of this section, notify the
Director of the number of any patent so extended. On
receipt of such notice, the Director shall confirm such
extension by placing a notice thereof in the official
file of such patent and publishing an appropriate


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
94 Stat. 3020; subsection (b)(4) added and subsections (a),
(b)(1), (b)(2), (c)(4), (c)(5), and (c)(7) amended Nov. 8,
1984, Public Law 98-620, sec. 501, 98 Stat. 3364; subsection (b)(3) amended Dec. 10, 1991, Public Law 102-204,
sec. 10, 105 Stat. 1641; subsection (a) amended Nov. 29,
1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat.
1501A-583 (S. 1948 sec. 4732(a)(12)); subsection (e)
amended Nov. 1, 2000, Public Law 106-404, sec. 6(1), 114
Stat. 1745; subsections (b)(4), (c)(4), and (c)(5) amended
Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat.
1905.)


notice of such extension in the Official Gazette of the  
35 U.S.C. 203 March-in rights.
Patent and Trademark Office.  
 
(a) With respect to any subject invention in
which a small business firm or nonprofit organization
has acquired title under this chapter, the Federal
agency under whose funding agreement the subject
invention was made shall have the right, in accordance with such procedures as are provided in regulations promulgated hereunder, to require the
contractor, an assignee, or exclusive licensee of a subject invention to grant a nonexclusive, partially exclusive, or exclusive license in any field of use to a
responsible applicant or applicants, upon terms that
are reasonable under the circumstances, and if the
contractor, assignee, or exclusive licensee refuses
such request, to grant such a license itself, if the Federal agency determines that such
 
(1) action is necessary because the contractor
or assignee has not taken, or is not expected to take
within a reasonable time, effective steps to achieve
practical application of the subject invention in such
field of use;
(2) action is necessary to alleviate health or
safety needs which are not reasonably satisfied by the  
contractor, assignee, or their licensees;
(3) action is necessary to meet requirements
for public use specified by Federal regulations and
such requirements are not reasonably satisfied by the
contractor, assignee, or licensees; or
(4) action is necessary because the agreement
required by section 204 has not been obtained or
waived or because a licensee of the exclusive right to
use or sell any subject invention in the United States is
in breach of its agreement obtained pursuant to section 204.
(b) A determination pursuant to this section or
section 202(b)(4) shall not be subject to the Contract
Disputes Act (41 U.S.C. § 601 et seq.). An administrative appeals procedure shall be established by regulations promulgated in accordance with section 206.
Additionally, any contractor, inventor, assignee, or
exclusive licensee adversely affected by a determination under this section may, at any time within sixty
days after the determination is issued, file a petition in
the United States Court of Federal Claims, which
shall have jurisdiction to determine the appeal on the
record and to affirm, reverse, remand or modify, as
appropriate, the determination of the Federal agency.
In cases described in paragraphs (1) and (3) of subsection (a), the agency’s determination shall be held in
abeyance pending the exhaustion of appeals or petitions filed under the preceding sentence.  


(Added Oct. 13, 1983, Public Law 98-127, sec. 4(a),
97 Stat. 832; amended Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 secs.
4732(a)(7) and 4732(a)(10)(A)).)


35 U.S.C. 156 Extension of patent term.  
(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
94 Stat. 3022; amended Nov. 8, 1984, Public Law 98-620,
sec. 501(9), 98 Stat. 3367; Oct. 29, 1992, Public Law 102572, sec. 902(b)(1), 106 Stat. 4516; amended Nov. 2, 2002,
Public Law 107-273, sec. 13206, 116 Stat. 1905.)


(a) The term of a patent which claims a product, a method of using a product, or a method of manufacturing a product shall be extended in accordance
35 U.S.C. 204 Preference for United States industry.
with this section from the original expiration date of
 
the patent, which shall include any patent term adjustment granted under section 154(b) if —
Notwithstanding any other provision of this chapter, no small business firm or nonprofit organization
(1) the term of the patent has not expired
which receives title to any subject invention and no
before an application is submitted under subsection
assignee of any such small business firm or nonprofit
(d)(1) for its extension;
(2) the term of the patent has never been
extended under subsection (e)(1) of this section;
(3) an application for extension is submitted
by the owner of record of the patent or its agent and in
accordance with the requirements of paragraphs (1)
through (4) of subsection (d);
(4) the product has been subject to a regulatory review period before its commercial marketing or
use;
(5)(A) except as provided in subparagraph (B)
or (C), the permission for the commercial marketing
or use of the product after such regulatory review
period is the first permitted commercial marketing or  
use of the product under the provision of law under
which such regulatory review period occurred;




(B) in the case of a patent which claims a
organization shall grant to any person the exclusive
method of manufacturing the product which primarily
right to use or sell any subject invention in the United
uses recombinant DNA technology in the manufacture of the product, the permission for the commercial
States unless such person agrees that any products
marketing or use of the product after such regulatory
embodying the subject invention or produced through
period is the first permitted commercial marketing or  
the use of the subject invention will be manufactured  
use of a product manufactured under the process
substantially in the United States. However, in individual cases, the requirement for such an agreement
claimed in the patent; or
may be waived by the Federal agency under whose
(C) for purposes of subparagraph (A), in  
funding agreement the invention was made upon a  
the case of a patent which —
showing by the small business firm, nonprofit organization, or assignee that reasonable but unsuccessful
(i) claims a new animal drug or a veterinary biological product which (I) is not covered by
efforts have been made to grant licenses on similar
the claims in any other patent which has been  
terms to potential licensees that would be likely to
extended, and (II) has received permission for the  
manufacture substantially in the United States or that
commercial marketing or use in non-food-producing
under the circumstances domestic manufacture is not
animals and in food-producing animals, and
commercially feasible.


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
94 Stat. 3023.)


35 U.S.C. 205 Confidentiality.


(ii) was not extended on the basis of the  
Federal agencies are authorized to withhold from
regulatory review period for use in non-food-producing animals, the permission for the commercial marketing or use of the drug or product after the
disclosure to the public information disclosing any
regulatory review period for use in food-producing
invention in which the Federal Government owns or
animals is the first permitted commercial marketing
may own a right, title, or interest (including a nonexclusive license) for a reasonable time in order for a
or use of the drug or product for administration to a
patent application to be filed. Furthermore, Federal
food-producing animal.  
agencies shall not be required to release copies of any
The product referred to in paragraphs
document which is part of an application for patent
filed with the United States Patent and Trademark
Office or with any foreign patent office.  


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
94 Stat. 3023.)


(4) and (5) is hereinafter in this section referred to as
35 U.S.C. 206 Uniform clauses and regulations.  
the “approved product.
(b) Except as provided in subsection (d)(5)(F),
the rights derived from any patent the term of which is
extended under this section shall during the period
during which the term of the patent is extended —
(1) in the case of a patent which claims a
product, be limited to any use approved for the product —
(A) before the expiration of the term of the
patent —
(i) under the provision of law under
which the applicable regulatory review occurred, or
(ii) under the provision of law under
which any regulatory review described in paragraph
(1), (4), or (5) of subsection (g) occurred, and
(B) on or after the expiration of the regulatory review period upon which the extension of the
patent was based;
(2) in the case of a patent which claims a
method of using a product, be limited to any use
claimed by the patent and approved for the product —
(A) before the expiration of the term of the
patent —
(i) under any provision of law under
which an applicable regulatory review occurred, and
(ii) under the provision of law under
which any regulatory review described in paragraph
(1), (4), or (5) of subsection (g) occurred, and
(B) on or after the expiration of the regulatory review period upon which the extension of the
patent was based; and
(3) in the case of a patent which claims a
method of manufacturing a product, be limited to the
method of manufacturing as used to make —
(A) the approved product, or


The Secretary of Commerce may issue regulations
which may be made applicable to Federal agencies
implementing the provisions of sections 202 through
204 of this chapter and shall establish standard funding agreement provisions required under this chapter.
The regulations and the standard funding agreement
shall be subject to public comment before their issuance.


(B) the product if it has been subject to a
(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
regulatory review period described in paragraph (1),  
94 Stat. 3023; amended Nov. 8, 1984, Public Law 98-620,  
(4), or (5) of subsection (g).
sec. 501(10), 98 Stat. 3367.)  


35 U.S.C. 207 Domestic and foreign protection of
federally owned inventions.


As used in this subsection, the term “product” includes an approved product.
(a) Each Federal agency is authorized to —


(c) The term of a patent eligible for extension
(1) apply for, obtain, and maintain patents or
under subsection (a) shall be extended by the time
other forms of protection in the United States and in
equal to the regulatory review period for the approved
foreign countries on inventions in which the Federal
product which period occurs after the date the patent
Government owns a right, title, or interest;
is issued, except that—
(2) grant nonexclusive, exclusive, or partially
(1) each period of the regulatory review
exclusive licenses under federally owned inventions,
period shall be reduced by any period determined
royalty-free or for royalties or other consideration,
under subsection (d)(2)(B) during which the applicant
and on such terms and conditions, including the grant
for the patent extension did not act with due diligence
to the licensee of the right of enforcement pursuant to
during such period of the regulatory review period;
the provisions of chapter 29 of this title as determined
(2) after any reduction required by paragraph
appropriate in the public interest;
(1), the period of extension shall include only one-half
(3) undertake all other suitable and necessary
of the time remaining in the periods described in paragraphs (1)(B)(i), (2)(B)(i), (3)(B)(i), (4)(B)(i), and  
steps to protect and administer rights to federally
(5)(B)(i) of subsection (g);
owned inventions on behalf of the Federal Government either directly or through contract, including
(3) if the period remaining in the term of a
acquiring rights for and administering royalties to the  
patent after the date of the approval of the approved
Federal Government in any invention, but only to the  
product under the provision of law under which such
extent the party from whom the rights are acquired
regulatory review occurred when added to the regulatory review period as revised under paragraphs (1)
voluntarily enters into the transaction, to facilitate the  
and (2) exceeds fourteen years, the period of extension shall be reduced so that the total of both such
licensing of a federally owned invention; and  
periods does not exceed fourteen years, and
(4) transfer custody and administration, in
(4) in no event shall more than one patent be
whole or in part, to another Federal agency, of the  
extended under subsection (e)(i) for the same regulatory review period for any product.  
right, title, or interest in any federally owned invention.  
(d)(1) To obtain an extension of the term of a
(b) For the purpose of assuring the effective
patent under this section, the owner of record of the
management of Government-owned inventions, the  
patent or its agent shall submit an application to the  
Secretary of Commerce authorized to
Director. Except as provided in paragraph (5), such an
(1) assist Federal agency efforts to promote
application may only be submitted within the sixty-
the licensing and utilization of Government-owned
day period beginning on the date the product received
inventions;
permission under the provision of law under which
(2) assist Federal agencies in seeking protection and maintaining inventions in foreign countries,  
the applicable regulatory review period occurred for  
including the payment of fees and costs connected
commercial marketing or use. The application shall
therewith; and
contain —
(3) consult with and advise Federal agencies
as to areas of science and technology research and
development with potential for commercial utilization.  




(A) the identity of the approved product
(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
and the Federal statute under which regulatory review
94 Stat. 3023; amended Nov. 8, 1984, Public Law 98-620,
occurred;  
sec. 501(11), 98 Stat. 3367; subsections (a)(2) and (a)(3)  
(B) the identity of the patent for which an
amended Nov. 1, 2000, Public Law 106-404, sec. 6(2), 114
extension is being sought and the identity of each
Stat. 1745.)
claim of such patent;  
(C) information to enable the Director to
determine under subsections (a) and (b) the eligibility
of a patent for extension and the rights that will be
derived from the extension and information to enable




35 U.S.C. 208 Regulations governing Federal
licensing.


the Director and the Secretary of Health and Human
The Secretary of Commerce is authorized to promulgate regulations specifying the terms and conditions upon which any federally owned invention,
Services or the Secretary of Agriculture to determine
other than inventions owned by the Tennessee Valley
the period of the extension under subsection (g);
Authority, may be licensed on a nonexclusive, partially exclusive, or exclusive basis.


(D) a brief description of the activities
(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
undertaken by the applicant during the applicable regulatory review period with respect to the approved
94 Stat. 3024; amended Nov. 8, 1984, Public Law 98-620,
product and the significant dates applicable to such
sec. 501(12), 98 Stat. 3367.)  
activities; and
(E) such patent or other information as the
Director may require.  
(2)(A) Within 60 days of the submittal of an
application for extension of the term of a patent under
paragraph (1), the Director shall notify —


35 U.S.C. 209 Licensing federally owned inventions.


(i) the Secretary of Agriculture if the
(a) AUTHORITY.—A Federal agency may
patent claims a drug product or a method of using or
grant an exclusive or partially exclusive license on a  
manufacturing a drug product and the drug product is
federally owned invention under section 207(a)(2)
subject to the Virus-Serum-Toxin Act, and
only if—
(ii) the Secretary of Health and Human
(1) granting the license is a reasonable and  
Services if the patent claims any other drug product, a
necessary incentive to—
medical device, or a food additive or color additive or
(A) call forth the investment capital and
a method of using or manufacturing such a product,  
expenditures needed to bring the invention to practical application; or
device, or additive and if the product, device, and  
(B) otherwise promote the invention’s utilization by the public;
additive are subject to the Federal Food, Drug and  
(2) the Federal agency finds that the public
Cosmetic Act, of the extension application and shall
will be served by the granting of the license, as indicated by the applicant’s intentions, plans, and ability
submit to the Secretary who is so notified a copy of
to bring the invention to practical application or otherwise promote the invention’s utilization by the public,  
the application. Not later than 30 days after the receipt
and that the proposed scope of exclusivity is not
of an application from the Director, the Secretary
greater than reasonably necessary to provide the  
reviewing the application shall review the dates contained in the application pursuant to paragraph (1)(C)  
incentive for bringing the invention to practical application, as proposed by the applicant, or otherwise to
and determine the applicable regulatory review
promote the invention’s utilization by the public;
period, shall notify the Director of the determination,
(3) the applicant makes a commitment to
and shall publish in the Federal Register a notice of
achieve practical application of the invention within a
such determination.  
reasonable time, which time may be extended by the  
agency upon the applicant’s request and the applicant’s demonstration that the refusal of such extension
would be unreasonable;
(4) granting the license will not tend to substantially lessen competition or create or maintain a
violation of the Federal antitrust laws; and
(5) in the case of an invention covered by a
foreign patent application or patent, the interests of  
the Federal Government or United States industry in
foreign commerce will be enhanced.  




(B)(i) If a petition is submitted to the Secretary making the determination under subparagraph
(b) MANUFACTURE IN UNITED
(A), not later than 180 days after the publication of the  
STATES.—A Federal agency shall normally grant a
determination under subparagraph (A), upon which it
license under section 207(a)(2) to use or sell any federally owned invention in the United States only to a  
may reasonably be determined that the applicant did
licensee who agrees that any products embodying
not act with due diligence during the applicable regulatory review period, the Secretary making the determination shall, in accordance with regulations
the invention or produced through the use of the  
promulgated by the Secretary, determine if the applicant acted with due diligence during the applicable
invention will be manufactured substantially in the  
regulatory review period. The Secretary making the  
United States.
determination shall make such determination not later
(c) SMALL BUSINESS.—First preference for
than 90 days after the receipt of such a petition. For a  
the granting of any exclusive or partially exclusive
drug product, device, or additive subject to the Federal Food, Drug, and Cosmetic Act or the Public
licenses under section 207(a)(2) shall be given to
Health Service Act, the Secretary may not delegate
small business firms having equal or greater likelihood as other applicants to bring the invention to
the authority to make the determination prescribed by
practical application within a reasonable time.
this clause to an office below the Office of the Commissioner of Food and Drugs. For a product subject to  
(d) TERMS AND CONDITIONS.—Any
the Virus-Serum-Toxin Act, the Secretary of Agriculture may not delegate the authority to make the determination prescribed by this clause to an office below
licenses granted under section 207(a)(2) shall contain
the Office of the Assistant Secretary for Marketing
such terms and conditions as the granting agency considers appropriate, and shall include provisions—
and Inspection Services.
(1) retaining a nontransferrable, irrevocable,
paid-up license for any Federal agency to practice the
invention or have the invention practiced throughout
the world by or on behalf of the Government of the  
United States;
(2) requiring periodic reporting on utilization
of the invention, and utilization efforts, by the licensee, but only to the extent necessary to enable the  
Federal agency to determine whether the terms of the  
license are being complied with, except that any such  
report shall be treated by the Federal agency as commercial and financial information obtained from a  
person and privileged and confidential and not subject  
to disclosure under section 552 of title 5; and
(3) empowering the Federal agency to terminate the license in whole or in part if the agency determines that—
(A) the licensee is not executing its commitment to achieve practical application of the invention, including commitments contained in any plan
submitted in support of its request for a license, and
the licensee cannot otherwise demonstrate to the satisfaction of the Federal agency that it has taken, or can
be expected to take within a reasonable time, effective
steps to achieve practical application of the invention;
(B) the licensee is in breach of an agreement described in subsection (b);
(C) termination is necessary to meet
requirements for public use specified by Federal regulations issued after the date of the license, and such
 


(ii) The Secretary making a determination under clause (i) shall notify the Director of the
determination and shall publish in the Federal Register a notice of such determination together with the
factual and legal basis for such determination. Any
interested person may request, within the 60-day
period beginning on the publication of a determination, the Secretary making the determination to hold
an informal hearing on the determination. If such a
request is made within such period, such Secretary
shall hold such hearing not later than 30 days after the
date of the request, or at the request of the person
making the request, not later than 60 days after such
date. The Secretary who is holding the hearing shall
provide notice of the hearing to the owner of
the patent involved and to any interested person and
provide the owner and any interested person an
opportunity to participate in the hearing. Within
30 days after the completion of the hearing, such Secretary shall affirm or revise the determination which
was the subject of the hearing and notify the Director
of any revision of the determination and shall publish
any such revision in the Federal Register.
(3) For the purposes of paragraph (2)(B), the
term “due diligence” means that degree of attention,
continuous directed effort, and timeliness as may reasonably be expected from, and are ordinarily exercised by, a person during a regulatory review period.
(4) An application for the extension of the
term of a patent is subject to the disclosure requirements prescribed by the Director.


requirements are not reasonably satisfied by the licensee; or


(5)(A) If the owner of record of the patent or
(D) the licensee has been found by a court
its agent reasonably expects that the applicable regulatory review period described in paragraphs
of competent jurisdiction to have violated the Federal
(1)(B)(ii), (2)(B)(ii), (3)(B)(ii), (4)(B)(ii), or (5)(B)(ii)
antitrust laws in connection with its performance
of subsection (g) that began for a product that is the  
under the license agreement.
subject of such patent may extend beyond the expiration of the patent term in effect, the owner or its agent
(e) PUBLIC NOTICE.—No exclusive or partially exclusive license may be granted under section
may submit an application to the Director for an
207(a)(2) unless public notice of the intention to grant
an exclusive or partially exclusive license on a federally owned invention has been provided in an appropriate manner at least 15 days before the license is
granted, and the Federal agency has considered all
comments received before the end of the comment
period in response to that public notice. This subsection shall not apply to the licensing of inventions
made under a cooperative research and development
agreement entered into under section 12 of the
Stevenson-Wydler Technology Innovation Act of
1980 (15 U.S.C. 3710a).
(f) PLAN.—No Federal agency shall grant any
license under a patent or patent application on a federally owned invention unless the person requesting the  
license has supplied the agency with a plan for development or marketing of the invention, except that any
such plan shall be treated by the Federal agency as
commercial and financial information obtained from a
person and privileged and confidential and not subject
to disclosure under section 552 of title 5.




interim extension during the period beginning 6  
(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
months, and ending 15 days before such term is due to
94 Stat. 3024; amended Nov. 1, 2000, Public Law 106-404,
expire. The application shall contain—
sec. 4, 114 Stat. 1743; subsections (d)(2) and (f) amended
Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat.
1905.)


(i) the identity of the product subject to
35 U.S.C. 210 Precedence of chapter.
regulating review and the Federal statute under which
such review is occurring;
(ii) the identity of the patent for which
interim extension is being sought and the identity of
each claim of such patent which claims the product
under regulatory review or a method of using or manufacturing the product;


(a) This chapter shall take precedence over any
other Act which would require a disposition of rights
in subject inventions of small business firms or nonprofit organizations contractors in a manner that is
inconsistent with this chapter, including but not necessarily limited to the following:
(1) section 10(a) of the Act of June 29, 1935,
as added by title I of the Act of August 14, 1946 (7


(iii) information to enable the Director to
determine under subsection (a)(1), (2), and (3) the eligibility of a patent for extension;


(iv) a brief description of the activities
U.S.C. 427i(a); 60 Stat. 1085);
undertaken by the applicant during the applicable regulatory review period to date with respect to the product under review and the significant dates applicable
to such activities; and
(v) such patent or other information as
the Director may require.  
(B) If the Director determines that, except
for permission to market or use the product commercially, the patent would be eligible for an extension of
the patent term under this section, the Director shall
publish in the Federal Register a notice of such determination, including the identity of the product under
regulatory review, and shall issue to the applicant a
certificate of interim extension for a period of not
more than 1 year.  
(C) The owner of record of a patent, or its
agent, for which an interim extension has been
granted under subparagraph (B), may apply for not
more than 4 subsequent interim extensions under this
paragraph, except that, in the case of a patent subject
to subsection (g)(6)(C), the owner of record of the
patent, or its agent, may apply for only 1 subsequent
interim extension under this paragraph. Each such
subsequent application shall be made during the
period beginning 60 days before, and ending 30 days
before, the expiration of the preceding interim extension.  
(D) Each certificate of interim extension
under this paragraph shall be recorded in the official
file of the patent and shall be considered part of the
original patent.
(E) Any interim extension granted under
this paragraph shall terminate at the end of the 60-day


(2) section 205(a) of the Act of August 14,
1946 (7 U.S.C. 1624(a); 60 Stat. 1090);


period beginning on the day on which the product
(3) section 501(c) of the Federal Mine Safety
involved receives permission for commercial marketing or use, except that, if within that 60-day period,
and Health Act of 1977 (30 U.S.C. 951(c); 83 Stat.
the applicant notifies the Director of such permission
742);
and submits any additional information under paragraph (1) of this subsection not previously contained
(4) section 30168(e) of title 49;
in the application for interim extension, the patent
 
shall be further extended, in accordance with the provisions of this section—
 
(5) section 12 of the National Science Foundation Act of 1950 (42 U.S.C. 1871(a); 82 Stat. 360);
(6) section 152 of the Atomic Energy Act of
1954 (42 U.S.C. 2182; 68 Stat. 943);
(7) section 305 of the National Aeronautics
and Space Act of 1958 (42 U.S.C. 2457);
(8) section 6 of the Coal Research Development Act of 1960 (30 U.S.C. 666; 74 Stat. 337);
(9) section 4 of the Helium Act Amendments
of 1960 (50 U.S.C. 167b; 74 Stat. 920);
(10) section 32 of the Arms Control and Disarmament Act of 1961 (22 U.S.C. 2572; 75 Stat. 634);
(11) section 9 of the Federal Nonnuclear
Energy Research and Development Act of 1974 (42


(i) for not to exceed 5 years from the
date of expiration of the original patent term; or
(ii) if the patent is subject to subsection
(g)(6)(C), from the date on which the product
involved receives approval for commercial marketing
or use.
(F) The rights derived from any patent the
term of which is extended under this paragraph shall,
during the period of interim extension—
(i) in the case of a patent which claims a
product, be limited to any use then under regulatory
review;
(ii) in the case of a patent which claims a
method of using a product, be limited to any use
claimed by the patent then under regulatory review;
and


U.S.C. 5908; 88 Stat. 1878);


(iii) in the case of a patent which claims a
(12) section 5(d) of the Consumer Product
method of manufacturing a product, be limited to the  
Safety Act (15 U.S.C. 2054(d); 86 Stat. 1211);
method of manufacturing as used to make the product
then under regulatory review.  


(e)(1) A determination that a patent is eligible
(13) section 3 of the Act of April 5, 1944 (30
for extension may be made by the Director solely on
the basis of the representations contained in the application for the extension. If the Director determines
that a patent is eligible for extension under subsection


(a) and that the requirements of paragraphs (1)
U.S.C. 323; 58 Stat. 191);
through (4) of subsection (d) have been complied
with, the Director shall issue to the applicant for the
extension of the term of the patent a certificate of
extension, under seal, for the period prescribed by
subsection (c). Such certificate shall be recorded in
the official file of the patent and shall be considered as
part of the original patent.  
(2) If the term of a patent for which an application has been submitted under subsection (d)(1)
would expire before a certificate of extension is
issued or denied under paragraph (1) respecting the
application, the Director shall extend, until such
determination is made, the term of the patent for peri-


(14) section 8001(c)(3) of the Solid Waste
Disposal Act (42 U.S.C. 6981(c); 90 Stat. 2829);
(15) section 219 of the Foreign Assistance Act
of 1961 (22 U.S.C. 2179; 83 Stat. 806);
(16) section 427(b) of the Federal Mine Health
and Safety Act of 1977 (30 U.S.C. 937(b); 86 Stat.
155);
(17) section 306(d) of the Surface Mining and
Reclamation Act of 1977 (30 U.S.C. 1226(d); 91 Stat.
455);
(18) section 21(d) of the Federal Fire Prevention and Control Act of 1974 (15 U.S.C. 2218(d); 88
Stat. 1548);
(19) section 6(b) of the Solar Photovoltaic
Energy Research Development and Demonstration
Act of 1978 (42 U.S.C. 5585(b); 92 Stat. 2516);
(20) section 12 of the Native Latex Commercialization and Economic Development Act of 1978
(7 U.S.C. 178j; 92 Stat. 2533); and
(21) section 408 of the Water Resources and
Development Act of 1978 (42 U.S.C. 7879; 92 Stat.
1360).




ods of up to one year if he determines that the patent
The Act creating this chapter shall be construed to take precedence over any future Act unless
is eligible for extension.


(f) For purposes of this section:


(1) The term “product” means:
that Act specifically cites this Act and provides that it
shall take precedence over this Act.


(A) A drug product.
(b) Nothing in this chapter is intended to alter
 
the effect of the laws cited in paragraph (a) of this section or any other laws with respect to the disposition
(B) Any medical device, food additive, or  
of rights in inventions made in the performance of
color additive subject to regulation under the Federal
funding agreements with persons other than nonprofit
Food, Drug, and Cosmetic Act.  
organizations or small business firms.  
(2) The term “drug product” means the active
(c) Nothing in this chapter is intended to limit
ingredient of—
the authority of agencies to agree to the disposition of
(A) a new drug, antibiotic drug, or human
rights in inventions made in the performance of work
biological product (as those terms are used in the Federal Food, Drug, and Cosmetic Act and the Public
under funding agreements with persons other than
Health Service Act) or  
nonprofit organizations or small business firms in
(B) a new animal drug or veterinary biological product (as those terms are used in the Federal
accordance with the Statement of Government Patent
Food, Drug, and Cosmetic Act and the Virus-Serum-
Policy issued on February 18, 1983, agency regulations, or other applicable regulations or to otherwise
Toxin Act) which is not primarily manufactured using
limit the authority of agencies to allow such persons
recombinant DNA, recombinant RNA, hybridoma
to retain ownership of inventions, except that all funding agreements, including those with other than small
technology, or other processes involving site specific
business firms and nonprofit organizations, shall
genetic manipulation techniques, including any salt or
include the requirements established in section
ester of the active ingredient, as a single entity or in
202(c)(4) and section 203 of this title. Any disposition
combination with another active ingredient.  
of rights in inventions made in accordance with the
(3) The term “major health or environmental
Statement or implementing regulations, including any  
effects test” means a test which is reasonably related
disposition occurring before enactment of this section,  
to the evaluation of the health or environmental
are hereby authorized.  
effects of a product, which requires at least six months
(d) Nothing in this chapter shall be construed to
to conduct, and the data from which is submitted to  
require the disclosure of intelligence sources or methods or to otherwise affect the authority granted to the
receive permission for commercial marketing or use.  
Director of Central Intelligence by statute or Executive order for the protection of intelligence sources or  
Periods of analysis or evaluation of test results are not
methods.  
to be included in determining if the conduct of a test
(e) The provisions of the Stevenson-Wydler
required at least six months.  
Technology Innovation Act of 1980 shall take precedence over the provisions of this chapter to the extent
(4)(A) Any reference to section 351 is a reference to section 351 of the Public Health Service Act.  
that they permit or require a disposition of rights in
subject inventions which is inconsistent with this
chapter.  
 
 
(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
94 Stat. 3026.)


(Subsection (c) amended Nov. 8, 1984, Public Law 98620, sec. 501(13), 98 Stat. 3367.)


(B) Any reference to section 503, 505, 512,  
(Subsection (e) added Oct. 20, 1986, Public Law 99502, sec. 9(c), 100 Stat. 1796.)  
or 515 is a reference to section 503, 505, 512, or 515
 
of the Federal Food, Drug and Cosmetic Act.  
(Subsection (a)(4) amended July 5, 1994, Public Law
(C) Any reference to the Virus-Serum-
103-272, sec. 5(j), 108 Stat. 1375.)  
Toxin Act is a reference to the Act of March 4, 1913
(21 U.S.C. 151 - 158).
(5) The term “informal hearing” has the
meaning prescribed for such term by section 201(y) of
the Federal Food, Drug and Cosmetic Act.  
(6) The term “patent” means a patent issued
by the United States Patent and Trademark Office.  
(7) The term “date of enactment” as used in
this section means September 24, 1984, for human


(Subsection (e) amended Mar. 7, 1996, Public Law
104-113, sec. 7, 110 Stat. 779.)


drug product, a medical device, food additive, or color
(Subsection (a) amended Nov. 13, 1998, Public Law
additive.  
105-393, sec. 220(c)(2), 112 Stat. 3625.)


(8) The term “date of enactment” as used in
(Subsections (a)(11), (a)(20), and (c) amended Nov. 2,
this section means the date of enactment of the
2002, Public Law 107-273, sec. 13206, 116 Stat. 1905.)  
Generic Animal Drug and Patent Term Restoration
Act for an animal drug or a veterinary biological
product.
(g) For purposes of this section, the term “regulatory review period” has the following meanings:
(1)(A)In the case of a product which is a new
drug, antibiotic drug, or human biological product, the
term means the period described in subparagraph (B)  
to which the limitation described in paragraph (6)
applies.


35 U.S.C. 211 Relationship to antitrust laws.


(B) The regulatory review period for a new
Nothing in this chapter shall be deemed to convey
drug, antibiotic drug, or human biological product is
to any person immunity from civil or criminal liability, or to create any defenses to actions, under any
the sum of —
antitrust law.  
(i) the period beginning on the date an
exemption under subsection (i) of section 505 or subsection (d) of section 507 became effective for the
approved product and ending on the date an application was initially submitted for such drug product
under section 351, 505, or 507, and
(ii) the period beginning on the date the
application was initially submitted for the approved
product under section 351, subsection (b) of section
505, or section 507 and ending on the date such application was approved under such section.
(2)(A) In the case of a product which is a food
additive or color additive, the term means the period
described in subparagraph (B) to which the limitation
described in paragraph (6) applies.  


(Added Dec.12, 1980, Public Law 96-517, sec. 6(a), 94
Stat. 3027.)


(B) The regulatory review period for a
35 U.S.C. 212 Disposition of rights in educational
food or color additive is the sum of
awards.
(i) the period beginning on the date a
major health or environmental effects test on the additive was initiated and ending on the date a petition
was initially submitted with respect to the product
under the Federal Food, Drug, and Cosmetic Act
requesting the issuance of a regulation for use of the
product, and
(ii) the period beginning on the date a
petition was initially submitted with respect to the
product under the Federal Food, Drug, and Cosmetic
Act requesting the issuance of a regulation for use of
the product, and ending on the date such regulation
became effective or, if objections were filed to such
regulation, ending on the date such objections were


No scholarship, fellowship, training grant, or other
funding agreement made by a Federal agency primarily to an awardee for educational purposes will contain any provision giving the Federal agency any
rights to inventions made by the awardee.


(Added Nov. 8, 1984, Public Law 98-620, sec.
501(14), 98 Stat. 3368.)


resolved and commercial marketing was permitted or,
==PART III — PATENTS AND PROTECTION OF PATENT RIGHTS==
if commercial marketing was permitted and later
revoked pending further proceedings as a result of
such objections, ending on the date such proceedings
were finally resolved and commercial marketing was
permitted.


(3)(A) In the case of a product which is a
medical device, the term means the period described
in subparagraph (B) to which the limitation described
in paragraph (6) applies.


(B) The regulatory review period for a
===CHAPTER 25 AMENDMENT AND CORRECTION OF PATENTS===
medical device is the sum of —  
(i) the period beginning on the date a
clinical investigation on humans involving the device
was begun and ending on the date an application was
initially submitted with respect to the device under
section 515, and
(ii) the period beginning on the date an
application was initially submitted with respect to the
device under section 515 and ending on the date such
application was approved under such Act or the
period beginning on the date a notice of completion of
a product development protocol was initially submitted under section 515(f)(5) and ending on the date the
protocol was declared completed under section
515(f)(6).
(4)(A) In the case of a product which is a new
animal drug, the term means the period described in
subparagraph (B) to which the limitation described in
paragraph (6) applies.




(B) The regulatory review period for a new
Sec.
animal drug product is the sum of
251 Reissue of defective patents.
(i) the period beginning on the earlier of  
252 Effect of reissue.
the date a major health or environmental effects test
253 Disclaimer.
on the drug was initiated or the date an exemption
254 Certificate of correction of Patent and Trade
under subsection (j) of section 512 became effective
for the approved new animal drug product and ending
on the date an application was initially submitted for
such animal drug product under section 512, and
(ii) the period beginning on the date the
application was initially submitted for the approved
animal drug product under subsection (b) of section
512 and ending on the date such application was
approved under such section.




(5)(A) In the case of a product which is a veterinary biological product, the term means the period
mark Office mistake.
described in subparagraph (B) to which the limitation
255 Certificate of correction of applicant’s mistake.
described in paragraph (6) applies.  
256 Correction of named inventor.  


(B) The regulatory period for a veterinary
35 U.S.C. 251 Reissue of defective patents.  
biological product is the sum of —
(i) the period beginning on the date the
authority to prepare an experimental biological product under the Virus- Serum-Toxin Act became effective and ending on the date an application for a license
was submitted under the Virus-Serum-Toxin Act, and
(ii) the period beginning on the date an
application for a license was initially submitted for
approval under the Virus-Serum-Toxin Act and ending on the date such license was issued.  
(6) A period determined under any of the
preceding paragraphs is subject to the following limitations:
(A) If the patent involved was issued after
the date of the enactment of this section, the period of
extension determined on the basis of the regulatory
review period determined under any such paragraph
may not exceed five years.  
(B) If the patent involved was issued
before the date of the enactment of this section and —
(i) no request for an exemption
described in paragraph (1)(B) or (4)(B) was submitted
and no request for the authority described in paragraph (5)(B) was submitted,
(ii) no major health or environment
effects test described in paragraph (2)(B) or (4)(B)
was initiated and no petition for a regulation or application for registration described in such paragraph
was submitted, or


Whenever any patent is, through error without any
deceptive intention, deemed wholly or partly inoperative or invalid, by reason of a defective specification
or drawing, or by reason of the patentee claiming
more or less than he had a right to claim in the patent,
the Director shall, on the surrender of such patent and
the payment of the fee required by law, reissue the
patent for the invention disclosed in the original


(iii) no clinical investigation described in
paragraph (3) was begun or product development protocol described in such paragraph was submitted,
before such date for the approved product the period
of extension determined on the basis of the regulatory
review period determined under any such paragraph
may not exceed five years.


(C) If the patent involved was issued
patent, and in accordance with a new and amended
before the date of the enactment of this section and if
application, for the unexpired part of the term of the  
an action described in subparagraph (B) was taken
original patent. No new matter shall be introduced
before the date of enactment of this section with  
into the application for reissue.
respect to the approved product and the commercial
marketing or use of the product has not been approved
before such date, the period of extension determined
on the basis of the regulatory review period determined under such paragraph may not exceed two
years or in the case of an approved product which is a
new animal drug or veterinary biological product (as


The Director may issue several reissued patents for
distinct and separate parts of the thing patented, upon
demand of the applicant, and upon payment of the
required fee for a reissue for each of such reissued
patents.


those terms are used in the Federal Food, Drug, and  
The provisions of this title relating to applications
Cosmetic Act or the Virus-Serum-Toxin Act), three
for patent shall be applicable to applications for reissue of a patent, except that application for reissue may
years.  
be made and sworn to by the assignee of the entire
interest if the application does not seek to enlarge the  
scope of the claims of the original patent.  


(h) The Director may establish such fees as the  
No reissued patent shall be granted enlarging the  
Director determines appropriate to cover the costs to
scope of the claims of the original patent unless
the Office of receiving and acting upon applications
applied for within two years from the grant of the
under this section.  
original patent.  


(Added Sept. 24, 1984, Public Law 98-417, sec.  
(Amended Nov. 29, 1999, Public Law 106-113, sec.  
201(a), 98 Stat. 1598; amended Nov. 16, 1988, Public Law
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
100-670, sec. 201(a)-(h), 102 Stat. 3984; Dec. 3, 1993,
4732(a)(10)(A)).)  
Public Law 103-179, secs. 5, 6, 107 Stat. 2040, 2042; Dec.
8, 1994, Public Law 103-465, sec. 532(c)(1), 108 Stat.
4987.)  


(Subsection (f) amended Nov. 21, 1997, Public Law
35 U.S.C. 252 Effect of reissue.  
105-115, sec. 125(b)(2)(P), 111 Stat. 2326.)


(Amended Nov. 29, 1999, Public Law 106-113, sec.  
The surrender of the original patent shall take effect
1000(a)(9), 113 Stat. 1501A-560, 582 (S. 1948 secs. 4404
upon the issue of the reissued patent, and every reissued patent shall have the same effect and operation in
and 4732(a)(10)(A)).)
law, on the trial of actions for causes thereafter arising, as if the same had been originally granted in such
amended form, but in so far as the claims of the original and reissued patents are substantially identical,
such surrender shall not affect any action then pending nor abate any cause of action then existing, and
the reissued patent, to the extent that its claims are
substantially identical with the original patent, shall
constitute a continuation thereof and have effect continuously from the date of the original patent.  
 
A reissued patent shall not abridge or affect the
right of any person or that person’s successors in business who, prior to the grant of a reissue, made, purchased, offered to sell, or used within the United
States, or imported into the United States, anything
patented by the reissued patent, to continue the use of,
to offer to sell, or to sell to others to be used, offered
for sale, or sold, the specific thing so made, purchased, offered for sale, used, or imported unless the
making, using, offering for sale, or selling of such
thing infringes a valid claim of the reissued patent
which was in the original patent. The court before
which such matter is in question may provide for the
continued manufacture, use, offer for sale, or sale of
the thing made, purchased, offered for sale, used, or
imported as specified, or for the manufacture, use,
offer for sale, or sale in the United States of which
substantial preparation was made before the grant of
the reissue, and the court may also provide for the
continued practice of any process patented by the reissue that is practiced, or for the practice of which substantial preparation was made, before the grant of the
reissue, to the extent and under such terms as the court
deems equitable for the protection of investments
made or business commenced before the grant of the
reissue.  


(Subsections (b)(3)(B), (d)(2)(B)(i), and (g)(6)(B)(iii)
(Amended Dec. 8, 1994, Public Law 103-465, sec.
amended Nov. 2, 2002, Public Law 107-273, sec. 13206,  
533(b)(2), 108 Stat. 4989; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-566 (S. 1948 sec.
116 Stat. 1904.)  
4507(8)).)  


35 U.S.C. 157 Statutory invention registration.  
35 U.S.C. 253 Disclaimer.  


(a) Notwithstanding any other provision of this
Whenever, without any deceptive intention, a claim
title, the Director is authorized to publish a statutory
of a patent is invalid the remaining claims shall not
invention registration containing the specification and
thereby be rendered invalid. A patentee, whether of  
drawings of a regularly filed application for a patent  
the whole or any sectional interest therein, may, on
without examination if the applicant —
payment of the fee required by law, make disclaimer
(1) meets the requirements of section 112 of  
of any complete claim, stating therein the extent of his
this title;
interest in such patent. Such disclaimer shall be in
(2) has complied with the requirements for
writing and recorded in the Patent and Trademark
printing, as set forth in regulations of the Director;
Office, and it shall thereafter be considered as part of
(3) waives the right to receive a patent on the  
the original patent to the extent of the interest possessed by the disclaimant and by those claiming under
invention within such period as may be prescribed by
him.  
the Director; and  
(4) pays application, publication, and other
processing fees established by the Director.
If an interference is declared with respect to  
such an application, a statutory invention registration
may not be published unless the issue of priority of  
invention is finally determined in favor of the applicant.  


In like manner any patentee or applicant may disclaim or dedicate to the public the entire term, or any
terminal part of the term, of the patent granted or to be
granted.


(b) The waiver under subsection (a)(3) of this
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
section by an applicant shall take effect upon publication of the statutory invention registration.  
Stat. 1949.)  
(c) A statutory invention registration published
pursuant to this section shall have all of the attributes
specified for patents in this title except those specified


35 U.S.C. 254 Certificate of correction of Patent
and Trademark Office mistake.


in section 183 and sections 271 through 289 of this
Whenever a mistake in a patent, incurred through  
title. A statutory invention registration shall not have
the fault of the Patent and Trademark Office, is clearly
any of the attributes specified for patents in any other
disclosed by the records of the Office, the Director  
provision of law other than this title. A statutory
may issue a certificate of correction stating the fact
invention registration published pursuant to this section shall give appropriate notice to the public, pursuant to regulations which the Director shall issue, of
and nature of such mistake, under seal, without
the preceding provisions of this subsection. The
charge, to be recorded in the records of patents. A
invention with respect to which a statutory invention
printed copy thereof shall be attached to each printed
certificate is published is not a patented invention for
copy of the patent, and such certificate shall be con-
purposes of section 292 of this title.


(d) The Director shall report to the Congress
annually on the use of statutory invention registrations. Such report shall include an assessment of the
degree to which agencies of the federal government
are making use of the statutory invention registration
system, the degree to which it aids the management of
federally developed technology, and an assessment of
the cost savings to the Federal Government of the
uses of such procedures.


(Added Nov. 8, 1984, Public Law 98-622, sec. 102(a),
sidered as part of the original patent. Every such
98 Stat. 3383; amended Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582, 583 (S. 1948
patent, together with such certificate, shall have the
secs. 4732(a)(10)(A) and 4732(a)(11)).)
same effect and operation in law on the trial of actions
for causes thereafter arising as if the same had been
originally issued in such corrected form. The Director
may issue a corrected patent without charge in lieu of
and with like effect as a certificate of correction.  


CHAPTER 15 — PLANT PATENTS
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


Sec.
35 U.S.C. 255 Certificate of correction of applicant’s mistake.  
161 Patents for plants.
162 Description, claim.  
163 Grant.
164 Assistance of the Department of Agriculture.


Whenever a mistake of a clerical or typographical
nature, or of minor character, which was not the fault
of the Patent and Trademark Office, appears in a
patent and a showing has been made that such mistake
occurred in good faith, the Director may, upon payment of the required fee, issue a certificate of correction, if the correction does not involve such changes
in the patent as would constitute new matter or would
require reexamination. Such patent, together with the
certificate, shall have the same effect and operation in
law on the trial of actions for causes thereafter arising
as if the same had been originally issued in such corrected form.


35 U.S.C. 161 Patents for plants.  
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
4732(a)(10)(A)).)


Whoever invents or discovers and asexually reproduces any distinct and new variety of plant, including
35 U.S.C. 256 Correction of named inventor.  
cultivated sports, mutants, hybrids, and newly found
seedlings, other than a tuber propagated plant or a
plant found in an uncultivated state, may obtain a
patent therefor, subject to the conditions and requirements of this title.  


The provisions of this title relating to patents for
Whenever through error a person is named in an
inventions shall apply to patents for plants, except as  
issued patent as the inventor, or through error an
otherwise provided.  
inventor is not named in an issued patent and such
error arose without any deceptive intention on his
part, the Director may, on application of all the parties
and assignees, with proof of the facts and such other
requirements as may be imposed, issue a certificate
correcting such error.  


(Amended Sept. 3, 1954, 68 Stat. 1190.)
The error of omitting inventors or naming persons
who are not inventors shall not invalidate the patent in
which such error occurred if it can be corrected as
provided in this section. The court before which such
matter is called in question may order correction of
the patent on notice and hearing of all parties concerned and the Director shall issue a certificate
accordingly.  


35 U.S.C. 162 Description, claim.  
(Amended Aug. 27, 1982, Public Law 97-247, sec.
6(b), 96 Stat. 320; Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
4732(a)(10)(A)).)


No plant patent shall be declared invalid for noncompliance with section 112 of this title if the description is as complete as is reasonably possible.
===CHAPTER 26 — OWNERSHIP AND ASSIGNMENT===




The claim in the specification shall be in formal
Sec.
terms to the plant shown and described.  
261 Ownership; assignment.
262 Joint owners.


35 U.S.C. 163 Grant.


In the case of a plant patent, the grant shall include
35 U.S.C. 261 Ownership; assignment.  
the right to exclude others from asexually reproducing
the plant, and from using, offering for sale, or selling
the plant so reproduced, or any of its parts, throughout
the United States, or from importing the plant so
reproduced, or any parts thereof, into the United
States.  


(Amended Oct. 27, 1998, Public Law 105-289, sec. 3,  
Subject to the provisions of this title, patents shall
112 Stat. 2781.)
have the attributes of personal property.  


35 U.S.C. 164 Assistance of the Department of  
Applications for patent, patents, or any interest
Agriculture.  
therein, shall be assignable in law by an instrument in
writing. The applicant, patentee, or his assigns or
legal representatives may in like manner grant and
convey an exclusive right under his application for
patent, or patents, to the whole or any specified part of  
the United States.  


The President may by Executive order direct the  
A certificate of acknowledgment under the hand
Secretary of Agriculture, in accordance with the  
and official seal of a person authorized to administer
requests of the Director, for the purpose of carrying
oaths within the United States, or, in a foreign country, of a diplomatic or consular officer of the United
into effect the provisions of this title with respect to  
States or an officer authorized to administer oaths
plants (1) to furnish available information of the  
whose authority is proved by a certificate of a diplomatic or consular officer of the United States, or apostille of an official designated by a foreign country
Department of Agriculture, (2) to conduct through the  
which, by treaty or convention, accords like effect to  
appropriate bureau or division of the Department
apostilles of designated officials in the United States,
research upon special problems, or (3) to detail to the
shall be prima facie evidence of the execution of an
Director officers and employees of the Department.  
assignment, grant, or conveyance of a patent or application for patent.  


(Amended Nov. 29, 1999, Public Law 106-113, sec.
An assignment, grant, or conveyance shall be void
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
as against any subsequent purchaser or mortgagee for
4732(a)(10)(A)).)
a valuable consideration, without notice, unless it is
recorded in the Patent and Trademark Office within
three months from its date or prior to the date of such
subsequent purchase or mortgage.  


CHAPTER 16 — DESIGNS
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
88 Stat. 1949; Aug. 27, 1982, Public Law 97-247, sec.
14(b), 96 Stat. 321.)


Sec.
35 U.S.C. 262 Joint owners.  
171 Patents for designs.
172 Right of priority.
173 Term of design patent.


In the absence of any agreement to the contrary,
each of the joint owners of a patent may make, use,
offer to sell, or sell the patented invention within the
United States, or import the patented invention into


35 U.S.C. 171 Patents for designs.


Whoever invents any new, original, and ornamental
the United States, without the consent of and without
design for an article of manufacture may obtain a
accounting to the other owners.  
patent therefor, subject to the conditions and requirements of this title.  


The provisions of this title relating to patents for
(Amended Dec. 8, 1994, Public Law 103-465, sec.
inventions shall apply to patents for designs, except as
533(b)(3), 108 Stat. 4989.)
otherwise provided.  


35 U.S.C. 172 Right of priority.
===CHAPTER 27 — GOVERNMENT INTERESTS IN PATENTS===


The right of priority provided for by subsections (a)
through (d) of section 119 of this title and the time
specified in section 102(d) shall be six months in the
case of designs. The right of priority provided for by
section 119(e) of this title shall not apply to designs.


(Amended Dec. 8, 1994, Public Law 103-465, sec.  
Sec.
532(c)(2), 108 Stat. 4987.)
266 [Repealed.]
267 Time for taking action in Government applica


35 U.S.C. 173 Term of design patent.


Patents for designs shall be granted for the term of
tions.  
fourteen years from the date of grant.  


(Amended Aug. 27, 1982, Public Law 97-247, sec. 16,
35 U.S.C. 266 [Repealed.]
96 Stat. 321; Dec. 8, 1994, Public Law 103-465, sec.
532(c)(3), 108 Stat. 4987.)


CHAPTER 17 — SECRECY OF CERTAIN
(Repealed July 24, 1965, Public Law 89-83, sec. 8, 79
INVENTIONS AND FILING APPLICATIONS
Stat. 261.)
IN FOREIGN COUNTRIES


35 U.S.C. 267 Time for taking action in Government applications.


Sec.
Notwithstanding the provisions of sections 133 and
181 Secrecy of certain inventions and withholding
151 of this title, the Director may extend the time for
taking any action to three years, when an application
has become the property of the United States and the
head of the appropriate department or agency of the
Government has certified to the Director that the
invention disclosed therein is important to the armament or defense of the United States.


(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


of patent.
===CHAPTER 28 — INFRINGEMENT OF PATENTS===
182 Abandonment of invention for unauthorized


disclosure.
183 Right to compensation.
184 Filing of application in foreign country.
185 Patent barred for filing without license.
186 Penalty.
187 Nonapplicability to certain persons.
188 Rules and regulations, delegation of power.


35 U.S.C. 181 Secrecy of certain inventions and
Sec.
withholding of patent.  
271 Infringement of patent.
272 Temporary presence in the United States.
273 Defense to infringement based on earlier inven


Whenever publication or disclosure by the publication of an application or by the grant of a patent on an
invention in which the Government has a property
interest might, in the opinion of the head of the interested Government agency, be detrimental to the
national security, the Commissioner of Patents upon
being so notified shall order that the invention be kept
secret and shall withhold the publication of an application or the grant of a patent therefor under the conditions set forth hereinafter.


Whenever the publication or disclosure of an invention by the publication of an application or by the
tor.
granting of a patent, in which the Government does
not have a property interest, might, in the opinion of
the Commissioner of Patents, be detrimental to the
national security, he shall make the application for
patent in which such invention is disclosed available
for inspection to the Atomic Energy Commission, the
Secretary of Defense, and the chief officer of any
other department or agency of the Government desig-


35 U.S.C. 271 Infringement of patent.


nated by the President as a defense agency of the  
(a) Except as otherwise provided in this title,
United States.  
whoever without authority makes, uses, offers to sell,
or sells any patented invention, within the United
States, or imports into the United States any patented
invention during the term of the patent therefor,
infringes the patent.
(b) Whoever actively induces infringement of a
patent shall be liable as an infringer.  


Each individual to whom the application is disclosed shall sign a dated acknowledgment thereof,
which acknowledgment shall be entered in the file of
the application. If, in the opinion of the Atomic
Energy Commission, the Secretary of a Defense
Department, or the chief officer of another department
or agency so designated, the publication or disclosure
of the invention by the publication of an application
or by the granting of a patent therefor would be detrimental to the national security, the Atomic Energy
Commission, the Secretary of a Defense Department,
or such other chief officer shall notify the Commissioner of Patents and the Commissioner of Patents
shall order that the invention be kept secret and shall
withhold the publication of the application or the
grant of a patent for such period as the national interest requires, and notify the applicant thereof. Upon
proper showing by the head of the department or
agency who caused the secrecy order to be issued that
the examination of the application might jeopardize
the national interest, the Commissioner of Patents
shall thereupon maintain the application in a sealed
condition and notify the applicant thereof. The owner
of an application which has been placed under a
secrecy order shall have a right to appeal from the
order to the Secretary of Commerce under rules prescribed by him.


An invention shall not be ordered kept secret and
(c) Whoever offers to sell or sells within the
the publication of an application or the grant of a  
United States or imports into the United States a component of a patented machine, manufacture, combination, or composition, or a material or apparatus for use
patent withheld for a period of more than one year.  
in practicing a patented process, constituting a material part of the invention, knowing the same to be
The Commissioner of Patents shall renew the order at
especially made or especially adapted for use in an
the end thereof, or at the end of any renewal period,
infringement of such patent, and not a staple article or
for additional periods of one year upon notification by  
commodity of commerce suitable for substantial non-
the head of the department or the chief officer of the  
infringing use, shall be liable as a contributory
agency who caused the order to be issued that an affirmative determination has been made that the national
infringer.  
interest continues to so require. An order in effect, or  
(d) No patent owner otherwise entitled to relief
issued, during a time when the United States is at war,
for infringement or contributory infringement of a
shall remain in effect for the duration of hostilities and
patent shall be denied relief or deemed guilty of misuse or illegal extension of the patent right by reason of
one year following cessation of hostilities. An order in  
his having done one or more of the following: (1)
effect, or issued, during a national emergency
derived revenue from acts which if performed by  
declared by the President shall remain in effect for the  
another without his consent would constitute contributory infringement of the patent; (2) licensed or  
duration of the national emergency and six months
authorized another to perform acts which if performed
thereafter. The Commissioner of Patents may rescind
without his consent would constitute contributory
any order upon notification by the heads of the departments and the chief officers of the agencies who
infringement of the patent; (3) sought to enforce his
caused the order to be issued that the publication or  
patent rights against infringement or contributory
disclosure of the invention is no longer deemed detrimental to the national security.  
infringement; (4) refused to license or use any rights
to the patent; or (5) conditioned the license of any
rights to the patent or the sale of the patented product
on the acquisition of a license to rights in another
patent or purchase of a separate product, unless, in
view of the circumstances, the patent owner has market power in the relevant market for the patent or patented product on which the license or sale is
conditioned.  
(e)(1) It shall not be an act of infringement to
make, use, offer to sell, or sell within the United
States or import into the United States a patented
invention (other than a new animal drug or veterinary
biological product (as those terms are used in the Federal Food, Drug, and Cosmetic Act and the Act of  
March 4, 1913) which is primarily manufactured
using recombinant DNA, recombinant RNA, hybridoma technology, or other processes involving site
specific genetic manipulation techniques) solely for
uses reasonably related to the development and submission of information under a Federal law which
regulates the manufacture, use, or sale of drugs or veterinary biological products.  


(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-566, 582 (S. 1948 secs.
4507(7) and 4732(a)(10)(B)).)


35 U.S.C. 182 Abandonment of invention for
(2) It shall be an act of infringement to submit —
unauthorized disclosure.


The invention disclosed in an application for patent
subject to an order made pursuant to section 181 of
this title may be held abandoned upon its being established by the Commissioner of Patents that in violation of said order the invention has been published or
disclosed or that an application for a patent therefor
has been filed in a foreign country by the inventor, his
successors, assigns, or legal representatives, or anyone in privity with him or them, without the consent
of the Commissioner of Patents. The abandonment
shall be held to have occurred as of the time of violation. The consent of the Commissioner of Patents
shall not be given without the concurrence of the
heads of the departments and the chief officers of the
agencies who caused the order to be issued. A holding
of abandonment shall constitute forfeiture by the
applicant, his successors, assigns, or legal representatives, or anyone in privity with him or them, of all
claims against the United States based upon such
invention.


(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(B)).)


35 U.S.C. 183 Right to compensation.
(A) an application under section 505(j) of
the Federal Food, Drug, and Cosmetic Act or
described in section 505(b)(2) of such Act for a drug
claimed in a patent or the use of which is claimed in a
patent, or
(B) an application under section 512 of
such Act or under the Act of March 4, 1913 (21


An applicant, his successors, assigns, or legal representatives, whose patent is withheld as herein provided, shall have the right, beginning at the date the
applicant is notified that, except for such order, his
application is otherwise in condition for allowance, or
February 1, 1952, whichever is later, and ending six
years after a patent is issued thereon, to apply to the
head of any department or agency who caused the
order to be issued for compensation for the damage
caused by the order of secrecy and/or for the use of
the invention by the Government, resulting from his
disclosure. The right to compensation for use shall
begin on the date of the first use of the invention by
the Government. The head of the department or
agency is authorized, upon the presentation of a


U.S.C. 151 - 158) for a drug or veterinary biological
product which is not primarily manufactured using
recombinant DNA, recombinant RNA, hybridoma
technology, or other processes involving site specific
genetic manipulation techniques and which is claimed
in a patent or the use of which is claimed in a patent, if
the purpose of such submission is to obtain approval
under such Act to engage in the commercial manufacture, use, or sale of a drug or veterinary biological
product claimed in a patent or the use of which is
claimed in a patent before the expiration of such
patent.


claim, to enter into an agreement with the applicant,
(3) In any action for patent infringement
his successors, assigns, or legal representatives, in full
brought under this section, no injunctive or other
settlement for the damage and/or use. This settlement
relief may be granted which would prohibit the making, using, offering to sell, or selling within the United  
agreement shall be conclusive for all purposes notwithstanding any other provision of law to the contrary. If full settlement of the claim cannot be effected,  
States or importing into the United States of a patented invention under paragraph (1).
the head of the department or agency may award and
(4) For an act of infringement described in  
pay to such applicant, his successors, assigns, or legal
paragraph (2)—
representatives, a sum not exceeding 75 per centum of
(A) the court shall order the effective date
the sum which the head of the department or agency
of any approval of the drug or veterinary biological
considers just compensation for the damage and/or
product involved in the infringement to be a date
use. A claimant may bring suit against the United  
which is not earlier than the date of the expiration of  
States in the United States Court of Federal Claims or
the patent which has been infringed,
in the District Court of the United States for the district in which such claimant is a resident for an
(B) injunctive relief may be granted
amount which when added to the award shall constitute just compensation for the damage and/or use of
against an infringer to prevent the commercial manufacture, use, offer to sell, or sale within the United
the invention by the Government. The owner of any  
States or importation into the United States of an
patent issued upon an application that was subject to a  
approved drug or veterinary biological product, and
secrecy order issued pursuant to section 181 of this
(C) damages or other monetary relief may  
title, who did not apply for compensation as above
be awarded against an infringer only if there has been
provided, shall have the right, after the date of issuance of such patent, to bring suit in the United States
commercial manufacture, use, offer to sell, or sale
Court of Federal Claims for just compensation for the
within the United States or importation into the  
damage caused by reason of the order of secrecy and/
United States of an approved drug or veterinary biological product.  
or use by the Government of the invention resulting
from his disclosure. The right to compensation for use
shall begin on the date of the first use of the invention
by the Government. In a suit under the provisions of
this section the United States may avail itself of all
defenses it may plead in an action under section 1498
of title 28. This section shall not confer a right of
action on anyone or his successors, assigns, or legal
representatives who, while in the full-time employment or service of the United States, discovered,
invented, or developed the invention on which the
claim is based.  


(Amended Apr. 2, 1982, Public Law 97-164, sec.
160(a)(12), 96 Stat. 48; Oct. 29, 1992, Public Law 102-572,
sec. 902 (b)(1), 106 Stat. 4516.)


35 U.S.C. 184 Filing of application in foreign
The remedies prescribed by subparagraphs
country.  
(A), (B), and (C) are the only remedies which may be
granted by a court for an act of infringement
described in paragraph (2), except that a court may
award attorney fees under section 285.  


Except when authorized by a license obtained from
(5) Where a person has filed an application
the Commissioner of Patents a person shall not file or  
described in paragraph (2) that includes a certification
cause or authorize to be filed in any foreign country
under subsection (b)(2)(A)(iv) or (j)(2)(A)(vii)(IV) of
prior to six months after filing in the United States an
section 505 of the Federal Food, Drug, and Cosmetic
application for patent or for the registration of a utility
Act (21 U.S.C. 355), and neither the owner of the
model, industrial design, or model in respect of an
patent that is the subject of the certification nor the  
invention made in this country. A license shall not be
holder of the approved application under subsection
granted with respect to an invention subject to an
(b) of such section for the drug that is claimed by the
order issued by the Commissioner of Patents pursuant
patent or a use of which is claimed by the patent
to section 181 of this title without the concurrence of
brought an action for infringement of such patent
the head of the departments and the chief officers of  
before the expiration of 45 days after the date on
the agencies who caused the order to be issued.
which the notice given under subsection (b)(3) or
The license may be granted retroactively where an
(j)(2)(B) of such section was received, the courts of  
application has been filed abroad through error and
the United States shall, to the extent consistent with
without deceptive intent and the application does not
the Constitution, have subject matter jurisdiction in
disclose an invention within the scope of section 181
any action brought by such person under section 2201
of this title.  
of title 28 for a declaratory judgment that such patent
is invalid or not infringed.
(f)(1) Whoever without authority supplies or
causes to be supplied in or from the United
States all or a substantial portion of the components
of a patented invention, where such components are
uncombined in whole or in part, in such manner as to  
actively induce the combination of such components
outside of the United States in a manner that would
infringe the patent if such combination occurred
within the United States, shall be liable as an
infringer.  


The term “application” when used in this chapter
includes applications and any modifications, amendments, or supplements thereto, or divisions thereof.


The scope of a license shall permit subsequent
(2) Whoever without authority supplies or
modifications, amendments, and supplements containing additional subject matter if the application
causes to be supplied in or from the United States any
upon which the request for the license is based is not,  
component of a patented invention that is especially
or was not, required to be made available for inspection under section 181 of this title and if such modifications, amendments, and supplements do not change
made or especially adapted for use in the invention
the general nature of the invention in a manner which
and not a staple article or commodity of commerce
would require such application to be made available
suitable for substantial noninfringing use, where such
for inspection under such section 181. In any case in
component is uncombined in whole or in part, knowing that such component is so made or adapted and  
which a license is not, or was not, required in order to  
intending that such component will be combined outside of the United States in a manner that would
file an application in any foreign country, such subsequent modifications, amendments, and supplements
infringe the patent if such combination occurred
may be made, without a license, to the application
within the United States, shall be liable as an
filed in the foreign country if the United States application was not required to be made available for
infringer.  
inspection under section 181 and if such modifications, amendments, and supplements do not, or did
(g) Whoever without authority imports into the
not, change the general nature of the invention in a
United States or offers to sell, sells, or uses within the
manner which would require the United States application to have been made available for inspection
United States a product which is made by a process
under such section 181.  
patented in the United States shall be liable as an
infringer, if the importation, offer to sell, sale, or use
of the product occurs during the term of such process
patent. In an action for infringement of a process


(Amended Aug. 23, 1988, Public Law 100-418, sec.
9101(b)(1), 102 Stat. 1567; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(B)).)


35 U.S.C. 185 Patent barred for filing without
license.


Notwithstanding any other provisions of law any
patent, no remedy may be granted for infringement on
person, and his successors, assigns, or legal representatives, shall not receive a United States patent for an
account of the noncommercial use or retail sale of a  
invention if that person, or his successors, assigns, or  
product unless there is no adequate remedy under this
legal representatives shall, without procuring the
title for infringement on account of the importation or
license prescribed in section 184 of this title, have
other use, offer to sell, or sale of that product. A product which is made by a patented process will, for purposes of this title, not be considered to be so made
after —


(1) it is materially changed by subsequent
processes; or
(2) it becomes a trivial and nonessential component of another product.
(h) As used in this section, the term “whoever”
includes any State, any instrumentality of a State, any
officer or employee of a State or instrumentality of a
State acting in his official capacity. Any State, and
any such instrumentality, officer, or employee, shall
be subject to the provisions of this title in the same
manner and to the same extent as any nongovernmental entity.
(i) As used in this section, an “offer for sale” or
an “offer to sell” by a person other than the patentee
or any assignee of the patentee, is that in which the
sale will occur before the expiration of the term of the
patent.


made, or consented to or assisted another’s making,
application in a foreign country for a patent or for the
registration of a utility model, industrial design, or
model in respect of the invention. A United States
patent issued to such person, his successors, assigns,
or legal representatives shall be invalid, unless the
failure to procure such license was through error and
without deceptive intent, and the patent does not disclose subject matter within the scope of section 181 of
this title.


(Amended Aug. 23, 1988, Public Law 100-418, sec.
(Subsection (e) added Sept. 24, 1984, Public Law 98417, sec. 202, 98 Stat. 1603.)  
9101(b)(2), 102 Stat. 1568; Nov. 2, 2002, Public Law 107273, sec. 13206, 116 Stat. 1904.)  


35 U.S.C. 186 Penalty.  
(Subsection (f) added Nov. 8, 1984, Public Law 98622, sec. 101(a), 98 Stat. 3383.)


Whoever, during the period or periods of time an
(Subsection (g) added Aug. 23, 1988, Public Law 100418, sec. 9003, 102 Stat. 1564.)
invention has been ordered to be kept secret and the
grant of a patent thereon withheld pursuant to section
181 of this title, shall, with knowledge of such order
and without due authorization, willfully publish or
disclose or authorize or cause to be published or disclosed the invention, or material information with
respect thereto, or whoever willfully, in violation of
the provisions of section 184 of this title, shall file or
cause or authorize to be filed in any foreign country
an application for patent or for the registration of a
utility model, industrial design, or model in respect of
any invention made in the United States, shall, upon
conviction, be fined not more than $10,000 or imprisoned for not more than two years, or both.  


(Amended Aug. 23, 1988, Public Law 100-418, sec.  
(Subsection (e) amended Nov. 16, 1988, Public Law  
9101(b)(3), 102 Stat. 1568.)  
100-670, sec. 201(i), 102 Stat. 3988.)  


35 U.S.C. 187 Nonapplicability to certain persons.  
(Subsection (d) amended Nov. 19, 1988, Public Law
100-703, sec. 201, 102 Stat. 4676.)


The prohibitions and penalties of this chapter shall
(Subsection (h) added Oct. 28, 1992, Public Law 102560, sec. 2(a)(1), 106 Stat. 4230.)
not apply to any officer or agent of the United States
acting within the scope of his authority, nor to any
person acting upon his written instructions or permission.  


35 U.S.C. 188 Rules and regulations, delegation of
(Subsections (a), (c), (e), and (g) amended Dec. 8,
power.  
1994, Public Law 103-465, sec. 533(a), 108 Stat. 4988.)


The Atomic Energy Commission, the Secretary of a
(Subsection (i) added Dec. 8, 1994, Public Law 103465, sec. 533(a), 108 Stat. 4988.)
defense department, the chief officer of any other
department or agency of the Government designated
by the President as a defense agency of the United
States, and the Secretary of Commerce, may separately issue rules and regulations to enable the respective department or agency to carry out the provisions
of this chapter, and may delegate any power conferred
by this chapter.  


CHAPTER 18 — PATENT RIGHTS IN
(Subsection (e)(5) added Dec. 8, 2003, Public Law
INVENTIONS MADE WITH FEDERAL
108-173, sec. 1101(d), 117 Stat. 2457.)
ASSISTANCE


35 U.S.C. 272 Temporary presence in the United
States.


Sec.
The use of any invention in any vessel, aircraft or
200 Policy and objective.
vehicle of any country which affords similar privileges to vessels, aircraft, or vehicles of the United
201 Definitions.
States, entering the United States temporarily or accidentally, shall not constitute infringement of any
202 Disposition of rights.
patent, if the invention is used exclusively for the
203 March-in rights.
needs of the vessel, aircraft, or vehicle and is not
204 Preference for United States industry.
offered for sale or sold in or used for the manufacture
205 Confidentiality.
of anything to be sold in or exported from the United
206 Uniform clauses and regulations.
States.  
207 Domestic and foreign protection of federally
 
(Amended Dec. 8, 1994, Public Law 103-465, sec.  
533(b)(4), 108 Stat. 4989.)
 
35 U.S.C. 273 Defense to infringement based on
earlier inventor.  


(a) DEFINITIONS.— For purposes of this section—
(1) the terms “commercially used” and
“commercial use” mean use of a method in the United
States, so long as such use is in connection with an
internal commercial use or an actual arm’s-length sale
or other arm’s-length commercial transfer of a useful
end result, whether or not the subject matter at issue is
accessible to or otherwise known to the public, except
that the subject matter for which commercial marketing or use is subject to a premarketing regulatory
review period during which the safety or efficacy of
the subject matter is established, including any period
specified in section 156(g), shall be deemed “commercially used” and in “commercial use” during such
regulatory review period;
(2) in the case of activities performed by a
nonprofit research laboratory, or nonprofit entity such
as a university, research center, or hospital, a use for
which the public is the intended beneficiary shall be
considered to be a use described in paragraph (1),
except that the use—
(A) may be asserted as a defense under this
section only for continued use by and in the laboratory or nonprofit entity; and
(B) may not be asserted as a defense with
respect to any subsequent commercialization or use
outside such laboratory or nonprofit entity;
(3) the term “method” means a method of
doing or conducting business; and
(4) the “effective filing date” of a patent is
the earlier of the actual filing date of the application


owned inventions.
208 Regulations governing Federal licensing.
209 Licensing federally owned inventions.
210 Precedence of chapter.
211 Relationship to antitrust laws.
212 Disposition of rights in educational awards.


35 U.S.C. 200 Policy and objective.


It is the policy and objective of the Congress to use
for the patent or the filing date of any earlier United  
the patent system to promote the utilization of inventions arising from federally supported research or  
States, foreign, or international application to which
development; to encourage maximum participation of
the subject matter at issue is entitled under section
small business firms in federally supported research
119, 120, or 365 of this title.  
and development efforts; to promote collaboration
between commercial concerns and nonprofit organizations, including universities; to ensure that inventions made by nonprofit organizations and small
business firms are used in a manner to promote free
competition and enterprise without unduly encumbering future research and discovery; to promote the  
commercialization and public availability of inventions made in the United States by United States
industry and labor; to ensure that the Government
obtains sufficient rights in federally supported inventions to meet the needs of the Government and protect
the public against nonuse or unreasonable use of  
inventions; and to minimize the costs of administering
policies in this area.  


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
(b) DEFENSE TO INFRINGEMENT.
94 Stat. 3018; amended Nov. 1, 2000, Public Law 106-404,
sec. 5, 114 Stat. 1745.)


(1) IN GENERAL.— It shall be a defense to
 
an action for infringement under section 271 of this
35 U.S.C. 201 Definitions.
title with respect to any subject matter that would otherwise infringe one or more claims for a method in the
 
patent being asserted against a person, if such person
As used in this chapter —
had, acting in good faith, actually reduced the subject
 
matter to practice at least 1 year before the effective
(a) The term “Federal agency” means any executive agency as defined in section 105 of title 5, and  
filing date of such patent, and commercially used the
the military departments as defined by section 102 of  
subject matter before the effective filing date of such
title 5.  
patent.  
(b) The term “funding agreement” means any
(2) EXHAUSTION OF RIGHT.— The sale
contract, grant, or cooperative agreement entered into
or other disposition of a useful end product produced
between any Federal agency, other than the Tennessee
by a patented method, by a person entitled to assert a
Valley Authority, and any contractor for the performance of experimental, developmental, or research
defense under this section with respect to that useful
work funded in whole or in part by the Federal Government. Such term includes any assignment, substitution of parties, or subcontract of any type entered
end result shall exhaust the patent owner’s rights
into for the performance of experimental, developmental, or research work under a funding agreement
under the patent to the extent such rights would have
as herein defined.
been exhausted had such sale or other disposition
(c) The term “contractor” means any person,
been made by the patent owner.  
small business firm, or nonprofit organization that is a  
(3) LIMITATIONS AND QUALIFICATIONS OF DEFENSE.— The defense to infringement under this section is subject to the following:
party to a funding agreement.  
(A) PATENT.— A person may not assert
(d) The term “invention” means any invention
the defense under this section unless the invention for
or discovery which is or may be patentable or otherwise protectable under this title or any novel variety
which the defense is asserted is for a method.  
of plant which is or may be protectable under the  
(B) DERIVATION.— A person may not
Plant Variety Protection Act (7 U.S.C. 2321, et seq.).  
assert the defense under this section if the subject
(e) The term “subject invention” means any
matter on which the defense is based was derived
invention of the contractor conceived or first actually
from the patentee or persons in privity with the patentee.
reduced to practice in the performance of work under
(C) NOT A GENERAL LICENSE.— The
a funding agreement: Provided, That in the case of a
defense asserted by a person under this section is not a
variety of plant, the date of determination (as defined
general license under all claims of the patent at issue,
in section 41(d) of the Plant Variety Protection Act (7
but extends only to the specific subject matter claimed
in the patent with respect to which the person can
assert a defense under this chapter, except that the
defense shall also extend to variations in the quantity
or volume of use of the claimed subject matter, and to
improvements in the claimed subject matter that do
not infringe additional specifically claimed subject
matter of the patent.
(4) BURDEN OF PROOF.— A person
asserting the defense under this section shall have the  




U.S.C. 2401(d)) must also occur during the period of
burden of establishing the defense by clear and convincing evidence.  
contract performance.  


(f) The term “practical application” means to
(5) ABANDONMENT OF USE.— A person
manufacture in the case of a composition or product,
who has abandoned commercial use of subject matter
to practice in the case of a process or method, or to  
may not rely on activities performed before the date
operate in the case of a machine or system; and, in
of such abandonment in establishing a defense under
each case, under such conditions as to establish that
this section with respect to actions taken after the date
the invention is being utilized and that its benefits are
of such abandonment.
to the extent permitted by law or Government regulations available to the public on reasonable terms.  
(6) PERSONAL DEFENSE.— The defense
(g) The term “made” when used in relation to
under this section may be asserted only by the person
any invention means the conception or first actual
who performed the acts necessary to establish the
reduction to practice of such invention.  
defense and, except for any transfer to the patent
(h) The term “small business firm” means a  
owner, the right to assert the defense shall not be
small business concern as defined at section 2 of Public Law 85-536 (15 U.S.C. 632) and implementing
licensed or assigned or transferred to another person
except as an ancillary and subordinate part of a good
faith assignment or transfer for other reasons of the  
entire enterprise or line of business to which the  
defense relates.  
(7) LIMITATION ON SITES.— A defense
under this section, when acquired as part of a good
faith assignment or transfer of an entire enterprise or
line of business to which the defense relates, may only
be asserted for uses at sites where the subject matter
that would otherwise infringe one or more of the
claims is in use before the later of the effective filing
date of the patent or the date of the assignment or  
transfer of such enterprise or line of business.  
(8) UNSUCCESSFUL ASSERTION OF
DEFENSE.— If the defense under this section is
pleaded by a person who is found to infringe the
patent and who subsequently fails to demonstrate a  
reasonable basis for asserting the defense, the court
shall find the case exceptional for the purpose of
awarding attorney fees under section 285 of this title.
(9) INVALIDITY.— A patent shall not be
deemed to be invalid under section 102 or 103 of this
title solely because a defense is raised or established
under this section.




regulations of the Administrator of the Small Business Administration.  
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-555 (S. 1948 sec. 4302).)


(i) The term “nonprofit organization” means
===CHAPTER 29 — REMEDIES FOR INFRINGEMENT OF PATENT, AND OTHER ACTIONS===
universities and other institutions of higher education
or an organization of the type described in section
501(c)(3) of the Internal Revenue Code of 1986 (26


U.S.C. 501(c)) and exempt from taxation under section 501(a) of the Internal Revenue Code (26 U.S.C.
501(a)) or any nonprofit scientific or educational
organization qualified under a State nonprofit organization statute.


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
Sec.
94 Stat. 3019.)
281 Remedy for infringement of patent.
282 Presumption of validity; defenses.
283 Injunction.


(Subsection (d) amended Nov. 8, 1984, Public Law 98620, sec. 501(1), 98 Stat. 3364.)


(Subsection (e) amended Nov. 8, 1984, Public Law 98620, sec. 501(2), 98 Stat. 3364.)


(Subsection (i) amended Oct. 22, 1986, Public Law 99514, sec. 2, 100 Stat. 2095.)
284 Damages.
285 Attorney fees.
286 Time limitation on damages.
287 Limitation on damages and other remedies;


(Subsection (a) amended Nov. 2, 2002, Public Law
107-273, sec. 13206, 116 Stat. 1904.)


35 U.S.C. 202 Disposition of rights.  
marking and notice.  
288 Action for infringement of a patent containing
an invalid claim.  
289 Additional remedy for infringement of design
 
patent.  
290 Notice of patent suits.
291 Interfering patents.
292 False marking.
293 Nonresident patentee; service and notice.
294 Voluntary arbitration.  
295 Presumptions: Product made by patented pro


(a) Each nonprofit organization or small business firm may, within a reasonable time after disclosure as required by paragraph (c)(1) of this section,  
cess.
elect to retain title to any subject invention: Provided,
296 Liability of States, instrumentalities of States,  
however, That a funding agreement may provide otherwise (i) when the contractor is not located in the
and State officials for infringement of patents.
United States or does not have a place of business
297 Improper and deceptive invention promotion
located in the United States or is subject to the control
of a foreign government, (ii) in exceptional circumstances when it is determined by the agency that
restriction or elimination of the right to retain title to
any subject invention will better promote the policy
and objectives of this chapter, (iii) when it is determined by a Government authority which is authorized
by statute or Executive order to conduct foreign intelligence or counterintelligence activities that the
restriction or elimination of the right to retain title to
any subject invention is necessary to protect the security of such activities, or (iv) when the funding agreement includes the operation of a Government-owned,
contractor-operated facility of the Department of
Energy primarily dedicated to that Department’s naval
nuclear propulsion or weapons related programs and
all funding agreement limitations under this subparagraph on the contractor’s right to elect title to a sub-


====35 U.S.C. 281 Remedy for infringement of patent.====


ject invention are limited to inventions occurring
A patentee shall have remedy by civil action for
under the above two programs of the Department of
infringement of his patent.  
Energy. The rights of the nonprofit organization or
small business firm shall be subject to the provisions
of paragraph (c) of this section and the other provisions of this chapter.  


(b)(1) The rights of the Government under subsection (a) shall not be exercised by a Federal agency
====35 U.S.C. 282 Presumption of validity; defenses.====
unless it first determines that at least one of the conditions identified in clauses (i) through (iii) of subsection (a) exists. Except in the case of subsection
 
(a)(iii), the agency shall file with the Secretary of
A patent shall be presumed valid. Each claim of a  
Commerce, within thirty days after the award of the  
patent (whether in independent, dependent, or multiple dependent form) shall be presumed valid independently of the validity of other claims; dependent or
applicable funding agreement, a copy of such determination. In the case of a determination under subsection (a)(ii), the statement shall include an analysis
multiple dependent claims shall be presumed valid
justifying the determination. In the case of determinations applicable to funding agreements with small
even though dependent upon an invalid claim. Notwithstanding the preceding sentence, if a claim to a  
business firms, copies shall also be sent to the Chief
composition of matter is held invalid and that claim
Counsel for Advocacy of the Small Business Administration. If the Secretary of Commerce believes that
was the basis of a determination of nonobviousness
any individual determination or pattern of determinations is contrary to the policies and objectives of this
under section 103(b)(1), the process shall no longer be
chapter or otherwise not in conformance with this
considered nonobvious solely on the basis of section
chapter, the Secretary shall so advise the head of the
103(b)(1). The burden of establishing invalidity of a
agency concerned and the Administrator of the Office
patent or any claim thereof shall rest on the party
of Federal Procurement Policy, and recommend corrective actions.
asserting such invalidity.  
 
The following shall be defenses in any action
involving the validity or infringement of a patent and  
shall be pleaded:
 
(1) Noninfringement, absence of liability for
infringement, or unenforceability,  
(2) Invalidity of the patent or any claim in suit
on any ground specified in part II of this title as a condition for patentability,  


(2) Whenever the Administrator of the Office
of Federal Procurement Policy has determined that
one or more Federal agencies are utilizing the authority of clause (i) or (ii) of subsection (a) of this section
in a manner that is contrary to the policies and objectives of this chapter the Administrator is authorized to
issue regulations describing classes of situations in
which agencies may not exercise the authorities of
those clauses.
(3) At least once every 5 years, the Comptroller General shall transmit a report to the Committees on the Judiciary of the Senate and House of
Representatives on the manner in which this chapter
is being implemented by the agencies and on such
other aspects of Government patent policies and practices with respect to federally funded inventions as the
Comptroller General believes appropriate.
(4) If the contractor believes that a determination is contrary to the policies and objectives of this
chapter or constitutes an abuse of discretion by the


(3) Invalidity of the patent or any claim in suit
for failure to comply with any requirement of sections
112 or 251 of this title,
(4) Any other fact or act made a defense by this
title.


agency, the determination shall be subject to the section 203(b).


(c) Each funding agreement with a small business firm or nonprofit organization shall contain
In actions involving the validity or infringement of
appropriate provisions to effectuate the following:
a patent the party asserting invalidity or noninfringement shall give notice in the pleadings or otherwise in
(1) That the contractor disclose each subject
writing to the adverse party at least thirty days before
invention to the Federal agency within a reasonable
the trial, of the country, number, date, and name of the  
time after it becomes known to contractor personnel
patentee of any patent, the title, date, and page numbers of any publication to be relied upon as anticipation of the patent in suit or, except in actions in the  
responsible for the administration of patent matters,  
United States Court of Federal Claims, as showing the  
and that the Federal Government may receive title to
state of the art, and the name and address of any person who may be relied upon as the prior inventor or as
any subject invention not disclosed to it within such
having prior knowledge of or as having previously
time.
used or offered for sale the invention of the patent in  
(2) That the contractor make a written election within two years after disclosure to the Federal
suit. In the absence of such notice proof of the said
agency (or such additional time as may be approved
matters may not be made at the trial except on such  
by the Federal agency) whether the contractor will
terms as the court requires.
retain title to a subject invention: Provided, That in  
any case where publication, on sale, or public use, has
initiated the one year statutory period in which valid
patent protection can still be obtained in the United  
States, the period for election may be shortened by the  
Federal agency to a date that is not more than sixty
days prior to the end of the statutory period: And provided further, That the Federal Government may  
receive title to any subject invention in which the contractor does not elect to retain rights or fails to elect
rights within such times.
(3) That a contractor electing rights in a subject invention agrees to file a patent application prior  
to any statutory bar date that may occur under this
title due to publication, on sale, or public use, and
shall thereafter file corresponding patent applications
in other countries in which it wishes to retain title
within reasonable times, and that the Federal Government may receive title to any subject inventions in the  
United States or other countries in which the contractor has not filed patent applications on the subject
invention within such times.  
(4) With respect to any invention in which
the contractor elects rights, the Federal agency shall
have a nonexclusive, nontransferable, irrevocable,
paid-up license to practice or have practiced for or on
behalf of the United States any subject invention
throughout the world: Provided, That the funding
agreement may provide for such additional rights,
including the right to assign or have assigned foreign
patent rights in the subject invention, as are determined by the agency as necessary for meeting the  


Invalidity of the extension of a patent term or any
portion thereof under section 154(b) or 156 of this
title because of the material failure—


(1) by the applicant for the extension, or


obligations of the United States under any treaty,
(2) by the Director, to comply with the requirements of such section shall be a defense in any action
international agreement, arrangement of cooperation,
involving the infringement of a patent during the
memorandum of understanding, or similar arrangement, including military agreements relating to weapons development and production.  
period of the extension of its term and shall be
pleaded. A due diligence determination under section
156(d)(2) is not subject to review in such an action.  


(5) The right of the Federal agency to require
(Amended July 24, 1965, Public Law 89-83, sec. 10,
periodic reporting on the utilization or efforts at
79 Stat. 261; Nov. 14, 1975, Public Law 94-131, sec. 10,
obtaining utilization that are being made by the contractor or his licensees or assignees: Provided, That
89 Stat. 692; Apr. 2, 1982, Public Law 97-164, sec. 161(7),  
any such information, as well as any information on
96 Stat. 49; Sept. 24, 1984, Public Law 98-417, sec. 203,
utilization or efforts at obtaining utilization obtained
98 Stat. 1603; Oct. 29, 1992, Public Law 102-572, sec.  
as part of a proceeding under section 203 of this chapter shall be treated by the Federal agency as commercial and financial information obtained from a person
902(b)(1), 106 Stat. 4516; Nov. 1, 1995, Public Law 10441, sec. 2, 109 Stat. 352; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-560, 582 (S. 1948
and privileged and confidential and not subject to disclosure under section 552 of title 5.  
secs. 4402(b)(1) and 4732(a)(10)(A)).)
(6) An obligation on the part of the contractor, in the event a United States patent application is
 
filed by or on its behalf or by any assignee of the contractor, to include within the specification of such
====35 U.S.C. 283 Injunction.====
application and any patent issuing thereon, a statement specifying that the invention was made with
Government support and that the Government has certain rights in the invention.  
(7) In the case of a nonprofit organization,


The several courts having jurisdiction of cases
under this title may grant injunctions in accordance
with the principles of equity to prevent the violation
of any right secured by patent, on such terms as the
court deems reasonable.


(A) a prohibition upon the assignment of rights to a
====35 U.S.C. 284 Damages.====
subject invention in the United States without the
approval of the Federal agency, except where such
assignment is made to an organization which has as
one of its primary functions the management of
inventions (provided that such assignee shall be subject to the same provisions as the contractor); (B) a
requirement that the contractor share royalties with
the inventor; (C) except with respect to a funding
agreement for the operation of a Government-ownedcontractor-operated facility, a requirement that the
balance of any royalties or income earned by the contractor with respect to subject inventions, after payment of expenses (including payments to inventors)
incidental to the administration of subject inventions,
be utilized for the support of scientific research, or
education; (D) a requirement that, except where it
proves infeasible after a reasonable inquiry, in the
licensing of subject inventions shall be given to small
business firms; and (E) with respect to a funding
agreement for the operation of a Government-ownedcontractor-operator facility, requirements (i) that after
payment of patenting costs, licensing costs, payments


Upon finding for the claimant the court shall award
the claimant damages adequate to compensate for the
infringement but in no event less that a reasonable
royalty for the use made of the invention by the
infringer, together with interest and costs as fixed by
the court.


to inventors, and other expenses incidental to the
When the damages are not found by a jury, the  
administration of subject inventions, 100 percent of
court shall assess them. In either event the court may
the balance of any royalties or income earned and
increase the damages up to three times the amount
retained by the contractor during any fiscal year, up to
found or assessed. Increased damages under this paragraph shall not apply to provisional rights under section 154(d) of this title.
an amount equal to 5 percent of the annual budget of
 
the facility, shall be used by the contractor for scientific research, development, and education consistent
The court may receive expert testimony as an aid to  
with the research and development mission and objectives of the facility, including activities that increase  
the determination of damages or of what royalty
the licensing potential of other inventions of the facility provided that if said balance exceeds 5 percent of
would be reasonable under the circumstances.  
the annual budget of the facility, that 75 percent of
such excess shall be paid to the Treasury of the United
States and the remaining 25 percent shall be used for
the same purposes as described above in this clause
(D); and (ii) that, to the extent it provides the most
effective technology transfer, the licensing of subject
inventions shall be administered by contractor
employees on location at the facility.  


(8) The requirements of sections 203 and 204
(Amended Nov. 29, 1999, Public Law 106-113, sec.  
of this chapter.  
1000(a)(9), 113 Stat. 1501A-566 (S. 1948 sec. 4507(9)).)
(d) If a contractor does not elect to retain title to
a subject invention in cases subject to this section, the
Federal agency may consider and after consultation
with the contractor grant requests for retention of
rights by the inventor subject to the provisions of this
Act and regulations promulgated hereunder.  
(e) In any case when a Federal employee is a
coinventor of any invention made with a nonprofit
organization, a small business firm, or a non-Federal
inventor, the Federal agency employing such coinventor may, for the purpose of consolidating rights in the
invention and if it finds that it would expedite the
development of the invention—
(1) license or assign whatever rights it may
acquire in the subject invention to the nonprofit organization, small business firm, or non-Federal inventor
in accordance with the provisions of this chapter; or
(2) acquire any rights in the subject invention
from the nonprofit organization, small business firm,
or non-Federal inventor, but only to the extent the
party from whom the rights are acquired voluntarily
enters into the transaction and no other transaction
under this chapter is conditioned on such acquisition.  


35 U.S.C. 285 Attorney fees.


(f)(1) No funding agreement with a small business firm or nonprofit organization shall contain a
The court in exceptional cases may award reasonable attorney fees to the prevailing party.
provision allowing a Federal agency to require the
licensing to third parties of inventions owned by the  


====35 U.S.C. 286 Time limitation on damages.====


contractor that are not subject inventions unless such
Except as otherwise provided by law, no recovery
provision has been approved by the head of the
shall be had for any infringement committed more
agency and a written justification has been signed by
than six years prior to the filing of the complaint or  
the head of the agency. Any such provision shall  
counterclaim for infringement in the action.  
clearly state whether the licensing may be required in
connection with the practice of a subject invention, a
specifically identified work object, or both. The head
of the agency may not delegate the authority to
approve provisions or sign justifications required by
this paragraph.  


(2) A Federal agency shall not require the  
In the case of claims against the United States Government for use of a patented invention, the period
licensing of third parties under any such provision
before bringing suit, up to six years, between the date
unless the head of the agency determines that the use
of receipt of a written claim for compensation by the  
of the invention by others is necessary for the practice
department or agency of the Government having
of a subject invention or for the use of a work object
authority to settle such claim, and the date of mailing
of the funding agreement and that such action is necessary to achieve the practical application of the subject invention or work object. Any such determination
by the Government of a notice to the claimant that his
shall be on the record after an opportunity for an
claim has been denied shall not be counted as a part of  
agency hearing. Any action commenced for judicial
the period referred to in the preceding paragraph.  
review of such determination shall be brought within
sixty days after notification of such determination.  


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
====35 U.S.C. 287 Limitation on damages and other remedies; marking and notice.====
94 Stat. 3020; subsection (b)(4) added and subsections (a),
(b)(1), (b)(2), (c)(4), (c)(5), and (c)(7) amended Nov. 8,
1984, Public Law 98-620, sec. 501, 98 Stat. 3364; subsection (b)(3) amended Dec. 10, 1991, Public Law 102-204,
sec. 10, 105 Stat. 1641; subsection (a) amended Nov. 29,
1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat.
1501A-583 (S. 1948 sec. 4732(a)(12)); subsection (e)
amended Nov. 1, 2000, Public Law 106-404, sec. 6(1), 114
Stat. 1745; subsections (b)(4), (c)(4), and (c)(5) amended
Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat.
1905.)


35 U.S.C. 203 March-in rights.  
(a) Patentees, and persons making, offering for
sale, or selling within the United States any patented
article for or under them, or importing any patented
article into the United States, may give notice to the
public that the same is patented, either by fixing
thereon the word “patent” or the abbreviation “pat.”,
together with the number of the patent, or when, from
the character of the article, this cannot be done, by
fixing to it, or to the package wherein one or more of
them is contained, a label containing a like notice. In
the event of failure so to mark, no damages shall be
recovered by the patentee in any action for infringement, except on proof that the infringer was notified
of the infringement and continued to infringe thereafter, in which event damages may be recovered only
for infringement occurring after such notice. Filing of
an action for infringement shall constitute such notice.  


(a) With respect to any subject invention in
(b)(1) An infringer under section 271(g) shall be
which a small business firm or nonprofit organization
subject to all the provisions of this title relating to  
has acquired title under this chapter, the Federal
damages and injunctions except to the extent those
agency under whose funding agreement the subject  
remedies are modified by this subsection or section
invention was made shall have the right, in accordance with such procedures as are provided in regulations promulgated hereunder, to require the  
9006 of the Process Patent Amendments Act of 1988.
contractor, an assignee, or exclusive licensee of a subject invention to grant a nonexclusive, partially exclusive, or exclusive license in any field of use to a
The modifications of remedies provided in this subsection shall not be available to any person who —  
responsible applicant or applicants, upon terms that
are reasonable under the circumstances, and if the  
contractor, assignee, or exclusive licensee refuses
such request, to grant such a license itself, if the Federal agency determines that such —  


(1) action is necessary because the contractor
(A) practiced the patented process;  
or assignee has not taken, or is not expected to take
within a reasonable time, effective steps to achieve
practical application of the subject invention in such
field of use;
(2) action is necessary to alleviate health or
safety needs which are not reasonably satisfied by the
contractor, assignee, or their licensees;
(3) action is necessary to meet requirements
for public use specified by Federal regulations and
such requirements are not reasonably satisfied by the  
contractor, assignee, or licensees; or
(4) action is necessary because the agreement
required by section 204 has not been obtained or
waived or because a licensee of the exclusive right to
use or sell any subject invention in the United States is
in breach of its agreement obtained pursuant to section 204.
(b) A determination pursuant to this section or
section 202(b)(4) shall not be subject to the Contract
Disputes Act (41 U.S.C. § 601 et seq.). An administrative appeals procedure shall be established by regulations promulgated in accordance with section 206.
Additionally, any contractor, inventor, assignee, or
exclusive licensee adversely affected by a determination under this section may, at any time within sixty
days after the determination is issued, file a petition in
the United States Court of Federal Claims, which
shall have jurisdiction to determine the appeal on the
record and to affirm, reverse, remand or modify, as
appropriate, the determination of the Federal agency.
In cases described in paragraphs (1) and (3) of subsection (a), the agency’s determination shall be held in
abeyance pending the exhaustion of appeals or petitions filed under the preceding sentence.


(B) owns or controls, or is owned or controlled by, the person who practiced the patented process; or
(C) had knowledge before the infringement
that a patented process was used to make the product
the importation, use, offer for sale, or sale of which
constitutes the infringement.
(2) No remedies for infringement under section 271(g) of this title shall be available with respect
to any product in the possession of, or in transit to, the
person subject to liability under such section before
that person had notice of infringement with respect to
that product. The person subject to liability shall bear
the burden of proving any such possession or transit.
(3)(A) In making a determination with respect
to the remedy in an action brought for infringement
under section 271(g), the court shall consider—


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
94 Stat. 3022; amended Nov. 8, 1984, Public Law 98-620,
sec. 501(9), 98 Stat. 3367; Oct. 29, 1992, Public Law 102572, sec. 902(b)(1), 106 Stat. 4516; amended Nov. 2, 2002,
Public Law 107-273, sec. 13206, 116 Stat. 1905.)
35 U.S.C. 204 Preference for United States industry.


Notwithstanding any other provision of this chapter, no small business firm or nonprofit organization
(i) the good faith demonstrated by the
which receives title to any subject invention and no
defendant with respect to a request for disclosure;
assignee of any such small business firm or nonprofit
(ii) the good faith demonstrated by the
plaintiff with respect to a request for disclosure, and  




organization shall grant to any person the exclusive  
(iii) the need to restore the exclusive  
right to use or sell any subject invention in the United
rights secured by the patent.  
States unless such person agrees that any products
embodying the subject invention or produced through
the use of the subject invention will be manufactured
substantially in the United States. However, in individual cases, the requirement for such an agreement
may be waived by the Federal agency under whose
funding agreement the invention was made upon a
showing by the small business firm, nonprofit organization, or assignee that reasonable but unsuccessful
efforts have been made to grant licenses on similar
terms to potential licensees that would be likely to
manufacture substantially in the United States or that
under the circumstances domestic manufacture is not
commercially feasible.  


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
(B) For purposes of subparagraph (A), the
94 Stat. 3023.)
following are evidence of good faith:
(i) a request for disclosure made by the
defendant;
(ii) a response within a reasonable time
by the person receiving the request for disclosure; and


35 U.S.C. 205 Confidentiality.


Federal agencies are authorized to withhold from
(iii) the submission of the response by
disclosure to the public information disclosing any
the defendant to the manufacturer, or if the manufacturer is not known, to the supplier, of the product to be
invention in which the Federal Government owns or
purchased by the defendant, together with a request
may own a right, title, or interest (including a nonexclusive license) for a reasonable time in order for a
for a written statement that the process claimed in any
patent application to be filed. Furthermore, Federal
patent disclosed in the response is not used to produce
agencies shall not be required to release copies of any
such product.  
document which is part of an application for patent
filed with the United States Patent and Trademark
Office or with any foreign patent office.  


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
The failure to perform any acts
94 Stat. 3023.)
described in the preceding sentence is evidence of
absence of good faith unless there are mitigating circumstances. Mitigating circumstances include the
case in which, due to the nature of the product, the
number of sources for the product, or like commercial
circumstances, a request for disclosure is not necessary or practicable to avoid infringement.  


35 U.S.C. 206 Uniform clauses and regulations.  
(4)(A) For purposes of this subsection, a
“request for disclosure” means a written request made
to a person then engaged in the manufacture of a
product to identify all process patents owned by or
licensed to that person, as of the time of the request,
that the person then reasonably believes could be
asserted to be infringed under section 271(g) if that
product were imported into, or sold, offered for sale,
or used in, the United States by an unauthorized person. A request for disclosure is further limited to a
request —


The Secretary of Commerce may issue regulations
(i) which is made by a person regularly
which may be made applicable to Federal agencies
engaged in the United States in the sale of the type of  
implementing the provisions of sections 202 through
products as those manufactured by the person to
204 of this chapter and shall establish standard funding agreement provisions required under this chapter.
whom the request is directed, or which includes facts
The regulations and the standard funding agreement
showing that the person making the request plans to  
shall be subject to public comment before their issuance.
engage in the sale of such products in the United
States;
(ii) which is made by such person before
the person’s first importation, use, offer for sale, or
sale of units of the product produced by an infringing
process and before the person had notice of infringement with respect to the product; and


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
94 Stat. 3023; amended Nov. 8, 1984, Public Law 98-620,
sec. 501(10), 98 Stat. 3367.)


35 U.S.C. 207 Domestic and foreign protection of  
(iii) which includes a representation by
federally owned inventions.  
the person making the request that such person will
promptly submit the patents identified pursuant to the
request to the manufacturer, or if the manufacturer is
not known, to the supplier, of the product to be purchased by the person making the request, and will
request from that manufacturer or supplier a written
statement that none of the processes claimed in those
patents is used in the manufacture of the product.  


(a) Each Federal agency is authorized to —
(B) In the case of a request for disclosure
received by a person to whom a patent is licensed, that
person shall either identify the patent or promptly
notify the licensor of the request for disclosure.


(1) apply for, obtain, and maintain patents or
(C) A person who has marked, in the manner prescribed by subsection (a), the number of the  
other forms of protection in the United States and in
process patent on all products made by the patented
foreign countries on inventions in which the Federal
process which have been offered for sale or sold by
Government owns a right, title, or interest;
that person in the United States, or imported by the  
(2) grant nonexclusive, exclusive, or partially
person into the United States, before a request for disclosure is received is not required to respond to the  
exclusive licenses under federally owned inventions,
request for disclosure. For purposes of the preceding
royalty-free or for royalties or other consideration,
sentence, the term “all products” does not include
and on such terms and conditions, including the grant
products made before the effective date of the Process
to the licensee of the right of enforcement pursuant to
Patent Amendments Act of 1988.  
the provisions of chapter 29 of this title as determined
(5)(A) For purposes of this subsection, notice
appropriate in the public interest;
of infringement means actual knowledge, or receipt
(3) undertake all other suitable and necessary
by a person of a written notification, or a combination
steps to protect and administer rights to federally
thereof, of information sufficient to persuade a reasonable person that it is likely that a product was
owned inventions on behalf of the Federal Government either directly or through contract, including
made by a process patented in the United States.  
acquiring rights for and administering royalties to the
Federal Government in any invention, but only to the
extent the party from whom the rights are acquired
voluntarily enters into the transaction, to facilitate the  
licensing of a federally owned invention; and
(4) transfer custody and administration, in
whole or in part, to another Federal agency, of the  
right, title, or interest in any federally owned invention.  
(b) For the purpose of assuring the effective
management of Government-owned inventions, the
Secretary of Commerce authorized to
(1) assist Federal agency efforts to promote
the licensing and utilization of Government-owned
inventions;
(2) assist Federal agencies in seeking protection and maintaining inventions in foreign countries,
including the payment of fees and costs connected
therewith; and
(3) consult with and advise Federal agencies
as to areas of science and technology research and
development with potential for commercial utilization.  


(B) A written notification from the patent
holder charging a person with infringement shall
specify the patented process alleged to have been used
and the reasons for a good faith belief that such process was used. The patent holder shall include in the
notification such information as is reasonably necessary to explain fairly the patent holder’s belief, except
that the patent holder is not required to disclose any
trade secret information.
(C) A person who receives a written notification described in subparagraph (B) or a written
response to a request for disclosure described in paragraph (4) shall be deemed to have notice of infringement with respect to any patent referred to in such
written notification or response unless that person,
absent mitigating circumstances—
(i) promptly transmits the written notification or response to the manufacturer or, if the
manufacturer is not known, to the supplier, of the
product purchased or to be purchased by that person;
and
(ii) receives a written statement from the
manufacturer or supplier which on its face sets forth a
well grounded factual basis for a belief that the identified patents are not infringed.
(D) For purposes of this subsection, a person who obtains a product made by a process patented
in the United States in a quantity which is abnormally
large in relation to the volume of business of such person or an efficient inventory level shall be rebuttably
presumed to have actual knowledge that the product
was made by such patented process.


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
(6) A person who receives a response to a
94 Stat. 3023; amended Nov. 8, 1984, Public Law 98-620,
request for disclosure under this subsection shall pay
sec. 501(11), 98 Stat. 3367; subsections (a)(2) and (a)(3)
to the person to whom the request was made a reasonable fee to cover actual costs incurred in complying
amended Nov. 1, 2000, Public Law 106-404, sec. 6(2), 114
with the request, which may not exceed the cost of a  
Stat. 1745.)
commercially available automated patent search of
 
the matter involved, but in no case more than $500.  


35 U.S.C. 208 Regulations governing Federal
(c)(1) With respect to a medical practitioner’s
licensing.  
performance of a medical activity that constitutes an
infringement under section 271(a) or (b) of this title,
the provisions of sections 281, 283, 284, and 285 of
this title shall not apply against the medical practitioner or against a related health care entity with respect
to such medical activity.  


The Secretary of Commerce is authorized to promulgate regulations specifying the terms and conditions upon which any federally owned invention,
(2) For the purposes of this subsection:
other than inventions owned by the Tennessee Valley
Authority, may be licensed on a nonexclusive, partially exclusive, or exclusive basis.


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
(A) the term “medical activity” means the
94 Stat. 3024; amended Nov. 8, 1984, Public Law 98-620,  
performance of a medical or surgical procedure on a
sec. 501(12), 98 Stat. 3367.)
body, but shall not include (i) the use of a patented
 
machine, manufacture, or composition of matter in
35 U.S.C. 209 Licensing federally owned inventions.
violation of such patent, (ii) the practice of a patented
 
use of a composition of matter in violation of such
(a) AUTHORITY.—A Federal agency may
patent, or (iii) the practice of a process in violation of
grant an exclusive or partially exclusive license on a  
a biotechnology patent.
federally owned invention under section 207(a)(2)
(B) the term “medical practitioner” means
only if—
any natural person who is licensed by a State to provide the medical activity described in subsection
(1) granting the license is a reasonable and
(c)(1) or who is acting under the direction of such person in the performance of the medical activity.
necessary incentive to—
(C) the term “related health care entity”
(A) call forth the investment capital and
shall mean an entity with which a medical practitioner
expenditures needed to bring the invention to practical application; or
has a professional affiliation under which the medical
(B) otherwise promote the invention’s utilization by the public;
practitioner performs the medical activity, including
(2) the Federal agency finds that the public
but not limited to a nursing home, hospital, university,
will be served by the granting of the license, as indicated by the applicant’s intentions, plans, and ability
medical school, health maintenance organization,  
to bring the invention to practical application or otherwise promote the invention’s utilization by the public,  
group medical practice, or a medical clinic.
and that the proposed scope of exclusivity is not  
(D) the term “professional affiliation” shall
greater than reasonably necessary to provide the
mean staff privileges, medical staff membership,
incentive for bringing the invention to practical application, as proposed by the applicant, or otherwise to
employment or contractual relationship, partnership
promote the invention’s utilization by the public;
or ownership interest, academic appointment, or other
(3) the applicant makes a commitment to
affiliation under which a medical practitioner provides the medical activity on behalf of, or in association with, the health care entity.
achieve practical application of the invention within a
(E) the term “body” shall mean a human
reasonable time, which time may be extended by the
body, organ or cadaver, or a nonhuman animal used in
agency upon the applicant’s request and the applicant’s demonstration that the refusal of such extension
medical research or instruction directly relating to the  
would be unreasonable;
treatment of humans.  
(4) granting the license will not tend to substantially lessen competition or create or maintain a  
violation of the Federal antitrust laws; and
(5) in the case of an invention covered by a  
foreign patent application or patent, the interests of
the Federal Government or United States industry in
foreign commerce will be enhanced.  




(b) MANUFACTURE IN UNITED
(F) the term “patented use of a composition of matter” does not include a claim for a method
STATES.—A Federal agency shall normally grant a  
of performing a medical or surgical procedure on a  
license under section 207(a)(2) to use or sell any federally owned invention in the United States only to a  
body that recites the use of a composition of matter
licensee who agrees that any products embodying
where the use of that composition of matter does not
the invention or produced through the use of the  
directly contribute to achievement of the objective of
invention will be manufactured substantially in the  
the claimed method.  
United States.  
(G) the term “State” shall mean any state or
(c) SMALL BUSINESS.—First preference for
territory of the United States, the District of Columbia, and the Commonwealth of Puerto Rico.
the granting of any exclusive or partially exclusive
(3) This subsection does not apply to the
licenses under section 207(a)(2) shall be given to  
activities of any person, or employee or agent of such
small business firms having equal or greater likelihood as other applicants to bring the invention to
person (regardless of whether such person is a tax
practical application within a reasonable time.
exempt organization under section 501(c) of the Internal Revenue Code), who is engaged in the commercial development, manufacture, sale, importation, or
(d) TERMS AND CONDITIONS.—Any
distribution of a machine, manufacture, or composition of matter or the provision of pharmacy or clinical
licenses granted under section 207(a)(2) shall contain
laboratory services (other than clinical laboratory services provided in a physician’s office), where such
such terms and conditions as the granting agency considers appropriate, and shall include provisions—
activities are:
(1) retaining a nontransferrable, irrevocable,  
(A) directly related to the commercial
paid-up license for any Federal agency to practice the
development, manufacture, sale, importation, or distribution of a machine, manufacture, or composition
invention or have the invention practiced throughout
of matter or the provision of pharmacy or clinical laboratory services (other than clinical laboratory services provided in a physician’s office), and  
the world by or on behalf of the Government of the
(B) regulated under the Federal Food,
United States;
Drug, and Cosmetic Act, the Public Health Service
(2) requiring periodic reporting on utilization
Act, or the Clinical Laboratories Improvement Act.
of the invention, and utilization efforts, by the licensee, but only to the extent necessary to enable the
(4) This subsection shall not apply to any
Federal agency to determine whether the terms of the
patent issued based on an application the earliest
license are being complied with, except that any such
effective filing date of which is prior to September 30,  
report shall be treated by the Federal agency as commercial and financial information obtained from a  
1996.
person and privileged and confidential and not subject
 
to disclosure under section 552 of title 5; and  
 
(3) empowering the Federal agency to terminate the license in whole or in part if the agency determines that—
(Amended Aug. 23, 1988, Public Law 100-418, sec.
(A) the licensee is not executing its commitment to achieve practical application of the invention, including commitments contained in any plan
9004(a), 102 Stat. 1564; Dec. 8, 1994, Public Law 103-465,
submitted in support of its request for a license, and
sec. 533(b)(5), 108 Stat. 4989.)  
the licensee cannot otherwise demonstrate to the satisfaction of the Federal agency that it has taken, or can
 
be expected to take within a reasonable time, effective
(Subsection (c) added Sept. 30, 1996, Public Law 104208, sec. 616, 110 Stat. 3009-67.)
steps to achieve practical application of the invention;  
(B) the licensee is in breach of an agreement described in subsection (b);
(C) termination is necessary to meet
requirements for public use specified by Federal regulations issued after the date of the license, and such


(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-589 (S. 1948 sec. 4803).)


====35 U.S.C. 288 Action for infringement of a patent containing an invalid claim.====


requirements are not reasonably satisfied by the licensee; or
Whenever, without deceptive intention, a claim of a
patent is invalid, an action may be maintained for the  
infringement of a claim of the patent which may be
valid. The patentee shall recover no costs unless a dis-


(D) the licensee has been found by a court
of competent jurisdiction to have violated the Federal
antitrust laws in connection with its performance
under the license agreement.
(e) PUBLIC NOTICE.—No exclusive or partially exclusive license may be granted under section
207(a)(2) unless public notice of the intention to grant
an exclusive or partially exclusive license on a federally owned invention has been provided in an appropriate manner at least 15 days before the license is
granted, and the Federal agency has considered all
comments received before the end of the comment
period in response to that public notice. This subsection shall not apply to the licensing of inventions
made under a cooperative research and development
agreement entered into under section 12 of the
Stevenson-Wydler Technology Innovation Act of
1980 (15 U.S.C. 3710a).
(f) PLAN.—No Federal agency shall grant any
license under a patent or patent application on a federally owned invention unless the person requesting the
license has supplied the agency with a plan for development or marketing of the invention, except that any
such plan shall be treated by the Federal agency as
commercial and financial information obtained from a
person and privileged and confidential and not subject
to disclosure under section 552 of title 5.


claimer of the invalid claim has been entered at the
Patent and Trademark Office before the commencement of the suit.


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,  
94 Stat. 3024; amended Nov. 1, 2000, Public Law 106-404,
88 Stat. 1949.)  
sec. 4, 114 Stat. 1743; subsections (d)(2) and (f) amended
Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat.  
1905.)  


35 U.S.C. 210 Precedence of chapter.  
====35 U.S.C. 289 Additional remedy for infringement of design patent.====


(a) This chapter shall take precedence over any
Whoever during the term of a patent for a design,
other Act which would require a disposition of rights
without license of the owner, (1) applies the patented
in subject inventions of small business firms or nonprofit organizations contractors in a manner that is
design, or any colorable imitation thereof, to any article of manufacture for the purpose of sale, or (2) sells
inconsistent with this chapter, including but not necessarily limited to the following:
or exposes for sale any article of manufacture to
(1) section 10(a) of the Act of June 29, 1935,  
which such design or colorable imitation has been
as added by title I of the Act of August 14, 1946 (7
applied shall be liable to the owner to the extent of his
total profit, but not less than $250, recoverable in any
United States district court having jurisdiction of the  
parties.


Nothing in this section shall prevent, lessen, or
impeach any other remedy which an owner of an
infringed patent has under the provisions of this title,
but he shall not twice recover the profit made from the
infringement.


U.S.C. 427i(a); 60 Stat. 1085);
====35 U.S.C. 290 Notice of patent suits.====


(2) section 205(a) of the Act of August 14,  
The clerks of the courts of the United States, within
1946 (7 U.S.C. 1624(a); 60 Stat. 1090);
one month after the filing of an action under this title,
shall give notice thereof in writing to the Director, setting forth so far as known the names and addresses of  
the parties, name of the inventor, and the designating
number of the patent upon which the action has been
brought. If any other patent is subsequently included
in the action he shall give like notice thereof. Within
one month after the decision is rendered or a judgment issued the clerk of the court shall give notice
thereof to the Director. The Director shall, on receipt
of such notices, enter the same in the file of such
patent.  


(3) section 501(c) of the Federal Mine Safety
(Amended Nov. 29, 1999, Public Law 106-113, sec.
and Health Act of 1977 (30 U.S.C. 951(c); 83 Stat.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
742);
4732(a)(10)(A)).)  
(4) section 30168(e) of title 49;


====35 U.S.C. 291 Interfering patents.====


(5) section 12 of the National Science Foundation Act of 1950 (42 U.S.C. 1871(a); 82 Stat. 360);
The owner of an interfering patent may have relief
(6) section 152 of the Atomic Energy Act of  
against the owner of another by civil action, and the
1954 (42 U.S.C. 2182; 68 Stat. 943);
court may adjudge the question of validity of any of  
(7) section 305 of the National Aeronautics
the interfering patents, in whole or in part. The provisions of the second paragraph of section 146 of this
and Space Act of 1958 (42 U.S.C. 2457);
title shall apply to actions brought under this section.
(8) section 6 of the Coal Research Development Act of 1960 (30 U.S.C. 666; 74 Stat. 337);
(9) section 4 of the Helium Act Amendments
of 1960 (50 U.S.C. 167b; 74 Stat. 920);
(10) section 32 of the Arms Control and Disarmament Act of 1961 (22 U.S.C. 2572; 75 Stat. 634);
(11) section 9 of the Federal Nonnuclear
Energy Research and Development Act of 1974 (42


====35 U.S.C. 292 False marking.====


U.S.C. 5908; 88 Stat. 1878);  
(a) Whoever, without the consent of the patentee, marks upon, or affixes to, or uses in advertising in
connection with anything made, used, offered for sale,
or sold by same person within the United States, or
imported by the person into the United States, the
name or any imitation of the name of the patentee, the
patent number, or the words “patent,” “patentee,” or
the like, with the intent of counterfeiting or imitating
the mark of the patentee, or of deceiving the public
and inducing them to believe that the thing was made,
offered for sale, sold, or imported into the United
States by or with the consent of the patentee; or


(12) section 5(d) of the Consumer Product
Whoever marks upon, or affixes to, or uses in
Safety Act (15 U.S.C. 2054(d); 86 Stat. 1211);  
advertising in connection with any unpatented article
the word “patent” or any word or number importing
the same is patented, for the purpose of deceiving the  
public; or


(13) section 3 of the Act of April 5, 1944 (30
Whoever marks upon, or affixes to, or uses in
advertising in connection with any article the words
“patent applied for,” “patent pending,” or any word
importing that an application for patent has been
made, when no application for patent has been made,
or if made, is not pending, for the purpose of deceiving the public —


U.S.C. 323; 58 Stat. 191);
Shall be fined not more than $500 for every
such offense.  


(14) section 8001(c)(3) of the Solid Waste
(b) Any person may sue for the penalty, in
Disposal Act (42 U.S.C. 6981(c); 90 Stat. 2829);
which event one-half shall go to the person suing and  
(15) section 219 of the Foreign Assistance Act
the other to the use of the United States.  
of 1961 (22 U.S.C. 2179; 83 Stat. 806);
(16) section 427(b) of the Federal Mine Health
and Safety Act of 1977 (30 U.S.C. 937(b); 86 Stat.
155);
(17) section 306(d) of the Surface Mining and  
Reclamation Act of 1977 (30 U.S.C. 1226(d); 91 Stat.
455);
(18) section 21(d) of the Federal Fire Prevention and Control Act of 1974 (15 U.S.C. 2218(d); 88
Stat. 1548);
(19) section 6(b) of the Solar Photovoltaic
Energy Research Development and Demonstration
Act of 1978 (42 U.S.C. 5585(b); 92 Stat. 2516);
(20) section 12 of the Native Latex Commercialization and Economic Development Act of 1978
(7 U.S.C. 178j; 92 Stat. 2533); and
(21) section 408 of the Water Resources and
Development Act of 1978 (42 U.S.C. 7879; 92 Stat.
1360).  


(Subsection (a) amended Dec. 8, 1994, Public Law
103-465, sec. 533(b)(6), 108 Stat. 4990.)


The Act creating this chapter shall be construed to take precedence over any future Act unless
====35 U.S.C. 293 Nonresident patentee; service and notice.====


Every patentee not residing in the United States
may file in the Patent and Trademark Office a written
designation stating the name and address of a person
residing within the United States on whom may be
served process or notice of proceedings affecting the
patent or rights thereunder. If the person designated
cannot be found at the address given in the last designation, or if no person has been designated, the United
States District Court for the District of Columbia shall
have jurisdiction and summons shall be served by
publication or otherwise as the court directs. The
court shall have the same jurisdiction to take any
action respecting the patent or rights thereunder that it
would have if the patentee were personally within the
jurisdiction of the court.


that Act specifically cites this Act and provides that it
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,  
shall take precedence over this Act.
88 Stat. 1949.)  
 
(b) Nothing in this chapter is intended to alter
the effect of the laws cited in paragraph (a) of this section or any other laws with respect to the disposition
of rights in inventions made in the performance of
funding agreements with persons other than nonprofit
organizations or small business firms.  
(c) Nothing in this chapter is intended to limit
the authority of agencies to agree to the disposition of
rights in inventions made in the performance of work
under funding agreements with persons other than
nonprofit organizations or small business firms in
accordance with the Statement of Government Patent
Policy issued on February 18, 1983, agency regulations, or other applicable regulations or to otherwise
limit the authority of agencies to allow such persons
to retain ownership of inventions, except that all funding agreements, including those with other than small
business firms and nonprofit organizations, shall
include the requirements established in section
202(c)(4) and section 203 of this title. Any disposition
of rights in inventions made in accordance with the
Statement or implementing regulations, including any
disposition occurring before enactment of this section,  
are hereby authorized.  
(d) Nothing in this chapter shall be construed to
require the disclosure of intelligence sources or methods or to otherwise affect the authority granted to the
Director of Central Intelligence by statute or Executive order for the protection of intelligence sources or
methods.  
(e) The provisions of the Stevenson-Wydler
Technology Innovation Act of 1980 shall take precedence over the provisions of this chapter to the extent
that they permit or require a disposition of rights in
subject inventions which is inconsistent with this
chapter.


====35 U.S.C. 294 Voluntary arbitration.====


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a),  
(a) A contract involving a patent or any right
94 Stat. 3026.)
under a patent may contain a provision requiring arbitration of any dispute relating to patent validity or
infringement arising under the contract. In the
absence of such a provision, the parties to an existing
patent validity or infringement dispute may agree in
writing to settle such dispute by arbitration. Any such
provision or agreement shall be valid, irrevocable, and
enforceable, except for any grounds that exist at law
or in equity for revocation of a contract.  
(b) Arbitration of such disputes, awards by
arbitrators, and confirmation of awards shall be governed by title 9, to the extent such title is not inconsistent with this section. In any such arbitration
proceeding, the defenses provided for under section
282 of this title shall be considered by the arbitrator if
raised by any party to the proceeding.  
(c) An award by an arbitrator shall be final and
binding between the parties to the arbitration but shall
have no force or effect on any other person. The parties to an arbitration may agree that in the event a
patent which is the subject matter of an award is subsequently determined to be invalid or unenforceable
in a judgment rendered by a court of competent jurisdiction from which no appeal can or has been taken,
such award may be modified by any court of competent jurisdiction upon application by any party to the
arbitration. Any such modification shall govern the
rights and obligations between such parties from the
date of such modification.
(d) When an award is made by an arbitrator, the
patentee, his assignee or licensee shall give notice
thereof in writing to the Director. There shall be a separate notice prepared for each patent involved in such
proceeding. Such notice shall set forth the names and
addresses of the parties, the name of the inventor, and
the name of the patent owner, shall designate the number of the patent, and shall contain a copy of the
award. If an award is modified by a court, the party
requesting such modification shall give notice of such
modification to the Director. The Director shall, upon
receipt of either notice, enter the same in the record of
the prosecution of such patent. If the required notice is


(Subsection (c) amended Nov. 8, 1984, Public Law 98620, sec. 501(13), 98 Stat. 3367.)


(Subsection (e) added Oct. 20, 1986, Public Law 99502, sec. 9(c), 100 Stat. 1796.)
not filed with the Director, any party to the proceeding
may provide such notice to the Director.  


(Subsection (a)(4) amended July 5, 1994, Public Law
(e) The award shall be unenforceable until the
103-272, sec. 5(j), 108 Stat. 1375.)
notice required by subsection (d) is received by the
Director.  


(Subsection (e) amended Mar. 7, 1996, Public Law  
(Added Aug. 27, 1982, Public Law 97-247, sec.
104-113, sec. 7, 110 Stat. 779.)  
17(b)(1), 96 Stat. 322; amended Nov. 29, 1999, Public Law  
106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948
sec. 4732(a)(10)(A)); subsections (b) and (c) amended Nov.
2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1905.)  


(Subsection (a) amended Nov. 13, 1998, Public Law
====35 U.S.C. 295 Presumption: Product made by patented process.====
105-393, sec. 220(c)(2), 112 Stat. 3625.)


(Subsections (a)(11), (a)(20), and (c) amended Nov. 2,  
In actions alleging infringement of a process patent
2002, Public Law 107-273, sec. 13206, 116 Stat. 1905.)
based on the importation, sale, offered for sale, or use
of a product which is made from a process patented in
the United States, if the court finds—


35 U.S.C. 211 Relationship to antitrust laws.  
(1) that a substantial likelihood exists that the
product was made by the patented process, and
(2) that the plaintiff has made a reasonable
effort to determine the process actually used in the
production of the product and was unable so to determine, the product shall be presumed to have been so
made, and the burden of establishing that the product
was not made by the process shall be on the party
asserting that it was not so made.  


Nothing in this chapter shall be deemed to convey
to any person immunity from civil or criminal liability, or to create any defenses to actions, under any
antitrust law.


(Added Dec.12, 1980, Public Law 96-517, sec. 6(a), 94
(Added Aug. 23, 1988, Public Law 100-418, sec.  
Stat. 3027.)  
9005(a), 102 Stat. 1566; amended Dec. 8, 1994, Public Law
103-465, sec. 533(b)(7), 108 Stat. 4990.)  


35 U.S.C. 212 Disposition of rights in educational
====35 U.S.C. 296 Liability of States, instrumentalities of States, and State officials for infringement of patents.====
awards.  


No scholarship, fellowship, training grant, or other  
(a) IN GENERAL. - Any State, any instrumentality of a State, and any officer or employee of a State
funding agreement made by a Federal agency primarily to an awardee for educational purposes will contain any provision giving the Federal agency any  
or instrumentality of a State, acting in his official
rights to inventions made by the awardee.  
capacity, shall not be immune, under the eleventh
amendment of the Constitution of the United States or  
under any other doctrine of sovereign immunity, from
suit in Federal court by any person, including any
governmental or nongovernmental entity, for infringement of a patent under section 271, or for any other
violation under this title.
(b) REMEDIES. - In a suit described in subsection (a) for a violation described in that subsection,
remedies (including remedies both at law and in
equity) are available for the violation to the same
extent as such remedies are available for such a violation in a suit against any private entity. Such remedies
include damages, interest, costs, and treble damages
under section 284, attorney fees under section 285,
and the additional remedy for infringement of design
patents under section 289.  


(Added Nov. 8, 1984, Public Law 98-620, sec.  
(Added Oct. 28, 1992, Public Law 102-560, sec.  
501(14), 98 Stat. 3368.)  
2(a)(2), 106 Stat. 4230.)  


PART III — PATENTS AND
35 U.S.C. 297 Improper and deceptive invention
PROTECTION OF PATENT RIGHTS
promotion.


 
(a) IN GENERAL.— An invention promoter
CHAPTER 25 — AMENDMENT AND
shall have a duty to disclose the following information to a customer in writing, prior to entering into a
CORRECTION OF PATENTS
contract for invention promotion services:
 
(1) the total number of inventions evaluated
 
by the invention promoter for commercial potential in
Sec.
the past 5 years, as well as the number of those inventions that received positive evaluations, and the number of those inventions that received negative
251 Reissue of defective patents.
evaluations;
252 Effect of reissue.
(2) the total number of customers who have
253 Disclaimer.
contracted with the invention promoter in the past
254 Certificate of correction of Patent and Trade
5 years, not including customers who have purchased
trade show services, research, advertising, or other
nonmarketing services from the invention promoter,
or who have defaulted in their payment to the invention promoter;
(3) the total number of customers known by
the invention promoter to have received a net financial profit as a direct result of the invention promotion
services provided by such invention promoter;
(4) the total number of customers known by
the invention promoter to have received license agreements for their inventions as a direct result of the
invention promotion services provided by such invention promoter; and
(5) the names and addresses of all previous
invention promotion companies with which the invention promoter or its officers have collectively or individually been affiliated in the previous 10 years.
(b) CIVIL ACTION.—




mark Office mistake.
(1) Any customer who enters into a contract
255 Certificate of correction of applicant’s mistake.
with an invention promoter and who is found by a
256 Correction of named inventor.
court to have been injured by any material false or
fraudulent statement or representation, or any omission of material fact, by that invention promoter (or
any agent, employee, director, officer, partner, or
independent contractor of such invention promoter),
or by the failure of that invention promoter to disclose
such information as required under subsection (a),


35 U.S.C. 251 Reissue of defective patents.


Whenever any patent is, through error without any
may recover in a civil action against the invention
deceptive intention, deemed wholly or partly inoperative or invalid, by reason of a defective specification
promoter (or the officers, directors, or partners of such  
or drawing, or by reason of the patentee claiming
invention promoter), in addition to reasonable costs
more or less than he had a right to claim in the patent,  
and attorneys’ fees-
the Director shall, on the surrender of such patent and
the payment of the fee required by law, reissue the
patent for the invention disclosed in the original


(A) the amount of actual damages incurred
 
by the customer; or
patent, and in accordance with a new and amended
(B) at the election of the customer at any
application, for the unexpired part of the term of the  
time before final judgment is rendered, statutory damages in a sum of not more than $5,000, as the court
original patent. No new matter shall be introduced
considers just.
into the application for reissue.  
(2) Notwithstanding paragraph (1), in a case
where the customer sustains the burden of proof, and  
the court finds, that the invention promoter intentionally misrepresented or omitted a material fact to such
customer, or willfully failed to disclose such information as required under subsection (a), with the purpose
of deceiving that customer, the court may increase
damages to not more than three times the amount
awarded, taking into account past complaints made
against the invention promoter that resulted in regulatory sanctions or other corrective actions based on
those records compiled by the Commissioner of Patents under subsection (d).
(c) DEFINITIONS.— For purposes of this section—
(1) a “contract for invention promotion services” means a contract by which an invention promoter undertakes invention promotion services for a
customer;
(2) a “customer” is any individual who enters
into a contract with an invention promoter for invention promotion services;
(3) the term “invention promoter” means any
person, firm, partnership, corporation, or other entity
who offers to perform or performs invention promotion services for, or on behalf of, a customer, and who
holds itself out through advertising in any mass media
as providing such services, but does not include—
(A) any department or agency of the Federal Government or of a State or local government;
(B) any nonprofit, charitable, scientific, or
educational organization, qualified under applicable
State law or described under section 170(b)(1)(A) of
the Internal Revenue Code of 1986;
(C) any person or entity involved in the  
evaluation to determine commercial potential of, or
offering to license or sell, a utility patent or a previously filed nonprovisional utility patent application;
(D) any party participating in a transaction
involving the sale of the stock or assets of a business;
or
(E) any party who directly engages in the
business of retail sales of products or the distribution
of products; and
(4) the term “invention promotion services”
means the procurement or attempted procurement for  
a customer of a firm, corporation, or other entity to
develop and market products or services that include
the invention of the customer.
(d) RECORDS OF COMPLAINTS.


The Director may issue several reissued patents for
distinct and separate parts of the thing patented, upon
demand of the applicant, and upon payment of the
required fee for a reissue for each of such reissued
patents.


The provisions of this title relating to applications
(1) RELEASE OF COMPLAINTS.— The  
for patent shall be applicable to applications for reissue of a patent, except that application for reissue may
Commissioner of Patents shall make all complaints
be made and sworn to by the assignee of the entire
received by the Patent and Trademark Office involving invention promoters publicly available, together
interest if the application does not seek to enlarge the
with any response of the invention promoters. The
scope of the claims of the original patent.  
Commissioner of Patents shall notify the invention
promoter of a complaint and provide a reasonable
opportunity to reply prior to making such complaint
publicly available.
(2) REQUEST FOR COMPLAINTS.— The
Commissioner of Patents may request complaints
relating to invention promotion services from any
Federal or State agency and include such complaints
in the records maintained under paragraph (1),
together with any response of the invention promoters.


No reissued patent shall be granted enlarging the
scope of the claims of the original patent unless
applied for within two years from the grant of the
original patent.


(Amended Nov. 29, 1999, Public Law 106-113, sec.  
(Added Nov. 29, 1999, Public Law 106-113, sec.  
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
1000(a)(9), 113 Stat. 1501A-552 (S. 1948 sec. 4102(a)).)  
4732(a)(10)(A)).)  


35 U.S.C. 252 Effect of reissue.
===CHAPTER 30 — PRIOR ART CITATIONS TO OFFICE AND EX PARTE REEXAMINATION OF PATENTS===


The surrender of the original patent shall take effect
upon the issue of the reissued patent, and every reissued patent shall have the same effect and operation in
law, on the trial of actions for causes thereafter arising, as if the same had been originally granted in such
amended form, but in so far as the claims of the original and reissued patents are substantially identical,
such surrender shall not affect any action then pending nor abate any cause of action then existing, and
the reissued patent, to the extent that its claims are
substantially identical with the original patent, shall
constitute a continuation thereof and have effect continuously from the date of the original patent.


A reissued patent shall not abridge or affect the
Sec.  
right of any person or that person’s successors in business who, prior to the grant of a reissue, made, purchased, offered to sell, or used within the United
States, or imported into the United States, anything
patented by the reissued patent, to continue the use of,
to offer to sell, or to sell to others to be used, offered
for sale, or sold, the specific thing so made, purchased, offered for sale, used, or imported unless the
making, using, offering for sale, or selling of such
thing infringes a valid claim of the reissued patent
which was in the original patent. The court before
which such matter is in question may provide for the
continued manufacture, use, offer for sale, or sale of
the thing made, purchased, offered for sale, used, or
imported as specified, or for the manufacture, use,
offer for sale, or sale in the United States of which
substantial preparation was made before the grant of
the reissue, and the court may also provide for the
continued practice of any process patented by the reissue that is practiced, or for the practice of which substantial preparation was made, before the grant of the
reissue, to the extent and under such terms as the court
deems equitable for the protection of investments
made or business commenced before the grant of the
reissue.  


(Amended Dec. 8, 1994, Public Law 103-465, sec.
301 Citation of prior art.  
533(b)(2), 108 Stat. 4989; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-566 (S. 1948 sec.
4507(8)).)


35 U.S.C. 253 Disclaimer.  
302 Request for reexamination.  


Whenever, without any deceptive intention, a claim
303 Determination of issue by Director.  
of a patent is invalid the remaining claims shall not
thereby be rendered invalid. A patentee, whether of
the whole or any sectional interest therein, may, on
payment of the fee required by law, make disclaimer
of any complete claim, stating therein the extent of his
interest in such patent. Such disclaimer shall be in
writing and recorded in the Patent and Trademark
Office, and it shall thereafter be considered as part of
the original patent to the extent of the interest possessed by the disclaimant and by those claiming under
him.  


In like manner any patentee or applicant may disclaim or dedicate to the public the entire term, or any
304 Reexamination order by Director.  
terminal part of the term, of the patent granted or to be
granted.  


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88
305 Conduct of reexamination proceedings.  
Stat. 1949.)


35 U.S.C. 254 Certificate of correction of Patent
306 Appeal.  
and Trademark Office mistake.  


Whenever a mistake in a patent, incurred through
307 Certificate of patentability, unpatentability, and  
the fault of the Patent and Trademark Office, is clearly
claim cancellation.  
disclosed by the records of the Office, the Director
may issue a certificate of correction stating the fact
and nature of such mistake, under seal, without
charge, to be recorded in the records of patents. A
printed copy thereof shall be attached to each printed
copy of the patent, and such certificate shall be con-


====35 U.S.C. 301 Citation of prior art.====


sidered as part of the original patent. Every such  
Any person at any time may cite to the Office in
patent, together with such certificate, shall have the  
writing prior art consisting of patents or printed publications which that person believes to have a bearing on the patentability of any claim of a particular patent.  
same effect and operation in law on the trial of actions
If the person explains in writing the pertinency and
for causes thereafter arising as if the same had been
manner of applying such prior art to at least one claim
originally issued in such corrected form. The Director
of the patent, the citation of such prior art and the
may issue a corrected patent without charge in lieu of
explanation thereof will become a part of the official
and with like effect as a certificate of correction.  
file of the patent. At the written request of the person
citing the prior art, his or her identity will be excluded
from the patent file and kept confidential.  


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,  
(Added Dec. 12, 1980, Public Law 96-517, sec. 1,  
88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.
94 Stat. 3015.)  
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)  


35 U.S.C. 255 Certificate of correction of applicant’s mistake.  
====35 U.S.C. 302 Request for reexamination.====


Whenever a mistake of a clerical or typographical
Any person at any time may file a request for reexamination by the Office of any claim of a patent on
nature, or of minor character, which was not the fault
the basis of any prior art cited under the provisions of
of the Patent and Trademark Office, appears in a
section 301 of this title. The request must be in writing and must be accompanied by payment of a reexamination fee established by the Director pursuant to
patent and a showing has been made that such mistake
the provisions of section 41 of this title. The request
occurred in good faith, the Director may, upon payment of the required fee, issue a certificate of correction, if the correction does not involve such changes
must set forth the pertinency and manner of applying
in the patent as would constitute new matter or would
cited prior art to every claim for which reexamination  
require reexamination. Such patent, together with the  
is requested. Unless the requesting person is the
certificate, shall have the same effect and operation in
owner of the patent, the Director promptly will send a
law on the trial of actions for causes thereafter arising
copy of the request to the owner of record of the
as if the same had been originally issued in such corrected form.  
patent.  


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,  
(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94
88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec.  
Stat. 3015; amended Nov. 29, 1999, Public Law 106-113,  
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 secs.  
4732(a)(10)(A)).)  
4732(a)(8) and 4732(a)(10)(A)).)  


35 U.S.C. 256 Correction of named inventor.  
====35 U.S.C. 303 Determination of issue by Director.====


Whenever through error a person is named in an
(a) Within three months following the filing of
issued patent as the inventor, or through error an
a request for reexamination under the provisions of
inventor is not named in an issued patent and such
section 302 of this title, the Director will determine
error arose without any deceptive intention on his
whether a substantial new question of patentability
part, the Director may, on application of all the parties
affecting any claim of the patent concerned is raised
and assignees, with proof of the facts and such other
by the request, with or without consideration of other
requirements as may be imposed, issue a certificate
patents or printed publications. On his own initiative,
correcting such error.
and any time, the Director may determine whether a  
 
substantial new question of patentability is raised by
The error of omitting inventors or naming persons
patents and publications discovered by him or cited
who are not inventors shall not invalidate the patent in
under the provisions of section 301 of this title. The  
which such error occurred if it can be corrected as
existence of a substantial new question of patentability is not precluded by the fact that a patent or printed
provided in this section. The court before which such
publication was previously cited by or to the Office or
matter is called in question may order correction of  
considered by the Office.
the patent on notice and hearing of all parties concerned and the Director shall issue a certificate
(b) A record of the Director’s determination
accordingly.  
under subsection (a) of this section will be placed in
the official file of the patent, and a copy promptly will
be given or mailed to the owner of record of the patent
and to the person requesting reexamination, if any.  


(Amended Aug. 27, 1982, Public Law 97-247, sec.
(c) A determination by the Director pursuant to
6(b), 96 Stat. 320; Nov. 29, 1999, Public Law 106-113, sec.
subsection (a) of this section that no substantial new
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
question of patentability has been raised will be final
4732(a)(10)(A)).)
and nonappealable. Upon such a determination, the
Director may refund a portion of the reexamination
fee required under section 302 of this title.  


CHAPTER 26 — OWNERSHIP AND
(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94
ASSIGNMENT
Stat. 3015; amended Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-581, 582 (S. 1948 secs.
4732(a)(9) and (4732(a)(10)(A)); subsection (a) amended
Nov. 2, 2002, Public Law 107-273, sec. 13105, 116 Stat.
1900.)


====35 U.S.C. 304 Reexamination order by Director.====


Sec.
If, in a determination made under the provisions of
261 Ownership; assignment.
subsection 303(a) of this title, the Director finds that a
262 Joint owners.
substantial new question of patentability affecting any
claim of a patent is raised, the determination will
include an order for reexamination of the patent for
resolution of the question. The patent owner will be
given a reasonable period, not less than two months
from the date a copy of the determination is given or
mailed to him, within which he may file a statement
on such question, including any amendment to his
patent and new claim or claims he may wish to propose, for consideration in the reexamination. If the
patent owner files such a statement, he promptly will
serve a copy of it on the person who has requested
reexamination under the provisions of section 302 of
this title. Within a period of two months from the date
of service, that person may file and have considered in
the reexamination a reply to any statement filed by the
patent owner. That person promptly will serve on the
patent owner a copy of any reply filed.  


(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94
Stat. 3016; amended Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


35 U.S.C. 261 Ownership; assignment.  
====35 U.S.C. 305 Conduct of reexamination proceedings.====


Subject to the provisions of this title, patents shall
After the times for filing the statement and reply
have the attributes of personal property.  
provided for by section 304 of this title have expired,
reexamination will be conducted according to the procedures established for initial examination under the
provisions of sections 132 and 133 of this title. In any
reexamination proceeding under this chapter, the
patent owner will be permitted to propose any amendment to his patent and a new claim or claims thereto,
in order to distinguish the invention as claimed from
the prior art cited under the provisions of section 301
of this title, or in response to a decision adverse to the
patentability of a claim of a patent. No proposed
amended or new claim enlarging the scope of a claim
of the patent will be permitted in a reexamination proceeding under this chapter. All reexamination proceedings under this section, including any appeal to
the Board of Patent Appeals and Interferences, will be
conducted with special dispatch within the Office.  


Applications for patent, patents, or any interest
(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94
therein, shall be assignable in law by an instrument in
Stat. 3016; amended Nov. 8, 1984, Public Law 98-622, sec.
writing. The applicant, patentee, or his assigns or
204(c), 98 Stat. 3388.)
legal representatives may in like manner grant and
convey an exclusive right under his application for
patent, or patents, to the whole or any specified part of
the United States.  


A certificate of acknowledgment under the hand
====35 U.S.C. 306 Appeal.====
and official seal of a person authorized to administer
oaths within the United States, or, in a foreign country, of a diplomatic or consular officer of the United
States or an officer authorized to administer oaths
whose authority is proved by a certificate of a diplomatic or consular officer of the United States, or apostille of an official designated by a foreign country
which, by treaty or convention, accords like effect to
apostilles of designated officials in the United States,
shall be prima facie evidence of the execution of an
assignment, grant, or conveyance of a patent or application for patent.  


An assignment, grant, or conveyance shall be void
The patent owner involved in a reexamination proceeding under this chapter may appeal under the provisions of section 134 of this title, and may seek court
as against any subsequent purchaser or mortgagee for
review under the provisions of sections 141 to 145 of
a valuable consideration, without notice, unless it is
this title, with respect to any decision adverse to the  
recorded in the Patent and Trademark Office within
patentability of any original or proposed amended or
three months from its date or prior to the date of such
new claim of the patent.  
subsequent purchase or mortgage.  


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,  
(Added Dec. 12, 1980, Public Law 96-517, sec. 1,  
88 Stat. 1949; Aug. 27, 1982, Public Law 97-247, sec.
94 Stat. 3016.)  
14(b), 96 Stat. 321.)  


35 U.S.C. 262 Joint owners.  
====35 U.S.C. 307 Certificate of patentability, unpatentability, and claim cancellation.====


In the absence of any agreement to the contrary,
(a) In a reexamination proceeding under this
each of the joint owners of a patent may make, use,  
chapter, when the time for appeal has expired or any  
offer to sell, or sell the patented invention within the  
appeal proceeding has terminated, the Director will
United States, or import the patented invention into
issue and publish a certificate canceling any claim of  
the patent finally determined to be unpatentable, confirming any claim of the patent determined to be patentable, and incorporating in the patent any proposed
amended or new claim determined to be patentable.
(b) Any proposed amended or new claim determined to be patentable and incorporated into a patent
following a reexamination proceeding will have the
same effect as that specified in section 252 of this title
for reissued patents on the right of any person who
made, purchased, or used within the United States, or
imported into the United States, anything patented by
such proposed amended or new claim, or who made
substantial preparation for the same, prior to issuance
of a certificate under the provisions of subsection (a)
of this section.


(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94
Stat. 3016; amended Dec. 8, 1994, Public Law 103-465,
sec. 533(b)(8), 108 Stat. 4990; Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948
sec. 4732(a)(10)(A)).)


the United States, without the consent of and without
===CHAPTER 31 — OPTIONAL INTER PARTES REEXAMINATION PROCEDURES===
accounting to the other owners.


(Amended Dec. 8, 1994, Public Law 103-465, sec.  
Sec.
533(b)(3), 108 Stat. 4989.)
311 Request for inter partes reexamination.  
312 Determination of issue by Director.
313 Inter partes reexamination order by Director.
314 Conduct of inter partes reexamination proceed


CHAPTER 27 — GOVERNMENT
INTERESTS IN PATENTS


ings.
315 Appeal.
316 Certificate of patentability, unpatentability, and


Sec.
claim cancellation.  
266 [Repealed.]
317 Inter partes reexamination prohibited.  
267 Time for taking action in Government applica
318 Stay of litigation.


====35 U.S.C. 311 Request for inter partes reexamination====


tions.  
(a) IN GENERAL.— Any third-party requester
at any time may file a request for inter partes reexamination by the Office of a patent on the basis of any
prior art cited under the provisions of section 301.
(b) REQUIREMENTS.— The request shall—


35 U.S.C. 266 [Repealed.]


(Repealed July 24, 1965, Public Law 89-83, sec. 8, 79
(1) be in writing, include the identity of the
Stat. 261.)
real party in interest, and be accompanied by payment
of an inter partes reexamination fee established by the
Director under section 41; and
(2) set forth the pertinency and manner of
applying cited prior art to every claim for which reexamination is requested.  
(c) COPY.— The Director promptly shall send
a copy of the request to the owner of record of the
patent.


35 U.S.C. 267 Time for taking action in Government applications.


Notwithstanding the provisions of sections 133 and
(Added Nov. 29, 1999, Public Law 106-113, sec.
151 of this title, the Director may extend the time for
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a));
taking any action to three years, when an application
subsections (a) and (c) amended Nov. 2, 2002, Public Law
has become the property of the United States and the
107-273, sec. 13202, 116 Stat. 1901.)
head of the appropriate department or agency of the
Government has certified to the Director that the
invention disclosed therein is important to the armament or defense of the United States.  


(Amended Nov. 29, 1999, Public Law 106-113, sec.
====35 U.S.C. 312 Determination of issue by Director====
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)


CHAPTER 28 INFRINGEMENT OF
(a) REEXAMINATION.Not later than
PATENTS
3 months after the filing of a request for inter partes
reexamination under section 311, the Director shall
determine whether a substantial new question of patentability affecting any claim of the patent concerned
is raised by the request, with or without consideration
of other patents or printed publications. The existence
of a substantial new question of patentability is not
precluded by the fact that a patent or printed publication was previously cited by or to the Office or considered by the Office.


(b) RECORD.— A record of the Director’s
determination under subsection (a) shall be placed in
the official file of the patent, and a copy shall be
promptly given or mailed to the owner of record of
the patent and to the third-party requester.
(c) FINAL DECISION.— A determination by
the Director under subsection (a) shall be final and
non-appealable. Upon a determination that no substantial new question of patentability has been raised,
the Director may refund a portion of the inter partes
reexamination fee required under section 311.


Sec.
271 Infringement of patent.
272 Temporary presence in the United States.
273 Defense to infringement based on earlier inven


(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a));
subsections (a) and (b) amended Nov. 2, 2002, Public Law
107-273, secs. 13105 and 13202, 116 Stat.1900-1901.)


tor.  
====35 U.S.C. 313 Inter partes reexamination order by Director====


35 U.S.C. 271 Infringement of patent.
If, in a determination made under section 312(a),
the Director finds that a substantial new question of
patentability affecting a claim of a patent is raised, the
determination shall include an order for inter partes
reexamination of the patent for resolution of the question. The order may be accompanied by the initial
action of the Patent and Trademark Office on the merits of the inter partes reexamination conducted in
accordance with section 314.
 
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)).)
 
====35 U.S.C. 314 Conduct of inter partes reexamination proceedings====


(a) Except as otherwise provided in this title,  
(a) IN GENERAL.— Except as otherwise provided in this section, reexamination shall be conducted according to the procedures established for
whoever without authority makes, uses, offers to sell,
initial examination under the provisions of sections
or sells any patented invention, within the United
132 and 133. In any inter partes reexamination proceeding under this chapter, the patent owner shall be
States, or imports into the United States any patented
permitted to propose any amendment to the patent and
invention during the term of the patent therefor,  
a new claim or claims, except that no proposed
infringes the patent.
amended or new claim enlarging the scope of the  
(b) Whoever actively induces infringement of a
claims of the patent shall be permitted.  
patent shall be liable as an infringer.  
 


(b) RESPONSE.—


(c) Whoever offers to sell or sells within the  
(1) With the exception of the inter partes
United States or imports into the United States a component of a patented machine, manufacture, combination, or composition, or a material or apparatus for use
reexamination request, any document filed by either
in practicing a patented process, constituting a material part of the invention, knowing the same to be
the patent owner or the third-party requester shall be  
especially made or especially adapted for use in an
served on the other party. In addition, the Office shall
infringement of such patent, and not a staple article or  
send to the third-party requester a copy of any communication sent by the Office to the patent owner concerning the patent subject to the inter partes
commodity of commerce suitable for substantial non-
reexamination proceeding.
infringing use, shall be liable as a contributory
(2) Each time that the patent owner files a
infringer.  
response to an action on the merits from the Patent
(d) No patent owner otherwise entitled to relief
and Trademark Office, the third-party requester shall
for infringement or contributory infringement of a  
have one opportunity to file written comments
patent shall be denied relief or deemed guilty of misuse or illegal extension of the patent right by reason of
addressing issues raised by the action of the Office or
his having done one or more of the following: (1)
the patent owner’s response thereto, if those written
derived revenue from acts which if performed by
comments are received by the Office within 30 days
another without his consent would constitute contributory infringement of the patent; (2) licensed or
after the date of service of the patent owner’s
authorized another to perform acts which if performed
response.  
without his consent would constitute contributory
(c) SPECIAL DISPATCH.— Unless otherwise
infringement of the patent; (3) sought to enforce his
provided by the Director for good cause, all inter
patent rights against infringement or contributory
partes reexamination proceedings under this section,  
infringement; (4) refused to license or use any rights
including any appeal to the Board of Patent Appeals
to the patent; or (5) conditioned the license of any
and Interferences, shall be conducted with special dispatch within the Office.  
rights to the patent or the sale of the patented product
on the acquisition of a license to rights in another
patent or purchase of a separate product, unless, in
view of the circumstances, the patent owner has market power in the relevant market for the patent or patented product on which the license or sale is
conditioned.  
(e)(1) It shall not be an act of infringement to
make, use, offer to sell, or sell within the United
States or import into the United States a patented
invention (other than a new animal drug or veterinary
biological product (as those terms are used in the Federal Food, Drug, and Cosmetic Act and the Act of
March 4, 1913) which is primarily manufactured
using recombinant DNA, recombinant RNA, hybridoma technology, or other processes involving site
specific genetic manipulation techniques) solely for
uses reasonably related to the development and submission of information under a Federal law which
regulates the manufacture, use, or sale of drugs or veterinary biological products.  




(2) It shall be an act of infringement to submit —
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a));
subsection (b)(1) amended Nov. 2, 2002, Public Law 107273, sec. 13202, 116 Stat. 1901.)  


====35 U.S.C. 315 Appeal====


(a) PATENT OWNER.— The patent owner
involved in an inter partes reexamination proceeding
under this chapter—
(1) may appeal under the provisions of section 134 and may appeal under the provisions of sections 141 through 144, with respect to any decision
adverse to the patentability of any original or proposed amended or new claim of the patent; and
(2) may be a party to any appeal taken by a
third-party requester under subsection (b).
(b) THIRD-PARTY REQUESTER.— A third-
party requester—
(1) may appeal under the provisions of section 134, and may appeal under the provisions of sections 141 through 144, with respect to any final
decision favorable to the patentability of any original
or proposed amended or new claim of the patent; and


(A) an application under section 505(j) of
 
the Federal Food, Drug, and Cosmetic Act or  
(2) may, subject to subsection (c), be a party
described in section 505(b)(2) of such Act for a drug
to any appeal taken by the patent owner under the provisions of section 134 or sections 141 through 144.
claimed in a patent or the use of which is claimed in a
(c) CIVIL ACTION.— A third-party requester
patent, or  
whose request for an inter partes reexamination
(B) an application under section 512 of  
results in an order under section 313 is estopped from
such Act or under the Act of March 4, 1913 (21
asserting at a later time, in any civil action arising in
whole or in part under section 1338 of title 28, the  
invalidity of any claim finally determined to be valid
and patentable on any ground which the third-party
requester raised or could have raised during the inter
partes reexamination proceedings. This subsection
does not prevent the assertion of invalidity based on
newly discovered prior art unavailable to the third-
party requester and the Patent and Trademark Office
at the time of the inter partes reexamination proceedings.




U.S.C. 151 - 158) for a drug or veterinary biological
(Added Nov. 29, 1999, Public Law 106-113, sec.  
product which is not primarily manufactured using
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a));
recombinant DNA, recombinant RNA, hybridoma
subsection (b) amended Nov. 2, 2002, Public Law 107-273,  
technology, or other processes involving site specific
sec. 13106, 116 Stat. 1900; subsection (c) amended Nov. 2,
genetic manipulation techniques and which is claimed
2002, Public Law 107-273, sec. 13202, 116 Stat. 1901.)
in a patent or the use of which is claimed in a patent, if
the purpose of such submission is to obtain approval
under such Act to engage in the commercial manufacture, use, or sale of a drug or veterinary biological
product claimed in a patent or the use of which is
claimed in a patent before the expiration of such
patent.  
 
(3) In any action for patent infringement
brought under this section, no injunctive or other
relief may be granted which would prohibit the making, using, offering to sell, or selling within the United
States or importing into the United States of a patented invention under paragraph (1).  
(4) For an act of infringement described in
paragraph (2)
(A) the court shall order the effective date
of any approval of the drug or veterinary biological
product involved in the infringement to be a date
which is not earlier than the date of the expiration of
the patent which has been infringed,
(B) injunctive relief may be granted
against an infringer to prevent the commercial manufacture, use, offer to sell, or sale within the United
States or importation into the United States of an
approved drug or veterinary biological product, and
(C) damages or other monetary relief may
be awarded against an infringer only if there has been
commercial manufacture, use, offer to sell, or sale
within the United States or importation into the
United States of an approved drug or veterinary biological product.  


====35 U.S.C. 316 Certificate of patentability, unpatentability and claim cancellation====


The remedies prescribed by subparagraphs
(a) IN GENERAL.— In an inter partes reexamination proceeding under this chapter, when the time
(A), (B), and (C) are the only remedies which may be
for appeal has expired or any appeal proceeding has
granted by a court for an act of infringement
terminated, the Director shall issue and publish a certificate canceling any claim of the patent finally determined to be unpatentable, confirming any claim of the
described in paragraph (2), except that a court may
patent determined to be patentable, and incorporating
award attorney fees under section 285.  
in the patent any proposed amended or new claim
determined to be patentable.
(b) AMENDED OR NEW CLAIM.— Any proposed amended or new claim determined to be patentable and incorporated into a patent following an inter
partes reexamination proceeding shall have the same
effect as that specified in section 252 of this title for
reissued patents on the right of any person who made,
purchased, or used within the United States, or
imported into the United States, anything patented by  
such proposed amended or new claim, or who made
substantial preparation therefor, prior to issuance of a
certificate under the provisions of subsection (a) of  
this section.
 
 
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)).)


(5) Where a person has filed an application
described in paragraph (2) that includes a certification
under subsection (b)(2)(A)(iv) or (j)(2)(A)(vii)(IV) of
section 505 of the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 355), and neither the owner of the
patent that is the subject of the certification nor the
holder of the approved application under subsection
(b) of such section for the drug that is claimed by the
patent or a use of which is claimed by the patent
brought an action for infringement of such patent
before the expiration of 45 days after the date on
which the notice given under subsection (b)(3) or
(j)(2)(B) of such section was received, the courts of
the United States shall, to the extent consistent with
the Constitution, have subject matter jurisdiction in
any action brought by such person under section 2201
of title 28 for a declaratory judgment that such patent
is invalid or not infringed.
(f)(1) Whoever without authority supplies or
causes to be supplied in or from the United
States all or a substantial portion of the components
of a patented invention, where such components are
uncombined in whole or in part, in such manner as to
actively induce the combination of such components
outside of the United States in a manner that would
infringe the patent if such combination occurred
within the United States, shall be liable as an
infringer.


====35 U.S.C. 317 Inter partes reexamination prohibited====


(2) Whoever without authority supplies or
(a) ORDER FOR REEXAMINATION.— Notwithstanding any provision of this chapter, once an
causes to be supplied in or from the United States any
order for inter partes reexamination of a patent has
component of a patented invention that is especially
been issued under section 313, neither the third-party
made or especially adapted for use in the invention
requester nor its privies may file a subsequent request
and not a staple article or commodity of commerce
for inter partes reexamination of the patent until an
suitable for substantial noninfringing use, where such
inter partes reexamination certificate is issued and  
component is uncombined in whole or in part, knowing that such component is so made or adapted and
published under section 316, unless authorized by the
intending that such component will be combined outside of the United States in a manner that would
Director.
infringe the patent if such combination occurred
(b) FINAL DECISION.— Once a final decision has been entered against a party in a civil action
within the United States, shall be liable as an  
arising in whole or in part under section 1338 of title
infringer.
28, that the party has not sustained its burden of proving the invalidity of any patent claim in suit or if a  
(g) Whoever without authority imports into the
final decision in an inter partes reexamination proceeding instituted by a third-party requester is favorable to the patentability of any original or proposed
United States or offers to sell, sells, or uses within the  
amended or new claim of the patent, then neither that
United States a product which is made by a process
party nor its privies may thereafter request an inter
patented in the United States shall be liable as an
partes reexamination of any such patent claim on the
infringer, if the importation, offer to sell, sale, or use
basis of issues which that party or its privies raised or
of the product occurs during the term of such process
could have raised in such civil action or inter partes
patent. In an action for infringement of a process
reexamination proceeding, and an inter partes reexamination requested by that party or its privies on the  
basis of such issues may not thereafter be maintained
by the Office, notwithstanding any other provision of
this chapter. This subsection does not prevent the  
assertion of invalidity based on newly discovered
prior art unavailable to the third-party requester and
the Patent and Trademark Office at the time of the
inter partes reexamination proceedings.




   
  (Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a));
subsections (a) and (b) amended Nov. 2, 2002, Public Law
107-273, sec. 13202, 116 Stat. 1901.)


patent, no remedy may be granted for infringement on
====35 U.S.C. 318 Stay of litigation====
account of the noncommercial use or retail sale of a
product unless there is no adequate remedy under this
title for infringement on account of the importation or
other use, offer to sell, or sale of that product. A product which is made by a patented process will, for purposes of this title, not be considered to be so made
after —


(1) it is materially changed by subsequent
Once an order for inter partes reexamination of a  
processes; or
patent has been issued under section 313, the patent
(2) it becomes a trivial and nonessential component of another product.
owner may obtain a stay of any pending litigation
(h) As used in this section, the term “whoever”
which involves an issue of patentability of any claims
includes any State, any instrumentality of a State, any  
of the patent which are the subject of the inter partes
officer or employee of a State or instrumentality of a
reexamination order, unless the court before which
State acting in his official capacity. Any State, and
such litigation is pending determines that a stay would
any such instrumentality, officer, or employee, shall
not serve the interests of justice.
be subject to the provisions of this title in the same
manner and to the same extent as any nongovernmental entity.
(i) As used in this section, an “offer for sale” or
an “offer to sell” by a person other than the patentee
or any assignee of the patentee, is that in which the
sale will occur before the expiration of the term of the
patent.  


(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)).)


(Subsection (e) added Sept. 24, 1984, Public Law 98417, sec. 202, 98 Stat. 1603.)
==PART IV — PATENT COOPERATION TREATY==


(Subsection (f) added Nov. 8, 1984, Public Law 98622, sec. 101(a), 98 Stat. 3383.)


(Subsection (g) added Aug. 23, 1988, Public Law 100418, sec. 9003, 102 Stat. 1564.)
===CHAPTER 35 — DEFINITIONS===


(Subsection (e) amended Nov. 16, 1988, Public Law
Sec.  
100-670, sec. 201(i), 102 Stat. 3988.)
351 Definitions.  


(Subsection (d) amended Nov. 19, 1988, Public Law
35 U.S.C. 351 Definitions.  
100-703, sec. 201, 102 Stat. 4676.)


(Subsection (h) added Oct. 28, 1992, Public Law 102560, sec. 2(a)(1), 106 Stat. 4230.)
When used in this part unless the context otherwise
indicates—


(Subsections (a), (c), (e), and (g) amended Dec. 8,  
(a) The term “treaty” means the Patent Cooperation Treaty done at Washington, on June 19, 1970.
1994, Public Law 103-465, sec. 533(a), 108 Stat. 4988.)
(b) The term “Regulations,” when capitalized,
 
means the Regulations under the treaty, done at Washington on the same date as the treaty. The term “regulations,” when not capitalized, means the regulations
(Subsection (i) added Dec. 8, 1994, Public Law 103465, sec. 533(a), 108 Stat. 4988.)
established by the Director under this title.
 
(c) The term “international application” means
(Subsection (e)(5) added Dec. 8, 2003, Public Law  
an application filed under the treaty.
108-173, sec. 1101(d), 117 Stat. 2457.)
(d) The term “international application originating in the United States” means an international application filed in the Patent and Trademark Office when
 
it is acting as a Receiving Office under the treaty, irrespective of whether or not the United States has been
35 U.S.C. 272 Temporary presence in the United
designated in that international application.
States.  
(e) The term “international application designating the United States” means an international
application specifying the United States as a country
in which a patent is sought, regardless where such
international application is filed.
(f) The term “Receiving Office” means a
national patent office or intergovernmental organization which receives and processes international applications as prescribed by the treaty and the
Regulations.
(g) The terms “International Searching Authority” and “International Preliminary Examining
Authority” mean a national patent office or intergovernmental organization as appointed under the treaty
which processes international applications as prescribed by the treaty and the Regulations.
(h) The term “International Bureau” means the
inter national intergovernmental organization which is
recognized as the coordinating body under the treaty
and the Regulations.
 
(i) Terms and expressions not defined in this
part are to be taken in the sense indicated by the treaty
and the Regulations.
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,  
89 Stat. 685; amended Nov. 8, 1984, Public Law 98-622,  
sec. 403(a), 98 Stat. 3392; Nov. 6, 1986, Public Law 99616, sec. 2 (a)-(c), 100 Stat. 3485; Nov. 29, 1999, Public  
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582
 
(S. 1948 sec. 4732(a)(10)(A)).)
 
===CHAPTER 36 — INTERNATIONAL STAGE===
 
Sec.  


The use of any invention in any vessel, aircraft or
361 Receiving Office.  
vehicle of any country which affords similar privileges to vessels, aircraft, or vehicles of the United
States, entering the United States temporarily or accidentally, shall not constitute infringement of any
patent, if the invention is used exclusively for the
needs of the vessel, aircraft, or vehicle and is not
offered for sale or sold in or used for the manufacture
of anything to be sold in or exported from the United
States.  


(Amended Dec. 8, 1994, Public Law 103-465, sec.
362 International Searching Authority and International Preliminary Examining Authority.  
533(b)(4), 108 Stat. 4989.)


35 U.S.C. 273 Defense to infringement based on
363 International application designating the United
earlier inventor.  
States: Effect.  


(a) DEFINITIONS.— For purposes of this section—
364 International stage: Procedure.  
(1) the terms “commercially used” and
 
“commercial use” mean use of a method in the United
365 Right of priority; benefit of the filing date of a  
States, so long as such use is in connection with an
prior application.
internal commercial use or an actual arm’s-length sale
or other arm’s-length commercial transfer of a useful
end result, whether or not the subject matter at issue is
accessible to or otherwise known to the public, except
that the subject matter for which commercial marketing or use is subject to a premarketing regulatory
review period during which the safety or efficacy of
the subject matter is established, including any period
specified in section 156(g), shall be deemed “commercially used” and in “commercial use” during such
regulatory review period;
(2) in the case of activities performed by a
nonprofit research laboratory, or nonprofit entity such
as a university, research center, or hospital, a use for
which the public is the intended beneficiary shall be
considered to be a use described in paragraph (1),
except that the use—
(A) may be asserted as a defense under this
section only for continued use by and in the laboratory or nonprofit entity; and
(B) may not be asserted as a defense with
respect to any subsequent commercialization or use
outside such laboratory or nonprofit entity;  
(3) the term “method” means a method of  
doing or conducting business; and
(4) the “effective filing date” of a patent is
the earlier of the actual filing date of the application  


366 Withdrawn international application.


367 Actions of other authorities: Review.


for the patent or the filing date of any earlier United
368 Secrecy of certain inventions; filing international applications in foreign countries.  
States, foreign, or international application to which
the subject matter at issue is entitled under section
119, 120, or 365 of this title.  


(b) DEFENSE TO INFRINGEMENT.
====35 U.S.C. 361 Receiving Office.====


(1) IN GENERAL.— It shall be a defense to
(a) The Patent and Trademark Office shall act
an action for infringement under section 271 of this
as a Receiving Office for international applications
title with respect to any subject matter that would otherwise infringe one or more claims for a method in the  
filed by nationals or residents of the United States. In
patent being asserted against a person, if such person
accordance with any agreement made between the  
had, acting in good faith, actually reduced the subject
United States and another country, the Patent and
matter to practice at least 1 year before the effective
Trademark Office may also act as a Receiving Office
filing date of such patent, and commercially used the
for international applications filed by residents or
subject matter before the effective filing date of such  
nationals of such country who are entitled to file international applications.  
patent.  
(b) The Patent and Trademark Office shall perform all acts connected with the discharge of duties
(2) EXHAUSTION OF RIGHT.— The sale
required of a Receiving Office, including the collection of international fees and their transmittal to the
or other disposition of a useful end product produced
International Bureau.
by a patented method, by a person entitled to assert a
(c) International applications filed in the Patent
defense under this section with respect to that useful
and Trademark Office shall be in the English language.  
end result shall exhaust the patent owner’s rights
(d) The international fee, and the transmittal
under the patent to the extent such rights would have
and search fees prescribed under section 376(a) of this  
been exhausted had such sale or other disposition
part, shall either be paid on filing of an international
been made by the patent owner.  
application or within such later time as may be fixed
(3) LIMITATIONS AND QUALIFICATIONS OF DEFENSE.— The defense to infringement under this section is subject to the following:
by the Director.  
(A) PATENT.— A person may not assert
 
the defense under this section unless the invention for
 
which the defense is asserted is for a method.
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
(B) DERIVATION.— A person may not
89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622,
assert the defense under this section if the subject
sec. 401(a), 403(a), 98 Stat. 3391-3392; Nov. 6, 1986, Public Law 99-616, sec. 2(d), 100 Stat. 3485; Nov. 29, 1999,  
matter on which the defense is based was derived
Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582
from the patentee or persons in privity with the patentee.  
(C) NOT A GENERAL LICENSE.— The
defense asserted by a person under this section is not a  
general license under all claims of the patent at issue,  
but extends only to the specific subject matter claimed
in the patent with respect to which the person can
assert a defense under this chapter, except that the
defense shall also extend to variations in the quantity
or volume of use of the claimed subject matter, and to
improvements in the claimed subject matter that do
not infringe additional specifically claimed subject
matter of the patent.  
(4) BURDEN OF PROOF.— A person
asserting the defense under this section shall have the


(S. 1948 sec. 4732(a)(10)(A)).)


burden of establishing the defense by clear and convincing evidence.  
====35 U.S.C. 362 International Searching Authority and International Preliminary Examining Authority.====


(5) ABANDONMENT OF USE.— A person
(a) The Patent and Trademark Office may act as
who has abandoned commercial use of subject matter
an International Searching Authority and International
may not rely on activities performed before the date
Preliminary Examining Authority with respect to  
of such abandonment in establishing a defense under
international applications in accordance with the  
this section with respect to actions taken after the date
terms and conditions of an agreement which may be  
of such abandonment.
concluded with the International Bureau, and may discharge all duties required of such Authorities, including the collection of handling fees and their
(6) PERSONAL DEFENSE.— The defense
transmittal to the International Bureau.  
under this section may be asserted only by the person
(b) The handling fee, preliminary examination
who performed the acts necessary to establish the
fee, and any additional fees due for international preliminary examination shall be paid within such time
defense and, except for any transfer to the patent
as may be fixed by the Director.  
owner, the right to assert the defense shall not be
licensed or assigned or transferred to another person
except as an ancillary and subordinate part of a good
faith assignment or transfer for other reasons of the
entire enterprise or line of business to which the  
defense relates.  
(7) LIMITATION ON SITES.— A defense
under this section, when acquired as part of a good
faith assignment or transfer of an entire enterprise or
line of business to which the defense relates, may only
be asserted for uses at sites where the subject matter
that would otherwise infringe one or more of the
claims is in use before the later of the effective filing
date of the patent or the date of the assignment or
transfer of such enterprise or line of business.
(8) UNSUCCESSFUL ASSERTION OF
DEFENSE.— If the defense under this section is
pleaded by a person who is found to infringe the
patent and who subsequently fails to demonstrate a
reasonable basis for asserting the defense, the court
shall find the case exceptional for the purpose of
awarding attorney fees under section 285 of this title.
(9) INVALIDITY.— A patent shall not be  
deemed to be invalid under section 102 or 103 of this
title solely because a defense is raised or established
under this section.




(Added Nov. 29, 1999, Public Law 106-113, sec.  
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
1000(a)(9), 113 Stat. 1501A-555 (S. 1948 sec. 4302).)  
89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622,
sec. 403 (a), 98 Stat. 3392; Nov. 6, 1986, Public Law 99616, sec. 4, 100 Stat. 3485; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
4732(a)(10)(A)).)  


CHAPTER 29 — REMEDIES FOR
====35 U.S.C. 363 International application designating the United States: Effect.====
INFRINGEMENT OF PATENT, AND OTHER
ACTIONS


An international application designating the United
States shall have the effect, from its international filing date under article 11 of the treaty, of a national
application for patent regularly filed in the Patent and
Trademark Office except as otherwise provided in
section 102(e) of this title.


Sec.
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
281 Remedy for infringement of patent.
89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622,
282 Presumption of validity; defenses.
sec. 403(a), 98 Stat. 3392.)
283 Injunction.


====35 U.S.C. 364 International stage: Procedure.====


(a) International applications shall be processed
by the Patent and Trademark Office when acting as a
Receiving Office, International Searching Authority,
or International Preliminary Examining Authority, in
accordance with the applicable provisions of the
treaty, the Regulations, and this title.


284 Damages.
(b) An applicant’s failure to act within prescribed time limits in connection with requirements
285 Attorney fees.
pertaining to a pending international application may
286 Time limitation on damages.
be excused upon a showing satisfactory to the Director of unavoidable delay, to the extent not precluded
287 Limitation on damages and other remedies;
by the treaty and the Regulations, and provided the
conditions imposed by the treaty and the Regulations
regarding the excuse of such failure to act are complied with.


(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622,
sec. 403(a), 98 Stat. 3392.)


marking and notice.  
(Subsection (a) amended Nov. 6, 1986, Public Law 99616, sec. 5, 100 Stat. 3485.)
288 Action for infringement of a patent containing
an invalid claim.  
289 Additional remedy for infringement of design


patent.  
(Amended Nov. 29, 1999, Public Law 106-113, sec.  
290 Notice of patent suits.  
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
291 Interfering patents.  
4732(a)(10)(A)).)
292 False marking.  
293 Nonresident patentee; service and notice.  
294 Voluntary arbitration.  
295 Presumptions: Product made by patented pro


cess.  
====35 U.S.C. 365 Right of priority; benefit of the filing date of a prior application.====
296 Liability of States, instrumentalities of States,
and State officials for infringement of patents.  
297 Improper and deceptive invention promotion


35 U.S.C. 281 Remedy for infringement of patent.
(a) In accordance with the conditions and
 
requirements of subsections (a) through (d) of section
A patentee shall have remedy by civil action for
119 of this title, a national application shall be entitled
infringement of his patent.  
to the right of priority based on a prior filed international application which designated at least one country other than the United States.  
 
(b) In accordance with the conditions and
35 U.S.C. 282 Presumption of validity; defenses.
requirements of section 119(a) of this title and the
 
treaty and the Regulations, an international application designating the United States shall be entitled to
A patent shall be presumed valid. Each claim of a  
the right of priority based on a prior foreign application, or a prior international application designating at
patent (whether in independent, dependent, or multiple dependent form) shall be presumed valid independently of the validity of other claims; dependent or  
least one country other than the United States.
multiple dependent claims shall be presumed valid
(c) In accordance with the conditions and
even though dependent upon an invalid claim. Notwithstanding the preceding sentence, if a claim to a  
requirements of section 120 of this title, an international application designating the United States shall  
composition of matter is held invalid and that claim  
be entitled to the benefit of the filing date of a prior
was the basis of a determination of nonobviousness
national application or a prior international application designating the United States, and a national
under section 103(b)(1), the process shall no longer be
application shall be entitled to the benefit of the filing
considered nonobvious solely on the basis of section
date of a prior international application designating
103(b)(1). The burden of establishing invalidity of a  
the United States. If any claim for the benefit of an
patent or any claim thereof shall rest on the party
earlier filing date is based on a prior international
asserting such invalidity.  
application which designated but did not originate in
the United States, the Director may require the filing
in the Patent and Trademark Office of a certified copy
of such application together with a translation thereof
into the English language, if it was filed in another
language.  


The following shall be defenses in any action
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
involving the validity or infringement of a patent and
89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622,
shall be pleaded:
sec. 403(a), 98 Stat. 3392; Dec. 8, 1994, Public Law 103465, sec. 532(c)(4), 108 Stat. 4987; Nov. 29, 1999, Public
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S.
1948 sec. 4732(a)(10)(A)).)


(1) Noninfringement, absence of liability for
====35 U.S.C. 366 Withdrawn international application.====
infringement, or unenforceability,
(2) Invalidity of the patent or any claim in suit
on any ground specified in part II of this title as a condition for patentability,


Subject to section 367 of this part, if an international application designating the United States is
withdrawn or considered withdrawn, either generally
or as to the United States, under the conditions of the
treaty and the Regulations, before the applicant has
complied with the applicable requirements prescribed
by section 371(c) of this part, the designation of the
United States shall have no effect after the date of
withdrawal and shall be considered as not having
been made, unless a claim for benefit of a prior filing
date under section 365(c) of this section was made in
a national application, or an international application
designating the United States, filed before the date of
such withdrawal. However, such withdrawn international application may serve as the basis for a claim of
priority under section 365 (a) and (b) of this part, if it
designated a country other than the United States.


(3) Invalidity of the patent or any claim in suit
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
for failure to comply with any requirement of sections
89 Stat. 687; amended Nov. 8, 1984, Public Law 98-622,  
112 or 251 of this title,  
sec. 401(b), 98 Stat. 3391.)
(4) Any other fact or act made a defense by this
title.  


====35 U.S.C. 367 Actions of other authorities: Review.====


In actions involving the validity or infringement of
(a) Where a Receiving Office other than the  
a patent the party asserting invalidity or noninfringement shall give notice in the pleadings or otherwise in
Patent and Trademark Office has refused to accord an
writing to the adverse party at least thirty days before
international filing date to an international application
the trial, of the country, number, date, and name of the  
designating the United States or where it has held
patentee of any patent, the title, date, and page numbers of any publication to be relied upon as anticipation of the patent in suit or, except in actions in the  
such application to be withdrawn either generally or
United States Court of Federal Claims, as showing the  
as to the United States, the applicant may request
state of the art, and the name and address of any person who may be relied upon as the prior inventor or as
review of the matter by the Director, on compliance
having prior knowledge of or as having previously
with the requirements of and within the time limits
used or offered for sale the invention of the patent in  
specified by the treaty and the Regulations. Such
suit. In the absence of such notice proof of the said
review may result in a determination that such application be considered as pending in the national stage.
matters may not be made at the trial except on such
(b) The review under subsection (a) of this section, subject to the same requirements and conditions,
terms as the court requires.  
may also be requested in those instances where an
international application designating the United States
is considered withdrawn due to a finding by the International Bureau under article 12 (3) of the treaty.  


Invalidity of the extension of a patent term or any
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
portion thereof under section 154(b) or 156 of this
89 Stat. 687; amended Nov. 8, 1984, Public Law 98-622,
title because of the material failure—
sec. 403(a), 98 Stat 3392; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)  


(1) by the applicant for the extension, or
====35 U.S.C. 368 Secrecy of certain inventions; filing international applications in foreign countries.====


(2) by the Director, to comply with the requirements of such section shall be a defense in any action
(a) International applications filed in the Patent
involving the infringement of a patent during the  
and Trademark Office shall be subject to the provisions of chapter 17 of this title.
period of the extension of its term and shall be
(b) In accordance with article 27 (8) of the  
pleaded. A due diligence determination under section
treaty, the filing of an international application in a
156(d)(2) is not subject to review in such an action.
country other than the United States on the invention
 
made in this country shall be considered to constitute
(Amended July 24, 1965, Public Law 89-83, sec. 10,  
the filing of an application in a foreign country within
79 Stat. 261; Nov. 14, 1975, Public Law 94-131, sec. 10,  
the meaning of chapter 17 of this title, whether or not
89 Stat. 692; Apr. 2, 1982, Public Law 97-164, sec. 161(7),  
the United States is designated in that international
96 Stat. 49; Sept. 24, 1984, Public Law 98-417, sec. 203,  
application.  
98 Stat. 1603; Oct. 29, 1992, Public Law 102-572, sec.
(c) If a license to file in a foreign country is
902(b)(1), 106 Stat. 4516; Nov. 1, 1995, Public Law 10441, sec. 2, 109 Stat. 352; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-560, 582 (S. 1948
refused or if an international application is ordered to
secs. 4402(b)(1) and 4732(a)(10)(A)).)
be kept secret and a permit refused, the Patent and
Trademark Office when acting as a Receiving Office,  
International Searching Authority, or International
Preliminary Examining Authority, may not disclose
the contents of such application to anyone not authorized to receive such disclosure.  


35 U.S.C. 283 Injunction.


The several courts having jurisdiction of cases
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
under this title may grant injunctions in accordance
89 Stat. 687; amended Nov. 8, 1984, Public Law 98-622,
with the principles of equity to prevent the violation
sec. 403(a), 98 Stat. 3392; Nov. 6, 1986, Public Law 99616, sec. 6, 100 Stat. 3486.)
of any right secured by patent, on such terms as the
court deems reasonable.  


===CHAPTER 37 — NATIONAL STAGE===


35 U.S.C. 284 Damages.  
Sec.
371 National stage: Commencement.  
372 National stage: Requirements and procedure.
373 Improper applicant.
374 Publication of international application: Effect.
375 Patent issued on international application:


Upon finding for the claimant the court shall award
the claimant damages adequate to compensate for the
infringement but in no event less that a reasonable
royalty for the use made of the invention by the
infringer, together with interest and costs as fixed by
the court.


When the damages are not found by a jury, the
Effect.  
court shall assess them. In either event the court may
376 Fees.  
increase the damages up to three times the amount
found or assessed. Increased damages under this paragraph shall not apply to provisional rights under section 154(d) of this title.  


The court may receive expert testimony as an aid to
====35 U.S.C. 371 National stage: Commencement.====
the determination of damages or of what royalty
would be reasonable under the circumstances.  


(Amended Nov. 29, 1999, Public Law 106-113, sec.
(a) Receipt from the International Bureau of
1000(a)(9), 113 Stat. 1501A-566 (S. 1948 sec. 4507(9)).)
copies of international applications with any amendments to the claims, international search reports, and
international preliminary examination reports including any annexes thereto may be required in the case of
international applications designating or electing the
United States.  


35 U.S.C. 285 Attorney fees.  
(b) Subject to subsection (f) of this section, the
national stage shall commence with the expiration of
the applicable time limit under article 22 (1) or (2), or
under article 39 (1)(a) of the treaty.  


The court in exceptional cases may award reasonable attorney fees to the prevailing party.  
(c) The applicant shall file in the Patent and
Trademark Office —
(1) the national fee provided in section 41(a)
of this title;
(2) a copy of the international application,
unless not required under subsection (a) of this section or already communicated by the International
Bureau, and a translation into the English language of
the international application, if it was filed in another
language;
(3) amendments, if any, to the claims in the
international application, made under article 19 of the
treaty, unless such amendments have been communicated to the Patent and Trademark Office by the International Bureau, and a translation into the English
language if such amendments were made in another
language;
(4) an oath or declaration of the inventor (or
other person authorized under chapter 11 of this title)
complying with the requirements of section 115 of
this title and with regulations prescribed for oaths or
declarations of applicants;
(5) a translation into the English language of
any annexes to the international preliminary examination report, if such annexes were made in another language.
(d) The requirement with respect to the national
fee referred to in subsection (c)(1), the translation
referred to in subsection (c)(2), and the oath or declaration referred to in subsection (c)(4) of this section
shall be complied with by the date of the commencement of the national stage or by such later time as may  
be fixed by the Director. The copy of the international
application referred to in subsection (c)(2) shall be
submitted by the date of the commencement of the
national stage. Failure to comply with these requirements shall be regarded as abandonment of the application by the parties thereof, unless it be shown to the
satisfaction of the Director that such failure to comply
was unavoidable. The payment of a surcharge may be
required as a condition of accepting the national fee
referred to in subsection (c)(1) or the oath or declaration referred to in subsection (c)(4) of this section if
these requirements are not met by the date of the commencement of the national stage. The requirements of
subsection (c)(3) of this section shall be complied
with by the date of the commencement of the national
stage, and failure to do so shall be regarded as a cancellation of the amendments to the claims in the international application made under article 19 of the
treaty. The requirement of subsection (c)(5) shall be
complied with at such time as may be fixed by the
Director and failure to do so shall be regarded as cancellation of the amendments made under article 34
(2)(b) of the treaty.  


35 U.S.C. 286 Time limitation on damages.  
(e) After an international application has
entered the national stage, no patent may be granted
or refused thereon before the expiration of the applicable time limit under article 28 or article 41 of the
treaty, except with the express consent of the applicant. The applicant may present amendments to the
specification, claims, and drawings of the application
after the national stage has commenced.  


Except as otherwise provided by law, no recovery
(f) At the express request of the applicant, the
shall be had for any infringement committed more
national stage of processing may be commenced at
than six years prior to the filing of the complaint or
any time at which the application is in order for such
counterclaim for infringement in the action.  
purpose and the applicable requirements of subsection
(c) of this section have been complied with.
 
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 688; amended Nov. 8, 1984, Public Law 98-622,
sec. 402(a)-(d), 403(a), 98 Stat. 3391, 3392.)


In the case of claims against the United States Government for use of a patented invention, the period
(Subsections (a), (b), (c), (d), and (e) amended Nov. 6,
before bringing suit, up to six years, between the date
1986, Public Law, 99-616, sec. 7, 100 Stat. 3486.)
of receipt of a written claim for compensation by the
department or agency of the Government having
authority to settle such claim, and the date of mailing
by the Government of a notice to the claimant that his
claim has been denied shall not be counted as a part of
the period referred to in the preceding paragraph.  


35 U.S.C. 287 Limitation on damages and other
(Subsection (c)(1) amended Dec. 10, 1991, Public Law
remedies; marking and notice.  
102-204, sec. 5(g)(2), 105 Stat. 1641.)


(a) Patentees, and persons making, offering for
(Amended Nov. 29, 1999, Public Law 106-113, sec.
sale, or selling within the United States any patented
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.  
article for or under them, or importing any patented
4732(a)(10)(A)).)
article into the United States, may give notice to the
public that the same is patented, either by fixing
thereon the word “patent” or the abbreviation “pat.”,
together with the number of the patent, or when, from
the character of the article, this cannot be done, by
fixing to it, or to the package wherein one or more of
them is contained, a label containing a like notice. In
the event of failure so to mark, no damages shall be
recovered by the patentee in any action for infringement, except on proof that the infringer was notified
of the infringement and continued to infringe thereafter, in which event damages may be recovered only
for infringement occurring after such notice. Filing of
an action for infringement shall constitute such notice.  


(b)(1) An infringer under section 271(g) shall be
(Subsection (d) amended Nov. 2, 2002, Public Law
subject to all the provisions of this title relating to
107-273, sec. 13206, 116 Stat. 1905.)
damages and injunctions except to the extent those
remedies are modified by this subsection or section
9006 of the Process Patent Amendments Act of 1988.  
The modifications of remedies provided in this subsection shall not be available to any person who —


(A) practiced the patented process;
====35 U.S.C. 372 National stage: Requirements and procedure.====


(B) owns or controls, or is owned or controlled by, the person who practiced the patented process; or
(a) All questions of substance and, within the  
(C) had knowledge before the infringement
scope of the requirements of the treaty and Regulations, procedure in an international application designating the United States shall be determined as in the  
that a patented process was used to make the product
case of national applications regularly filed in the  
the importation, use, offer for sale, or sale of which
Patent and Trademark Office.  
constitutes the infringement.
(2) No remedies for infringement under section 271(g) of this title shall be available with respect
to any product in the possession of, or in transit to, the  
person subject to liability under such section before
that person had notice of infringement with respect to
that product. The person subject to liability shall bear
the burden of proving any such possession or transit.  
(3)(A) In making a determination with respect
to the remedy in an action brought for infringement
under section 271(g), the court shall consider—


(b) In case of international applications designating but not originating in, the United States
(1) the Director may cause to be reexamined
questions relating to form and contents of the application in accordance with the requirements of the treaty
and the Regulations;
(2) the Director may cause the question of
unity of invention to be reexamined under section 121
of this title, within the scope of the requirements of
the treaty and the Regulations; and
(3) the Director may require a verification of
the translation of the international application or any
other document pertaining to the application if the
application or other document was filed in a language
other than English.


(i) the good faith demonstrated by the
defendant with respect to a request for disclosure;
(ii) the good faith demonstrated by the
plaintiff with respect to a request for disclosure, and


(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 689; amended Nov. 8, 1984, Public Law 98-622,
sec. 402(e), (f), 403(a), 98 Stat. 3392; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582


(iii) the need to restore the exclusive
(S. 1948 sec. 4732(a)(10)(A)).)
rights secured by the patent.  


(B) For purposes of subparagraph (A), the
====35 U.S.C. 373 Improper applicant.====
following are evidence of good faith:
(i) a request for disclosure made by the
defendant;
(ii) a response within a reasonable time
by the person receiving the request for disclosure; and


An international application designating the United
States, shall not be accepted by the Patent and Trademark Office for the national stage if it was filed by
anyone not qualified under chapter 11 of this title to
be an applicant for the purpose of filing a national
application in the United States. Such international
applications shall not serve as the basis for the benefit
of an earlier filing date under section 120 of this title
in a subsequently filed application, but may serve as
the basis for a claim of the right of priority under subsections (a) through (d) of section 119 of this title, if
the United States was not the sole country designated
in such international application.


(iii) the submission of the response by
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
the defendant to the manufacturer, or if the manufacturer is not known, to the supplier, of the product to be
89 Stat. 689; amended Nov. 8, 1984, Public Law 98-622,  
purchased by the defendant, together with a request
sec. 403(a), 98 Stat. 3392; Dec. 8, 1994, Public Law 103465, sec. 532(c)(5), 108 Stat. 4987.)


====35 U.S.C. 374 Publication of international application.====


for a written statement that the process claimed in any
The publication under the treaty defined in section
patent disclosed in the response is not used to produce
351(a) of this title, of an international application designating the United States shall be deemed a publication under section 122(b), except as provided in  
such product.  
sections 102(e) and 154(d) of this title.  


The failure to perform any acts
described in the preceding sentence is evidence of
absence of good faith unless there are mitigating circumstances. Mitigating circumstances include the
case in which, due to the nature of the product, the
number of sources for the product, or like commercial
circumstances, a request for disclosure is not necessary or practicable to avoid infringement.


(4)(A) For purposes of this subsection, a
(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89
“request for disclosure” means a written request made
Stat. 689; amended Nov. 29, 1999, Public Law 106-113,
to a person then engaged in the manufacture of a
sec. 1000(a)(9), 113 Stat. 1501A-566 (S. 1948 sec.
product to identify all process patents owned by or
4507(10)); amended Nov. 2, 2002, Public Law 107-273,  
licensed to that person, as of the time of the request,
sec.13205, 116 Stat. 1903.)
that the person then reasonably believes could be
asserted to be infringed under section 271(g) if that
product were imported into, or sold, offered for sale,  
or used in, the United States by an unauthorized person. A request for disclosure is further limited to a
request —


(i) which is made by a person regularly
====35 U.S.C. 375 Patent issued on international application: Effect.====
engaged in the United States in the sale of the type of
products as those manufactured by the person to
whom the request is directed, or which includes facts
showing that the person making the request plans to
engage in the sale of such products in the United
States;
(ii) which is made by such person before
the person’s first importation, use, offer for sale, or
sale of units of the product produced by an infringing
process and before the person had notice of infringement with respect to the product; and


(a) A patent may be issued by the Director
based on an international application designating the
United States, in accordance with the provisions of
this title. Subject to section 102(e) of this title, such
patent shall have the force and effect of a patent
issued on a national application filed under the provisions of chapter 11 of this title.
(b) Where due to an incorrect translation the
scope of a patent granted on an international application designating the United States, which was not
originally filed in the English language, exceeds the
scope of the international application in its original
language, a court of competent jurisdiction may retroactively limit the scope of the patent, by declaring it
unenforceable to the extent that it exceeds the scope
of the international application in its original language.
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 689; amended Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)
====35 U.S.C. 376 Fees.====


(iii) which includes a representation by
(a) The required payment of the international
the person making the request that such person will
fee and the handling fee, which amounts are specified
promptly submit the patents identified pursuant to the
in the Regulations, shall be paid in United States currency. The Patent and Trademark Office shall charge a
request to the manufacturer, or if the manufacturer is
national fee as provided in section 41(a), and may also
not known, to the supplier, of the product to be purchased by the person making the request, and will
charge the following fees:
request from that manufacturer or supplier a written
(1) A transmittal fee (see section 361(d)).
statement that none of the processes claimed in those
(2) A search fee (see section 361(d)).  
patents is used in the manufacture of the product.  


(B) In the case of a request for disclosure
received by a person to whom a patent is licensed, that
person shall either identify the patent or promptly
notify the licensor of the request for disclosure.


(C) A person who has marked, in the manner prescribed by subsection (a), the number of the
process patent on all products made by the patented
process which have been offered for sale or sold by
that person in the United States, or imported by the
person into the United States, before a request for disclosure is received is not required to respond to the
request for disclosure. For purposes of the preceding
sentence, the term “all products” does not include
products made before the effective date of the Process
Patent Amendments Act of 1988.
(5)(A) For purposes of this subsection, notice
of infringement means actual knowledge, or receipt
by a person of a written notification, or a combination
thereof, of information sufficient to persuade a reasonable person that it is likely that a product was
made by a process patented in the United States.




(B) A written notification from the patent
(3) A supplemental search fee (to be paid
holder charging a person with infringement shall
when required).  
specify the patented process alleged to have been used
(4) A preliminary examination fee and any  
and the reasons for a good faith belief that such process was used. The patent holder shall include in the
additional fees (see section 362(b)).  
notification such information as is reasonably necessary to explain fairly the patent holder’s belief, except
(5) Such other fees as established by the
that the patent holder is not required to disclose any  
Director.
trade secret information.  
(b) The amounts of fees specified in subsection
(C) A person who receives a written notification described in subparagraph (B) or a written
 
response to a request for disclosure described in paragraph (4) shall be deemed to have notice of infringement with respect to any patent referred to in such
 
written notification or response unless that person,
(a) of this section, except the international fee and the  
absent mitigating circumstances—
handling fee, shall be prescribed by the Director. He
(i) promptly transmits the written notification or response to the manufacturer or, if the  
may refund any sum paid by mistake or in excess of
manufacturer is not known, to the supplier, of the
the fees so specified, or if required under the treaty
product purchased or to be purchased by that person;
and
(ii) receives a written statement from the
manufacturer or supplier which on its face sets forth a
well grounded factual basis for a belief that the identified patents are not infringed.  
(D) For purposes of this subsection, a person who obtains a product made by a process patented
in the United States in a quantity which is abnormally
large in relation to the volume of business of such person or an efficient inventory level shall be rebuttably




and the Regulations. The Director may also refund
any part of the search fee, the national fee, the preliminary examination fee and any additional fees, where
he determines such refund to be warranted.


presumed to have actual knowledge that the product
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
was made by such patented process.  
89 Stat. 690, amended Nov. 8, 1984, Public Law 98-622,
sec. 402(g), 403(a), 98 Stat. 3392; Nov. 6, 1986, Public
Law 99-616, sec. 8(a) & (b), 100 Stat. 3486; Dec. 10, 1991,
Public Law 102-204, sec. 5(g)(1), 105 Stat. 1640; amended
Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113
Stat. 1501-582 (S. 1948 sec. 4732(a)(10)(A)); subsections
(a)(1)-(a)(3) amended Nov. 2, 2002, Public Law 107-273,
sec. 13206, 116 Stat. 1905.)


(6) A person who receives a response to a
==LAWS NOT IN TITLE 35, UNITED STATES CODE==
request for disclosure under this subsection shall pay
to the person to whom the request was made a reasonable fee to cover actual costs incurred in complying
with the request, which may not exceed the cost of a
commercially available automated patent search of
the matter involved, but in no case more than $500.


(c)(1) With respect to a medical practitioner’s
performance of a medical activity that constitutes an
infringement under section 271(a) or (b) of this title,
the provisions of sections 281, 283, 284, and 285 of
this title shall not apply against the medical practitioner or against a related health care entity with respect
to such medical activity.


(2) For the purposes of this subsection:
====18 U.S.C. 1001 Statements or entries generally.====


(A) the term “medical activity” means the
(a) Except as otherwise provided in this section, whoever, in any matter within the jurisdiction of  
performance of a medical or surgical procedure on a
the executive, legislative, or judicial branch of the
body, but shall not include (i) the use of a patented
Government of the United States, knowingly and willfully —
machine, manufacture, or composition of matter in
(1) falsifies, conceals, or covers up by any
violation of such patent, (ii) the practice of a patented
trick, scheme, or device a material fact;
use of a composition of matter in violation of such
(2) makes any materially false, fictitious, or
patent, or (iii) the practice of a process in violation of
fraudulent statement or representation; or  
a biotechnology patent.  
(3) makes or uses any false writing or document knowing the same to contain any materially
(B) the term “medical practitioner” means
false, fictitious, or fraudulent statement or entry; shall
any natural person who is licensed by a State to provide the medical activity described in subsection
be fined under this title or imprisoned not more than
(c)(1) or who is acting under the direction of such person in the performance of the medical activity.
5 years, or both.  
(C) the term “related health care entity”
(b) Subsection (a) does not apply to a party to a
shall mean an entity with which a medical practitioner
judicial proceeding, or that party’s counsel, for statements, representations, writings or documents submitted by such party or counsel to a judge or magistrate
has a professional affiliation under which the medical
in that proceeding.
practitioner performs the medical activity, including  
(c) With respect to any matter within the jurisdiction of the legislative branch, subsection (a) shall  
but not limited to a nursing home, hospital, university,  
apply only to —
medical school, health maintenance organization,  
(1) administrative matters, including a claim
group medical practice, or a medical clinic.
for payment, a matter related to the procurement of
(D) the term “professional affiliation” shall
property or services, personnel or employment practices, or support services, or a document required by
mean staff privileges, medical staff membership,
law, rule, or regulation to be submitted to the Congress or any office or officer within the legislative
employment or contractual relationship, partnership
branch; or
or ownership interest, academic appointment, or other
(2) any investigation or review, conducted
affiliation under which a medical practitioner provides the medical activity on behalf of, or in association with, the health care entity.  
pursuant to the authority of any committee, subcommittee, commission or office of the Congress, consistent with applicable rules of the House or Senate.
(E) the term “body” shall mean a human
 
body, organ or cadaver, or a nonhuman animal used in
(Amended Sept. 13, 1994, Public Law 103-322, sec.  
medical research or instruction directly relating to the
330016(1)(L), 108 Stat. 2147; Oct. 11, 1996, Public Law
treatment of humans.  
104-292, Sec. 2, 110 Stat. 3459.)


====18 U.S.C. 2071 Concealment, removal, or mutilation generally.====


(F) the term “patented use of a composition of matter” does not include a claim for a method
(a) Whoever willfully and unlawfully conceals, removes, mutilates, obliterates, or destroys, or  
of performing a medical or surgical procedure on a
attempts to do so, or, with intent to do so takes and
body that recites the use of a composition of matter
carries away any record, proceeding, map, book,
where the use of that composition of matter does not
paper, document, or other thing, filed or deposited
directly contribute to achievement of the objective of
with any clerk or officer of any court of the United
the claimed method.
States, or in any public office, or with any judicial or
(G) the term “State” shall mean any state or
public officer of the United States, shall be fined
territory of the United States, the District of Columbia, and the Commonwealth of Puerto Rico.
under this title or imprisoned not more than three
(3) This subsection does not apply to the
years, or both.  
activities of any person, or employee or agent of such
person (regardless of whether such person is a tax
exempt organization under section 501(c) of the Internal Revenue Code), who is engaged in the commercial development, manufacture, sale, importation, or  
distribution of a machine, manufacture, or composition of matter or the provision of pharmacy or clinical
laboratory services (other than clinical laboratory services provided in a physician’s office), where such
activities are:
(A) directly related to the commercial
development, manufacture, sale, importation, or distribution of a machine, manufacture, or composition
of matter or the provision of pharmacy or clinical laboratory services (other than clinical laboratory services provided in a physician’s office), and
(B) regulated under the Federal Food,  
Drug, and Cosmetic Act, the Public Health Service
Act, or the Clinical Laboratories Improvement Act.
(4) This subsection shall not apply to any
patent issued based on an application the earliest
effective filing date of which is prior to September 30,  
1996.  


(b) Whoever, having the custody of any such
record, proceeding, map, book, document, paper, or
other thing, willfully and unlawfully conceals,
removes, mutilates, obliterates, falsifies, or destroys
the same, shall be fined under this title or imprisoned
not more than three years, or both; and shall forfeit his
office and be disqualified from holding any office
under the United States. As used in this subsection,
the term “office” does not include the office held by
any person as a retired officer of the Armed Forces of
the United States.


(Amended Aug. 23, 1988, Public Law 100-418, sec.
(Amended Nov. 5, 1990, Public Law 101-510, sec.  
9004(a), 102 Stat. 1564; Dec. 8, 1994, Public Law 103-465,
552(a), 104 Stat. 1566; Sept. 13, 1994, Public Law 103322, sec. 330016(1)(I), 108 Stat. 2147.)
sec. 533(b)(5), 108 Stat. 4989.)
 
(Subsection (c) added Sept. 30, 1996, Public Law 104208, sec. 616, 110 Stat. 3009-67.)
 
(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-589 (S. 1948 sec. 4803).)
 
35 U.S.C. 288 Action for infringement of a patent
containing an invalid claim.
 
Whenever, without deceptive intention, a claim of a
patent is invalid, an action may be maintained for the
infringement of a claim of the patent which may be
valid. The patentee shall recover no costs unless a dis-
 
 
claimer of the invalid claim has been entered at the
Patent and Trademark Office before the commencement of the suit.
 
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
88 Stat. 1949.)
 
35 U.S.C. 289 Additional remedy for infringement
of design patent.
 
Whoever during the term of a patent for a design,
without license of the owner, (1) applies the patented
design, or any colorable imitation thereof, to any article of manufacture for the purpose of sale, or (2) sells
or exposes for sale any article of manufacture to
which such design or colorable imitation has been
applied shall be liable to the owner to the extent of his
total profit, but not less than $250, recoverable in any
United States district court having jurisdiction of the
parties.
 
Nothing in this section shall prevent, lessen, or
impeach any other remedy which an owner of an
infringed patent has under the provisions of this title,
but he shall not twice recover the profit made from the
infringement.
 
35 U.S.C. 290 Notice of patent suits.
 
The clerks of the courts of the United States, within
one month after the filing of an action under this title,
shall give notice thereof in writing to the Director, setting forth so far as known the names and addresses of
the parties, name of the inventor, and the designating
number of the patent upon which the action has been
brought. If any other patent is subsequently included
in the action he shall give like notice thereof. Within
one month after the decision is rendered or a judgment issued the clerk of the court shall give notice
thereof to the Director. The Director shall, on receipt
of such notices, enter the same in the file of such
patent.
 
(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)
 
35 U.S.C. 291 Interfering patents.
 
The owner of an interfering patent may have relief
against the owner of another by civil action, and the
court may adjudge the question of validity of any of
the interfering patents, in whole or in part. The provisions of the second paragraph of section 146 of this
title shall apply to actions brought under this section.
 
35 U.S.C. 292 False marking.
 
(a) Whoever, without the consent of the patentee, marks upon, or affixes to, or uses in advertising in
connection with anything made, used, offered for sale,
or sold by same person within the United States, or
imported by the person into the United States, the
name or any imitation of the name of the patentee, the
patent number, or the words “patent,” “patentee,” or
the like, with the intent of counterfeiting or imitating
the mark of the patentee, or of deceiving the public
and inducing them to believe that the thing was made,
offered for sale, sold, or imported into the United
States by or with the consent of the patentee; or
 
Whoever marks upon, or affixes to, or uses in
advertising in connection with any unpatented article
the word “patent” or any word or number importing
the same is patented, for the purpose of deceiving the
public; or
 
Whoever marks upon, or affixes to, or uses in
advertising in connection with any article the words
“patent applied for,” “patent pending,” or any word
importing that an application for patent has been
made, when no application for patent has been made,
or if made, is not pending, for the purpose of deceiving the public —
 
Shall be fined not more than $500 for every
such offense.
 
(b) Any person may sue for the penalty, in
which event one-half shall go to the person suing and
the other to the use of the United States.
 
(Subsection (a) amended Dec. 8, 1994, Public Law
103-465, sec. 533(b)(6), 108 Stat. 4990.)
 
35 U.S.C. 293 Nonresident patentee; service and
notice.
 
Every patentee not residing in the United States
may file in the Patent and Trademark Office a written
designation stating the name and address of a person
residing within the United States on whom may be
served process or notice of proceedings affecting the
patent or rights thereunder. If the person designated
cannot be found at the address given in the last designation, or if no person has been designated, the United
States District Court for the District of Columbia shall
have jurisdiction and summons shall be served by
publication or otherwise as the court directs. The
court shall have the same jurisdiction to take any
action respecting the patent or rights thereunder that it
 
 
would have if the patentee were personally within the
jurisdiction of the court.
 
(Amended Jan. 2, 1975, Public Law 93-596, sec. 1,
88 Stat. 1949.)
 
35 U.S.C. 294 Voluntary arbitration.
 
(a) A contract involving a patent or any right
under a patent may contain a provision requiring arbitration of any dispute relating to patent validity or
infringement arising under the contract. In the
absence of such a provision, the parties to an existing
patent validity or infringement dispute may agree in
writing to settle such dispute by arbitration. Any such
provision or agreement shall be valid, irrevocable, and
enforceable, except for any grounds that exist at law
or in equity for revocation of a contract.
(b) Arbitration of such disputes, awards by
arbitrators, and confirmation of awards shall be governed by title 9, to the extent such title is not inconsistent with this section. In any such arbitration
proceeding, the defenses provided for under section
282 of this title shall be considered by the arbitrator if
raised by any party to the proceeding.
(c) An award by an arbitrator shall be final and
binding between the parties to the arbitration but shall
have no force or effect on any other person. The parties to an arbitration may agree that in the event a
patent which is the subject matter of an award is subsequently determined to be invalid or unenforceable
in a judgment rendered by a court of competent jurisdiction from which no appeal can or has been taken,
such award may be modified by any court of competent jurisdiction upon application by any party to the
arbitration. Any such modification shall govern the
rights and obligations between such parties from the
date of such modification.
(d) When an award is made by an arbitrator, the
patentee, his assignee or licensee shall give notice
thereof in writing to the Director. There shall be a separate notice prepared for each patent involved in such
proceeding. Such notice shall set forth the names and
addresses of the parties, the name of the inventor, and
the name of the patent owner, shall designate the number of the patent, and shall contain a copy of the
award. If an award is modified by a court, the party
requesting such modification shall give notice of such
modification to the Director. The Director shall, upon
receipt of either notice, enter the same in the record of
the prosecution of such patent. If the required notice is
 
 
not filed with the Director, any party to the proceeding
may provide such notice to the Director.
 
(e) The award shall be unenforceable until the
notice required by subsection (d) is received by the
Director.
 
(Added Aug. 27, 1982, Public Law 97-247, sec.
17(b)(1), 96 Stat. 322; amended Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948
sec. 4732(a)(10)(A)); subsections (b) and (c) amended Nov.
2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1905.)
 
35 U.S.C. 295 Presumption: Product made by patented process.
 
In actions alleging infringement of a process patent
based on the importation, sale, offered for sale, or use
of a product which is made from a process patented in
the United States, if the court finds—
 
(1) that a substantial likelihood exists that the
product was made by the patented process, and
(2) that the plaintiff has made a reasonable
effort to determine the process actually used in the
production of the product and was unable so to determine, the product shall be presumed to have been so
made, and the burden of establishing that the product
was not made by the process shall be on the party
asserting that it was not so made.
 
 
(Added Aug. 23, 1988, Public Law 100-418, sec.
9005(a), 102 Stat. 1566; amended Dec. 8, 1994, Public Law
103-465, sec. 533(b)(7), 108 Stat. 4990.)
 
35 U.S.C. 296 Liability of States, instrumentalities
of States, and State officials for
infringement of patents.
 
(a) IN GENERAL. - Any State, any instrumentality of a State, and any officer or employee of a State
or instrumentality of a State, acting in his official
capacity, shall not be immune, under the eleventh
amendment of the Constitution of the United States or
under any other doctrine of sovereign immunity, from
suit in Federal court by any person, including any
governmental or nongovernmental entity, for infringement of a patent under section 271, or for any other
violation under this title.
(b) REMEDIES. - In a suit described in subsection (a) for a violation described in that subsection,
remedies (including remedies both at law and in
equity) are available for the violation to the same
extent as such remedies are available for such a violation in a suit against any private entity. Such remedies
 
 
 
include damages, interest, costs, and treble damages
under section 284, attorney fees under section 285,
and the additional remedy for infringement of design
patents under section 289.
 
(Added Oct. 28, 1992, Public Law 102-560, sec.
2(a)(2), 106 Stat. 4230.)
 
35 U.S.C. 297 Improper and deceptive invention
promotion.
 
(a) IN GENERAL.— An invention promoter
shall have a duty to disclose the following information to a customer in writing, prior to entering into a
contract for invention promotion services:
(1) the total number of inventions evaluated
by the invention promoter for commercial potential in
the past 5 years, as well as the number of those inventions that received positive evaluations, and the number of those inventions that received negative
evaluations;
(2) the total number of customers who have
contracted with the invention promoter in the past
5 years, not including customers who have purchased
trade show services, research, advertising, or other
nonmarketing services from the invention promoter,
or who have defaulted in their payment to the invention promoter;
(3) the total number of customers known by
the invention promoter to have received a net financial profit as a direct result of the invention promotion
services provided by such invention promoter;
(4) the total number of customers known by
the invention promoter to have received license agreements for their inventions as a direct result of the
invention promotion services provided by such invention promoter; and
(5) the names and addresses of all previous
invention promotion companies with which the invention promoter or its officers have collectively or individually been affiliated in the previous 10 years.
(b) CIVIL ACTION.—
 
 
(1) Any customer who enters into a contract
with an invention promoter and who is found by a
court to have been injured by any material false or
fraudulent statement or representation, or any omission of material fact, by that invention promoter (or
any agent, employee, director, officer, partner, or
independent contractor of such invention promoter),
or by the failure of that invention promoter to disclose
such information as required under subsection (a),
 
 
may recover in a civil action against the invention
promoter (or the officers, directors, or partners of such
invention promoter), in addition to reasonable costs
and attorneys’ fees-
 
(A) the amount of actual damages incurred
by the customer; or
(B) at the election of the customer at any
time before final judgment is rendered, statutory damages in a sum of not more than $5,000, as the court
considers just.
(2) Notwithstanding paragraph (1), in a case
where the customer sustains the burden of proof, and
the court finds, that the invention promoter intentionally misrepresented or omitted a material fact to such
customer, or willfully failed to disclose such information as required under subsection (a), with the purpose
of deceiving that customer, the court may increase
damages to not more than three times the amount
awarded, taking into account past complaints made
against the invention promoter that resulted in regulatory sanctions or other corrective actions based on
those records compiled by the Commissioner of Patents under subsection (d).
(c) DEFINITIONS.— For purposes of this section—
(1) a “contract for invention promotion services” means a contract by which an invention promoter undertakes invention promotion services for a
customer;
(2) a “customer” is any individual who enters
into a contract with an invention promoter for invention promotion services;
(3) the term “invention promoter” means any
person, firm, partnership, corporation, or other entity
who offers to perform or performs invention promotion services for, or on behalf of, a customer, and who
holds itself out through advertising in any mass media
as providing such services, but does not include—
(A) any department or agency of the Federal Government or of a State or local government;
(B) any nonprofit, charitable, scientific, or
educational organization, qualified under applicable
State law or described under section 170(b)(1)(A) of
the Internal Revenue Code of 1986;
(C) any person or entity involved in the
evaluation to determine commercial potential of, or
offering to license or sell, a utility patent or a previously filed nonprovisional utility patent application;
 
 
 
(D) any party participating in a transaction
involving the sale of the stock or assets of a business;
or
(E) any party who directly engages in the
business of retail sales of products or the distribution
of products; and
(4) the term “invention promotion services”
means the procurement or attempted procurement for
a customer of a firm, corporation, or other entity to
develop and market products or services that include
the invention of the customer.
(d) RECORDS OF COMPLAINTS.—
 
 
(1) RELEASE OF COMPLAINTS.— The
Commissioner of Patents shall make all complaints
received by the Patent and Trademark Office involving invention promoters publicly available, together
with any response of the invention promoters. The
Commissioner of Patents shall notify the invention
promoter of a complaint and provide a reasonable
opportunity to reply prior to making such complaint
publicly available.
(2) REQUEST FOR COMPLAINTS.— The
Commissioner of Patents may request complaints
relating to invention promotion services from any
Federal or State agency and include such complaints
in the records maintained under paragraph (1),
together with any response of the invention promoters.
 
 
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-552 (S. 1948 sec. 4102(a)).)
 
CHAPTER 30 — PRIOR ART CITATIONS TO
OFFICE AND EX PARTE REEXAMINATION
OF PATENTS
 
 
Sec.
 
301 Citation of prior art.
 
302 Request for reexamination.
 
303 Determination of issue by Director.
 
304 Reexamination order by Director.
 
305 Conduct of reexamination proceedings.
 
306 Appeal.
 
307 Certificate of patentability, unpatentability, and
claim cancellation.
 
35 U.S.C. 301 Citation of prior art.
Any person at any time may cite to the Office in
 
writing prior art consisting of patents or printed publi
 
cations which that person believes to have a bearing
on the patentability of any claim of a particular patent.
If the person explains in writing the pertinency and
manner of applying such prior art to at least one claim
of the patent, the citation of such prior art and the
explanation thereof will become a part of the official
file of the patent. At the written request of the person
citing the prior art, his or her identity will be excluded
from the patent file and kept confidential.
 
(Added Dec. 12, 1980, Public Law 96-517, sec. 1,
94 Stat. 3015.)
 
35 U.S.C. 302 Request for reexamination.
 
Any person at any time may file a request for reexamination by the Office of any claim of a patent on
the basis of any prior art cited under the provisions of
section 301 of this title. The request must be in writing and must be accompanied by payment of a reexamination fee established by the Director pursuant to
the provisions of section 41 of this title. The request
must set forth the pertinency and manner of applying
cited prior art to every claim for which reexamination
is requested. Unless the requesting person is the
owner of the patent, the Director promptly will send a
copy of the request to the owner of record of the
patent.
 
(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94
Stat. 3015; amended Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 secs.
4732(a)(8) and 4732(a)(10)(A)).)
 
35 U.S.C. 303 Determination of issue by Director.
 
(a) Within three months following the filing of
a request for reexamination under the provisions of
section 302 of this title, the Director will determine
whether a substantial new question of patentability
affecting any claim of the patent concerned is raised
by the request, with or without consideration of other
patents or printed publications. On his own initiative,
and any time, the Director may determine whether a
substantial new question of patentability is raised by
patents and publications discovered by him or cited
under the provisions of section 301 of this title. The
existence of a substantial new question of patentability is not precluded by the fact that a patent or printed
publication was previously cited by or to the Office or
considered by the Office.
(b) A record of the Director’s determination
under subsection (a) of this section will be placed in
the official file of the patent, and a copy promptly will
 
 
 
be given or mailed to the owner of record of the patent
and to the person requesting reexamination, if any.
 
(c) A determination by the Director pursuant to
subsection (a) of this section that no substantial new
question of patentability has been raised will be final
and nonappealable. Upon such a determination, the
Director may refund a portion of the reexamination
fee required under section 302 of this title.
 
(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94
Stat. 3015; amended Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-581, 582 (S. 1948 secs.
4732(a)(9) and (4732(a)(10)(A)); subsection (a) amended
Nov. 2, 2002, Public Law 107-273, sec. 13105, 116 Stat.
1900.)
 
35 U.S.C. 304 Reexamination order by Director.
 
If, in a determination made under the provisions of
subsection 303(a) of this title, the Director finds that a
substantial new question of patentability affecting any
claim of a patent is raised, the determination will
include an order for reexamination of the patent for
resolution of the question. The patent owner will be
given a reasonable period, not less than two months
from the date a copy of the determination is given or
mailed to him, within which he may file a statement
on such question, including any amendment to his
patent and new claim or claims he may wish to propose, for consideration in the reexamination. If the
patent owner files such a statement, he promptly will
serve a copy of it on the person who has requested
reexamination under the provisions of section 302 of
this title. Within a period of two months from the date
of service, that person may file and have considered in
the reexamination a reply to any statement filed by the
patent owner. That person promptly will serve on the
patent owner a copy of any reply filed.
 
(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94
Stat. 3016; amended Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)
 
35 U.S.C. 305 Conduct of reexamination proceedings.
 
After the times for filing the statement and reply
provided for by section 304 of this title have expired,
reexamination will be conducted according to the procedures established for initial examination under the
provisions of sections 132 and 133 of this title. In any
reexamination proceeding under this chapter, the
patent owner will be permitted to propose any amendment to his patent and a new claim or claims thereto,
in order to distinguish the invention as claimed from
the prior art cited under the provisions of section 301
of this title, or in response to a decision adverse to the
patentability of a claim of a patent. No proposed
amended or new claim enlarging the scope of a claim
of the patent will be permitted in a reexamination proceeding under this chapter. All reexamination proceedings under this section, including any appeal to
the Board of Patent Appeals and Interferences, will be
conducted with special dispatch within the Office.
 
(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94
Stat. 3016; amended Nov. 8, 1984, Public Law 98-622, sec.
204(c), 98 Stat. 3388.)
 
35 U.S.C. 306 Appeal.
 
The patent owner involved in a reexamination proceeding under this chapter may appeal under the provisions of section 134 of this title, and may seek court
review under the provisions of sections 141 to 145 of
this title, with respect to any decision adverse to the
patentability of any original or proposed amended or
new claim of the patent.
 
(Added Dec. 12, 1980, Public Law 96-517, sec. 1,
94 Stat. 3016.)
 
35 U.S.C. 307 Certificate of patentability, unpatentability, and claim cancellation.
 
(a) In a reexamination proceeding under this
chapter, when the time for appeal has expired or any
appeal proceeding has terminated, the Director will
issue and publish a certificate canceling any claim of
the patent finally determined to be unpatentable, confirming any claim of the patent determined to be patentable, and incorporating in the patent any proposed
amended or new claim determined to be patentable.
(b) Any proposed amended or new claim determined to be patentable and incorporated into a patent
following a reexamination proceeding will have the
same effect as that specified in section 252 of this title
for reissued patents on the right of any person who
made, purchased, or used within the United States, or
imported into the United States, anything patented by
such proposed amended or new claim, or who made
substantial preparation for the same, prior to issuance
of a certificate under the provisions of subsection (a)
of this section.
 
 
 
(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94
Stat. 3016; amended Dec. 8, 1994, Public Law 103-465,
sec. 533(b)(8), 108 Stat. 4990; Nov. 29, 1999, Public Law
106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948
sec. 4732(a)(10)(A)).)
 
CHAPTER 31 — OPTIONAL INTER PARTES
REEXAMINATION PROCEDURES
 
Sec.
311 Request for inter partes reexamination.
312 Determination of issue by Director.
313 Inter partes reexamination order by Director.
314 Conduct of inter partes reexamination proceed
 
 
ings.
315 Appeal.
316 Certificate of patentability, unpatentability, and
 
claim cancellation.
317 Inter partes reexamination prohibited.
318 Stay of litigation.
 
35 U.S.C. 311 Request for inter partes reexamination
 
(a) IN GENERAL.— Any third-party requester
at any time may file a request for inter partes reexamination by the Office of a patent on the basis of any
prior art cited under the provisions of section 301.
(b) REQUIREMENTS.— The request shall—
 
 
(1) be in writing, include the identity of the
real party in interest, and be accompanied by payment
of an inter partes reexamination fee established by the
Director under section 41; and
(2) set forth the pertinency and manner of
applying cited prior art to every claim for which reexamination is requested.
(c) COPY.— The Director promptly shall send
a copy of the request to the owner of record of the
patent.
 
 
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a));
subsections (a) and (c) amended Nov. 2, 2002, Public Law
107-273, sec. 13202, 116 Stat. 1901.)
 
35 U.S.C. 312 Determination of issue by Director
 
(a) REEXAMINATION.— Not later than
3 months after the filing of a request for inter partes
reexamination under section 311, the Director shall
determine whether a substantial new question of patentability affecting any claim of the patent concerned
is raised by the request, with or without consideration
of other patents or printed publications. The existence
of a substantial new question of patentability is not
precluded by the fact that a patent or printed publication was previously cited by or to the Office or considered by the Office.
 
(b) RECORD.— A record of the Director’s
determination under subsection (a) shall be placed in
the official file of the patent, and a copy shall be
promptly given or mailed to the owner of record of
the patent and to the third-party requester.
(c) FINAL DECISION.— A determination by
the Director under subsection (a) shall be final and
non-appealable. Upon a determination that no substantial new question of patentability has been raised,
the Director may refund a portion of the inter partes
reexamination fee required under section 311.
 
 
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a));
subsections (a) and (b) amended Nov. 2, 2002, Public Law
107-273, secs. 13105 and 13202, 116 Stat.1900-1901.)
 
35 U.S.C. 313 Inter partes reexamination order by
Director
 
If, in a determination made under section 312(a),
the Director finds that a substantial new question of
patentability affecting a claim of a patent is raised, the
determination shall include an order for inter partes
reexamination of the patent for resolution of the question. The order may be accompanied by the initial
action of the Patent and Trademark Office on the merits of the inter partes reexamination conducted in
accordance with section 314.
 
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)).)
 
35 U.S.C. 314 Conduct of inter partes reexamination proceedings
 
(a) IN GENERAL.— Except as otherwise provided in this section, reexamination shall be conducted according to the procedures established for
initial examination under the provisions of sections
132 and 133. In any inter partes reexamination proceeding under this chapter, the patent owner shall be
permitted to propose any amendment to the patent and
a new claim or claims, except that no proposed
amended or new claim enlarging the scope of the
claims of the patent shall be permitted.
 
 
(b) RESPONSE.—
 
(1) With the exception of the inter partes
reexamination request, any document filed by either
the patent owner or the third-party requester shall be
served on the other party. In addition, the Office shall
send to the third-party requester a copy of any communication sent by the Office to the patent owner concerning the patent subject to the inter partes
reexamination proceeding.
(2) Each time that the patent owner files a
response to an action on the merits from the Patent
and Trademark Office, the third-party requester shall
have one opportunity to file written comments
addressing issues raised by the action of the Office or
the patent owner’s response thereto, if those written
comments are received by the Office within 30 days
after the date of service of the patent owner’s
response.
(c) SPECIAL DISPATCH.— Unless otherwise
provided by the Director for good cause, all inter
partes reexamination proceedings under this section,
including any appeal to the Board of Patent Appeals
and Interferences, shall be conducted with special dispatch within the Office.
 
 
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a));
subsection (b)(1) amended Nov. 2, 2002, Public Law 107273, sec. 13202, 116 Stat. 1901.)
 
35 U.S.C. 315 Appeal
 
(a) PATENT OWNER.— The patent owner
involved in an inter partes reexamination proceeding
under this chapter—
(1) may appeal under the provisions of section 134 and may appeal under the provisions of sections 141 through 144, with respect to any decision
adverse to the patentability of any original or proposed amended or new claim of the patent; and
(2) may be a party to any appeal taken by a
third-party requester under subsection (b).
(b) THIRD-PARTY REQUESTER.— A third-
party requester—
(1) may appeal under the provisions of section 134, and may appeal under the provisions of sections 141 through 144, with respect to any final
decision favorable to the patentability of any original
or proposed amended or new claim of the patent; and
 
 
(2) may, subject to subsection (c), be a party
to any appeal taken by the patent owner under the provisions of section 134 or sections 141 through 144.
(c) CIVIL ACTION.— A third-party requester
whose request for an inter partes reexamination
results in an order under section 313 is estopped from
asserting at a later time, in any civil action arising in
whole or in part under section 1338 of title 28, the
invalidity of any claim finally determined to be valid
and patentable on any ground which the third-party
requester raised or could have raised during the inter
partes reexamination proceedings. This subsection
does not prevent the assertion of invalidity based on
newly discovered prior art unavailable to the third-
party requester and the Patent and Trademark Office
at the time of the inter partes reexamination proceedings.
 
 
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a));
subsection (b) amended Nov. 2, 2002, Public Law 107-273,
sec. 13106, 116 Stat. 1900; subsection (c) amended Nov. 2,
2002, Public Law 107-273, sec. 13202, 116 Stat. 1901.)
 
35 U.S.C. 316 Certificate of patentability, unpatentability and claim cancellation
 
(a) IN GENERAL.— In an inter partes reexamination proceeding under this chapter, when the time
for appeal has expired or any appeal proceeding has
terminated, the Director shall issue and publish a certificate canceling any claim of the patent finally determined to be unpatentable, confirming any claim of the
patent determined to be patentable, and incorporating
in the patent any proposed amended or new claim
determined to be patentable.
(b) AMENDED OR NEW CLAIM.— Any proposed amended or new claim determined to be patentable and incorporated into a patent following an inter
partes reexamination proceeding shall have the same
effect as that specified in section 252 of this title for
reissued patents on the right of any person who made,
purchased, or used within the United States, or
imported into the United States, anything patented by
such proposed amended or new claim, or who made
substantial preparation therefor, prior to issuance of a
certificate under the provisions of subsection (a) of
this section.
 
 
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)).)
 
 
35 U.S.C. 317 Inter partes reexamination prohibited
 
(a) ORDER FOR REEXAMINATION.— Notwithstanding any provision of this chapter, once an
order for inter partes reexamination of a patent has
been issued under section 313, neither the third-party
requester nor its privies may file a subsequent request
for inter partes reexamination of the patent until an
inter partes reexamination certificate is issued and
published under section 316, unless authorized by the
Director.
(b) FINAL DECISION.— Once a final decision has been entered against a party in a civil action
arising in whole or in part under section 1338 of title
28, that the party has not sustained its burden of proving the invalidity of any patent claim in suit or if a
final decision in an inter partes reexamination proceeding instituted by a third-party requester is favorable to the patentability of any original or proposed
amended or new claim of the patent, then neither that
party nor its privies may thereafter request an inter
partes reexamination of any such patent claim on the
basis of issues which that party or its privies raised or
could have raised in such civil action or inter partes
reexamination proceeding, and an inter partes reexamination requested by that party or its privies on the
basis of such issues may not thereafter be maintained
by the Office, notwithstanding any other provision of
this chapter. This subsection does not prevent the
assertion of invalidity based on newly discovered
prior art unavailable to the third-party requester and
the Patent and Trademark Office at the time of the
inter partes reexamination proceedings.
 
 
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a));
subsections (a) and (b) amended Nov. 2, 2002, Public Law
107-273, sec. 13202, 116 Stat. 1901.)
 
35 U.S.C. 318 Stay of litigation
 
Once an order for inter partes reexamination of a
patent has been issued under section 313, the patent
owner may obtain a stay of any pending litigation
which involves an issue of patentability of any claims
of the patent which are the subject of the inter partes
reexamination order, unless the court before which
such litigation is pending determines that a stay would
not serve the interests of justice.
 
(Added Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)).)
 
PART IV — PATENT COOPERATION
TREATY
 
 
CHAPTER 35 — DEFINITIONS
 
Sec.
351 Definitions.
 
35 U.S.C. 351 Definitions.
 
When used in this part unless the context otherwise
indicates—
 
(a) The term “treaty” means the Patent Cooperation Treaty done at Washington, on June 19, 1970.
(b) The term “Regulations,” when capitalized,
means the Regulations under the treaty, done at Washington on the same date as the treaty. The term “regulations,” when not capitalized, means the regulations
established by the Director under this title.
(c) The term “international application” means
an application filed under the treaty.
(d) The term “international application originating in the United States” means an international application filed in the Patent and Trademark Office when
it is acting as a Receiving Office under the treaty, irrespective of whether or not the United States has been
designated in that international application.
(e) The term “international application designating the United States” means an international
application specifying the United States as a country
in which a patent is sought, regardless where such
international application is filed.
(f) The term “Receiving Office” means a
national patent office or intergovernmental organization which receives and processes international applications as prescribed by the treaty and the
Regulations.
(g) The terms “International Searching Authority” and “International Preliminary Examining
Authority” mean a national patent office or intergovernmental organization as appointed under the treaty
which processes international applications as prescribed by the treaty and the Regulations.
(h) The term “International Bureau” means the
inter national intergovernmental organization which is
recognized as the coordinating body under the treaty
and the Regulations.
 
 
 
(i) Terms and expressions not defined in this
part are to be taken in the sense indicated by the treaty
and the Regulations.
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 685; amended Nov. 8, 1984, Public Law 98-622,
sec. 403(a), 98 Stat. 3392; Nov. 6, 1986, Public Law 99616, sec. 2 (a)-(c), 100 Stat. 3485; Nov. 29, 1999, Public
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582
 
(S. 1948 sec. 4732(a)(10)(A)).)
 
CHAPTER 36 — INTERNATIONAL STAGE
 
Sec.
 
361 Receiving Office.
 
362 International Searching Authority and International Preliminary Examining Authority.
 
363 International application designating the United
States: Effect.
 
364 International stage: Procedure.
 
365 Right of priority; benefit of the filing date of a
prior application.
 
366 Withdrawn international application.
 
367 Actions of other authorities: Review.
 
368 Secrecy of certain inventions; filing international applications in foreign countries.
 
35 U.S.C. 361 Receiving Office.
 
(a) The Patent and Trademark Office shall act
as a Receiving Office for international applications
filed by nationals or residents of the United States. In
accordance with any agreement made between the
United States and another country, the Patent and
Trademark Office may also act as a Receiving Office
for international applications filed by residents or
nationals of such country who are entitled to file international applications.
(b) The Patent and Trademark Office shall perform all acts connected with the discharge of duties
required of a Receiving Office, including the collection of international fees and their transmittal to the
International Bureau.
(c) International applications filed in the Patent
and Trademark Office shall be in the English language.
(d) The international fee, and the transmittal
and search fees prescribed under section 376(a) of this
part, shall either be paid on filing of an international
application or within such later time as may be fixed
by the Director.
 
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622,
sec. 401(a), 403(a), 98 Stat. 3391-3392; Nov. 6, 1986, Public Law 99-616, sec. 2(d), 100 Stat. 3485; Nov. 29, 1999,
Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582
 
(S. 1948 sec. 4732(a)(10)(A)).)
 
35 U.S.C. 362 International Searching Authority
 
and International Preliminary
 
Examining Authority.
 
(a) The Patent and Trademark Office may act as
an International Searching Authority and International
Preliminary Examining Authority with respect to
international applications in accordance with the
terms and conditions of an agreement which may be
concluded with the International Bureau, and may discharge all duties required of such Authorities, including the collection of handling fees and their
transmittal to the International Bureau.
(b) The handling fee, preliminary examination
fee, and any additional fees due for international preliminary examination shall be paid within such time
as may be fixed by the Director.
 
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622,
sec. 403 (a), 98 Stat. 3392; Nov. 6, 1986, Public Law 99616, sec. 4, 100 Stat. 3485; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)
 
35 U.S.C. 363 International application designating the United States: Effect.
 
An international application designating the United
States shall have the effect, from its international filing date under article 11 of the treaty, of a national
application for patent regularly filed in the Patent and
Trademark Office except as otherwise provided in
section 102(e) of this title.
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622,
sec. 403(a), 98 Stat. 3392.)
 
35 U.S.C. 364 International stage: Procedure.
 
(a) International applications shall be processed
by the Patent and Trademark Office when acting as a
Receiving Office, International Searching Authority,
or International Preliminary Examining Authority, in
accordance with the applicable provisions of the
treaty, the Regulations, and this title.
 
 
(b) An applicant’s failure to act within prescribed time limits in connection with requirements
pertaining to a pending international application may
be excused upon a showing satisfactory to the Director of unavoidable delay, to the extent not precluded
by the treaty and the Regulations, and provided the
conditions imposed by the treaty and the Regulations
regarding the excuse of such failure to act are complied with.
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622,
sec. 403(a), 98 Stat. 3392.)
 
(Subsection (a) amended Nov. 6, 1986, Public Law 99616, sec. 5, 100 Stat. 3485.)
 
(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)
 
35 U.S.C. 365 Right of priority; benefit of the filing date of a prior application.
 
(a) In accordance with the conditions and
requirements of subsections (a) through (d) of section
119 of this title, a national application shall be entitled
to the right of priority based on a prior filed international application which designated at least one country other than the United States.
(b) In accordance with the conditions and
requirements of section 119(a) of this title and the
treaty and the Regulations, an international application designating the United States shall be entitled to
the right of priority based on a prior foreign application, or a prior international application designating at
least one country other than the United States.
(c) In accordance with the conditions and
requirements of section 120 of this title, an international application designating the United States shall
be entitled to the benefit of the filing date of a prior
national application or a prior international application designating the United States, and a national
application shall be entitled to the benefit of the filing
date of a prior international application designating
the United States. If any claim for the benefit of an
earlier filing date is based on a prior international
application which designated but did not originate in
the United States, the Director may require the filing
in the Patent and Trademark Office of a certified copy
of such application together with a translation thereof
 
 
into the English language, if it was filed in another
language.
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622,
sec. 403(a), 98 Stat. 3392; Dec. 8, 1994, Public Law 103465, sec. 532(c)(4), 108 Stat. 4987; Nov. 29, 1999, Public
Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S.
1948 sec. 4732(a)(10)(A)).)
 
35 U.S.C. 366 Withdrawn international application.
 
Subject to section 367 of this part, if an international application designating the United States is
withdrawn or considered withdrawn, either generally
or as to the United States, under the conditions of the
treaty and the Regulations, before the applicant has
complied with the applicable requirements prescribed
by section 371(c) of this part, the designation of the
United States shall have no effect after the date of
withdrawal and shall be considered as not having
been made, unless a claim for benefit of a prior filing
date under section 365(c) of this section was made in
a national application, or an international application
designating the United States, filed before the date of
such withdrawal. However, such withdrawn international application may serve as the basis for a claim of
priority under section 365 (a) and (b) of this part, if it
designated a country other than the United States.
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 687; amended Nov. 8, 1984, Public Law 98-622,
sec. 401(b), 98 Stat. 3391.)
 
35 U.S.C. 367 Actions of other authorities:
Review.
 
(a) Where a Receiving Office other than the
Patent and Trademark Office has refused to accord an
international filing date to an international application
designating the United States or where it has held
such application to be withdrawn either generally or
as to the United States, the applicant may request
review of the matter by the Director, on compliance
with the requirements of and within the time limits
specified by the treaty and the Regulations. Such
review may result in a determination that such application be considered as pending in the national stage.
(b) The review under subsection (a) of this section, subject to the same requirements and conditions,
may also be requested in those instances where an
international application designating the United States
 
 
 
is considered withdrawn due to a finding by the International Bureau under article 12 (3) of the treaty.
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 687; amended Nov. 8, 1984, Public Law 98-622,
sec. 403(a), 98 Stat 3392; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)
 
35 U.S.C. 368 Secrecy of certain inventions; filing
international applications in foreign
countries.
 
(a) International applications filed in the Patent
and Trademark Office shall be subject to the provisions of chapter 17 of this title.
(b) In accordance with article 27 (8) of the
treaty, the filing of an international application in a
country other than the United States on the invention
made in this country shall be considered to constitute
the filing of an application in a foreign country within
the meaning of chapter 17 of this title, whether or not
the United States is designated in that international
application.
(c) If a license to file in a foreign country is
refused or if an international application is ordered to
be kept secret and a permit refused, the Patent and
Trademark Office when acting as a Receiving Office,
International Searching Authority, or International
Preliminary Examining Authority, may not disclose
the contents of such application to anyone not authorized to receive such disclosure.
 
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 687; amended Nov. 8, 1984, Public Law 98-622,
sec. 403(a), 98 Stat. 3392; Nov. 6, 1986, Public Law 99616, sec. 6, 100 Stat. 3486.)
 
CHAPTER 37 — NATIONAL STAGE
 
Sec.
371 National stage: Commencement.
372 National stage: Requirements and procedure.
373 Improper applicant.
374 Publication of international application: Effect.
375 Patent issued on international application:
 
 
Effect.
376 Fees.
 
35 U.S.C. 371 National stage: Commencement.
 
(a) Receipt from the International Bureau of
copies of international applications with any amendments to the claims, international search reports, and
international preliminary examination reports including any annexes thereto may be required in the case of
international applications designating or electing the
United States.
 
(b) Subject to subsection (f) of this section, the
national stage shall commence with the expiration of
the applicable time limit under article 22 (1) or (2), or
under article 39 (1)(a) of the treaty.
(c) The applicant shall file in the Patent and
Trademark Office —
(1) the national fee provided in section 41(a)
of this title;
(2) a copy of the international application,
unless not required under subsection (a) of this section or already communicated by the International
Bureau, and a translation into the English language of
the international application, if it was filed in another
language;
(3) amendments, if any, to the claims in the
international application, made under article 19 of the
treaty, unless such amendments have been communicated to the Patent and Trademark Office by the International Bureau, and a translation into the English
language if such amendments were made in another
language;
(4) an oath or declaration of the inventor (or
other person authorized under chapter 11 of this title)
complying with the requirements of section 115 of
this title and with regulations prescribed for oaths or
declarations of applicants;
(5) a translation into the English language of
any annexes to the international preliminary examination report, if such annexes were made in another language.
(d) The requirement with respect to the national
fee referred to in subsection (c)(1), the translation
referred to in subsection (c)(2), and the oath or declaration referred to in subsection (c)(4) of this section
shall be complied with by the date of the commencement of the national stage or by such later time as may
be fixed by the Director. The copy of the international
application referred to in subsection (c)(2) shall be
submitted by the date of the commencement of the
national stage. Failure to comply with these requirements shall be regarded as abandonment of the application by the parties thereof, unless it be shown to the
satisfaction of the Director that such failure to comply
was unavoidable. The payment of a surcharge may be
 
 
 
required as a condition of accepting the national fee
referred to in subsection (c)(1) or the oath or declaration referred to in subsection (c)(4) of this section if
these requirements are not met by the date of the commencement of the national stage. The requirements of
subsection (c)(3) of this section shall be complied
with by the date of the commencement of the national
stage, and failure to do so shall be regarded as a cancellation of the amendments to the claims in the international application made under article 19 of the
treaty. The requirement of subsection (c)(5) shall be
complied with at such time as may be fixed by the
Director and failure to do so shall be regarded as cancellation of the amendments made under article 34
(2)(b) of the treaty.
 
(e) After an international application has
entered the national stage, no patent may be granted
or refused thereon before the expiration of the applicable time limit under article 28 or article 41 of the
treaty, except with the express consent of the applicant. The applicant may present amendments to the
specification, claims, and drawings of the application
after the national stage has commenced.
(f) At the express request of the applicant, the
national stage of processing may be commenced at
any time at which the application is in order for such
purpose and the applicable requirements of subsection
(c) of this section have been complied with.
 
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 688; amended Nov. 8, 1984, Public Law 98-622,
sec. 402(a)-(d), 403(a), 98 Stat. 3391, 3392.)
 
(Subsections (a), (b), (c), (d), and (e) amended Nov. 6,
1986, Public Law, 99-616, sec. 7, 100 Stat. 3486.)
 
(Subsection (c)(1) amended Dec. 10, 1991, Public Law
102-204, sec. 5(g)(2), 105 Stat. 1641.)
 
(Amended Nov. 29, 1999, Public Law 106-113, sec.
1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)
 
(Subsection (d) amended Nov. 2, 2002, Public Law
107-273, sec. 13206, 116 Stat. 1905.)
 
35 U.S.C. 372 National stage: Requirements and
procedure.
 
(a) All questions of substance and, within the
scope of the requirements of the treaty and Regulations, procedure in an international application designating the United States shall be determined as in the
case of national applications regularly filed in the
Patent and Trademark Office.
 
(b) In case of international applications designating but not originating in, the United States
(1) the Director may cause to be reexamined
questions relating to form and contents of the application in accordance with the requirements of the treaty
and the Regulations;
(2) the Director may cause the question of
unity of invention to be reexamined under section 121
of this title, within the scope of the requirements of
the treaty and the Regulations; and
(3) the Director may require a verification of
the translation of the international application or any
other document pertaining to the application if the
application or other document was filed in a language
other than English.
 
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 689; amended Nov. 8, 1984, Public Law 98-622,
sec. 402(e), (f), 403(a), 98 Stat. 3392; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582
 
(S. 1948 sec. 4732(a)(10)(A)).)
 
35 U.S.C. 373 Improper applicant.
 
An international application designating the United
States, shall not be accepted by the Patent and Trademark Office for the national stage if it was filed by
anyone not qualified under chapter 11 of this title to
be an applicant for the purpose of filing a national
application in the United States. Such international
applications shall not serve as the basis for the benefit
of an earlier filing date under section 120 of this title
in a subsequently filed application, but may serve as
the basis for a claim of the right of priority under subsections (a) through (d) of section 119 of this title, if
the United States was not the sole country designated
in such international application.
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 689; amended Nov. 8, 1984, Public Law 98-622,
sec. 403(a), 98 Stat. 3392; Dec. 8, 1994, Public Law 103465, sec. 532(c)(5), 108 Stat. 4987.)
 
35 U.S.C. 374 Publication of international application.
 
The publication under the treaty defined in section
351(a) of this title, of an international application designating the United States shall be deemed a publication under section 122(b), except as provided in
sections 102(e) and 154(d) of this title.
 
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89
Stat. 689; amended Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-566 (S. 1948 sec.
4507(10)); amended Nov. 2, 2002, Public Law 107-273,
sec.13205, 116 Stat. 1903.)
 
35 U.S.C. 375 Patent issued on international
application: Effect.
 
(a) A patent may be issued by the Director
based on an international application designating the
United States, in accordance with the provisions of
this title. Subject to section 102(e) of this title, such
patent shall have the force and effect of a patent
issued on a national application filed under the provisions of chapter 11 of this title.
(b) Where due to an incorrect translation the
scope of a patent granted on an international application designating the United States, which was not
originally filed in the English language, exceeds the
scope of the international application in its original
language, a court of competent jurisdiction may retroactively limit the scope of the patent, by declaring it
unenforceable to the extent that it exceeds the scope
of the international application in its original language.
 
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 689; amended Nov. 29, 1999, Public Law 106-113,
sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec.
4732(a)(10)(A)).)
 
35 U.S.C. 376 Fees.
 
(a) The required payment of the international
fee and the handling fee, which amounts are specified
in the Regulations, shall be paid in United States currency. The Patent and Trademark Office shall charge a
national fee as provided in section 41(a), and may also
charge the following fees:
(1) A transmittal fee (see section 361(d)).
(2) A search fee (see section 361(d)).
 
 
 
 
(3) A supplemental search fee (to be paid
when required).
(4) A preliminary examination fee and any
additional fees (see section 362(b)).
(5) Such other fees as established by the
Director.
(b) The amounts of fees specified in subsection
 
 
(a) of this section, except the international fee and the
handling fee, shall be prescribed by the Director. He
may refund any sum paid by mistake or in excess of
the fees so specified, or if required under the treaty
 
 
and the Regulations. The Director may also refund
any part of the search fee, the national fee, the preliminary examination fee and any additional fees, where
he determines such refund to be warranted.
 
(Added Nov. 14, 1975, Public Law 94-131, sec. 1,
89 Stat. 690, amended Nov. 8, 1984, Public Law 98-622,
sec. 402(g), 403(a), 98 Stat. 3392; Nov. 6, 1986, Public
Law 99-616, sec. 8(a) & (b), 100 Stat. 3486; Dec. 10, 1991,
Public Law 102-204, sec. 5(g)(1), 105 Stat. 1640; amended
Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113
Stat. 1501-582 (S. 1948 sec. 4732(a)(10)(A)); subsections
(a)(1)-(a)(3) amended Nov. 2, 2002, Public Law 107-273,
sec. 13206, 116 Stat. 1905.)
 
LAWS NOT IN TITLE 35, UNITED STATES
CODE
 
 
18 U.S.C. 1001 Statements or entries generally.
 
(a) Except as otherwise provided in this section, whoever, in any matter within the jurisdiction of
the executive, legislative, or judicial branch of the
Government of the United States, knowingly and willfully —
(1) falsifies, conceals, or covers up by any
trick, scheme, or device a material fact;
(2) makes any materially false, fictitious, or
fraudulent statement or representation; or
(3) makes or uses any false writing or document knowing the same to contain any materially
false, fictitious, or fraudulent statement or entry; shall
be fined under this title or imprisoned not more than
5 years, or both.
(b) Subsection (a) does not apply to a party to a
judicial proceeding, or that party’s counsel, for statements, representations, writings or documents submitted by such party or counsel to a judge or magistrate
in that proceeding.
(c) With respect to any matter within the jurisdiction of the legislative branch, subsection (a) shall
apply only to —
(1) administrative matters, including a claim
for payment, a matter related to the procurement of
property or services, personnel or employment practices, or support services, or a document required by
law, rule, or regulation to be submitted to the Congress or any office or officer within the legislative
branch; or
 
 
 
PATENT LAWS 2071
 
(2) any investigation or review, conducted
pursuant to the authority of any committee, subcommittee, commission or office of the Congress, consistent with applicable rules of the House or Senate.
 
(Amended Sept. 13, 1994, Public Law 103-322, sec.
330016(1)(L), 108 Stat. 2147; Oct. 11, 1996, Public Law
104-292, Sec. 2, 110 Stat. 3459.)
 
18 U.S.C. 2071 Concealment, removal, or mutilation generally.
 
(a) Whoever willfully and unlawfully conceals, removes, mutilates, obliterates, or destroys, or
attempts to do so, or, with intent to do so takes and
carries away any record, proceeding, map, book,
paper, document, or other thing, filed or deposited
with any clerk or officer of any court of the United
States, or in any public office, or with any judicial or
public officer of the United States, shall be fined
under this title or imprisoned not more than three
years, or both.
 
(b) Whoever, having the custody of any such
record, proceeding, map, book, document, paper, or
other thing, willfully and unlawfully conceals,
removes, mutilates, obliterates, falsifies, or destroys
the same, shall be fined under this title or imprisoned
not more than three years, or both; and shall forfeit his
office and be disqualified from holding any office
under the United States. As used in this subsection,
the term “office” does not include the office held by
any person as a retired officer of the Armed Forces of
the United States.
 
(Amended Nov. 5, 1990, Public Law 101-510, sec.  
552(a), 104 Stat. 1566; Sept. 13, 1994, Public Law 103322, sec. 330016(1)(I), 108 Stat. 2147.)  
 
 
INDEX OF PATENT LAWS
 
A
 
Abandoned applications, fee on petition to revive.41(a)7
Abandonment of application by failure to prose
cute. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .133, 371
Abandonment of invention:
Bar to patent. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102
By violation of secrecy . . . . . . . . . . . . . . . . . . . . .182
Adjustment of patent term . . . . . . . . . . . . . . . . . . . 154
Administrative Patent Judges . . . . . . . . . . . . . . . . . . . . .6
Administrator, executor, or guardian. . . . . . . . . . . . . . 117
Affidavits and depositions in contested cases,
rules for taking. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23
Agreement to terminate interference. . . . . . . . . . . . . .135
Agriculture, Secretary of, to furnish information,
and detail employees to Director for plant patent . . 164
Allowance and issue of patents. . . . . . . . . . . . . . . . . .153
Allowance, notice of . . . . . . . . . . . . . . . . . . . . . . . . . .151
Amendment:
Copying claim of issued patent. . . . . . . . . . . . . . .135
Time for. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .133, 135
Annual indexes of patents. . . . . . . . . . . . . . . . . . . . . . .10
Annual report of the Director . . . . . . . . . . . . . . . . . . . .13
Apostille on assignment . . . . . . . . . . . . . . . . . . . . . . .261
Appeals to Board of Patent Appeals and Interfer
ences. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .134
Fee.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .41(a)6, 134
Hearing of . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .6
Reexamination proceedings. . . . . . . . . . . . . . . . . .306
Appeals to Court of Appeals for the Federal Cir
cuit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .141
Certificate of decision of Court recorded in the
United States Patent and Trademark Office . . . . 144
Determination of Appeal; revision of decision . . . 144
From Board of Patent Appeals and Interfer
ences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .141
Grounds of decision to be furnished court. . . . . . . 143
Notice of appeal. . . . . . . . . . . . . . . . . . . . . . . . . . .142
Proceedings on appeal. . . . . . . . . . . . . . . . . . . . . .143
Applicant for foreign patent, license required. . . . . . .184
Applicant for international application . . . . . . . . . . . . 373
Applicant, notified of interference . . . . . . . . . . . . . . . 135
Application:
Abandonment of, by failure to prosecute . . . . . . . 133
Assignment of . . . . . . . . . . . . . . . . . . . . . . . . . . . .261
Confidential while pending. . . . . . . . . . . . . . . . . .122
Continuing. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .120
Description; specification and claim . . . . . . . . . . . 112
Divisional. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121
 
 
Drawings. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
Effect of defective execution . . . . . . . . . . . . . . . . . 26
Effective as of date of earliest foreign applica
tion in certain cases . . . . . . . . . . . . . . . . . . . . . . 119
Examination of invention.. . . . . . . . . . . . . . . . . . 131
Fee on filing. . . . . . . . . . . . . . . . . . . . . . . 41(a)1, 111
For deceased or insane inventors . . . . . . . . . . . . . 117
May be made by legal representative of
deceased or incapacitated inventor. . . . . . . . . . . 117
Must be made within specified time after for
eign application for right of priority. . . . . . . . . . 119
Oath of applicant (See Oath in patent applica
tion)
Owned by Government. . . . . . . . . . . . . . . . . . . . . 267
Provisional . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .111
Publication . . . . . . . . . . . . . . . . . . . . . . 102, 122, 181
Reissue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 251
Secrecy order . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181
What to contain. . . . . . . . . . . . . . . . . . . . . . . . . . . .111
When filed by other than inventor . . . . . . . . 118, 121
Appointments, how made. . . . . . . . . . . . . . . . . . . . . . . . 3
Arbitration of interferences . . . . . . . . . . . . . . . . . . . . 135
Arbitration, voluntary. . . . . . . . . . . . . . . . . . . . . . . . . 294
Article patented marked with number of patent. . . . . 287
Assignee:
May file application in certain cases . . . . . . . . . . . . . 118
May file divisional application. . . . . . . . . . . . . . . 121
May file reissue application . . . . . . . . . . . . . . . . . 251
Patent may be issued to . . . . . . . . . . . . . . . . . . . . 152
Assignments, patent . . . . . . . . . . . . . . . . . . . . . . . . . . 261
Establishing prima facie execution of . . . . . . . . . . . . 261
Fees for recording. . . . . . . . . . . . . . . . . . . . . . 41(a)10
Must be recorded in United States Patent and
Trademark Office to issue patent to assignee. . . 152
Patent may issue to assignee. . . . . . . . . . . . . . . . . 152
Recording in Patent and Trademark Office . . . . . 261
Attorney fees in infringement suit. . . . . . . . . . . . . . . 285
Attorneys and agents:
May be refused recognition for misconduct. . . . . . 32
Petition toDistrict Court, DC. . . . . . . . . . . . . . . . . 32
Suspension or exclusion from practice. . . . . . . . . . 32
Unauthorized practitioners. . . . . . . . . . . . . . . . . . . 33
 
 
B
 
Bars to grant of a patent. . . . . . . . . . . . . . . . . . . 102, 103
Benefit of earlier filing date in foreign country . . . . . 119
Benefit of earlier filing date in United States. . . . . . . 120
Best mode required. . . . . . . . . . . . . . . . . . . . . . . . . . . 112
Bill in equity (See Civil action)
 
 
 
Board of Patent Appeals and Interferences, how
constituted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .6
 
 
C
 
Certificate of correction:
Applicant’s mistake . . . . . . . . . . . . . . . . . . . . . . . .255
Fee for applicant’s mistake . . . . . . . . . . . . . . . .41(a)8
Office mistake . . . . . . . . . . . . . . . . . . . . . . . . . . . .254
Certified copies:
Fee for certification . . . . . . . . . . . . . . . . . . . . .41(a)11
Of drawings and specifications of patents
issued. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9
Of records, furnished to Court of Appeals for
the Federal Circuit in appeals . . . . . . . . . . . . . . .143
Citation of prior art in patent. . . . . . . . . . . . . . . . . . . .301
Citizenship required in oath. . . . . . . . . . . . . . . . . . . . .115
Civil action:
Election of in case of interference. . . . . . . . . . . . .141
Infringement. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .291
In case of interference . . . . . . . . . . . . . . . . . . . . . .146
Jurisdiction, plurality of parties, foreign party . . . 146
To obtain patent. . . . . . . . . . . . . . . . . . . . . . . . . . .145
Claim of patent:
Independent or dependent . . . . . . . . . . . . . . . .41, 112
Independent or dependent, validity . . . . . . . . . . . . 282
Invalid, effect of. . . . . . . . . . . . . . . . . . . . . . . . . . .253
Invalid, suits on patent with. . . . . . . . . . . . . . . . . .288
Notice of rejection. . . . . . . . . . . . . . . . . . . . . . . . .132
Too extensive or narrow, remedy. . . . . . . . . . . . . .251
What to cover. . . . . . . . . . . . . . . . . . . . . . . . . . . . .112
Classification of patents . . . . . . . . . . . . . . . . . . . . . . . . .8
Clerk of United States Court may summon witness
in
Interference cases. . . . . . . . . . . . . . . . . . . . . . . . . . .24
Must notify Director of patent suits. . . . . . . . . . . .290
Commerce, Department of, United States Patent
and Trademark Office in . . . . . . . . . . . . . . . . . . . . . . .1
Commerce, Secretary of:
Appointments by . . . . . . . . . . . . . . . . . . . . . . . . . . . .3
Commissioner for Patents:
How appointed and duties . . . . . . . . . . . . . . . . . . . . .3
Member of Board. . . . . . . . . . . . . . . . . . . . . . . . . . . .6
Commonly owned invention and reference subject
matter. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Compensation, right to because of secrecy order . . . . 183
Composition of matter:
Patentable. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .101
Specimens of ingredients may be required . . . . . . 114
Concealment of records. . . . . . . . . . . . . . 18 U.S.C. 2071
Confidential status of application . . . . . . . . . . . . 122, 205
Continuing application . . . . . . . . . . . . . . . . . . . . . . . .120
Contributory infringement. . . . . . . . . . . . . . . . . . . . . .271
 
 
Copies of records, fees. . . . . . . . . . . . . . . . . . . . . . . . . 41
Correction of inventors in patent . . . . . . . . . . . . . . . . 256
Correction of letters patent. . . . . . . . . . . . . . . . . 254, 255
 
 
D
 
Damages for infringement. . . . . . . . . . . . . . . . . . . . . 284
Day of taking any action or paying any fee falling
on Saturday, Sunday, or holiday. . . . . . . . . . . . . . . . 21
Death or incapacity of inventor . . . . . . . . . . . . . . . . . 117
Decisions in patent cases, printing of. . . . . . . . . . . . . . 10
Declaration in lieu of oath . . . . . . . . . . . . . . . . . . . . . . 25
Dedication of term . . . . . . . . . . . . . . . . . . . . . . . . . . . 253
Defective execution of documents, effect of . . . . . . . . 26
Defenses in action for infringement. . . . . . . . . . . . . . 282
Definitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100, 351
Deposit with United States Postal Service . . . . . . . . . . 21
Depositions, Director may establish rules for . . . . . . . 23
Deputy Commissioner . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Member of Board. . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Description of invention.. . . . . . . . . . . . . . . . . . . . . . 112
Design patents:
Double recovery, not allowed.. . . . . . . . . . . . . . . 289
Fees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41(a)3
For what granted.. . . . . . . . . . . . . . . . . . . . . . . . . 171
Liability for infringement of. . . . . . . . . . . . . . . . . 289
Penalty for unauthorized use of patented
design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 289
Prior foreign applications. . . . . . . . . . . . . . . . . . . 172
Right of priority . . . . . . . . . . . . . . . . . . . . . . . . . . 172
Subject to same provisions as other patents . . . . . 171
Term of . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
Unauthorized use of . . . . . . . . . . . . . . . . . . . . . . . 289
Designated office . . . . . . . . . . . . 363, 366, 367, 371, 372
Determination of patent term adjustment . . . . . . . . . . 154
Director:
Annual report to Congress . . . . . . . . . . . . . . . . . . . 13
Consult with Patent Public Advisory Committee.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Duties of. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
How appointed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Intellectual Property Policy Issues, advises
President, Federal Departments . . . . . . . . . . . . . . . 2
May disbar attorneys.. . . . . . . . . . . . . . . . . . . . . . . 32
May establish charges.. . . . . . . . . . . . . . . . . . . . . . 41
May make rules for taking affidavits and depositions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Member of Board. . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Reexamination order.. . . . . . . . . . . . . . . . . . . . . . 304
Shall cause examination to be made. . . . . . . . . . . 131
To establish regulations . . . . . . . . . . . . . . . . . . . . . . 3
To furnish court with grounds of decision, on
appeal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
 
 
 
To prescribe rules and regulations governing
recognition of attorneys and agents. . . . . . . . . . . . . 2
To sign patents or have name printed thereon
and attested . . . . . . . . . . . . . . . . . . . . . . . . . . . . .153
To superintend grant of patents . . . . . . . . . . . . . . . . .3
Disbarment of attorneys and agents . . . . . . . . . . . . . . .32
Disclaimer:
Fee.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .41(a)5
How filed and by whom . . . . . . . . . . . . . . . . . . . .253
Must be filed before commencement of suit to
recover costs . . . . . . . . . . . . . . . . . . . . . . . . . . . .288
Nature of . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .253
District Court for District of Columbia:
Jurisdiction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .146
Review of disbarment of attorneys and agents . . . . 32
Division of application . . . . . . . . . . . . . . . . . . . . . . . .121
Division of patent on reissue. . . . . . . . . . . . . . . . . . . .251
Drawing:
Attached to patent . . . . . . . . . . . . . . . . . . . . . . . . .154
Part of patent . . . . . . . . . . . . . . . . . . . . . . . . . . . . .154
Printing of . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10
When necessary. . . . . . . . . . . . . . . . . . . . . . . . . . .113
Duties of Director . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3
 
 
E
 
Elected office. . . . . . . . . . . . . . . . . . . . . . . . . . . .371, 372
Employees of United States Patent and Trademark
Office. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3
How appointed. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3
Restrictions on as to interest in patents . . . . . . . . . . . 4
English language. . . . . . . . . . . . . . . . . . . . . . . . . . . . .361
Entry into national phase in United States . . . . . . . . . 371
Error in naming inventors . . . . . . . . . . . . . . . . . . . . . .116
Establishment of date of invention by reference to
knowledge or use in foreign country. . . . . . . . . . . .104
Establishment, United States Patent and Trade
mark Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1
Examination:
Applicants shallbe notified of rejection on. . . . . .132
To be made of application and alleged inven
tion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .131
Exchange of United States Patent and Trademark
Office Publications for other publications . . . . . . . . . 10
Exchange of printed copies of patents and pub
lished application of patents with foreign coun
tries. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11
Executors, administrators or guardians . . . . . . . . . . . . 117
Extension of patent term . . . . . . . . . . . . . . . . . . . . . . .155
 
 
Extension of time to reply fee . . . . . . . . . . . . . . . .41(a)8
 
F
 
Falsely making or labeling articles as patented . . . . . 292
Federal agency, defined . . . . . . . . . . . . . . . . . . . . . . . 200
Federal Assistance, inventions made with:
Confidentiality . . . . . . . . . . . . . . . . . . . . . . . . . . . 205
Definitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
Disposition of rights. . . . . . . . . . . . . . . . . . . . . . . 202
Domestic and foreign protection of federally
owned inventions . . . . . . . . . . . . . . . . . . . . . . . . 207
Educational awards. . . . . . . . . . . . . . . . . . . . . . . . 212
March-in rights. . . . . . . . . . . . . . . . . . . . . . . . . . . 203
Policyand objective of. . . . . . . . . . . . . . . . . . . . . 200
Precedence of chapter over other Acts . . . . . . . . . 210
Preference for United States industry. . . . . . . . . . 204
Regulations governing Federal licensing . . . . . . . 208
Relationship to antitrust laws. . . . . . . . . . . . . . . . 211
Restrictions on licensing of federally owned
inventions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 209
Uniform clausesand regulations . . . . . . . . . . . . . 206
Fees:
Amount of. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
For attorney awarded by court. . . . . . . . . . . . . . . 285
For records, publications, and services not
specified in statute . . . . . . . . . . . . . . . . . . . . . . . . 41
How paid and refunded. . . . . . . . . . . . . . . . . . . . . . 42
Independent inventor, 50% reduction. . . . . . . . . 41(h)
International. . . . . . . . . . . . . . . . . . . . . . . . . 361, 376
Nonprofit organization, 50% reduction . . . . . . . 41(h)
Payable to Director. . . . . . . . . . . . . . . . . . . . . . . 42(a)
Small business, 50% reduction. . . . . . . . . . . . . . 41(h)
Small entity, 50% reduction . . . . . . . . . . . . 41(h), 133
To witness interference cases . . . . . . . . . . . . . . . . . 24
Filing application by other than inventor . . . . . . . . . . 118
Filing date requirements. . . . . . . . . . . . . . . . . . . . . . . .111
Filing fee, Amount of. . . . . . . . . . . . . . . . . . . . . . . 41(a)1
Foreign applications:
License to file required. . . . . . . . . . . . . . . . . . . . . 184
Penalty for filing without license . . . . . . . . . 185, 186
Foreign countries, exchange of printed copies of
patents and published application of patents
with. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Foreign country, knowledge of use in, not used to
establish date of invention . . . . . . . . . . . . . . . 102, 104
Foreign patentee:
Jurisdiction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 293
Service . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 293
Foreign patents:
Copies of, exchanged for United States patents
and published application of patents . . . . . . . . . . 11
 
 
 
Prior, effect on United States application for
patent. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102
Foreign priority . . . . . . . . . . . . . . . . .119(a)-(d),365, 373
Fraudulent statements. . . . . . . . . . . . . . . 18 U.S.C. 1001
Funding agreement, defined . . . . . . . . . . . . . . . . . . . .200
 
 
G
 
Government interests in patents . . . . . . . . . . . . . . . . .267
 
 
H
 
Holiday, time for action expiring on . . . . . . . . . . . . . . .21
 
 
I
 
 
Importation of products made by a patented pro
cess. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .295
Improvements, patents may be granted for . . . . . . . . . 101
Indexes of patents and patentees, printing of . . . . . . . . 10
Infringement, patent: Action for . . . . . . . . . . . . . . . . .281
Attorney fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . .285
By United States, time limitation in suit for . . . . . 286
Clerk of court to notify United States Patent
and Trademark Office of suit. . . . . . . . . . . . . . . .290
Contributory. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .271
Damages for.. . . . . . . . . . . . . . . . . . . . . . . . . . . . .284
Defenses in suit for . . . . . . . . . . . . . . . . . . . .273, 282
Defined. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .271
Design patent. . . . . . . . . . . . . . . . . . . . . . . . . . . . .289
Injunction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .283
Notice of, necessary to recovery of damages . . . . 287
Pleading defense and special matters to be
proved in suit. . . . . . . . . . . . . . . . . . . . . . . . . . . .282
Suit for, when a claim is invalid . . . . . . . . . . . . . .288
Temporary presence in United States . . . . . . . . . . 272
Time limitation. . . . . . . . . . . . . . . . . . . . . . . . . . . .286
Injunctions may be granted by court having juris
diction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .283
Insane persons, patent applications of . . . . . . . . . . . . . 117
Interference, patent:
Agreements, between parties, relating to ter
mination, to be filed in Patent and Trademark
Office. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .135
Appeal to court. . . . . . . . . . . . . . . . . . . . . . . . . . . .141
Arbitration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .135
Determination of priority. . . . . . . . . . . . . . . .102, 135
Parties to be notified of . . . . . . . . . . . . . . . . . . . . .135
Review of decision by civil action. . . . . . . . . 145, 146
Rules for taking testimony. . . . . . . . . . . . . . . . . . . .23
International application . . . . . . . 351, 365, 366, 367, 375
Fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .376
National phase in United States. . . . . . . . . . . . . . .371
Priority rights. . . . . . . . . . . . . . . . . . . . . . . . . . . . .365
 
 
Interfering patent:
How set aside. . . . . . . . . . . . . . . . . . . . . . . . . . . . 291
Jurisdiction, plurality of parties, foreign party146, 291
Relief against . . . . . . . . . . . . . . . . . . . . . . . . . . . . 291
International Bureau. . . . . . .. . . . . . . 351, 361, 362, 371
International Preliminary Examining
Authority.. . . . . . . . . . . . . . . . . . . . . . . . 362, 364, 368
International Searching Authority . . . 351, 362, 364, 368
International studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Intervening rights on reissue . . . . . . . . . . . . . . . . . . . 252
Invalid patent claim disclaimer . . . . . . . . . . . . . . . . . 288
Invalidityof term extension . . . . . . . . . . . . . . . . . . . . 282
Invention date as affected by activity abroad . . . . . . . 104
Invention, defined. . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
Invention made abroad. . . . . . . . . . . . . . . . . . . . . . . . 104
Inventions promotion, improper and deceptive . . . . . 297
Inventions in outer space . . . . . . . . . . . . . . . . . . . . . . 105
Inventions patentable. . . . . . . . . . . . . . . . . . . . . . . . . 101
Inventions previously patented abroad. . . . . . . . . . . . 102
Inventive step . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Inventor:
Correction of patent . . . . . . . . . . . . . . . . . . . . . . . 256
Death or incapacity. . . . . . . . . . . . . . . . . . . . . . . . 117
May obtain patent. . . . . . . . . . . . . . . . . . . . . . . . . 101
Oath for joint.. . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
Refuses to sign . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
To make application . . . . . . . . . . . . . . . . . . . . . . . 111
Inventor’s certificate as reference. . . . . . . . . . . . . . . . 102
Inventor’s certificate priority right . . . . . . . . . . . . . . . 119
Issue of patent. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
Issue fee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
If not paid within three months, patent withheld. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
Nonpayment. . . . . . . . . . . . . . . . . . . . . . . . . . 41, 151
Payment of . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
 
 
J
 
Joint inventors . . . . . . . . . . . . . . . . . . . . . . . . . . 116, 256
Joint owners. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 262
Jurisdiction of District Court for District of
Columbia. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
 
 
K
 
Knowledge or use in foreign country no bar to
patent. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
 
 
L
 
Legal representative of dead or incapacitated
inventor. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
Liability of States. . . . . . . . . . . . . . . . . . . . . . . . . . . . 296
 
 
 
Libraries, public, copies of patents and published
applications for patents for.. . . . . . . . . . . . . . . . .12, 41
Library. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7
License for foreign filing. . . . . . . . . . . . . . . . . . . . . . .184
Limitation on damages . . . . . . . . . . . . . . . .154, 286, 287
 
 
M
 
Machines patentable . . . . . . . . . . . . . . . . . . . . . . . . . .100
Maintenance fees. . . . . . . . . . . . . . . . . . . . . . . . . . . 41(b)
Late payment . . . . . . . . . . . . . . . . . . . . . . . . . . . .41(c)
Manufactures patentable . . . . . . . . . . . . . . . . . . . . . . .101
Marking articles falsely as patented . . . . . . . . . . . . . .292
Marking articles patented . . . . . . . . . . . . . . . . . . . . . .287
Misjoinder of inventor. . . . . . . . . . . . . . . . .116, 202, 256
Mistake in patent, certificate thereof issued . . . . 254, 255
Model, shall be furnished if required. . . . . . . . . . . . . .114
Money:
Paid by mistake or in excess, refunded . . . . . . . . . .42
Received for fees, etc. to be paid into Treasury. . . . 42
Multiple dependent claim . . . . . . . . . . . . . . . . . . . . . .112
Fee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .41
Mutilation of records.. . . . . . . . . . . . . . . 18 U.S.C. 2071
 
 
N
 
National Security . . . . . . . . . . . . . . . . . . . . . .3, 122, 181
National stage of international application . 371, 372, 373
New matter inadmissible in reissue. . . . . . . . . . . . . . .251
New matter, may not be introduced by amendment . . 132
Nonjoinder of inventor . . . . . . . . . . . . . . . . . . . . . . . .256
Nonobviousness. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103
Nonprofit organization, defined . . . . . . . . . . . . . . . . .200
Nonresident patentee. . . . . . . . . . . . . . . . . . . . . . . . . .293
Notice as regards patents:
As to proof in infringement suits. . . . . . . . . . . . . .282
Of allowance of patent. . . . . . . . . . . . . . . . . . . . . .151
Of appeal to the Court of Appeals for the Fed
eral Circuit.. . . . . . . . . . . . . . . . . . . . . . . . .142, 143
Of interference. . . . . . . . . . . . . . . . . . . . . . . . . . . .135
Of patent suit, decision to be given United
States Patent and Trademark Office by clerk
of court.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .290
Of rejection of an application . . . . . . . . . . . . . . . .132
Of suit to be entered on file of patent . . . . . . . . . .290
To the public by Federal agency . . . . . . . . . . . . . .209
To the public that invention is patented. . . . . . . . .287
Novelty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102
 
 
O
 
Oath in patent application . . . . . . . . . . . . . . . . . .115, 152
Before whom taken in foreign countries . . . . . 25, 115
Before whom taken in the United States . . . . . . . . 115
 
 
Declaration in lieu of . . . . . . . . . . . . . . . . . . . . . . . 25
Joint inventors. . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
Must be made by inventor, if living. . . . . . . . . . . 115
Requirements of . . . . . . . . . . . . . . . . . . . . . . . . . . 115
To be made by legal representative if inventor
is dead or incapacitated . . . . . . . . . . . . . . . . . . . 117
Obviousness. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Officer of United States Patent and Trademark
Office may attest patents. . . . . . . . . . . . . . . . . . . . . 153
Officers and employees:
Of United States Patent and Trademark Office . . . . 3
Of United States Patent and Trademark Office,
restrictions on as to interests in patents . . . . . . . . . 4
Official Gazette:
Exchange for publications . . . . . . . . . . . . . . . . . . . 11
Printing and distribution of. . . . . . . . . . . . . . . . . . . 11
Public Advisory Committee Report. . . . . . . . . . . . . 5
Owners, joint . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 262
Ownership assignment . . . . . . . . . . . . . . . . . . . . . . . . 261
 
 
P
 
Paris Convention . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
Patent and Trademark Office: See United States
Patent and Trademark Office
Patent Cooperation Treaty:
Definitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 351
Patent fees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
Disposition of. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Patent laws, printing of. . . . . . . . . . . . . . . . . . . . . . . . . 10
Patent pending, false marking as . . . . . . . . . . . . . . . . 292
Patent Public Advisory Committee . . . . . . . . . . . . . . 3, 5
Appointment, timing and basis.. . . . . . . . . . . . . . . . 5
Duties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Consultation with Director. . . . . . . . . . . . . . . . . . 3, 5
Patent term adjustment. . . . . . . . . . . . . . . . . . . . . . . . 154
Patent term extension. . . . . . . . . . . . . . . . . . . . . . . . . 155
Patent term extensionapplication.. . . . . . . . . . . . . . . 156
Patent term restoration . . . . . . . . . . . . . . . . . . . . . . .155A
Patentability, conditions for . . . . . . . . . . . . . . . . 102, 103
Patentable inventions. . . . . . . . . . . . . . . . . . . . . . . . . 101
Patented article, marked as such. . . . . . . . . . . . . . . . . 287
Patentee:
Defined.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
Notified of interference. . . . . . . . . . . . . . . . . . . . . 135
Patents:
Application for . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
Assignment of. . . . . . . . . . . . . . . . . . . . . . . . . . . . 261
Based on international application . . . . . . . . . . . . 375
Certified copies of. . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Classification of . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Contents and duration of. . . . . . . . . . . . . . . . . . . . 154
Copies supplied to public libraries . . . . . . . . . . 12, 41
 
 
 
Copying claim of. . . . . . . . . . . . . . . . . . . . . . . . . .135
Date, duration, and form . . . . . . . . . . . . . . . . . . . .154
Design (See Design patents)
Effect of adverse interference decision . . . . . . . . . 135
Exchange of printed copies with foreign coun
tries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11
Fee on issuing . . . . . . . . . . . . . . . . . . . . . . . . . . . . .41
Filing application in foreign country . . . . . . . . . . . 184
For what granted . . . . . . . . . . . . . . . . . . . . . . . . . .101
Foreign knowledge or use no bar to grant of. . . . .102
How issued, attested, and recorded . . . . . . . . . . . . 153
May be granted to assignee . . . . . . . . . . . . . . . . . .152
May be withheld in certain cases. . . . . . . . . . . . . .181
Obtainable by civil action . . . . . . . . . . . . . . . . . . .145
Personal property.. . . . . . . . . . . . . . . . . . . . . . . . .261
Presumption of validity . . . . . . . . . . . . . . . . . . . . .282
Price of copies . . . . . . . . . . . . . . . . . . . . . . . . . .41(a)9
Printing of . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10
Reissuing of, when defective. . . . . . . . . . . . . . . . .251
Rights of invention made with federal assis
tance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200 - 212
Restrictions on officers and employees of
United States Patent and Trademark Office as
to interest in. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4
Surrender of, to take effect on reissue . . . . . . . . . . 251
Term. . . . . . . . . . . . . . . . . . . . . . 154, 155, 166A, 156
Term adjustment . . . . . . . . . . . . . . . . . . . . . . . . . .154
Term extension. . . . . . . . . . . . . . . . . . . . . . . .155, 156
Term restoration.. . . . . . . . . . . . . . . . . . . . . . . . 155A
Time of issue, payment of issue fee. . . . . . . . . . . .151
To be authenticated by seal of United States
Patent and Trademark Office. . . . . . . . . . . . . . . . . .2
When to issue. . . . . . . . . . . . . . . . . . . . . . . . . . . . .151
Withheld for nonpayment of issue fee. . . . . . . . . .151
Patent rights in inventions made with Federal
assistance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200-212
Confidentiality. . . . . . . . . . . . . . . . . . . . . . . . . . . .205
Definitions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .201
Disposition of rights. . . . . . . . . . . . . . . . . . . . . . . .202
Domestic and foreign protection of federally
owned inventions. . . . . . . . . . . . . . . . . . . . . . . . .207
Educational awards . . . . . . . . . . . . . . . . . . . . . . . .212
March-in rights . . . . . . . . . . . . . . . . . . . . . . . . . . .203
Policy and objective of . . . . . . . . . . . . . . . . . . . . .200
Precedence of chapter over other Acts . . . . . . . . . 210
Preference for United States industry . . . . . . . . . . 204
Regulations governing federal licensing . . . . . . . . 208
Relationship to antitrust laws. . . . . . . . . . . . . . . . .211
Restrictions on licensing of federally owned
inventions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .209
Uniform clauses and regulations . . . . . . . . . . . . . .206
Period for response . . . . . . . . . . . . . . . . . . . . . . . .21, 133
 
 
Photolithography, Headings of drawings printed . . . . . 10
Plant patents:
Claim. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162, 164
Description . . . . . . . . . . . . . . . . . . . . . . . . . . 162, 163
Fees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
Nature of right. . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
Plants patentable. . . . . . . . . . . . . . . . . . . . . . . . . . 161
Secretary of Agriculture to furnish information
and detail employees . . . . . . . . . . . . . . . . . . . . . 164
Pleading and proof in action for infringement . . . . . . 282
Postal Service deposit. . . . . . . . . . . . . . . . . . . . . . . . . . 21
Practical application, defined. . . . . . . . . . . . . . . . . . . 200
Pre-issuance opposition, when prohibited . . . . . . . . . 122
Presumption of product made by patented process . . 295
Presumption of validity of patents. . . . . . . . . . . . . . . 282
Printed publication bar to a patent. . . . . . . . . . . . . . . 102
Printing:
Decisions in patent cases . . . . . . . . . . . . . . . . . . . . 10
Of papers filed . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
United States Patent and Trademark Office . . . . . . 10
Printing headings of drawings by United States
Patent and Trademark Office . . . . . . . . . . . . . . . . . . 10
Prior art, citation of. . . . . . . . . . . . . . . . . . . . . . . . . . . 301
Prior patenting or publication bar to patent . . . . . . . . 102
Priority, foreign.. . . . . . . . . . . . . . . . . . . . . . . . . 119, 365
Priority of invention.. . . . . . . . . . . . . . . . . . . . . . . . . 102
Priority of invention, determined by Board of
Patent Appeals and Interferences . . . . . . . . . . . . . . 135
Priority, right of, under treaty or law . . . . . . . . . . . . . 119
For design applications. . . . . . . . . . . . . . . . . . . . . 172
Process defined.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
Process Patent Amendment Act of 1988 . . . . . . . . . . 287
Process patentable . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
Product made by patent process. . . . . . . . . . . . . . . . . 295
Property of United States Patent and Trademark
Office. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Provisional applications . . . . . . . . . . . . . . . . . . . .111, 119
Provisional rights. . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
Protest and pre-issuance opposition, when prohibited . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
Public use or sale. . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
Of invention bar to a patent . . . . . . . . . . . . . . . . . 102
Publication of international application, effect. . . . . . 374
Publication of patent applications . . . . . . . . . . . 122, 181
Publications regarding patents and trademarks . . . . . . 10
 
 
R
Receiving Office. . . . . . . . . . . . . 351, 361, 364, 367, 368
Recording of assignments. . . . . . . . . . . . . . . . . . . . . . 261
Reexamination order by Director . . . . . . . . . . . . 304, 313
Reexamination procedure
 
 
Appeal. . . . . . . . . . . . . . . . . . . . . . 134, 141, 306, 315
 
 
 
Certificate of patentability, unpatentability,
and claim cancellation. . . . . . . . . . . . . . . . .307, 316
Conduct of reexamination proceedings . . . . . 305, 314
Determination of issue by Director . . . . . . . . 303, 312
Determination of new question . . . . . . . . . . . 303, 312
Ex Parte . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 302-307
Inter Partes. . . . . . . . . . . . . . . . . . . . . . . . . . . 311-318
When prohibited. . . . . . . . . . . . . . . . . . . . . . . . .317
Request. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .302, 311
Special dispatch. . . . . . . . . . . . . . . . . . . . . . .305, 314
Stay of litigation.. . . . . . . . . . . . . . . . . . . . . . . . . .318
Reexamination to be made after first rejection, if
desired . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .132
References, to be cited on examination. . . . . . . . . . . .132
Refund of money paid by mistake or in excess. . . . . . .42
Reissue of patents:
Application fee. . . . . . . . . . . . . . . . . . . . . . . . . .41(a)4
Application may be made by assignee in cer
tain cases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .251
By reason of defective claims . . . . . . . . . . . . . . . .251
Effect of. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .252
For unexpired term of original patent . . . . . . . . . . 251
Intervening rights. . . . . . . . . . . . . . . . . . . . . . . . . .252
Of defective patents. . . . . . . . . . . . . . . . . . . . . . . .251
To contain no new matter.. . . . . . . . . . . . . . . . . . .251
Rejection, applicant shall be notified of reasons
for. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .132
Remedy for infringement of patent. . . . . . . . . . . . . . .281
Removal of records . . . . . . . . . . . . . . . . . 18 U.S.C. 2071
Report to Congress, annual . . . . . . . . . . . . . . . . . . . . . .13
Request for reexamination proceeding . . . . . . . . 302, 311
Restoration of patent. . . . . . . . . . . . . . . . . . . . . . . . 155A
Restrictions on officers and employees of United
States Patent and Trademark Office as to inter
est in patents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4
Retention of revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . .2
Revival if delay unavoidable. . . . . . . . . . . . . . . . . . . .133
Right of foreign priority . . . . . . . . . . . . . . . . . . . . . . .365
Right to compensation because of secrecy order. . . . . 183
Rules for taking testimony, Director to establish . . . . . 23
Rules of practice:
Authority for . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2
Printing of . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10
 
 
S
 
Saturday, time for action expiring on . . . . . . . . . . . . . .21
Seal of United States Patent and Trademark Office . . . . 2
Secrecy of applications . . . . . . . . . . . . . . . . . . . . . . . .122
Secrecy of certain inventions. . . . . . . . . . . . . . . 181 - 188
Secrecy of international application . . . . . . . . . . . . . . 368
 
 
Secrecy order . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181
Small business firm, defined . . . . . . . . . . . . . . . . . . . 200
Small entity status. . . . . . . . . . . . . . . . . . . . . . . . . . . 2, 41
Specification(s):
Contents of . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
If defective, reissue to correct. . . . . . . . . . . . . . . . 251
Part of patent. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
Printing of. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10, 41
Uncertified copies, price of. . . . . . . . . . . . . . . . . . . 41
Specimens, may be required. . . . . . . . . . . . . . . . . . . . 114
Statutory invention registration . . . . . . . . . . . . . . . . . 157
Subpoenas to witnesses . . . . . . . . . . . . . . . . . . . . . . . . 24
Suit against the United States. . . . . . . . . . . . . . . . . . . 286
Suit in equity (See Civil action)
Sunday,time for action expiring on . . . . . . . . . . . . . . . 21
Surcharge for later filing of fee or oath . . . . . . . . . . . 111
 
 
T
 
Term extension:
For administrative delays . . . . . . . . . . . . . . . . . . . 154
For delays due to interference, secrecy orders,
and/or appellate review. . . . . . . . . . . . . . . . . . . . 154
Regulatory review. . . . . . . . . . . . . . . . . . . . . . . . . 156
Term of patent:
Design. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
Disclaimer of . . . . . . . . . . . . . . . . . . . . . . . . . . . . 253
Extension . . . . . . . . . . . . . . . . . . . . . . . . . . . 155, 156
Period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
Restoration . . . . . . . . . . . . . . . . . . . . . . . . . . . . .155A
Testimony,rules for taking. . . . . . . . . . . . . . . . . . . . . . 23
Time:
Expiring on Saturday, Sunday, or holiday . . . . . . . 21
For payment of issue fee. . . . . . . . . . . . . . . . . . . . 151
For taking action in Government cases . . . . . . . . 267
Limitation on damages. . . . . . . . . . . . . . . . . . . . . 286
Within which action must be taken.. . . . . . . . . . . 133
Title of invention . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
Trademark fees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42(c)
Trademarks, reference to . . . . . . . . . . . . . . . . . 1, 2, 3, 10
Translation error in international application . . . . . . . 375
 
 
U
 
Unauthorized disclosure. . . .. . .. . . . . . . . . . . . . . . . 182
Unauthorized person may not lawfully assist per
sons in transaction of business before the Office . . . 33
Under Secretary of Commerce for Intellectual
Property. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
United States as designated office . . . . . . . . . . . . . . . 363
United States, defined. . . . . . . . . . . . . . . . . . . . . . . . . 100
 
 
 
United States Patent and Trademark Office:
In Department of Commerce. . . . . . . . . . . . . . . . . . .1
Library. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7
Printing. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .10
Rules, authority for . . . . . . . . . . . . . . . . . . . . . . . . . .2
Seal of . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2
 
 
Unpatented article, penalty for deceptive marking . . . 292
Use in foreign countries, no bar to grant of patent . . . 102
 
 
V
 
 
Verified translation requirement . . . . . . . . . . . . . . . . .372
 
 
Voluntary arbitration.. . . . . . . . . . . . . . . . . . . . . . . . . 294
 
 
W
 
Withdrawal of international application . . . . . . . . . . . 366
Withholding of patent. . . . . . . . . . . . . . . . . . . . . . . . . 181
Witness:
 
 
Failing to attend or refusing to testify. . . . . . . . . . . 24
Fees of, interference cases . . . . . . . . . . . . . . . . . . . 24
In interference summoned by clerk of United
 
 
States court.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Whenin contempt, punishment . . . . . . . . . . . . . . . 24

Latest revision as of 13:20, December 7, 2011

United States Code Title 35 – Patents

PART I — UNITED STATES PATENT AND TRADEMARK OFFICE[edit | edit source]

CHAPTER 1 — ESTABLISHMENT, OFFICERS AND EMPLOYEES, FUNCTIONS[edit | edit source]

35 U.S.C. 1 Establishment.[edit | edit source]

(a) ESTABLISHMENT.— The United States Patent and Trademark Office is established as an agency of the United States, within the Department of Commerce. In carrying out its functions, the United States Patent and Trademark Office shall be subject to the policy direction of the Secretary of Commerce, but otherwise shall retain responsibility for decisions regarding the management and administration of its operations and shall exercise independent control of its budget allocations and expenditures, personnel decisions and processes, procurements, and other administrative and management functions in accordance with this title and applicable provisions of law. Those operations designed to grant and issue patents and those operations which are designed to facilitate the registration of trademarks shall be treated as separate operating units within the Office. (b) OFFICES.— The United States Patent and Trademark Office shall maintain its principal office in the metropolitan Washington, D.C., area, for the service of process and papers and for the purpose of carrying out its functions. The United States Patent and Trademark Office shall be deemed, for purposes of venue in civil actions, to be a resident of the district in which its principal office is located, except where jurisdiction is otherwise provided by law. The United States Patent and Trademark Office may establish satellite offices in such other places in the United States as it considers necessary and appropriate in the conduct of its business. (c) REFERENCE.— For purposes of this title, the United States Patent and Trademark Office shall also be referred to as the “Office” and the “Patent and Trademark Office”.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-572 (S. 1948 sec. 4711).)

35 U.S.C. 2 Powers and duties.[edit | edit source]

(a) IN GENERAL.— The United States Patent and Trademark Office, subject to the policy direction of the Secretary of Commerce— (1) shall be responsible for the granting and issuing of patents and the registration of trademarks; and (2) shall be responsible for disseminating to the public information with respect to patents and trademarks. (b) SPECIFIC POWERS.— The Office—

(1) shall adopt and use a seal of the Office, which shall be judicially noticed and with which letters patent, certificates of trademark registrations, and papers issued by the Office shall be authenticated; (2) may establish regulations, not inconsistent with law, which— (A) shall govern the conduct of proceedings in the Office; (B) shall be made in accordance with section 553 of title 5; (C) shall facilitate and expedite the processing of patent applications, particularly those which can be filed, stored, processed, searched, and retrieved electronically, subject to the provisions of section 122 relating to the confidential status of applications; (D) may govern the recognition and conduct of agents, attorneys, or other persons representing applicants or other parties before the Office, and may require them, before being recognized as representatives of applicants or other persons, to show that they are of good moral character and reputation and are possessed of the necessary qualifications to render to applicants or other persons valuable service, advice, and assistance in the presentation or prosecution of their applications or other business before the Office; (E) shall recognize the public interest in continuing to safeguard broad access to the United States patent system through the reduced fee structure for small entities under section 41(h)(1) of this title; and (F) provide for the development of a performance-based process that includes quantitative and qualitative measures and standards for evaluating cost-effectiveness and is consistent with the principles of impartiality and competitiveness; (3) may acquire, construct, purchase, lease, hold, manage, operate, improve, alter, and renovate any real, personal, or mixed property, or any interest therein, as it considers necessary to carry out its functions; (4)(A) may make such purchases, contracts for the construction, or management and operation of facilities, and contracts for supplies or services, without regard to the provisions of subtitle I and chapter 33 of title 40, title III of the Federal Property and Administrative Services Act of 1949 (41 U.S.C. 251 et seq.), and the McKinney-Vento Homeless Assistance Act (42 U.S.C. 11301 et seq.);


(B) may enter into and perform such purchases and contracts for printing services, including the process of composition, platemaking, presswork, silk screen processes, binding, microform, and the products of such processes, as it considers necessary to carry out the functions of the Office, without regard to sections 501 through 517 and 1101 through 1123 of title 44; (5) may use, with their consent, services, equipment, personnel, and facilities of other departments, agencies, and instrumentalities of the Federal Government, on a reimbursable basis, and cooperate with such other departments, agencies, and instrumentalities in the establishment and use of services, equipment, and facilities of the Office; (6) may, when the Director determines that it is practicable, efficient, and cost-effective to do so, use, with the consent of the United States and the agency, instrumentality, Patent and Trademark Office, or international organization concerned, the services, records, facilities, or personnel of any State or local government agency or instrumentality or foreign patent and trademark office or international organization to perform functions on its behalf; (7) may retain and use all of its revenues and receipts, including revenues from the sale, lease, or disposal of any real, personal, or mixed property, or any interest therein, of the Office;


(8) shall advise the President, through the Secretary of Commerce, on national and certain international intellectual property policy issues; (9) shall advise Federal departments and agencies on matters of intellectual property policy in the United States and intellectual property protection in other countries; (10) shall provide guidance, as appropriate, with respect to proposals by agencies to assist foreign governments and international intergovernmental organizations on matters of intellectual property protection; (11) may conduct programs, studies, or exchanges of items or services regarding domestic and international intellectual property law and the effectiveness of intellectual property protection domestically and throughout the world; (12)(A) shall advise the Secretary of Commerce on programs and studies relating to intellectual property policy that are conducted, or authorized to be conducted, cooperatively with foreign intellectual property offices and international intergovernmental organizations; and


(B) may conduct programs and studies described in subparagraph (A); and (13)(A) in coordination with the Department of State, may conduct programs and studies cooperatively with foreign intellectual property offices and international intergovernmental organizations; and


(B) with the concurrence of the Secretary of State, may authorize the transfer of not to exceed $100,000 in any year to the Department of State for the purpose of making special payments to international intergovernmental organizations for studies and programs for advancing international cooperation concerning patents, trademarks, and other matters. (c) CLARIFICATION OF SPECIFIC POWERS.— (1) The special payments under subsection (b)(13)(B) shall be in addition to any other payments or contributions to international organizations described in subsection (b)(13)(B) and shall not be subject to any limitations imposed by law on the amounts of such other payments or contributions by the United States Government.



(2) Nothing in subsection (b) shall derogate from the duties of the Secretary of State or from the duties of the United States Trade Representative as set forth in section 141 of the Trade Act of 1974 (19 U.S.C. 2171).

(3) Nothing in subsection (b) shall derogate from the duties and functions of the Register of Copyrights or otherwise alter current authorities relating to copyright matters. (4) In exercising the Director’s powers under paragraphs (3) and (4)(A) of subsection (b), the Director shall consult with the Administrator of General Services. (5) In exercising the Director’s powers and duties under this section, the Director shall consult with the Register of Copyrights on all copyright and related matters. (d) CONSTRUCTION.— Nothing in this section shall be construed to nullify, void, cancel, or interrupt any pending request-for-proposal let or contract issued by the General Services Administration for the specific purpose of relocating or leasing space to the United States Patent and Trademark Office.


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-572 (S. 1948 sec. 4712); subsection (b)(4)(A) amended Oct. 30, 2000, Public Law 106-400, sec. 2, 114 Stat. 1675; subsections (b)(2)(B) and (b)(4)(B) amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1904; subsection (b)(4)(A) amended Dec. 15, 2003, Public Law 108-178, sec. 4(g), 117 Stat. 2641.)

35 U.S.C. 3 Officers and employees.[edit | edit source]

(a) UNDER SECRETARY AND DIRECTOR.— (1) IN GENERAL.— The powers and duties of the United States Patent and Trademark Office shall be vested in an Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office (in this title referred to as the “Director”), who shall be a citizen of the United States and who shall be appointed by the President, by and with the advice and consent of the Senate. The Director shall be a person who has a professional background and experience in patent or trademark law. (2) DUTIES.—

(A) IN GENERAL.— The Director shall be responsible for providing policy direction and management supervision for the Office and for the issuance of patents and the registration of trademarks. The Director shall perform these duties in a fair, impartial, and equitable manner.

(B) CONSULTING WITH THE PUBLIC ADVISORY COMMITTEES.— The Director shall consult with the Patent Public Advisory Committee established in section 5 on a regular basis on matters relating to the patent operations of the Office, shall consult with the Trademark Public Advisory Committee established in section 5 on a regular basis on matters relating to the trademark operations of the Office, and shall consult with the respective Public Advisory Committee before submitting budgetary proposals to the Office of Management and Budget or changing or proposing to change patent or trademark user fees or patent or trademark regulations which are subject to the requirement to provide notice and opportunity for public comment under section 553 of title 5, as the case may be. (3) OATH.— The Director shall, before taking office, take an oath to discharge faithfully the duties of the Office. (4) REMOVAL.— The Director may be removed from office by the President. The President shall provide notification of any such removal to both Houses of Congress. (b) OFFICERS AND EMPLOYEES OF THE OFFICE.— (1) DEPUTY UNDER SECRETARY AND DEPUTY DIRECTOR.— The Secretary of Commerce, upon nomination by the Director, shall appoint a Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the United States Patent and Trademark Office who shall be vested with the authority to act in the capacity of the Director in the event of the absence or incapacity of the Director. The Deputy Director shall be a citizen of the United States who has a professional background and experience in patent or trademark law. (2) COMMISSIONERS.—

(A) APPOINTMENT AND DUTIES.— The Secretary of Commerce shall appoint a Commissioner for Patents and a Commissioner for Trademarks, without regard to chapter 33, 51, or 53 of title 5. The Commissioner for Patents shall be a citizen of the United States with demonstrated management ability and professional background and experience in patent law and serve for a term of 5 years. The Commissioner for Trademarks shall be a citizen of the United States with demonstrated management ability and professional background and experience in trademark law and serve for a term of 5 years. The Commissioner for Patents and the Commissioner for Trademarks shall serve as the chief operating officers for the operations of the Office relating to patents and trademarks, respectively, and shall be responsible for the management and direction of all aspects of the activities of the Office that affect the administration of patent and trademark operations, respectively. The Secretary may reappoint a Commissioner to subsequent terms of 5 years as long as the performance of the Commissioner as set forth in the performance agreement in subparagraph (B) is satisfactory.

(B) SALARY AND PERFORMANCE AGREEMENT.— The Commissioners shall be paid an annual rate of basic pay not to exceed the maximum rate of basic pay for the Senior Executive Service established under section 5382 of title 5, including any applicable locality-based comparability payment that may be authorized under section 5304(h)(2)(C) of title 5. The compensation of the Commissioners shall be considered, for purposes of section 207(c)(2)(A) of title 18, to be the equivalent of that described under clause (ii) of section 207(c)(2)(A) of title 18. In addition, the Commissioners may receive a bonus in an amount of up to, but not in excess of, 50 percent of the Commissioners’ annual rate of basic pay, based upon an evaluation by the Secretary of Commerce, acting through the Director, of the Commissioners’ performance as defined in an annual performance agreement between the Commissioners and the Secretary. The annual performance agreements shall incorporate measurable organization and individual goals in key operational areas as delineated in an annual performance plan agreed to by the Commissioners and the Secretary. Payment of a bonus under this subparagraph may be made to the Commissioners only to the extent that such payment does not cause the Commissioners’ total aggregate compensation in a calendar year to equal or exceed the amount of the salary of the Vice President under section 104 of title 3. (C) REMOVAL.— The Commissioners may be removed from office by the Secretary for misconduct or nonsatisfactory performance under the performance agreement described in subparagraph (B), without regard to the provisions of title 5. The Secretary shall provide notification of any such removal to both Houses of Congress.

(3) OTHER OFFICERS AND EMPLOYEES.— The Director shall— (A) appoint such officers, employees (including attorneys), and agents of the Office as the Director considers necessary to carry out the functions of the Office; and (B) define the title, authority, and duties of such officers and employees and delegate to them such of the powers vested in the Office as the Director may determine. The Office shall not be subject to any administratively or statutorily imposed limitation on positions or personnel, and no positions or personnel of the Office shall be taken into account for purposes of applying any such limitation

(4) TRAINING OF EXAMINERS.— The Office shall submit to the Congress a proposal to provide an incentive program to retain as employees patent and trademark examiners of the primary examiner grade or higher who are eligible for retirement, for the sole purpose of training patent and trademark examiners. (5) NATIONAL SECURITY POSITIONS.— The Director, in consultation with the Director of the Office of Personnel Management, shall maintain a program for identifying national security positions and providing for appropriate security clearances, in order to maintain the secrecy of certain inventions, as described in section 181, and to prevent disclosure of sensitive and strategic information in the interest of national security. (c) CONTINUED APPLICABILITY OF TITLE 5. — Officers and employees of the Office shall be subject to the provisions of title 5, relating to Federal employees. (d) ADOPTION OF EXISTING LABOR AGREEMENTS.— The Office shall adopt all labor agreements which are in effect, as of the day before the effective date of the Patent and Trademark Office Efficiency Act, with respect to such Office (as then in effect). (e) CARRYOVER OF PERSONNEL.—

(1) FROM PTO.— Effective as of the effective date of the Patent and Trademark Office Efficiency Act, all officers and employees of the Patent and Trademark Office on the day before such effective date shall become officers and employees of the Office, without a break in service.

(2) OTHER PERSONNEL.— Any individual who, on the day before the effective date of the Patent and Trademark Office Efficiency Act, is an officer or employee of the Department of Commerce (other than an officer or employee under paragraph (1)) shall be transferred to the Office, as necessary to carry out the purposes of this Act, if— (A) such individual serves in a position for which a major function is the performance of work reimbursed by the Patent and Trademark Office, as determined by the Secretary of Commerce; (B) such individual serves in a position that performed work in support of the Patent and Trademark Office during at least half of the incumbent’s work time, as determined by the Secretary of Commerce; or (C) such transfer would be in the interest of the Office, as determined by the Secretary of Commerce in consultation with the Director.

Any transfer under this paragraph shall be effective as of the same effective date as referred to in paragraph (1), and shall be made without a break in service.

(f) TRANSITION PROVISIONS.—

(1) INTERIM APPOINTMENT OF DIRECTOR.— On or after the effective date of the Patent and Trademark Office Efficiency Act, the President shall appoint an individual to serve as the Director until the date on which a Director qualifies under subsection (a). The President shall not make more than one such appointment under this subsection. (2) CONTINUATION IN OFFICE OF CERTAIN OFFICERS.— (A) The individual serving as the Assistant Commissioner for Patents on the day before the effective date of the Patent and Trademark Office Efficiency Act may serve as the Commissioner for Patents until the date on which a Commissioner for Patents is appointed under subsection (b). (B) The individual serving as the Assistant Commissioner for Trademarks on the day before the effective date of the Patent and Trademark Office Efficiency Act may serve as the Commissioner for


Trademarks until the date on which a Commissioner for Trademarks is appointed under subsection (b).

(Amended Sept. 6, 1958, Public Law 85-933, sec. 1, 

72 Stat. 1793; Sept. 23, 1959, Public Law 86-370, sec. 1(a), 73 Stat. 650; Aug. 14, 1964, Public Law 88-426, sec. 305(26), 78 Stat. 425; Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Jan. 2, 1975, Public Law 93-601, sec. 1, 88 Stat. 1956; Aug. 27, 1982, Public Law 97-247, sec. 4, 96 Stat. 319; Oct. 25, 1982, Public Law 97-366, sec. 4, 96 Stat. 1760; Nov. 8, 1984, Public Law 98-622, sec. 405, 98 Stat. 3392; Oct. 28, 1998, Public Law 105-304, sec. 401(a)(1), 112 Stat. 2887; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-575 (S. 1948 sec. 4713); subsections (a)(2)(B), (b)(2), and (c) amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1904.)

35 U.S.C. 4 Restrictions on officers and employees as to interest in patents.[edit | edit source]

Officers and employees of the Patent and Trademark Office shall be incapable, during the period of their appointments and for one year thereafter, of applying for a patent and of acquiring, directly or indirectly, except by inheritance or bequest, any patent or any right or interest in any patent, issued or to be issued by the Office. In patents applied for thereafter they shall not be entitled to any priority date earlier than one year after the termination of their appointment.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949.)

35 U.S.C. 5 Patent and Trademark Office Public Advisory Committees.[edit | edit source]

(a) ESTABLISHMENT OF PUBLIC ADVISORY COMMITTEES.— (1) APPOINTMENT.— The United States Patent and Trademark Office shall have a Patent Public Advisory Committee and a Trademark Public Advisory Committee, each of which shall have nine voting members who shall be appointed by the Secretary of Commerce and serve at the pleasure of the Secretary of Commerce. Members of each Public Advisory Committee shall be appointed for a term of 3 years, except that of the members first appointed, three shall be appointed for a term of 1 year, and three shall be appointed for a term of 2 years. In making appointments to each Committee, the Secretary of Commerce shall consider the risk of loss of competitive advantage in international commerce or other harm to United States companies as a result of such appointments.

(2) CHAIR.— The Secretary shall designate a chair of each Advisory Committee, whose term as chair shall be for 3 years. (3) TIMING OF APPOINTMENTS.— Initial appointments to each Advisory Committee shall be made within 3 months after the effective date of the Patent and Trademark Office Efficiency Act. Vacancies shall be filled within 3 months after they occur. (b) BASIS FOR APPOINTMENTS.— Members of each Advisory Committee— (1) shall be citizens of the United States who shall be chosen so as to represent the interests of diverse users of the United States Patent and Trademark Office with respect to patents, in the case of the Patent Public Advisory Committee, and with respect to trademarks, in the case of the Trademark Public Advisory Committee; (2) shall include members who represent small and large entity applicants located in the United States in proportion to the number of applications filed by such applicants, but in no case shall members who represent small entity patent applicants, including small business concerns, independent inventors, and nonprofit organizations, constitute less than 25 percent of the members of the Patent Public Advisory Committee, and such members shall include at least one independent inventor; and (3) shall include individuals with substantial background and achievement in finance, management, labor relations, science, technology, and office automation. In addition to the voting members, each Advisory Committee shall include a representative of each labor organization recognized by the United States Patent and Trademark Office. Such representatives shall be nonvoting members of the Advisory Committee to which they are appointed. (c) MEETINGS.— Each Advisory Committee shall meet at the call of the chair to consider an agenda set by the chair. (d) DUTIES.— Each Advisory Committee shall— (1) review the policies, goals, performance, budget, and user fees of the United States Patent and Trademark Office with respect to patents, in the case of the Patent Public Advisory Committee, and with respect to Trademarks, in the case of the Trademark Public Advisory Committee, and advise the Director on these matters;

(2) within 60 days after the end of each fiscal year— (A) prepare an annual report on the matters referred to in paragraph (1); (B) transmit the report to the Secretary of Commerce, the President, and the Committees on the Judiciary of the Senate and the House of Representatives; and (C) publish the report in the Official Gazette of the United States Patent and Trademark Office. (e) COMPENSATION.— Each member of each Advisory Committee shall be compensated for each day (including travel time) during which such member is attending meetings or conferences of that Advisory Committee or otherwise engaged in the business of that Advisory Committee, at the rate which is the daily equivalent of the annual rate of basic pay in effect for level III of the Executive Schedule under section 5314 of title 5. While away from such member’s home or regular place of business such member shall be allowed travel expenses, including per diem in lieu of subsistence, as authorized by section 5703 of title 5. (f) ACCESS TO INFORMATION.— Members of each Advisory Committee shall be provided access to records and information in the United States Patent and Trademark Office, except for personnel or other privileged information and information concerning patent applications required to be kept in confidence by section 122. (g) APPLICABILITY OF CERTAIN ETHICS LAWS.— Members of each Advisory Committee shall be special Government employees within the meaning of section 202 of title 18. (h) INAPPLICABILITY OF FEDERAL ADVISORY COMMITTEE ACT.— The Federal Advisory Committee Act (5 U.S.C. App.) shall not apply to each Advisory Committee. (i) OPEN MEETINGS.— The meetings of each Advisory Committee shall be open to the public, except that each Advisory Committee may by majority vote meet in executive session when considering personnel, privileged, or other confidential information. (j) INAPPLICABILITY OF PATENT PROHIBITION.— Section 4 shall not apply to voting members of the Advisory Committees.

(Added Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-578 (S. 1948 sec. 4714); subsections (e) and (g) amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1904; subsection (i) amended and subsection (j) added Nov. 2, 2002, Public Law 107-273, sec. 13203, 116 Stat. 1902.)

35 U.S.C. 6 Board of Patent Appeals and Interferences.[edit | edit source]

(a) ESTABLISHMENT AND COMPOSITION.— There shall be in the United States Patent and Trademark Office a Board of Patent Appeals and Interferences. The Director, the Deputy Commissioner, the Commissioner for Patents, the Commissioner for Trademarks, and the administrative patent judges shall constitute the Board. The administrative patent judges shall be persons of competent legal knowledge and scientific ability who are appointed by the Director. (b) DUTIES.— The Board of Patent Appeals and Interferences shall, on written appeal of an applicant, review adverse decisions of examiners upon applications for patents and shall determine priority and patentability of invention in interferences declared under section 135(a). Each appeal and interference shall be heard by at least three members of the Board, who shall be designated by the Director. Only the Board of Patent Appeals and Interferences may grant rehearings.


(Repealed by Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4715(a).)

(Added Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4717(2)).)

(Subsection (a) amended Nov. 2, 2002, Public Law 107-273, sec. 13203, 116 Stat. 1902.)

35 U.S.C. 7 Library.[edit | edit source]

The Director shall maintain a library of scientific and other works and periodicals, both foreign and domestic, in the Patent and Trademark Office to aid the officers in the discharge of their duties.

(Repealed Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4717(1)).)

(Transferred from 35 U.S.C. 8 Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S.

1948 sec. 4717(1)); amended Jan. 2, 1975, Public Law 93596, sec. 1, 88 Stat. 1949.)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 8 Classification of patents.[edit | edit source]

The Director may revise and maintain the classification by subject matter of United States letters patent, and such other patents and printed publications as may be necessary or practicable, for the purpose of determining with readiness and accuracy the novelty of inventions for which applications for patent are filed.

(Transferred to 35 U.S.C. 7 Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4717(1)).)

(Transferred from 35 U.S.C. 9 Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4717(1)).)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 9 Certified copies of records.[edit | edit source]

The Director may furnish certified copies of specifications and drawings of patents issued by the Patent and Trademark Office, and of other records available either to the public or to the person applying therefor.

(Transferred to 35 U.S.C. 8 Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4717(1)).)

(Transferred from 35 U.S.C. 10 Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4717(1)); amended Jan. 2, 1975, Public Law 93596, sec. 1, 88 Stat. 1949.)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 10 Publications.[edit | edit source]

(a) The Director may publish in printed, typewritten, or electronic form, the following: (1) Patents and published applications for patents, including specifications and drawings, together with copies of the same. The Patent and Trademark Office may print the headings of the drawings for patents for the purpose of photolithography. (2) Certificates of trademark registrations, including statements and drawings, together with copies of the same. (3) The Official Gazette of the United States Patent and Trademark Office. (4) Annual indexes of patents and patentees, and of trademarks and registrants. (5) Annual volumes of decisions in patent and trademark cases. (6) Pamphlet copies of the patent laws and rules of practice, laws and rules relating to trademarks, and circulars or other publications relating to the business of the Office. (b) The Director may exchange any of the publications specified in items 3, 4, 5, and 6 of subsection (a) of this section for publications desirable for the use of the Patent and Trademark Office.


(Transferred to 35 U.S.C. 9 Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4717(1)).)

(Transferred from 35 U.S.C. 11 Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S 1948 sec. 4717(1)); amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-589 (S. 1948 sec. 4804(b)).)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-565, 582 (S. 1948 secs. 4507(1) and 4732(a)(10)(A)).)

35 U.S.C. 11 Exchange of copies of patents and applications with foreign countries.[edit | edit source]

The Director may exchange copies of specifications and drawings of United States patents and published applications for patents for those of foreign countries.

The Director shall not enter into an agreement to 

provide such copies of specifications and drawings of United States patents and applications to a foreign country, other than a NAFTA country or a WTO member country, without the express authorization of the Secretary of Commerce. For purposes of this section, the terms “NAFTA country” and “WTO member country” have the meanings given those terms in section 104(b).

(Transferred to 35 U.S.C. 10 Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S 1948 sec. 4717(1)).)

(Transferred from 35 U.S.C. 12 Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S 1948 sec. 4717(1)); amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-591 (S. 1948 sec. 4808).)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-565, 582 (S. 1948 secs. 4507(2)(A), 4507(2)(B), and 4732(a)(10)(A)).)

35 U.S.C. 12 Copies of patents and applications for public libraries.[edit | edit source]

The Director may supply copies of specifications and drawings of patents and published applications for patents in printed or electronic form to public libraries in the United States which shall maintain such copies for the use of the public, at the rate for each year’s issue established for this purpose in section 41(d) of this title.

(Transferred to 35 U.S.C. 11 Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4717(1)).)

(Transferred from 35 U.S.C. 13 Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S 1948 sec. 4717(1)); amended Aug. 27, 1982, Public Law 97-247, sec. 15, 96 Stat. 321; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-589 (S. 1948 sec. 4804(c)).)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-565, 566, 582 (S. 1948 secs. 4507(3)(A), 4507(3)(B), 4507(4), and 4732(a)(10)(A)).)

35 U.S.C. 13 Annual report to Congress.[edit | edit source]

The Director shall report to the Congress, not later 

than 180 days after the end of each fiscal year, the moneys received and expended by the Office, the purposes for which the moneys were spent, the quality and quantity of the work of the Office, the nature of training provided to examiners, the evaluation of the Commissioner of Patents and the Commissioner of Trademarks by the Secretary of Commerce, the compensation of the Commissioners, and other information relating to the Office.

(Transferred to 35 U.S.C. 12 Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S 1948 sec. 4717(1)).)

(Transferred from 35 U.S.C. 14 Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S 1948 sec. 4717(1)).)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-565, 581 (S. 1948 secs. 4507(2), 4718).)

CHAPTER 2 — PROCEEDINGS IN THE PATENT AND TRADEMARK OFFICE[edit | edit source]

35 U.S.C. 21 Filing date and day for taking action.[edit | edit source]

(a) The Director may by rule prescribe that any paper or fee required to be filed in the Patent and Trademark Office will be considered filed in the Office on the date on which it was deposited with the United States Postal Service or would have been deposited with the United States Postal Service but for postal service interruptions or emergencies designated by the Director. (b) When the day, or the last day, for taking any action or paying any fee in the United States Patent and Trademark Office falls on Saturday, Sunday, or a Federal holiday within the District of Columbia, the action may be taken, or fee paid, on the next succeeding secular or business day.


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Aug. 27, 1982, Public Law 97-247, sec. 12, 96 Stat. 321; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 22 Printing of papers filed.[edit | edit source]

The Director may require papers filed in the Patent and Trademark Office to be printed, typewritten, or on an electronic medium.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582, 589 (S. 1948 secs. 4732(a)(10)(A), 4804(a)).)

35 U.S.C. 23 Testimony in Patent and Trademark Office cases.

The Director may establish rules for taking affidavits and depositions required in cases in the Patent and Trademark Office. Any officer authorized by law to take depositions to be used in the courts of the United States, or of the State where he resides, may take such affidavits and depositions.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 24 Subpoenas, witnesses.[edit | edit source]

The clerk of any United States court for the district wherein testimony is to be taken for use in any contested case in the Patent and Trademark Office, shall, upon the application of any party thereto, issue a subpoena for any witness residing or being within such district, commanding him to appear and testify before an officer in such district authorized to take depositions and affidavits, at the time and place stated in the subpoena. The provisions of the Federal Rules of Civil Procedure relating to the attendance of witnesses and to the production of documents and things shall apply to contested cases in the Patent and Trademark Office.

Every witness subpoenaed and in attendance shall be allowed the fees and traveling expenses allowed to witnesses attending the United States district courts.

A judge of a court whose clerk issued a subpoena may enforce obedience to the process or punish disobedience as in other like cases, on proof that a witness, served with such subpoena, neglected or refused to appear or to testify. No witness shall be deemed guilty of contempt for disobeying such subpoena unless his fees and traveling expenses in going to, and returning from, and one day’s attendance at the place of examination, are paid or tendered him at the time of the service of the subpoena; nor for refusing to disclose any secret matter except upon appropriate order of the court which issued the subpoena.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949.)

35 U.S.C. 25 Declaration in lieu of oath.[edit | edit source]

(a) The Director may by rule prescribe that any document to be filed in the Patent and Trademark Office and which is required by any law, rule, or other regulation to be under oath may be subscribed to by a written declaration in such form as the Director may prescribe, such declaration to be in lieu of the oath otherwise required.


(b) Whenever such written declaration is used, the document must warn the declarant that willful false statements and the like are punishable by fine or imprisonment, or both (18 U.S.C. 1001).

(Added Mar. 26, 1964, Public Law 88-292, sec. 1, 78 Stat. 171; amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 26 Effect of defective execution.[edit | edit source]

Any document to be filed in the Patent and Trademark Office and which is required by any law, rule, or other regulation to be executed in a specified manner may be provisionally accepted by the Director despite a defective execution, provided a properly executed document is submitted within such time as may be prescribed.

(Added Mar. 26, 1964, Public Law 88-292, sec. 1, 78 Stat. 171; amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

CHAPTER 3 — PRACTICE BEFORE PATENT[edit | edit source]

35 U.S.C. 31 [Repealed].[edit | edit source]

(Repealed Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580 (S. 1948 sec. 4715(b)).)

35 U.S.C. 32 Suspension or exclusion from practice.[edit | edit source]

The Director may, after notice and opportunity for a hearing, suspend or exclude, either generally or in any particular case, from further practice before the Patent and Trademark Office, any person, agent, or attorney shown to be incompetent or disreputable, or guilty of gross misconduct, or who does not comply with the regulations established under section 2(b)(2)(D) of this title, or who shall, by word, circular, letter, or advertising, with intent to defraud in any manner, deceive, mislead, or threaten any applicant or prospective applicant, or other person having immediate or prospective business before the Office. The reasons for any such suspension or exclusion shall be duly recorded. The Director shall have the discretion to designate any attorney who is an officer or employee of the United States Patent and Trademark Office to conduct the hearing required by this section. The United States District Court for the District of Columbia, under such conditions and upon such proceedings as it by its rules determines, may review the action of the Director upon the petition of the person so refused recognition or so suspended or excluded.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat.1949; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-580, 581, 582 (S. 1948 secs. 4715(c), 4719, 4732(a)(10)(A)).)

35 U.S.C. 33 Unauthorized representation as practitioner.[edit | edit source]

Whoever, not being recognized to practice before the Patent and Trademark Office, holds himself out or permits himself to be held out as so recognized, or as being qualified to prepare or prosecute applications for patent, shall be fined not more than $1,000 for each offense.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949.)

CHAPTER 4 — PATENT FEES; FUNDING; SEARCH SYSTEMS[edit | edit source]

35 U.S.C. 41 Patent fees; patent and trademark search systems.[edit | edit source]

  • Editor’s Note: During fiscal years 2005 and

2006, subsections (a) and (b) of section 41 of title 35, United States Code, shall be administered as though subsections (a) and (b) read as follows:

(a) GENERAL FEES. — The Director shall charge the following fees: (1) FILING AND BASIC NATIONAL FEES. — (A) On filing each application for an original patent, except for design, plant, or provisional applications, $300. (B) On filing each application for an original design patent, $200. (C) On filing each application for an original plant patent, $200. (D) On filing each provisional application for an original patent, $200. (E) On filing each application for the reissue of a patent, $300. (F) The basic national fee for each international application filed under the treaty defined in section 351(a) of this title entering the national stage under section 371 of this title, $300. (G) In addition, excluding any sequence listing or computer program listing filed in electronic medium as prescribed by the Director, for any application the specification and drawings of which exceed 100 sheets of paper (or equivalent as prescribed by the Director if filed in an electronic medium), $250 for each additional 50 sheets of paper (or equivalent as prescribed by the Director if filed in an electronic medium) or fraction thereof. (2) EXCESS CLAIMS FEES. — In addition to the fee specified in paragraph (1) — (A) on filing or on presentation at any other time, $200 for each claim in independent form in excess of 3; (B) on filing or on presentation at any other time, $50 for each claim (whether dependent or independent) in excess of 20; and (C) for each application containing a multiple dependent claim, $360.


For the purpose of computing fees under this paragraph, a multiple dependent claim referred to in section 112 of this title or any claim depending therefrom shall be considered as separate dependent claims in accordance with the number of claims to which reference is made. The Director may by regulation provide for a refund of any part of the fee specified in this paragraph for any claim that is canceled before an examination on the merits, as prescribed by the Director, has been made of the application under section 131 of this title. Errors in payment of the additional fees under this paragraph may be rectified in accordance with regulations prescribed by the Director.

(3) EXAMINATION FEES. —

(A) For examination of each application for an original patent, except for design, plant, provisional, or international applications, $200. (B) For examination of each application for an original design patent, $130.


(C) For examination of each application for an original plant patent, $160. (D) For examination of the national stage of each international application, $200. (E) For examination of each application for the reissue of a patent, $600.


The provisions of section 111(a) of this title 

relating to the payment of the fee for filing the application shall apply to the payment of the fee specified in this paragraph with respect to an application filed under section 111(a) of this title. The provisions of section 371(d) of this title relating to the payment of the national fee shall apply to the payment of the fee specified in this paragraph with respect to an international application.

(4) ISSUE FEES. —

(A) For issuing each original patent, except for design or plant patents, $1,400. (B) For issuing each original design patent, $800. (C) For issuing each original plant patent, $1,100. (D) For issuing each reissue patent, $1,400.


(5) DISCLAIMER FEE. — On filing each disclaimer, $130. (6) APPEAL FEES. —


(A) On filing an appeal from the examiner to the Board of Patent Appeals and Interferences, $500. (B) In addition, on filing a brief in support of the appeal, $500, and on requesting an oral hearing in the appeal before the Board of Patent Appeals and Interferences, $1,000. (7) REVIVAL FEES. — On filing each petition for the revival of an unintentionally abandoned application for a patent, for the unintentionally delayed payment of the fee for issuing each patent, or for an unintentionally delayed response by the patent owner in any reexamination proceeding, $1,500, unless the petition is filed under section 133 or 151 of this title, in which case the fee shall be $500. (8) EXTENSION FEES. — For petitions for 1-month extensions of time to take actions required by the Director in an application — (A) on filing a first petition, $120; (B) on filing a second petition, $330; and (C) on filing a third or subsequent petition, $570. (b) MAINTENANCE FEES. — The Director shall charge the following fees for maintaining in force all patents based on applications filed on or after December 12, 1980: (1) 3 years and 6 months after grant, $900. (2) 7 years and 6 months after grant, $2,300. (3) 11 years and 6 months after grant, $3,800. Unless payment of the applicable maintenance fee is received in the United States Patent and Trademark Office on or before the date the fee is due or within a grace period of 6 months thereafter, the patent will expire as of the end of such grace period. The Director may require the payment of a surcharge as a condition of accepting within such 6-month grace period the payment of an applicable maintenance fee. No fee may be established for maintaining a design or plant patent in force.

(Dec. 8, 2004, Public Law 108-447, sec. 801, 118 Stat. 2809.)

The bracketed text below is the unamended text of 35 U.S.C. 41(a) and (b), which may continue to have effect following fiscal year 2006:

[(a) The Director shall charge the following fees: (1)(A) On filing each application for an original patent, except in design or plant cases, $690.

(B) In addition, on filing or on presentation at any other time, $78 for each claim in independent form which is in excess of 3, $18 for each claim (whether independent or dependent) which is in excess of 20, and $260 for each application containing a multiple dependent claim.

(C) On filing each provisional application for an original patent, $150.

(2) For issuing each original or reissue patent, except in design or plant cases, $1,210.

(3) In design and plant cases

(A) on filing each design application, $310;

(B) on filing each plant application, $480;

(C) on issuing each design patent, $430; and


(D) on issuing each plant patent, $580.

(4)(A)On filing each application for the reissue of a patent, $690.

(B) In addition, on filing or on presentation at any other time, $78 for each claim in independent form which is in excess of the number of independent claims of the original patent, and $18 for each claim (whether independent or dependent) which is in excess of 20 and also in excess of the number of claims of the original patent.

(5) On filing each disclaimer, $110. (6)(A) On filing an appeal from the examiner

to the Board of Patent Appeals and Interferences, $300.

(B) In addition, on filing a brief in support of the appeal, $300, and on requesting an oral hearing in the appeal before the Board of Patent Appeals and Interferences, $260. (7) On filing each petition for the revival of an unintentionally abandoned application for a patent, for the unintentionally delayed payment of the fee for issuing each patent, or for an unintentionally delayed response by the patent owner in any reexamination proceeding, $1,210, unless the petition is filed under section 133 or 151 of this title, in which case the fee shall be $110.

(8) For petitions for 1-month extensions of time to take actions required by the Director in an application

(A) on filing a first petition, $110;

(B) on filing a second petition, $270; and

(C) on filing a third or subsequent petition, $490.

(9) Basic national fee for an international application where the Patent and Trademark Office was the International Preliminary Examining Authority and the International Searching Authority, $670. (10) Basic national fee for an international application where the Patent and Trademark Office was the International Searching Authority but not the International Preliminary Examining Authority, $690. (11) Basic national fee for an international application where the Patent and Trademark Office was neither the International Searching Authority nor the International Preliminary Examining Authority, $970.

(12) Basic national fee for an international application where the international preliminary examination has been paid to the Patent and Trademark Office, and the international preliminary examination report states that the provisions of Article 33 (2), (3), and (4) of the Patent Cooperation Treaty have been satisfied for all claims in the application entering the national stage, $96.

(13) For filing or later presentation of each independent claim in the national stage of an international application in excess of 3, $78. (14) For filing or later presentation of each claim (whether independent or dependent) in a national stage of an international application in excess of 20, $18. (15) For each national stage of an international application containing a multiple dependent claim, $260. For the purpose of computing fees, a multiple dependent claim as referred to in section 112 of this title or any claim depending therefrom shall be considered as separate dependent claims in accordance with the number of claims to which reference is made. Errors in payment of the additional fees may be rectified in accordance with regulations of the Director.

(b) The Director shall charge the following fees for maintaining in force all patents based on applications filed on or after December 12, 1980:

(1) 3 years and 6 months after grant, $830.

(2) 7 years and 6 months after grant, $1,900.

(3) 11 years and 6 months after grant, $2,910.

Unless payment of the applicable maintenance fee is received in the Patent and Trademark Office on or before the date the fee is due or within a grace period of six months thereafter, the patent will expire as of the end of such grace period. The Director may require the payment of a surcharge as a condition of accepting within such 6-month grace period the payment of an applicable maintenance fee. No fee may be established for maintaining a design or plant patent in force.]

(c)(1) The Director may accept the payment of any maintenance fee required by subsection (b) of this section which is made within twenty-four months after the six-month grace period if the delay is shown to the satisfaction of the Director to have been unintentional, or at any time after the six-month grace period if the delay is shown to the satisfaction of the Director to have been unavoidable. The Director may require the payment of a surcharge as a condition of accepting payment of any maintenance fee after the six-month grace period. If the Director accepts payment of a maintenance fee after the six-month grace period, the patent shall be considered as not having expired at the end of the grace period.

(2) A patent, the term of which has been maintained as a result of the acceptance of a payment of a maintenance fee under this subsection, shall not abridge or affect the right of any person or that person’s successors in business who made, purchased, offered to sell, or used anything protected by the patent within the United States, or imported anything protected by the patent into the United States after the 6-month grace period but prior to the acceptance of a maintenance fee under this subsection, to continue the use of, to offer for sale, or to sell to others to be used, offered for sale, or sold, the specific thing so made, purchased, offered for sale, used, or imported. The court before which such matter is in question may provide for the continued manufacture, use, offer for sale, or sale of the thing made, purchased, offered for sale, or used within the United States, or imported into the United States, as specified, or for the manufacture, use, offer for sale, or sale in the United States of which substantial preparation was made after the 6month grace period but before the acceptance of a maintenance fee under this subsection, and the court may also provide for the continued practice of any process that is practiced, or for the practice of which substantial preparation was made, after the 6-month grace period but before the acceptance of a maintenance fee under this subsection, to the extent and under such terms as the court deems equitable for the protection of investments made or business commenced after the 6-month grace period but before the acceptance of a maintenance fee under this subsection.

  • Editor’s Note: During fiscal years 2005 and

2006, subsection (d) of section 41 of title 35, United States Code, shall be administered as though subsection (d) reads as follows:

(d) PATENT SEARCH AND OTHER FEES. —

(1) PATENT SEARCH FEES. —

(A) The Director shall charge a fee for the search of each application for a patent, except for provisional applications. The Director shall establish the fees charged under this paragraph to recover an amount not to exceed the estimated average cost to the Office of searching applications for patent either by acquiring a search report from a qualified search authority, or by causing a search by Office personnel to be made, of each application for patent. For the 3year period beginning on the date of enactment of this

Act, the fee for a search by a qualified search authority of a patent application described in clause (i), (iv), or (v) of subparagraph (B) may not exceed $500, of a patent application described in clause (ii) of subparagraph (B) may not exceed $100, and of a patent application described in clause (iii) of subparagraph (B) may not exceed $300. The Director may not increase any such fee by more than 20 percent in each of the next three 1-year periods, and the Director may not increase any such fee thereafter.

(B) For purposes of determining the fees to be established under this paragraph, the cost to the Office of causing a search of an application to be made by Office personnel shall be deemed to be — (i) $500 for each application for an original patent, except for design, plant, provisional, or international applications; (ii) $100 for each application for an original design patent;

(iii) $300 for each application for an original plant patent;

(iv) $500 for the national stage of each international application; and (v) $500 for each application for the reissue of a patent. (C) The provisions of section 111 (a)(3) of this title relating to the payment of the fee for filing the application shall apply to the payment of the fee specified in this paragraph with respect to an application filed under section 111(a) of this title. The provisions of section 371(d) of this title relating to the payment of the national fee shall apply to the payment of the fee specified in this paragraph with respect to an international application. (D) The Director may by regulation provide for a refund of any part of the fee specified in this paragraph for any applicant who files a written declaration of express abandonment as prescribed by the Director before an examination has been made of the application under section 131 of this title, and for any applicant who provides a search report that meets the conditions prescribed by the Director. (E) For purposes of subparagraph (A), a “qualified search authority” may not include a commercial entity unless — (i) the Director conducts a pilot program of limited scope, conducted over a period of not more than 18 months, which demonstrates that searches by commercial entities of the available prior art relating to the subject matter of inventions claimed in patent applications —

(I) are accurate; and

(II) meet or exceed the standards of searches conducted by and used by the Patent and Trademark Office during the patent examination process; (ii) the Director submits a report on the results of the pilot program to Congress and the Patent Public Advisory Committee that includes — (I) a description of the scope and duration o f the pilot program; (II) the identity of each commercial entity participating in the pilot program;

(III) an explanation of the methodology used to evaluate the accuracy and quality of the search reports; and

(IV) an assessment of the effects that the pilot program, as compared to searches conducted by the Patent and Trademark Office, had and will have on —

(aa) patentability determinations; (bb) productivity of the Patent and Trademark Office;

(cc) costs to the Patent and Trade

mark Office; (dd) costs to patent applicants; and (ee) other relevant factors;

(iii) the Patent Public Advisory Committee reviews and analyzes the Director’s report under clause (ii) and the results of the pilot program and submits a separate report on its analysis to the Director and the Congress that includes —

(I) an independent evaluation of the effects that the pilot program, as compared to searches conducted by the Patent and Trademark Office, had and will have on the factors set forth in clause (ii)(IV); and (II) an analysis of the reasonableness, appropriateness, and effectiveness of the methods used in the pilot program to make the evaluations required under clause (ii)(IV); and (iv) Congress does not, during the 1year period beginning on the date on which the Patent Public Advisory Committee submits its report to the Congress under clause (iii), enact a law prohibiting searches by commercial entities of the available prior art relating to the subject matter of inventions claimed in patent applications.

(F) The Director shall require that any search by a qualified search authority that is a commercial entity is conducted in the United States by persons that —

(i) if individuals, are United States citizens; and

(ii) if business concerns, are organized under the laws of the United States or any State and employ United States citizens to perform the searches.

(G) A search of an application that is the subject of a secrecy order under section 181 or otherwise involves classified information may only be conducted by Office personnel.

(H) A qualified search authority that is a commercial entity may not conduct a search of a patent application if the entity has any direct or indirect financial interest in any patent or in any pending or imminent application for patent filed or to be filed in the Patent and Trademark Office.

(2) OTHER FEES. — The Director shall establish fees for all other processing, services, or materials relating to patents not specified in this section to recover the estimated average cost to the Office of such processing, services; or materials, except that the Director shall charge the following fees for the following services:

(A) For recording a document affecting title, $40 per property.

(B) For each photocopy, $.25 per page.

(C) For each black and white copy of a patent, $3. The yearly fee for providing a library specified in section 12 of this title with uncertified printed copies of the specifications and drawings for all patents in that year shall be $50.

(Dec. 8, 2004, Public Law 108-447, sec. 801, 118 Stat. 2809.)

The bracketed text below is the unamended text of 35 U.S.C. 41(d), which may continue to have effect following fiscal year 2006:

(d) The Director shall establish fees for all other processing, services, or materials relating to patents not specified in this section to recover the estimated average cost to the Office of such processing, services, or materials, except that the Director shall charge the following fees for the following services:

(1) For recording a document affecting title, $40 per property.

(2) For each photocopy, $.25 per page.

(3) For each black and white copy of a patent, $3. The yearly fee for providing a library specified in section 13 of this title with uncertified printed copies of the specifications and drawings for all patents issued in that year shall be $50.]


(e) The Director may waive the payment of any fee for any service or material related to patents in connection with an occasional or incidental request made by a department or agency of the Government, or any officer thereof. The Director may provide any applicant issued a notice under section 132 of this title with a copy of the specifications and drawings for all patents referred to in that notice without charge. (f) The fees established in subsections (a) and

(b) of this section may be adjusted by the Director on October 1, 1992, and every year thereafter, to reflect any fluctuations occurring during the previous 12 months in the Consumer Price Index, as determined by the Secretary of Labor. Changes of less than 1 per centum may be ignored.


  • Editor’s Note: During fiscal years 2005 and

2006, subsection (f) of section 41 of title 35, United States Code applies to the fees established under section 801 of Public Law 108-447. (Dec. 8, 2004, Public Law 108-447, sec. 801, 118 Stat. 2809.)

(g) No fee established by the Director under this section shall take effect until at least 30 days after notice of the fee has been published in the Federal Register and in the Official Gazette of the Patent and Trademark Office.

  • Editor’s Note: During fiscal years 2005 and

2006, subsection (h) of section 41 of title 35, United States Code, shall be administered as though subsection (h) reads as follows:

(h)(1) Subject to paragraph (3), fees charged under subsections (a), (b) and (d)(1) shall be reduced by 50 percent with respect to their application to any small business concern as defined under section 3 of the Small Business Act, and to any independent inventor or nonprofit organization as defined in regulations issued by the Director.

(2) With respect to its application to any entity described in paragraph (1), any surcharge or fee charged under subsection (c) or (d) shall not be higher than the surcharge or fee required of any other entity under the same or substantially similar circumstances.

(3) The fee charged under subsection (a)(l)(A) shall be reduced by 75 percent with respect to its application to any entity to which paragraph (1) applies, if the application is filed by electronic means as prescribed by the Director.

(Dec. 8, 2004, Public Law 108-447, sec. 801, 118 Stat. 2809.)

The bracketed text below is the unamended text of 35 U.S.C. 41(h), which may continue to have effect following fiscal year 2006:

[(h)(1) Fees charged under subsection (a) or (b) shall be reduced by 50 percent with respect to their application to any small business concern as defined under section 3 of the Small Business Act, and to any independent inventor or nonprofit organization as defined in regulations issued by the Director.

(2) With respect to its application to any entity described in paragraph (1), any surcharge or fee charged under subsection (c) or (d) shall not be higher than the surcharge or fee required of any other entity under the same or substantially similar circumstances.] (i)(1) The Director shall maintain, for use by the public, paper, microform or electronic collections of United States patents, foreign patent documents, and United States trademark registrations arranged to permit search for and retrieval of information. The Director may not impose fees directly for the use of such collections, or for the use of the public patent and trademark search rooms or libraries.


(2) The Director shall provide for the full deployment of the automated search systems of the Patent and Trademark Office so that such systems are available for use by the public, and shall assure full access by the public to, and dissemination of, patent and trademark information, using a variety of automated methods, including electronic bulletin boards and remote access by users to mass storage and retrieval systems. (3) The Director may establish reasonable fees for access by the public to the automated search systems of the Patent and Trademark Office. If such fees are established, a limited amount of free access shall be made available to users of the systems for purposes of education and training. The Director may waive the payment by an individual of fees authorized by this subsection upon a showing of need or hardship, and if such waiver is in the public interest.

(4) The Director shall submit to the Congress an annual report on the automated search systems of the Patent and Trademark Office and the access by the public to such systems. The Director shall also publish such report in the Federal Register. The Director shall provide an opportunity for the submission of comments by interested persons on each such report.

(Amended July 24, 1965, Public Law 89-83, sec. 1, 2, 

79 Stat. 259; Jan. 2, 1975, Public Law 93-596, sec. 1, Jan. 2, 1975, 88 Stat. 1949; Nov. 14, 1975, Public Law 94-131, sec. 3, 89 Stat. 690.)

(Subsection (g) amended Dec. 12, 1980, Public Law 96-517, sec. 2, 94 Stat. 3017; Aug. 27, 1982, Public Law 97-247, sec. 3(a)-(e), 96 Stat. 317.)

(Subsections (a)-(d) amended Sept. 8, 1982, Public Law 97-256, sec. 101, 96 Stat. 816.)

(Subsection (a)(6) amended Nov. 8, 1984, Public Law 98-622, sec. 204(a), 98 Stat. 3388.)

(Subsection (h) added Nov. 6, 1986, Public Law 99607, sec. 1(b)(2), 100 Stat. 3470.)

(Subsections (a), (b), (d), (f), and (g) amended Dec. 10, 1991, Public Law 102-204, sec. 5, 105 Stat. 1637.)

(Subsections (a)(9) - (15) and (i) added Dec. 10, 1991, Public Law 102-204, sec. 5, 105 Stat. 1637.)

(Subsection (c)(1) amended Oct. 23, 1992, Public Law 102-444, sec. 1, 106 Stat. 2245.)

(Subsection (a)(1)(C) added Dec. 8, 1994, Public Law 103-465, sec. 532(b)(2), 108 Stat. 4986.)

(Subsection (c)(2) amended, Dec. 8, 1994, Public Law 103-465, sec. 533(b)(1), 108 Stat. 4988.)

(Subsections (a)-(b) revised Nov. 10, 1998, Public Law 105-358, sec. 3, 112 Stat. 3272.)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-554, 570, 582, 589 (S. 1948 secs. 4202, 4605(a), 4732(a)(5), 4732(a)(10)(A)) and 4804(d)).)

35 U.S.C. 42 Patent and Trademark Office funding.

(a) All fees for services performed by or materials furnished by the Patent and Trademark Office will be payable to the Director.

(b) All fees paid to the Director and all appropriations for defraying the costs of the activities of the Patent and Trademark Office will be credited to the Patent and Trademark Office Appropriation Account in the Treasury of the United States.

(c) To the extent and in the amounts provided in advance in appropriations Acts, fees authorized in this title or any other Act to be charged or established by the Director shall be collected by and shall be available to the Director to carry out the activities of the Patent and Trademark Office. All fees available to the Director under section 31 of the Trademark Act of 1946 shall be used only for the processing of trademark registrations and for other activities, services and materials relating to trademarks and to cover a proportionate share of the administrative costs of the Patent and Trademark Office.

(d) The Director may refund any fee paid by mistake or any amount paid in excess of that required.

(e) The Secretary of Commerce shall, on the day each year on which the President submits the annual budget to the Congress, provide to the Committees on the Judiciary of the Senate and the House of Representatives:

(1) a list of patent and trademark fee collections by the Patent and Trademark Office during the preceding fiscal year;

(2) a list of activities of the Patent and Trademark Office during the preceding fiscal year which were supported by patent fee expenditures, trademark fee expenditures, and appropriations;

(3) budget plans for significant programs, projects, and activities of the Office, including out- year funding estimates;

(4) any proposed disposition of surplus fees by the Office; and

(5) such other information as the committees consider necessary.


(Amended Nov. 14, 1975, Public Law 94-131, sec. 4, 89 Stat. 690; Dec. 12, 1980, Public Law 96-517, sec. 3, 94 Stat. 3018; Aug. 27, 1982, Public Law 97-247, sec. 3(g), 96 Stat. 319; Sept. 13, 1982, Public Law 97-258, sec. 3(i), 96 Stat. 1065.)

(Subsection (c) amended Dec. 10, 1991, Public Law 102-204, sec. 5(e), 105 Stat. 1640.)

(Subsection (e) added Dec. 10, 1991, Public Law 102204, sec. 4, 105 Stat. 1637.)

(Subsection (c) revised Nov. 10, 1998, Public Law 105-358, sec. 4, 112 Stat. 3274.)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-555, 582 (S. 1948 secs. 4205 and 4732(a)(10)(A)).)

PART II — PATENTABILITY OF INVENTIONS AND GRANT OF PATENTS[edit | edit source]

CHAPTER 10 — PATENTABILITY OF INVENTIONS[edit | edit source]

Sec.

100 Definitions.

101 Inventions patentable.

102 Conditions for patentability; novelty and loss of right to patent.

103 Conditions for patentability; non-obvious sub ject matter.

104 Invention made abroad.

105 Inventions in outer space.

35 U.S.C. 100 Definitions.[edit | edit source]

When used in this title unless the context otherwise indicates

(a) The term “invention” means invention or discovery.

(b) The term “process” means process, art, or method, and includes a new use of a known process, machine, manufacture, composition of matter, or material.

(c) The terms “United States” and “this country” mean the United States of America, its territories and possessions.

(d) The word “patentee” includes not only the patentee to whom the patent was issued but also the successors in title to the patentee.

(e) The term “third-party requester” means a person requesting ex parte reexamination under section 302 or inter partes reexamination under section 311 who is not the patent owner.

(Subsection (e) added Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-567 (S. 1948 sec. 4603).)

35 U.S.C. 101 Inventions patentable.[edit | edit source]

Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.

35 U.S.C. 102 Conditions for patentability; novelty and loss of right to patent.[edit | edit source]

A person shall be entitled to a patent unless —

(a) the invention was known or used by others in this country, or patented or described in a printed publication in this or a foreign country, before the invention thereof by the applicant for patent, or

(b) the invention was patented or described in a printed publication in this or a foreign country or in public use or on sale in this country, more than one year prior to the date of the application for patent in the United States, or

(c) he has abandoned the invention, or

(d) the invention was first patented or caused to be patented, or was the subject of an inventor’s certificate, by the applicant or his legal representatives or assigns in a foreign country prior to the date of the application for patent in this country on an application for patent or inventor’s certificate filed more than twelve months before the filing of the application in the United States, or

(e) the invention was described in — (1) an application for patent, published under section 122(b), by another filed in the United States before the invention by the applicant for patent or (2) a patent granted on an application for patent by another filed in the United States before the invention by the applicant for patent, except that an international application filed under the treaty defined in section 351(a) shall have the effects for the purposes of this subsection of an application filed in the United States only if the international application designated the United States and was published under Article 21(2) of such treaty in the English language; or

(f) he did not himself invent the subject matter sought to be patented, or

(g)(1) during the course of an interference conducted under section 135 or section 291, another inventor involved therein establishes, to the extent permitted in section 104, that before such person’s invention thereof the invention was made by such other inventor and not abandoned, suppressed, or concealed, or (2) before such person’s invention thereof, the invention was made in this country by another inventor who had not abandoned, suppressed, or concealed it. In determining priority of invention under this subsection, there shall be considered not only the respective dates of conception and reduction to practice of the invention, but also the reasonable diligence of one who was first to conceive and last to reduce to practice, from a time prior to conception by the other.

(Amended July 28, 1972, Public Law 92-358, sec. 2, 86 Stat. 501; Nov. 14, 1975, Public Law 94-131, sec. 5, 89 Stat. 691.)

(Subsection (e) amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-565 (S. 1948 sec. 4505).)

(Subsection (g) amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-590 (S. 1948 sec. 4806).)

(Subsection (e) amended Nov. 2, 2002, Public Law 107-273, sec. 13205, 116 Stat. 1903.)

35 U.S.C. 103 Conditions for patentability; non-obvious subject matter.[edit | edit source]

(a) A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102 of this title, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Patentability shall not be negatived by the manner in which the invention was made.

(b)(1) Notwithstanding subsection (a), and upon timely election by the applicant for patent to proceed under this subsection, a biotechnological process using or resulting in a composition of matter that is novel under section 102 and nonobvious under subsection (a) of this section shall be considered nonobvious if

(A) claims to the process and the composition of matter are contained in either the same application for patent or in separate applications having the same effective filing date; and

(B) the composition of matter, and the process at the time it was invented, were owned by the same person or subject to an obligation of assignment to the same person.

(2) A patent issued on a process under paragraph (1)

(A) shall also contain the claims to the composition of matter used in or made by that process, or

(B) shall, if such composition of matter is claimed in another patent, be set to expire on the same date as such other patent, notwithstanding section

154.

(3) For purposes of paragraph (1), the term “biotechnological process” means (A) a process of genetically altering or otherwise inducing a single- or multi-celled organism to (i) express an exogenous nucleotide sequence, (ii) inhibit, eliminate, augment, or alter expression of an endogenous nucleotide sequence, or


(iii) express a specific physiological characteristic not naturally associated with said organism;

(B) cell fusion procedures yielding a cell line that expresses a specific protein, such as a monoclonal antibody; and (C) a method of using a product produced by a process defined by subparagraph (A) or (B), or a combination of subparagraphs (A) and (B). (c)(1) Subject matter developed by another person, which qualifies as prior art only under one or more of subsections (e), (f), and (g) of section 102 of this title, shall not preclude patentability under this section where the subject matter and the claimed invention were, at the time the claimed invention was made, owned by the same person or subject to an obligation of assignment to the same person.


(2) For purposes of this subsection, subject matter developed by another person and a claimed invention shall be deemed to have been owned by the same person or subject to an obligation of assignment to the same person if —

(A) the claimed invention was made by or on behalf of parties to a joint research agreement that was in effect on or before the date the claimed invention was made;

(B) the claimed invention was made as a result of activities undertaken within the scope of the joint research agreement; and

(C) the application for patent for the claimed invention discloses or is amended to disclose the names of the parties to the joint research agreement.

(3) For purposes of paragraph (2), the term “joint research agreement” means a written contract, grant, or cooperative agreement entered into by two or more persons or entities for the performance of experimental, developmental, or research work in the field of the claimed invention.

(Amended Nov. 8, 1984, Public Law 98-622, sec. 103, 98 Stat. 3384; Nov. 1, 1995, Public Law 104-41, sec.1, 109 Stat. 3511.)

(Subsection (c) amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-591 (S. 1948 sec. 4807).)

(Subsection (c) amended Dec. 10, 2004, Public Law 

108-453 , sec. 2, 118 Stat. 3596.)

35 U.S.C. 104 Invention made abroad.[edit | edit source]

(a) IN GENERAL.—

(1) PROCEEDINGS.—In proceedings in the Patent and Trademark Office, in the courts, and before any other competent authority, an applicant for a patent, or a patentee, may not establish a date of invention by reference to knowledge or use thereof, or other activity with respect thereto, in a foreign country other than a NAFTA country or a WTO member country, except as provided in sections 119 and 365 of this title. (2) RIGHTS.—If an invention was made by a person, civil or military— (A) while domiciled in the United States, and serving in any other country in connection with operations by or on behalf of the United States, (B) while domiciled in a NAFTA country and serving in another country in connection with operations by or on behalf of that NAFTA country, or (C) while domiciled in a WTO member country and serving in another country in connection with operations by or on behalf of that WTO member country, that person shall be entitled to the same rights of priority in the United States with respect to such invention as if such invention had been made in the United States, that NAFTA country, or that WTO member country, as the case may be. (3) USE OF INFORMATION.—To the extent that any information in a NAFTA country or a WTO member country concerning knowledge, use, or other activity relevant to proving or disproving a date of invention has not been made available for use in a proceeding in the Patent and Trademark Office, a court, or any other competent authority to the same extent as such information could be made available in the United States, the Director, court, or such other authority shall draw appropriate inferences, or take other action permitted by statute, rule, or regulation, in favor of the party that requested the information in the proceeding.

(b) DEFINITIONS.—As used in this section—

(1) The term “NAFTA country” has the meaning given that term in section 2(4) of the North American Free Trade Agreement Implementation Act; and (2) The term “WTO member country” has the meaning given that term in section 2(10) of the Uruguay Round Agreements Act.


(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Nov. 14, 1975, Public Law 94-131, sec. 6, 89 Stat. 691; Nov. 8, 1984, Public Law 98-622, sec. 403(a), 98 Stat. 3392; Dec. 8, 1993, Public Law 103-182, sec. 331, 107 Stat. 2113; Dec. 8, 1994, Public Law 103-465, sec. 531(a), 108 Stat. 4982; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 105 Inventions in outer space.[edit | edit source]

(a) Any invention made, used, or sold in outer space on a space object or component thereof under the jurisdiction or control of the United States shall be considered to be made, used or sold within the United States for the purposes of this title, except with respect to any space object or component thereof that is specifically identified and otherwise provided for by an international agreement to which the United States is a party, or with respect to any space object or component thereof that is carried on the registry of a foreign state in accordance with the Convention on Registration of Objects Launched into Outer Space. (b) Any invention made, used, or sold in outer space on a space object or component thereof that is carried on the registry of a foreign state in accordance with the Convention on Registration of Objects Launched into Outer Space, shall be considered to be made, used, or sold within the United States for the purposes of this title if specifically so agreed in an international agreement between the United States and the state of registry.


(Added Nov. 15, 1990, Public Law 101-580, sec. 1(a), 104 Stat. 2863.)

CHAPTER 11 — APPLICATION FOR PATENT[edit | edit source]

Sec.

111 Application.

112 Specification.

113 Drawings.

114 Models, specimens.

115 Oath of applicant.

116 Inventors.

117 Death or incapacity of inventor.

118 Filing by other than inventor.

119 Benefit of earlier filing date; right of priority.

120 Benefit of earlier filing date in the United States.

121 Divisional applications.

122 Confidential status of applications; publication

of patent applications.

35 U.S.C. 111 Application.[edit | edit source]

(a) IN GENERAL.—

(1) WRITTEN APPLICATION.—An application for patent shall be made, or authorized to be made, by the inventor, except as otherwise provided in this title, in writing to the Director.

(2) CONTENTS.—Such application shall include—

(A) a specification as prescribed by section 112 of this title;

(B) a drawing as prescribed by section 113 of this title; and

(C) an oath by the applicant as prescribed by section 115 of this title.

(3) FEE AND OATH.—The application must be accompanied by the fee required by law. The fee and oath may be submitted after the specification and any required drawing are submitted, within such period and under such conditions, including the payment of a surcharge, as may be prescribed by the Director.

(4) FAILURE TO SUBMIT.—Upon failure to submit the fee and oath within such prescribed period, the application shall be regarded as abandoned, unless it is shown to the satisfaction of the Director that the delay in submitting the fee and oath was unavoidable or unintentional. The filing date of an application shall be the date on which the specification and any required drawing are received in the Patent and Trademark Office.

(b) PROVISIONAL APPLICATION.—

(1) AUTHORIZATION.—A provisional application for patent shall be made or authorized to be made by the inventor, except as otherwise provided in this title, in writing to the Director. Such application shall include—

(A) a specification as prescribed by the first paragraph of section 112 of this title; and

(B) a drawing as prescribed by section 113 of this title.

(2) CLAIM.—A claim, as required by the second through fifth paragraphs of section 112, shall not be required in a provisional application.

(3) FEE.—

(A) The application must be accompanied by the fee required by law.

(B) The fee may be submitted after the specification and any required drawing are submitted, within such period and under such conditions, including the payment of a surcharge, as may be prescribed by the Director.

(C) Upon failure to submit the fee within such prescribed period, the application shall be regarded as abandoned, unless it is shown to the satisfaction of the Director that the delay in submitting the fee was unavoidable or unintentional.

(4) FILING DATE.—The filing date of a provisional application shall be the date on which the specification and any required drawing are received in the Patent and Trademark Office.

(5) ABANDONMENT.—Notwithstanding the absence of a claim, upon timely request and as prescribed by the Director, a provisional application may be treated as an application filed under subsection (a). Subject to section 119(e)(3) of this title, if no such request is made, the provisional application shall be regarded as abandoned 12 months after the filing date of such application and shall not be subject to revival after such 12-month period.

(6) OTHER BASIS FOR PROVISIONAL APPLICATION.—Subject to all the conditions in this subsection and section 119(e) of this title, and as prescribed by the Director, an application for patent filed under subsection (a) may be treated as a provisional application for patent.

(7) NO RIGHT OF PRIORITY OR BENEFIT OF EARLIEST FILING DATE.—A provisional application shall not be entitled to the right of priority of any other application under section 119 or 365(a) of this title or to the benefit of an earlier filing date in the United States under section 120, 121, or 365(c) of this title.

(8) APPLICABLE PROVISIONS.—The provisions of this title relating to applications for patent shall apply to provisional applications for patent, except as otherwise provided, and except that provisional applications for patent shall not be subject to sections 115, 131, 135, and 157 of this title.

35 U.S.C. 112 Specification.[edit | edit source]

The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention.

The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.

A claim may be written in independent or, if the nature of the case admits, in dependent or multiple dependent form.

Subject to the following paragraph, a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers.

A claim in multiple dependent form shall contain a reference, in the alternative only, to more than one claim previously set forth and then specify a further limitation of the subject matter claimed. A multiple dependent claim shall not serve as a basis for any other multiple dependent claim. A multiple dependent claim shall be construed to incorporate by reference all the limitations of the particular claim in relation to which it is being considered.

An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof.

(Amended July 24, 1965, Public Law 89-83, sec. 9, 79 Stat. 261; Nov. 14, 1975, Public Law 94-131, sec. 7, 89 Stat. 691.)

35 U.S.C. 113 Drawings.[edit | edit source]

The applicant shall furnish a drawing where necessary for the understanding of the subject matter sought to be patented. When the nature of such subject matter admits of illustration by a drawing and the applicant has not furnished such a drawing, the Director may require its submission within a time period of not less than two months from the sending of a notice thereof. Drawings submitted after the filing date of the application may not be used (i) to overcome any insufficiency of the specification due to lack of an enabling disclosure or otherwise inadequate disclosure therein, or (ii) to supplement the original disclosure thereof for the purpose of interpretation of the scope of any claim.

(Amended Nov. 14, 1975, Public Law 94-131, sec. 8, 89 Stat. 691; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 114 Models, specimens.[edit | edit source]

The Director may require the applicant to furnish a model of convenient size to exhibit advantageously the several parts of his invention.

When the invention relates to a composition of matter, the Director may require the applicant to furnish specimens or ingredients for the purpose of inspection or experiment.

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 115 Oath of applicant.[edit | edit source]

The applicant shall make oath that he believes himself to be the original and first inventor of the process, machine, manufacture, or composition of matter, or improvement thereof, for which he solicits a patent; and shall state of what country he is a citizen. Such oath may be made before any person within the United States authorized by law to administer oaths, or, when made in a foreign country, before any diplomatic or consular officer of the United States authorized to administer oaths, or before any officer having an official seal and authorized to administer oaths in the foreign country in which the applicant may be, whose authority is proved by certificate of a diplomatic or consular officer of the United States, or apostille of an official designated by a foreign country which, by treaty or convention, accords like effect to apostilles of designated officials in the United States. Such oath is valid if it complies with the laws of the state or country where made. When the application is made as provided in this title by a person other than the inventor, the oath may be so varied in form that it can be made by him. For purposes of this section, a consular officer shall include any United States citizen serving overseas, authorized to perform notarial functions pursuant to section 1750 of the Revised Statutes, as amended (22 U.S.C. 4221).

(Amended Aug. 27, 1982, Public Law 97-247, sec. 14(a), 96 Stat. 321; Oct. 21, 1998, Pub. L. 105-277, sec. 2222(d), 112 Stat. 2681-818.)

35 U.S.C. 116 Inventors.[edit | edit source]

When an invention is made by two or more persons jointly, they shall apply for patent jointly and each make the required oath, except as otherwise provided in this title. Inventors may apply for a patent jointly even though (1) they did not physically work together or at the same time, (2) each did not make the same type or amount of contribution, or (3) each did not make a contribution to the subject matter of every claim of the patent.

If a joint inventor refuses to join in an application for patent or cannot be found or reached after diligent effort, the application may be made by the other inventor on behalf of himself and the omitted inventor. The Director, on proof of the pertinent facts and after such notice to the omitted inventor as he prescribes, may grant a patent to the inventor making the application, subject to the same rights which the omitted inventor would have had if he had been joined. The omitted inventor may subsequently join in the application.

Whenever through error a person is named in an application for patent as the inventor, or through an error an inventor is not named in an application, and


such error arose without any deceptive intention on his part, the Director may permit the application to be amended accordingly, under such terms as he prescribes.

(Amended Aug. 27, 1982, Public Law 97-247, sec. 6(a), 96 Stat. 320; Nov. 8, 1984, Public Law 98-622, sec. 104(a), 98 Stat. 3384; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 117 Death or incapacity of inventor.[edit | edit source]

Legal representatives of deceased inventors and of those under legal incapacity may make application for patent upon compliance with the requirements and on the same terms and conditions applicable to the inventor.

35 U.S.C. 118 Filing by other than inventor.[edit | edit source]

Whenever an inventor refuses to execute an application for patent, or cannot be found or reached after diligent effort, a person to whom the inventor has assigned or agreed in writing to assign the invention or who otherwise shows sufficient proprietary interest in the matter justifying such action, may make application for patent on behalf of and as agent for the inventor on proof of the pertinent facts and a showing that such action is necessary to preserve the rights of the parties or to prevent irreparable damage; and the Director may grant a patent to such inventor upon such notice to him as the Director deems sufficient, and on compliance with such regulations as he prescribes.

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 119 Benefit of earlier filing date; right of priority.[edit | edit source]

(a) An application for patent for an invention filed in this country by any person who has, or whose legal representatives or assigns have, previously regularly filed an application for a patent for the same invention in a foreign country which affords similar privileges in the case of applications filed in the United States or to citizens of the United States, or in a WTO member country, shall have the same effect as the same application would have if filed in this country on the date on which the application for patent for the same invention was first filed in such foreign country, if the application in this country is filed within twelve months from the earliest date on which such foreign application was filed; but no patent shall be granted on any application for patent for an invention which had been patented or described in a printed publication in any country more than one year before the date of the actual filing of the application in this country, or which had been in public use or on sale in this country more than one year prior to such filing.

(b)(1)No application for patent shall be entitled to this right of priority unless a claim is filed in the Patent and Trademark Office, identifying the foreign application by specifying the application number on that foreign application, the intellectual property authority or country in or for which the application was filed, and the date of filing the application, at such time during the pendency of the application as required by the Director.

(2) The Director may consider the failure of the applicant to file a timely claim for priority as a waiver of any such claim. The Director may establish procedures, including the payment of a surcharge, to accept an unintentionally delayed claim under this section. (3) The Director may require a certified copy of the original foreign application, specification, and drawings upon which it is based, a translation if not in the English language, and such other information as the Director considers necessary. Any such certification shall be made by the foreign intellectual property authority in which the foreign application was filed and show the date of the application and of the filing of the specification and other papers. (c) In like manner and subject to the same conditions and requirements, the right provided in this section may be based upon a subsequent regularly filed application in the same foreign country instead of the first filed foreign application, provided that any foreign application filed prior to such subsequent application has been withdrawn, abandoned, or otherwise disposed of, without having been laid open to public inspection and without leaving any rights outstanding, and has not served, nor thereafter shall serve, as a basis for claiming a right of priority. (d) Applications for inventors’ certificates filed in a foreign country in which applicants have a right to apply, at their discretion, either for a patent or for an inventor’s certificate shall be treated in this country in the same manner and have the same effect for purpose of the right of priority under this section as applications for patents, subject to the same conditions and requirements of this section as apply to applications for patents, provided such applicants are entitled to the benefits of the Stockholm Revision of the Paris Convention at the time of such filing.

(e)(1)An application for patent filed under section 111(a) or section 363 of this title for an invention disclosed in the manner provided by the first paragraph of section 112 of this title in a provisional application filed under section 111(b) of this title, by an inventor or inventors named in the provisional application, shall have the same effect, as to such invention, as though filed on the date of the provisional application filed under section 111(b) of this title, if the application for patent filed under section 111(a) or section 363 of this title is filed not later than 12 months after the date on which the provisional application was filed and if it contains or is amended to contain a specific reference to the provisional application. No application shall be entitled to the benefit of an earlier filed provisional application under this subsection unless an amendment containing the specific reference to the earlier filed provisional application is submitted at such time during the pendency of the application as required by the Director. The Director may consider the failure to submit such an amendment within that time period as a waiver of any benefit under this subsection. The Director may establish procedures, including the payment of a surcharge, to accept an unintentionally delayed submission of an amendment under this subsection during the pendency of the application

(2) A provisional application filed under section 111(b) of this title may not be relied upon in any proceeding in the Patent and Trademark Office unless the fee set forth in subparagraph (A) or (C) of section 41(a)(1) of this title has been paid. (3) If the day that is 12 months after the filing date of a provisional application falls on a Saturday, Sunday, or Federal holiday within the District of Columbia, the period of pendency of the provisional application shall be extended to the next succeeding secular or business day. (f) Applications for plant breeder’s rights filed in a WTO member country (or in a foreign UPOV Contracting Party) shall have the same effect for the purpose of the right of priority under subsections (a)


through (c) of this section as applications for patents, subject to the same conditions and requirements of this section as apply to applications for patents.

(g) As used in this section—

(1) the term “WTO member country” has the same meaning as the term is defined in section 104(b)(2) of this title; and (2) the term “UPOV Contracting Party” means a member of the International Convention for the Protection of New Varieties of Plants.


(Amended Oct. 3, 1961, Public Law 87-333, sec. 1, 75 Stat. 748; July 28, 1972, Public Law 92-358, sec. 1, 86 Stat. 501; Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Dec. 8, 1994, Public Law 103-465, sec. 532(b)(1), 108 Stat. 4985.)

(Subsection (b) amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-563 (S. 1948 sec.4503(a)).)

(Subsection (e) amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-564, 588, 589

(S. 1948 secs. 4503(b)(2), 4801 and 4802).) (Subsections (f) and (g) added Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-589

(S. 1948 sec. 4802).)

35 U.S.C. 120 Benefit of earlier filing date in the United States.[edit | edit source]

An application for patent for an invention disclosed in the manner provided by the first paragraph of section 112 of this title in an application previously filed in the United States, or as provided by section 363 of this title, which is filed by an inventor or inventors named in the previously filed application shall have the same effect, as to such invention, as though filed on the date of the prior application, if filed before the patenting or abandonment of or termination of proceedings on the first application or on an application similarly entitled to the benefit of the filing date of the first application and if it contains or is amended to contain a specific reference to the earlier filed application. No application shall be entitled to the benefit of an earlier filed application under this section unless an amendment containing the specific reference to the earlier filed application is submitted at such time during the pendency of the application as required by the Director. The Director may consider the failure to submit such an amendment within that time period as a waiver of any benefit under this section. The Director may establish procedures, including the payment of a surcharge, to accept an unintentionally delayed submission of an amendment under this section.

(Amended Nov. 14, 1975, Public Law 94-131, sec. 9, 89 Stat. 691; Nov. 8, 1984, Public Law 98-622, sec. 104(b), 98 Stat. 3385; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-563 (S. 1948 sec. 4503(b)(1)).)

35 U.S.C. 121 Divisional applications.[edit | edit source]

If two or more independent and distinct inventions are claimed in one application, the Director may require the application to be restricted to one of the inventions. If the other invention is made the subject of a divisional application which complies with the requirements of section 120 of this title it shall be entitled to the benefit of the filing date of the original application. A patent issuing on an application with respect to which a requirement for restriction under this section has been made, or on an application filed as a result of such a requirement, shall not be used as a reference either in the Patent and Trademark Office or in the courts against a divisional application or against the original application or any patent issued on either of them, if the divisional application is filed before the issuance of the patent on the other application. If a divisional application is directed solely to subject matter described and claimed in the original application as filed, the Director may dispense with signing and execution by the inventor. The validity of a patent shall not be questioned for failure of the Director to require the application to be restricted to one invention.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 122 Confidential status of applications; publication of patent applications.[edit | edit source]

(a) CONFIDENTIALITY.— Except as provided in subsection (b), applications for patents shall be kept in confidence by the Patent and Trademark Office and no information concerning the same given without authority of the applicant or owner unless necessary to carry out the provisions of an Act of Congress or in such special circumstances as may be determined by the Director.

(b) PUBLICATION.—

(1) IN GENERAL.—

(A) Subject to paragraph (2), each application for a patent shall be published, in accordance with procedures determined by the Director, promptly after the expiration of a period of 18 months from the earliest filing date for which a benefit is sought under this title. At the request of the applicant, an application may be published earlier than the end of such 18month period. (B) No information concerning published patent applications shall be made available to the public except as the Director determines. (C) Notwithstanding any other provision of law, a determination by the Director to release or not to release information concerning a published patent application shall be final and nonreviewable. (2) EXCEPTIONS.—

(A) An application shall not be published if that application is— (i) no longer pending;

(ii) subject to a secrecy order under section 181 of this title;

(iii) a provisional application filed under section 111(b) of this title; or

(iv) an application for a design patent filed under chapter 16 of this title. (B)(i) If an applicant makes a request upon filing, certifying that the invention disclosed in the application has not and will not be the subject of an application filed in another country, or under a multilateral international agreement, that requires publication of applications 18 months after filing, the application shall not be published as provided in paragraph (1).

(ii) An applicant may rescind a request made under clause (i) at any time.

(iii) An applicant who has made a request under clause (i) but who subsequently files, in a foreign country or under a multilateral international agreement specified in clause (i), an application directed to the invention disclosed in the application filed in the Patent and Trademark Office, shall notify the Director of such filing not later than 45 days after the date of the filing of such foreign or international application. A failure of the applicant to provide such notice within the prescribed period shall result in the application being regarded as abandoned, unless it is shown to the satisfaction of the Director that the delay in submitting the notice was unintentional.

(iv) If an applicant rescinds a request made under clause (i) or notifies the Director that an application was filed in a foreign country or under a multilateral international agreement specified in clause (i), the application shall be published in accordance with the provisions of paragraph (1) on or as soon as is practical after the date that is specified in clause (i). (v) If an applicant has filed applications in one or more foreign countries, directly or through a multilateral international agreement, and such foreign filed applications corresponding to an application filed in the Patent and Trademark Office or the description of the invention in such foreign filed applications is less extensive than the application or description of the invention in the application filed in the Patent and Trademark Office, the applicant may submit a redacted copy of the application filed in the Patent and Trademark Office eliminating any part or description of the invention in such application that is not also contained in any of the corresponding applications filed in a foreign country. The Director may only publish the redacted copy of the application unless the redacted copy of the application is not received within 16 months after the earliest effective filing date for which a benefit is sought under this title. The provisions of section 154(d) shall not apply to a claim if the description of the invention published in the redacted application filed under this clause with respect to the claim does not enable a person skilled in the art to make and use the subject matter of the claim. (c) PROTEST AND PRE-ISSUANCE OPPOSITION.— The Director shall establish appropriate procedures to ensure that no protest or other form of pre-issuance opposition to the grant of a patent on an application may be initiated after publication of the application without the express written consent of the applicant. (d) NATIONAL SECURITY.— No application for patent shall be published under subsection (b)(1) if the publication or disclosure of such invention would be detrimental to the national security. The Director shall establish appropriate procedures to ensure that such applications are promptly identified and the secrecy of such inventions is maintained in accordance with chapter 17 of this title.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-563 (S. 1948 sec. 4503(b)(1)).)

CHAPTER 12 — EXAMINATION OF APPLICATION[edit | edit source]

Sec. 131 Examination of application. 132 Notice of rejection; reexamination. 133 Time for prosecuting application. 134 Appeal to the Board of Patent Appeals and

Interferences. 135 Interferences.

35 U.S.C. 131 Examination of application.[edit | edit source]

The Director shall cause an examination to be made of the application and the alleged new invention; and if on such examination it appears that the applicant is entitled to a patent under the law, the Director shall issue a patent therefor.

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 132 Notice of rejection; reexamination.[edit | edit source]

(a) Whenever, on examination, any claim for a patent is rejected, or any objection or requirement made, the Director shall notify the applicant thereof, stating the reasons for such rejection, or objection or requirement, together with such information and references as may be useful in judging of the propriety of continuing the prosecution of his application; and if after receiving such notice, the applicant persists in his claim for a patent, with or without amendment, the application shall be reexamined. No amendment shall introduce new matter into the disclosure of the invention. (b) The Director shall prescribe regulations to provide for the continued examination of applications for patent at the request of the applicant. The Director may establish appropriate fees for such continued examination and shall provide a 50 percent reduction in such fees for small entities that qualify for reduced fees under section 41(h)(1) of this title.


(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-560, 582 (S. 1948 secs. 4403 and 4732(a)(10)(A)).)

35 U.S.C. 133 Time for prosecuting application.[edit | edit source]

Upon failure of the applicant to prosecute the application within six months after any action therein, of which notice has been given or mailed to the applicant, or within such shorter time, not less than thirty days, as fixed by the Director in such action, the application shall be regarded as abandoned by the parties thereto, unless it be shown to the satisfaction of the Director that such delay was unavoidable.

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 134 Appeal to the Board of Patent Appeals and Interferences.[edit | edit source]

(a) PATENT APPLICANT.— An applicant for a patent, any of whose claims has been twice rejected, may appeal from the decision of the primary examiner to the Board of Patent Appeals and Interferences, having once paid the fee for such appeal. (b) PATENT OWNER.— A patent owner in any reexamination proceeding may appeal from the final rejection of any claim by the primary examiner to the Board of Patent Appeals and Interferences, having once paid the fee for such appeal. (c) THIRD-PARTY.— A third-party requester in an inter partes proceeding may appeal to the Board of Patent Appeals and Interferences from the final decision of the primary examiner favorable to the patentability of any original or proposed amended or new claim of a patent, having once paid the fee for such appeal.

(Amended Nov. 8, 1984, Public Law 98-622, sec. 204(b)(1), 98 Stat. 3388; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4605(b)); subsections (a)-(c) amended Nov. 2, 2002, Public Law 107-273, secs. 13106 and 13202, 116 Stat. 1901.)

35 U.S.C. 135 Interferences.[edit | edit source]

(a) Whenever an application is made for a patent which, in the opinion of the Director, would interfere with any pending application, or with any unexpired patent, an interference may be declared and the Director shall give notice of such declaration to the applicants, or applicant and patentee, as the case may be. The Board of Patent Appeals and Interferences shall determine questions of priority of the inventions and may determine questions of patentability. Any final decision, if adverse to the claim of an applicant, shall constitute the final refusal by the Patent and Trademark Office of the claims involved, and the Director may issue a patent to the applicant who is adjudged the prior inventor. A final judgment adverse to a patentee from which no appeal or other review has been or can be taken or had shall constitute cancellation of the claims involved in the patent, and notice of such cancellation shall be endorsed on copies of the patent distributed after such cancellation by the Patent and Trademark Office.

(b)(1)A claim which is the same as, or for the same or substantially the same subject matter as, a claim of an issued patent may not be made in any application unless such a claim is made prior to one year from the date on which the patent was granted.

(2) A claim which is the same as, or for the same or substantially the same subject matter as, a claim of an application published under section 122(b) of this title may be made in an application filed after the application is published only if the claim is made before 1 year after the date on which the application is published. (c) Any agreement or understanding between parties to an interference, including any collateral agreements referred to therein, made in connection with or in contemplation of the termination of the interference, shall be in writing and a true copy thereof filed in the Patent and Trademark Office before the termination of the interference as between the said parties to the agreement or understanding. If any party filing the same so requests, the copy shall be kept separate from the file of the interference, and made available only to Government agencies on written request, or to any person on a showing of good cause. Failure to file the copy of such agreement or understanding shall render permanently unenforceable such agreement or understanding and any patent of such parties involved in the interference or any patent subsequently issued on any application of such parties so involved. The Director may, however, on a showing of good cause for failure to file within the time prescribed, permit the filing of the agreement or understanding during the six-month period subsequent to the termination of the interference as between the parties to the agreement or understanding.

The Director shall give notice to the parties or their attorneys of record, a reasonable time prior to said termination, of the filing requirement of this section. If the Director gives such notice at a later time, irrespective of the right to file such agreement or understanding within the six-month period on a showing of good cause, the parties may file such agreement or understanding within sixty days of the receipt of such notice.

Any discretionary action of the Director under this subsection shall be reviewable under section 10 of the Administrative Procedure Act.

(d) Parties to a patent interference, within such time as may be specified by the Director by regulation, may determine such contest or any aspect thereof by arbitration. Such arbitration shall be governed by the provisions of title 9 to the extent such title is not inconsistent with this section. The parties shall give notice of any arbitration award to the Director, and such award shall, as between the parties to the arbitration, be dispositive of the issues to which it relates. The arbitration award shall be unenforceable until such notice is given. Nothing in this subsection shall preclude the Director from determining patentability of the invention involved in the interference.

(Subsection (c) added Oct. 15, 1962, Public Law 87831, 76 Stat. 958.)

(Subsections (a) and (c) amended, Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949.)

(Subsection (a) amended Nov. 8, 1984, Public Law 98622, sec. 202, 98 Stat. 3386.)

(Subsection (d) added Nov. 8, 1984, Public Law 98622, sec. 105, 98 Stat. 3385.)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-566, 582 (S. 1948 secs. 4507(11) and 4732(a)(10)(A)).)

CHAPTER 13 — REVIEW OF PATENT AND TRADEMARK OFFICE DECISION[edit | edit source]

Sec. 141 Appeal to Court of Appeals for the Federal Cir


cuit. 142 Notice of appeal. 143 Proceedings on appeal. 144 Decision on appeal. 145 Civil action to obtain patent. 146 Civil action in case of interference.

35 U.S.C. 141 Appeal to the Court of Appeals for the Federal Circuit.[edit | edit source]

An applicant dissatisfied with the decision in an appeal to the Board of Patent Appeals and Interferences under section 134 of this title may appeal the decision to the United States Court of Appeals for the Federal Circuit. By filing such an appeal the applicant waives his or her right to proceed under section 145 of this title. A patent owner, or a third-party requester in an inter partes reexamination proceeding, who is in any reexamination proceeding dissatisfied with the final decision in an appeal to the Board of Patent Appeals and Interferences under section 134 may appeal the decision only to the United States Court of Appeals for the Federal Circuit. A party to an interference dissatisfied with the decision of the Board of Patent Appeals and Interferences on the interference may appeal the decision to the United States Court of Appeals for the Federal Circuit, but such appeal shall be dismissed if any adverse party to such interference, within twenty days after the appellant has filed notice of appeal in accordance with section 142 of this title, files notice with the Director that the party elects to have all further proceedings conducted as provided in section 146 of this title. If the appellant does not, within thirty days after filing of such notice by the adverse party, file a civil action under section 146, the decision appealed from shall govern the further proceedings in the case.

(Amended Apr. 2, 1982, Public Law 97-164, sec. 163(a)(7), (b)(2), 96 Stat. 49, 50; Nov. 8, 1984, Public Law 98-622, sec. 203(a), 98 Stat. 3387; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-571, 582

(S. 1948 secs. 4605(c) and 4732(a)(10)(A)); Nov. 2, 2002, Public Law 107-273, sec. 13106, 116 Stat. 1901.)

35 U.S.C. 142 Notice of appeal.[edit | edit source]

When an appeal is taken to the United States Court of Appeals for the Federal Circuit, the appellant shall file in the Patent and Trademark Office a written notice of appeal directed to the Director, within such time after the date of the decision from which the appeal is taken as the Director prescribes, but in no case less than 60 days after that date.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Apr. 2, 1982, Public Law 97-164, sec. 163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-620, sec. 414(a), 98 Stat. 3363; Nov. 29, 1999, Public Law 106 113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 143 Proceedings on appeal.[edit | edit source]

With respect to an appeal described in section 142 of this title, the Director shall transmit to the United States Court of Appeals for the Federal Circuit a certified list of the documents comprising the record in the Patent and Trademark Office. The court may request that the Director forward the original or certified copies of such documents during the pendency of the appeal. In an ex parte case or any reexamination case, the Director shall submit to the court in writing the grounds for the decision of the Patent and Trademark Office, addressing all the issues involved in the appeal. The court shall, before hearing an appeal, give notice of the time and place of the hearing to the Director and the parties in the appeal.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Apr. 2, 1982, Public Law 97-164, sec. 163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-620, sec. 414(a), 98 Stat. 3363; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-571, 582 (S. 1948 secs. 4605(d) and 4732(a)(10)(A)); Nov. 2, 2002, Public Law 107-273, sec. 13202, 116 Stat. 1901.)

35 U.S.C. 144 Decision on appeal.[edit | edit source]

The United States Court of Appeals for the Federal Circuit shall review the decision from which an appeal is taken on the record before the Patent and Trademark Office. Upon its determination the court shall issue to the Director its mandate and opinion, which shall be entered of record in the Patent and Trademark Office and shall govern the further proceedings in the case.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Apr. 2, 1982, Public Law 97-164, sec. 163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-620, sec. 414(a), 98 Stat. 3363; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 145 Civil action to obtain patent.[edit | edit source]

An applicant dissatisfied with the decision of the Board of Patent Appeals and Interferences in an appeal under section 134(a) of this title may, unless appeal has been taken to the United States Court of Appeals for the Federal Circuit, have remedy by civil action against the Director in the United States District Court for the District of Columbia if commenced within such time after such decision, not less than sixty days, as the Director appoints. The court may adjudge that such applicant is entitled to receive a patent for his invention, as specified in any of his claims involved in the decision of the Board of Patent Appeals and Interferences, as the facts in the case may appear, and such adjudication shall authorize the Director to issue such patent on compliance with the requirements of law. All the expenses of the proceedings shall be paid by the applicant.

(Amended Apr. 2, 1982, Public Law 97-164, sec. 163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-622, sec. 203(b), 98 Stat. 3387; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-571, 582 (S. 1948 secs. 4605(e) and 4732(a)(10)(A).)

35 U.S.C. 146 Civil action in case of interference.[edit | edit source]

Any party to an interference dissatisfied with the decision of the Board of Patent Appeals and Interferences may have remedy by civil action, if commenced within such time after such decision, not less than sixty days, as the Director appoints or as provided in section 141 of this title, unless he has appealed to the United States Court of Appeals for the Federal Circuit, and such appeal is pending or has been decided. In such suits the record in the Patent and Trademark Office shall be admitted on motion of either party upon the terms and conditions as to costs, expenses, and the further cross-examination of the witnesses as the court imposes, without prejudice to the right of the parties to take further testimony. The testimony and exhibits of the record in the Patent and Trademark Office when admitted shall have the same effect as if originally taken and produced in the suit.

Such suit may be instituted against the party in interest as shown by the records of the Patent and Trademark Office at the time of the decision complained of, but any party in interest may become a party to the action. If there be adverse parties residing in a plurality of districts not embraced within the same state, or an adverse party residing in a foreign country, the United States District Court for the District of Columbia shall have jurisdiction and may issue summons against the adverse parties directed to the marshal of any district in which any adverse party resides. Summons against adverse parties residing in foreign countries may be served by publication or otherwise as the court directs. The Director shall not be a necessary party but he shall be notified of the filing of the suit by the clerk of the court in which it is filed and shall have the right to intervene. Judgment of the court in favor of the right of an applicant to a patent shall authorize the Director to issue such patent on the filing in the Patent and Trademark Office of a certified copy of the judgment and on compliance with the requirements of law.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Apr. 2, 1982, Public Law 97-164, sec. 163(a)(7), 96 Stat. 49; Nov. 8, 1984, Public Law 98-622, sec. 203(c), 98 Stat. 3387; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

CHAPTER 14 — ISSUE OF PATENT[edit | edit source]

Sec. 151 Issue of patent. 152 Issue of patent to assignee. 153 How issued. 154 Contents and term of patent; provisional rights. 155 Patent term extension. 155A Patent term restoration. 156 Extension of patent term. 157 Statutory invention registration.


35 U.S.C. 151 Issue of patent.[edit | edit source]

If it appears that applicant is entitled to a patent under the law, a written notice of allowance of the application shall be given or mailed to the applicant. The notice shall specify a sum, constituting the issue fee or a portion thereof, which shall be paid within three months thereafter.

Upon payment of this sum the patent shall issue, but if payment is not timely made, the application shall be regarded as abandoned.

Any remaining balance of the issue fee shall be paid within three months from the sending of a notice thereof, and, if not paid, the patent shall lapse at the termination of this three-month period. In calculating the amount of a remaining balance, charges for a page or less may be disregarded.

If any payment required by this section is not timely made, but is submitted with the fee for delayed payment and the delay in payment is shown to have been unavoidable, it may be accepted by the Director as though no abandonment or lapse had ever occurred.

(Amended July 24, 1965, Public Law 89-83, sec. 4, 79 Stat. 260; Jan. 2, 1975, Public Law 93-601, sec. 3, 88 Stat. 1956; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)); Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 152 Issue of patent to assignee.[edit | edit source]

Patents may be granted to the assignee of the inventor of record in the Patent and Trademark Office, upon the application made and the specification sworn to by the inventor, except as otherwise provided in this title.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949.)

35 U.S.C. 153 How issued.[edit | edit source]

Patents shall be issued in the name of the United States of America, under the seal of the Patent and Trademark Office, and shall be signed by the Director or have his signature placed thereon and shall be recorded in the Patent and Trademark Office.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)); Nov. 2, 2002, Public Law 107-273, sec. 13203, 116 Stat. 1902.)

35 U.S.C. 154 Contents and term of patent; provisional rights.[edit | edit source]

(a) IN GENERAL.—

(1) CONTENTS.—Every patent shall contain a short title of the invention and a grant to the patentee, his heirs or assigns, of the right to exclude others from making, using, offering for sale, or selling the invention throughout the United States or importing the invention into the United States, and, if the invention is a process, of the right to exclude others from using, offering for sale or selling throughout the United States, or importing into the United States, products made by that process, referring to the specification for the particulars thereof. (2) TERM.—Subject to the payment of fees under this title, such grant shall be for a term beginning on the date on which the patent issues and ending 20 years from the date on which the application for the patent was filed in the United States or, if the application contains a specific reference to an earlier filed application or applications under section 120, 121, or 365(c) of this title, from the date on which the earliest such application was filed.

(3) PRIORITY.—Priority under section 119, 365(a), or 365(b) of this title shall not be taken into account in determining the term of a patent. (4) SPECIFICATION AND DRAWING.—A copy of the specification and drawing shall be annexed to the patent and be a part of such patent. (b) ADJUSTMENT OF PATENT TERM.— (1) PATENT TERM GUARANTEES.—

(A) GUARANTEE OF PROMPT PATENT AND TRADEMARK OFFICE RESPONSES.— Subject to the limitations under paragraph (2), if the issue of an original patent is delayed due to the failure of the Patent and Trademark Office to— (i) provide at least one of the notifications under section 132 of this title or a notice of allowance under section 151 of this title not later than 14 months after— (I) the date on which an application was filed under section 111(a) of this title; or (II) the date on which an international application fulfilled the requirements of section 371 of this title; (ii) respond to a reply under section 132, or to an appeal taken under section 134, within 4 months after the date on which the reply was filed or the appeal was taken;

(iii) act on an application within 4 months after the date of a decision by the Board of Patent Appeals and Interferences under section 134 or 135 or a decision by a Federal court under section 141, 145, or 146 in a case in which allowable claims remain in the application; or

(iv) issue a patent within 4 months after the date on which the issue fee was paid under section 151 and all outstanding requirements were satisfied, the term of the patent shall be extended 1 day for each day after the end of the period specified in clause (i), (ii), (iii), or (iv), as the case may be, until the action described in such clause is taken. (B) GUARANTEE OF NO MORE THAN 3-YEAR APPLICATION PENDENCY.— Subject to the limitations under paragraph (2), if the issue of an original patent is delayed due to the failure of the United States Patent and Trademark Office to issue a patent within 3 years after the actual filing date of the application in the United States, not including—

(i) any time consumed by continued examination of the application requested by the applicant under section 132(b); (ii) any time consumed by a proceeding under section 135(a), any time consumed by the imposition of an order under section 181, or any time consumed by appellate review by the Board of Patent Appeals and Interferences or by a Federal court; or

(iii) any delay in the processing of the application by the United States Patent and Trademark Office requested by the applicant except as permitted by paragraph (3)(C), the term of the patent shall be extended 1 day for each day after the end of that 3-year period until the patent is issued.

(C) GUARANTEE OR ADJUSTMENTS FOR DELAYS DUE TO INTERFERENCES, SECRECY ORDERS, AND APPEALS.— Subject to the limitations under paragraph (2), if the issue of an original patent is delayed due to— (i) a proceeding under section 135(a);

(ii) the imposition of an order under section 181; or

(iii) appellate review by the Board of Patent Appeals and Interferences or by a Federal court in a case in which the patent was issued under a decision in the review reversing an adverse determination of patentability, the term of the patent shall be extended 1 day for each day of the pendency of the proceeding, order, or review, as the case may be.

(2) LIMITATIONS.—

(A) IN GENERAL.— To the extent that periods of delay attributable to grounds specified in paragraph (1) overlap, the period of any adjustment granted under this subsection shall not exceed the actual number of days the issuance of the patent was delayed. (B) DISCLAIMED TERM.— No patent the term of which has been disclaimed beyond a specified date may be adjusted under this section beyond the expiration date specified in the disclaimer. (C) REDUCTION OF PERIOD OF ADJUSTMENT.— (i) The period of adjustment of the term of a patent under paragraph (1) shall be reduced by a period equal to the period of time during which the applicant failed to engage in reasonable efforts to conclude prosecution of the application.

(ii) With respect to adjustments to patent term made under the authority of paragraph (1)(B), an applicant shall be deemed to have failed to engage in reasonable efforts to conclude processing or examination of an application for the cumulative total of any periods of time in excess of 3 months that are taken to respond to a notice from the Office making any rejection, objection, argument, or other request, measuring such 3-month period from the date the notice was given or mailed to the applicant.

(iii) The Director shall prescribe regulations establishing the circumstances that constitute a failure of an applicant to engage in reasonable efforts to conclude processing or examination of an application.

(3) PROCEDURES FOR PATENT TERM ADJUSTMENT DETERMINATION.— (A) The Director shall prescribe regulations establishing procedures for the application for and determination of patent term adjustments under this subsection. (B) Under the procedures established under subparagraph (A), the Director shall— (i) make a determination of the period of any patent term adjustment under this subsection, and shall transmit a notice of that determination with the written notice of allowance of the application under section 151; and (ii) provide the applicant one opportunity to request reconsideration of any patent term adjustment determination made by the Director. (C) The Director shall reinstate all or part of the cumulative period of time of an adjustment under paragraph (2)(C) if the applicant, prior to the issuance of the patent, makes a showing that, in spite of all due care, the applicant was unable to respond within the 3-month period, but in no case shall more than three additional months for each such response beyond the original 3-month period be reinstated. (D) The Director shall proceed to grant the patent after completion of the Director’s determination of a patent term adjustment under the procedures established under this subsection, notwithstanding any appeal taken by the applicant of such determination.


(4) APPEAL OF PATENT TERM ADJUSTMENT DETERMINATION.— (A) An applicant dissatisfied with a determination made by the Director under paragraph (3) shall have remedy by a civil action against the Director filed in the United States District Court for the District of Columbia within 180 days after the grant of the patent. Chapter 7 of title 5 shall apply to such action. Any final judgment resulting in a change to the period of adjustment of the patent term shall be served on the Director, and the Director shall thereafter alter the term of the patent to reflect such change. (B) The determination of a patent term adjustment under this subsection shall not be subject to appeal or challenge by a third party prior to the grant of the patent. (c) CONTINUATION.—


(1) DETERMINATION.—The term of a patent that is in force on or that results from an application filed before the date that is 6 months after the date of the enactment of the Uruguay Round Agreements Act shall be the greater of the 20-year term as provided in subsection (a), or 17 years from grant, subject to any terminal disclaimers. (2) REMEDIES.—The remedies of sections 283, 284, and 285 of this title shall not apply to acts which — (A) were commenced or for which substantial investment was made before the date that is 6 months after the date of the enactment of the Uruguay Round Agreements Act; and (B) became infringing by reason of paragraph (1). (3) REMUNERATION.—The acts referred to in paragraph (2) may be continued only upon the payment of an equitable remuneration to the patentee that is determined in an action brought under chapter 28 and chapter 29 (other than those provisions excluded by paragraph (2)) of this title. (d) PROVISIONAL RIGHTS.—


(1) IN GENERAL.— In addition to other rights provided by this section, a patent shall include the right to obtain a reasonable royalty from any person who, during the period beginning on the date of publication of the application for such patent under section 122(b), or in the case of an international application filed under the treaty defined in section 351(a) designating the United States under Article 21(2)(a) of such treaty, the date of publication of the application, and ending on the date the patent is issued—

(A) (i) makes, uses, offers for sale, or sells in the United States the invention as claimed in the published patent application or imports such an invention into the United States; or (ii) if the invention as claimed in the published patent application is a process, uses, offers for sale, or sells in the United States or imports into the United States products made by that process as claimed in the published patent application; and (B) had actual notice of the published patent application and, in a case in which the right arising under this paragraph is based upon an international application designating the United States that is published in a language other than English, had a translation of the international application into the English language. (2) RIGHT BASED ON SUBSTANTIALLY IDENTICAL INVENTIONS.— The right under paragraph (1) to obtain a reasonable royalty shall not be available under this subsection unless the invention as claimed in the patent is substantially identical to the invention as claimed in the published patent application. (3) TIME LIMITATION ON OBTAINING A REASONABLE ROYALTY.— The right under paragraph (1) to obtain a reasonable royalty shall be available only in an action brought not later than 6 years after the patent is issued. The right under paragraph (1) to obtain a reasonable royalty shall not be affected by the duration of the period described in paragraph (1). (4) REQUIREMENTS FOR INTERNATIONAL APPLICATIONS— (A) EFFECTIVE DATE.— The right under paragraph (1) to obtain a reasonable royalty based upon the publication under the treaty defined in section 351(a) of an international application designating the United States shall commence on the date of publication under the treaty of the international application, or, if the publication under the treaty of the international application is in a language other than English, on the date on which the Patent and Trademark Office receives a translation of the publication in the English language.

(B) COPIES.— The Director may require the applicant to provide a copy of the international application and a translation thereof.

(Amended July 24, 1965, Public Law 89-83, sec. 5, 79 Stat. 261; Dec. 12, 1980, Public Law 96-517, sec. 4, 94 Stat. 3018; Aug. 23, 1988, Public Law 100-418, sec. 9002, 102 Stat. 1563; Dec. 8, 1994, Public Law 103-465, sec. 532 (a)(1), 108 Stat. 4983; Oct. 11, 1996, Public Law 104-295, sec. 20(e)(1), 110 Stat. 3529.)

(Subsection (b) amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-557 (S. 1948 sec. 4402(a)).)

(Subsection (d) added Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-564 (S. 1948 sec. 4504).)

(Subsection (b)(4) amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1904; subsection (d)(4)(A) amended Nov. 2, 2002, Public Law 107-273, sec. 13204, 116 Stat. 1902.)

35 U.S.C. 155 Patent term extension.[edit | edit source]

Notwithstanding the provisions of section 154, the term of a patent which encompasses within its scope a composition of matter or a process for using such composition shall be extended if such composition or process has been subjected to a regulatory review by the Federal Food and Drug Administration pursuant to the Federal Food, Drug and Cosmetic Act leading to the publication of regulation permitting the interstate distribution and sale of such composition or process and for which there has thereafter been a stay of regulation of approval imposed pursuant to section 409 of the Federal Food, Drug and Cosmetic Act, which stay was in effect on January 1, 1981, by a length of time to be measured from the date such stay of regulation of approval was imposed until such proceedings are finally resolved and commercial marketing permitted. The patentee, his heirs, successors, or assigns shall notify the Director within 90 days of the date of enactment of this section or the date the stay of regulation of approval has been removed, whichever is later, of the number of the patent to be extended and the date the stay was imposed and the date commercial marketing was permitted. On receipt of such notice, the Director shall promptly issue to the owner of record of the patent a certificate of extension, under seal, stating the fact and length of the extension and identifying the composition of matter or process for using such composition to which such extension is applicable. Such certificate shall be recorded in the official file of each patent extended and such certificate shall be considered as part of the original patent, and an appropriate notice shall be published in the Official Gazette of the Patent and Trademark Office.

(Added Jan. 4, 1983, Public Law 97-414, sec. 11(a), 96 Stat. 2065; amended Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 secs. 4732(a)(6) and 4732(a)(10)(A)).)

35 U.S.C. 155A Patent term restoration.[edit | edit source]

(a) Notwithstanding section 154 of this title, the term of each of the following patents shall be extended in accordance with this section: (1) Any patent which encompasses within its scope a composition of matter which is a new drug product, if during the regulatory review of the product by the Federal Food and Drug Administration — (A) the Federal Food and Drug Administration notified the patentee, by letter dated February 20, 1976, that such product’s new drug application was not approvable under section 505(b)(1) of the Federal Food, Drug and Cosmetic Act; (B) in 1977 the patentee submitted to the Federal Food and Drug Administration the results of a health effects test to evaluate the carcinogenic potential of such product; (C) the Federal Food and Drug Administration approved, by letter dated December 18, 1979, the new drug application for such application; and (D) the Federal Food and Drug Administration approved, by letter dated May 26, 1981, a supplementary application covering the facility for the production of such product. (2) Any patent which encompasses within its scope a process for using the composition described in paragraph (1). (b) The term of any patent described in subsection (a) shall be extended for a period equal to the period beginning February 20, 1976, and ending May 26, 1981, and such patent shall have the effect as if originally issued with such extended term. (c) The patentee of any patent described in subsection (a) of this section shall, within ninety days after the date of enactment of this section, notify the Director of the number of any patent so extended. On receipt of such notice, the Director shall confirm such extension by placing a notice thereof in the official file of such patent and publishing an appropriate notice of such extension in the Official Gazette of the Patent and Trademark Office.

(Added Oct. 13, 1983, Public Law 98-127, sec. 4(a), 97 Stat. 832; amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 secs. 4732(a)(7) and 4732(a)(10)(A)).)

35 U.S.C. 156 Extension of patent term.[edit | edit source]

(a) The term of a patent which claims a product, a method of using a product, or a method of manufacturing a product shall be extended in accordance with this section from the original expiration date of the patent, which shall include any patent term adjustment granted under section 154(b) if — (1) the term of the patent has not expired before an application is submitted under subsection (d)(1) for its extension; (2) the term of the patent has never been extended under subsection (e)(1) of this section; (3) an application for extension is submitted by the owner of record of the patent or its agent and in accordance with the requirements of paragraphs (1) through (4) of subsection (d); (4) the product has been subject to a regulatory review period before its commercial marketing or use; (5)(A) except as provided in subparagraph (B) or (C), the permission for the commercial marketing or use of the product after such regulatory review period is the first permitted commercial marketing or use of the product under the provision of law under which such regulatory review period occurred;

(B) in the case of a patent which claims a method of manufacturing the product which primarily uses recombinant DNA technology in the manufacture of the product, the permission for the commercial marketing or use of the product after such regulatory period is the first permitted commercial marketing or use of a product manufactured under the process claimed in the patent; or (C) for purposes of subparagraph (A), in the case of a patent which — (i) claims a new animal drug or a veterinary biological product which (I) is not covered by the claims in any other patent which has been extended, and (II) has received permission for the commercial marketing or use in non-food-producing animals and in food-producing animals, and

(ii) was not extended on the basis of the regulatory review period for use in non-food-producing animals, the permission for the commercial marketing or use of the drug or product after the regulatory review period for use in food-producing animals is the first permitted commercial marketing or use of the drug or product for administration to a food-producing animal. The product referred to in paragraphs

(4) and (5) is hereinafter in this section referred to as the “approved product.” (b) Except as provided in subsection (d)(5)(F), the rights derived from any patent the term of which is extended under this section shall during the period during which the term of the patent is extended — (1) in the case of a patent which claims a product, be limited to any use approved for the product — (A) before the expiration of the term of the patent — (i) under the provision of law under which the applicable regulatory review occurred, or (ii) under the provision of law under which any regulatory review described in paragraph (1), (4), or (5) of subsection (g) occurred, and (B) on or after the expiration of the regulatory review period upon which the extension of the patent was based; (2) in the case of a patent which claims a method of using a product, be limited to any use claimed by the patent and approved for the product — (A) before the expiration of the term of the patent — (i) under any provision of law under which an applicable regulatory review occurred, and (ii) under the provision of law under which any regulatory review described in paragraph (1), (4), or (5) of subsection (g) occurred, and (B) on or after the expiration of the regulatory review period upon which the extension of the patent was based; and (3) in the case of a patent which claims a method of manufacturing a product, be limited to the method of manufacturing as used to make — (A) the approved product, or

(B) the product if it has been subject to a regulatory review period described in paragraph (1), (4), or (5) of subsection (g).

As used in this subsection, the term “product” includes an approved product.

(c) The term of a patent eligible for extension under subsection (a) shall be extended by the time equal to the regulatory review period for the approved product which period occurs after the date the patent is issued, except that— (1) each period of the regulatory review period shall be reduced by any period determined under subsection (d)(2)(B) during which the applicant for the patent extension did not act with due diligence during such period of the regulatory review period; (2) after any reduction required by paragraph (1), the period of extension shall include only one-half of the time remaining in the periods described in paragraphs (1)(B)(i), (2)(B)(i), (3)(B)(i), (4)(B)(i), and (5)(B)(i) of subsection (g); (3) if the period remaining in the term of a patent after the date of the approval of the approved product under the provision of law under which such regulatory review occurred when added to the regulatory review period as revised under paragraphs (1) and (2) exceeds fourteen years, the period of extension shall be reduced so that the total of both such periods does not exceed fourteen years, and (4) in no event shall more than one patent be extended under subsection (e)(i) for the same regulatory review period for any product. (d)(1) To obtain an extension of the term of a patent under this section, the owner of record of the patent or its agent shall submit an application to the Director. Except as provided in paragraph (5), such an application may only be submitted within the sixty- day period beginning on the date the product received permission under the provision of law under which the applicable regulatory review period occurred for commercial marketing or use. The application shall contain —

(A) the identity of the approved product and the Federal statute under which regulatory review occurred; (B) the identity of the patent for which an extension is being sought and the identity of each claim of such patent; (C) information to enable the Director to determine under subsections (a) and (b) the eligibility of a patent for extension and the rights that will be derived from the extension and information to enable the Director and the Secretary of Health and Human Services or the Secretary of Agriculture to determine the period of the extension under subsection (g);

(D) a brief description of the activities undertaken by the applicant during the applicable regulatory review period with respect to the approved product and the significant dates applicable to such activities; and (E) such patent or other information as the Director may require. (2)(A) Within 60 days of the submittal of an application for extension of the term of a patent under paragraph (1), the Director shall notify —

(i) the Secretary of Agriculture if the patent claims a drug product or a method of using or manufacturing a drug product and the drug product is subject to the Virus-Serum-Toxin Act, and (ii) the Secretary of Health and Human Services if the patent claims any other drug product, a medical device, or a food additive or color additive or a method of using or manufacturing such a product, device, or additive and if the product, device, and additive are subject to the Federal Food, Drug and Cosmetic Act, of the extension application and shall submit to the Secretary who is so notified a copy of the application. Not later than 30 days after the receipt of an application from the Director, the Secretary reviewing the application shall review the dates contained in the application pursuant to paragraph (1)(C) and determine the applicable regulatory review period, shall notify the Director of the determination, and shall publish in the Federal Register a notice of such determination.


(B)(i) If a petition is submitted to the Secretary making the determination under subparagraph (A), not later than 180 days after the publication of the determination under subparagraph (A), upon which it may reasonably be determined that the applicant did not act with due diligence during the applicable regulatory review period, the Secretary making the determination shall, in accordance with regulations promulgated by the Secretary, determine if the applicant acted with due diligence during the applicable regulatory review period. The Secretary making the determination shall make such determination not later than 90 days after the receipt of such a petition. For a drug product, device, or additive subject to the Federal Food, Drug, and Cosmetic Act or the Public Health Service Act, the Secretary may not delegate the authority to make the determination prescribed by this clause to an office below the Office of the Commissioner of Food and Drugs. For a product subject to the Virus-Serum-Toxin Act, the Secretary of Agriculture may not delegate the authority to make the determination prescribed by this clause to an office below the Office of the Assistant Secretary for Marketing and Inspection Services.

(ii) The Secretary making a determination under clause (i) shall notify the Director of the determination and shall publish in the Federal Register a notice of such determination together with the factual and legal basis for such determination. Any interested person may request, within the 60-day period beginning on the publication of a determination, the Secretary making the determination to hold an informal hearing on the determination. If such a request is made within such period, such Secretary shall hold such hearing not later than 30 days after the date of the request, or at the request of the person making the request, not later than 60 days after such date. The Secretary who is holding the hearing shall provide notice of the hearing to the owner of the patent involved and to any interested person and provide the owner and any interested person an opportunity to participate in the hearing. Within 30 days after the completion of the hearing, such Secretary shall affirm or revise the determination which was the subject of the hearing and notify the Director of any revision of the determination and shall publish any such revision in the Federal Register. (3) For the purposes of paragraph (2)(B), the term “due diligence” means that degree of attention, continuous directed effort, and timeliness as may reasonably be expected from, and are ordinarily exercised by, a person during a regulatory review period. (4) An application for the extension of the term of a patent is subject to the disclosure requirements prescribed by the Director.


(5)(A) If the owner of record of the patent or its agent reasonably expects that the applicable regulatory review period described in paragraphs (1)(B)(ii), (2)(B)(ii), (3)(B)(ii), (4)(B)(ii), or (5)(B)(ii) of subsection (g) that began for a product that is the subject of such patent may extend beyond the expiration of the patent term in effect, the owner or its agent may submit an application to the Director for an


interim extension during the period beginning 6 months, and ending 15 days before such term is due to expire. The application shall contain—

(i) the identity of the product subject to regulating review and the Federal statute under which such review is occurring; (ii) the identity of the patent for which interim extension is being sought and the identity of each claim of such patent which claims the product under regulatory review or a method of using or manufacturing the product;


(iii) information to enable the Director to determine under subsection (a)(1), (2), and (3) the eligibility of a patent for extension;

(iv) a brief description of the activities undertaken by the applicant during the applicable regulatory review period to date with respect to the product under review and the significant dates applicable to such activities; and (v) such patent or other information as the Director may require. (B) If the Director determines that, except for permission to market or use the product commercially, the patent would be eligible for an extension of the patent term under this section, the Director shall publish in the Federal Register a notice of such determination, including the identity of the product under regulatory review, and shall issue to the applicant a certificate of interim extension for a period of not more than 1 year. (C) The owner of record of a patent, or its agent, for which an interim extension has been granted under subparagraph (B), may apply for not more than 4 subsequent interim extensions under this paragraph, except that, in the case of a patent subject to subsection (g)(6)(C), the owner of record of the patent, or its agent, may apply for only 1 subsequent interim extension under this paragraph. Each such subsequent application shall be made during the period beginning 60 days before, and ending 30 days before, the expiration of the preceding interim extension. (D) Each certificate of interim extension under this paragraph shall be recorded in the official file of the patent and shall be considered part of the original patent. (E) Any interim extension granted under this paragraph shall terminate at the end of the 60-day


period beginning on the day on which the product involved receives permission for commercial marketing or use, except that, if within that 60-day period, the applicant notifies the Director of such permission and submits any additional information under paragraph (1) of this subsection not previously contained in the application for interim extension, the patent shall be further extended, in accordance with the provisions of this section—

(i) for not to exceed 5 years from the date of expiration of the original patent term; or (ii) if the patent is subject to subsection (g)(6)(C), from the date on which the product involved receives approval for commercial marketing or use. (F) The rights derived from any patent the term of which is extended under this paragraph shall, during the period of interim extension— (i) in the case of a patent which claims a product, be limited to any use then under regulatory review; (ii) in the case of a patent which claims a method of using a product, be limited to any use claimed by the patent then under regulatory review; and


(iii) in the case of a patent which claims a method of manufacturing a product, be limited to the method of manufacturing as used to make the product then under regulatory review.

(e)(1) A determination that a patent is eligible for extension may be made by the Director solely on the basis of the representations contained in the application for the extension. If the Director determines that a patent is eligible for extension under subsection

(a) and that the requirements of paragraphs (1) through (4) of subsection (d) have been complied with, the Director shall issue to the applicant for the extension of the term of the patent a certificate of extension, under seal, for the period prescribed by subsection (c). Such certificate shall be recorded in the official file of the patent and shall be considered as part of the original patent. (2) If the term of a patent for which an application has been submitted under subsection (d)(1) would expire before a certificate of extension is issued or denied under paragraph (1) respecting the application, the Director shall extend, until such determination is made, the term of the patent for peri-



ods of up to one year if he determines that the patent is eligible for extension.

(f) For purposes of this section:

(1) The term “product” means:

(A) A drug product.

(B) Any medical device, food additive, or color additive subject to regulation under the Federal Food, Drug, and Cosmetic Act. (2) The term “drug product” means the active ingredient of— (A) a new drug, antibiotic drug, or human biological product (as those terms are used in the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act) or (B) a new animal drug or veterinary biological product (as those terms are used in the Federal Food, Drug, and Cosmetic Act and the Virus-Serum- Toxin Act) which is not primarily manufactured using recombinant DNA, recombinant RNA, hybridoma technology, or other processes involving site specific genetic manipulation techniques, including any salt or ester of the active ingredient, as a single entity or in combination with another active ingredient. (3) The term “major health or environmental effects test” means a test which is reasonably related to the evaluation of the health or environmental effects of a product, which requires at least six months to conduct, and the data from which is submitted to receive permission for commercial marketing or use. Periods of analysis or evaluation of test results are not to be included in determining if the conduct of a test required at least six months. (4)(A) Any reference to section 351 is a reference to section 351 of the Public Health Service Act.


(B) Any reference to section 503, 505, 512, or 515 is a reference to section 503, 505, 512, or 515 of the Federal Food, Drug and Cosmetic Act. (C) Any reference to the Virus-Serum- Toxin Act is a reference to the Act of March 4, 1913 (21 U.S.C. 151 - 158). (5) The term “informal hearing” has the meaning prescribed for such term by section 201(y) of the Federal Food, Drug and Cosmetic Act. (6) The term “patent” means a patent issued by the United States Patent and Trademark Office. (7) The term “date of enactment” as used in this section means September 24, 1984, for human


drug product, a medical device, food additive, or color additive.

(8) The term “date of enactment” as used in this section means the date of enactment of the Generic Animal Drug and Patent Term Restoration Act for an animal drug or a veterinary biological product. (g) For purposes of this section, the term “regulatory review period” has the following meanings: (1)(A)In the case of a product which is a new drug, antibiotic drug, or human biological product, the term means the period described in subparagraph (B) to which the limitation described in paragraph (6) applies.


(B) The regulatory review period for a new drug, antibiotic drug, or human biological product is the sum of — (i) the period beginning on the date an exemption under subsection (i) of section 505 or subsection (d) of section 507 became effective for the approved product and ending on the date an application was initially submitted for such drug product under section 351, 505, or 507, and (ii) the period beginning on the date the application was initially submitted for the approved product under section 351, subsection (b) of section 505, or section 507 and ending on the date such application was approved under such section. (2)(A) In the case of a product which is a food additive or color additive, the term means the period described in subparagraph (B) to which the limitation described in paragraph (6) applies.


(B) The regulatory review period for a food or color additive is the sum of — (i) the period beginning on the date a major health or environmental effects test on the additive was initiated and ending on the date a petition was initially submitted with respect to the product under the Federal Food, Drug, and Cosmetic Act requesting the issuance of a regulation for use of the product, and (ii) the period beginning on the date a petition was initially submitted with respect to the product under the Federal Food, Drug, and Cosmetic Act requesting the issuance of a regulation for use of the product, and ending on the date such regulation became effective or, if objections were filed to such regulation, ending on the date such objections were



resolved and commercial marketing was permitted or, if commercial marketing was permitted and later revoked pending further proceedings as a result of such objections, ending on the date such proceedings were finally resolved and commercial marketing was permitted.

(3)(A) In the case of a product which is a medical device, the term means the period described in subparagraph (B) to which the limitation described in paragraph (6) applies.

(B) The regulatory review period for a medical device is the sum of — (i) the period beginning on the date a clinical investigation on humans involving the device was begun and ending on the date an application was initially submitted with respect to the device under section 515, and (ii) the period beginning on the date an application was initially submitted with respect to the device under section 515 and ending on the date such application was approved under such Act or the period beginning on the date a notice of completion of a product development protocol was initially submitted under section 515(f)(5) and ending on the date the protocol was declared completed under section 515(f)(6). (4)(A) In the case of a product which is a new animal drug, the term means the period described in subparagraph (B) to which the limitation described in paragraph (6) applies.


(B) The regulatory review period for a new animal drug product is the sum of — (i) the period beginning on the earlier of the date a major health or environmental effects test on the drug was initiated or the date an exemption under subsection (j) of section 512 became effective for the approved new animal drug product and ending on the date an application was initially submitted for such animal drug product under section 512, and (ii) the period beginning on the date the application was initially submitted for the approved animal drug product under subsection (b) of section 512 and ending on the date such application was approved under such section.


(5)(A) In the case of a product which is a veterinary biological product, the term means the period described in subparagraph (B) to which the limitation described in paragraph (6) applies.

(B) The regulatory period for a veterinary biological product is the sum of — (i) the period beginning on the date the authority to prepare an experimental biological product under the Virus- Serum-Toxin Act became effective and ending on the date an application for a license was submitted under the Virus-Serum-Toxin Act, and (ii) the period beginning on the date an application for a license was initially submitted for approval under the Virus-Serum-Toxin Act and ending on the date such license was issued. (6) A period determined under any of the preceding paragraphs is subject to the following limitations: (A) If the patent involved was issued after the date of the enactment of this section, the period of extension determined on the basis of the regulatory review period determined under any such paragraph may not exceed five years. (B) If the patent involved was issued before the date of the enactment of this section and — (i) no request for an exemption described in paragraph (1)(B) or (4)(B) was submitted and no request for the authority described in paragraph (5)(B) was submitted, (ii) no major health or environment effects test described in paragraph (2)(B) or (4)(B) was initiated and no petition for a regulation or application for registration described in such paragraph was submitted, or


(iii) no clinical investigation described in paragraph (3) was begun or product development protocol described in such paragraph was submitted, before such date for the approved product the period of extension determined on the basis of the regulatory review period determined under any such paragraph may not exceed five years.

(C) If the patent involved was issued before the date of the enactment of this section and if an action described in subparagraph (B) was taken before the date of enactment of this section with respect to the approved product and the commercial marketing or use of the product has not been approved before such date, the period of extension determined on the basis of the regulatory review period determined under such paragraph may not exceed two years or in the case of an approved product which is a new animal drug or veterinary biological product (as


those terms are used in the Federal Food, Drug, and Cosmetic Act or the Virus-Serum-Toxin Act), three years.

(h) The Director may establish such fees as the Director determines appropriate to cover the costs to the Office of receiving and acting upon applications under this section.

(Added Sept. 24, 1984, Public Law 98-417, sec. 201(a), 98 Stat. 1598; amended Nov. 16, 1988, Public Law 100-670, sec. 201(a)-(h), 102 Stat. 3984; Dec. 3, 1993, Public Law 103-179, secs. 5, 6, 107 Stat. 2040, 2042; Dec. 8, 1994, Public Law 103-465, sec. 532(c)(1), 108 Stat. 4987.)

(Subsection (f) amended Nov. 21, 1997, Public Law 105-115, sec. 125(b)(2)(P), 111 Stat. 2326.)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-560, 582 (S. 1948 secs. 4404 and 4732(a)(10)(A)).)

(Subsections (b)(3)(B), (d)(2)(B)(i), and (g)(6)(B)(iii) amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1904.)

35 U.S.C. 157 Statutory invention registration.

(a) Notwithstanding any other provision of this title, the Director is authorized to publish a statutory invention registration containing the specification and drawings of a regularly filed application for a patent without examination if the applicant — (1) meets the requirements of section 112 of this title; (2) has complied with the requirements for printing, as set forth in regulations of the Director; (3) waives the right to receive a patent on the invention within such period as may be prescribed by the Director; and (4) pays application, publication, and other processing fees established by the Director. If an interference is declared with respect to such an application, a statutory invention registration may not be published unless the issue of priority of invention is finally determined in favor of the applicant.


(b) The waiver under subsection (a)(3) of this section by an applicant shall take effect upon publication of the statutory invention registration. (c) A statutory invention registration published pursuant to this section shall have all of the attributes specified for patents in this title except those specified


in section 183 and sections 271 through 289 of this title. A statutory invention registration shall not have any of the attributes specified for patents in any other provision of law other than this title. A statutory invention registration published pursuant to this section shall give appropriate notice to the public, pursuant to regulations which the Director shall issue, of the preceding provisions of this subsection. The invention with respect to which a statutory invention certificate is published is not a patented invention for purposes of section 292 of this title.

(d) The Director shall report to the Congress annually on the use of statutory invention registrations. Such report shall include an assessment of the degree to which agencies of the federal government are making use of the statutory invention registration system, the degree to which it aids the management of federally developed technology, and an assessment of the cost savings to the Federal Government of the uses of such procedures.

(Added Nov. 8, 1984, Public Law 98-622, sec. 102(a), 98 Stat. 3383; amended Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582, 583 (S. 1948 secs. 4732(a)(10)(A) and 4732(a)(11)).)

CHAPTER 15 — PLANT PATENTS[edit | edit source]

Sec. 161 Patents for plants. 162 Description, claim. 163 Grant. 164 Assistance of the Department of Agriculture.


35 U.S.C. 161 Patents for plants.

Whoever invents or discovers and asexually reproduces any distinct and new variety of plant, including cultivated sports, mutants, hybrids, and newly found seedlings, other than a tuber propagated plant or a plant found in an uncultivated state, may obtain a patent therefor, subject to the conditions and requirements of this title.

The provisions of this title relating to patents for inventions shall apply to patents for plants, except as otherwise provided.

(Amended Sept. 3, 1954, 68 Stat. 1190.)

35 U.S.C. 162 Description, claim.

No plant patent shall be declared invalid for noncompliance with section 112 of this title if the description is as complete as is reasonably possible.


The claim in the specification shall be in formal terms to the plant shown and described.

35 U.S.C. 163 Grant.

In the case of a plant patent, the grant shall include the right to exclude others from asexually reproducing the plant, and from using, offering for sale, or selling the plant so reproduced, or any of its parts, throughout the United States, or from importing the plant so reproduced, or any parts thereof, into the United States.

(Amended Oct. 27, 1998, Public Law 105-289, sec. 3, 112 Stat. 2781.)

35 U.S.C. 164 Assistance of the Department of Agriculture.

The President may by Executive order direct the Secretary of Agriculture, in accordance with the requests of the Director, for the purpose of carrying into effect the provisions of this title with respect to plants (1) to furnish available information of the Department of Agriculture, (2) to conduct through the appropriate bureau or division of the Department research upon special problems, or (3) to detail to the Director officers and employees of the Department.

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

CHAPTER 16 — DESIGNS[edit | edit source]

Sec. 171 Patents for designs. 172 Right of priority. 173 Term of design patent.


35 U.S.C. 171 Patents for designs.

Whoever invents any new, original, and ornamental design for an article of manufacture may obtain a patent therefor, subject to the conditions and requirements of this title.

The provisions of this title relating to patents for inventions shall apply to patents for designs, except as otherwise provided.

35 U.S.C. 172 Right of priority.

The right of priority provided for by subsections (a) through (d) of section 119 of this title and the time specified in section 102(d) shall be six months in the case of designs. The right of priority provided for by section 119(e) of this title shall not apply to designs.

(Amended Dec. 8, 1994, Public Law 103-465, sec. 532(c)(2), 108 Stat. 4987.)

35 U.S.C. 173 Term of design patent.

Patents for designs shall be granted for the term of fourteen years from the date of grant.

(Amended Aug. 27, 1982, Public Law 97-247, sec. 16, 96 Stat. 321; Dec. 8, 1994, Public Law 103-465, sec. 532(c)(3), 108 Stat. 4987.)

CHAPTER 17 — SECRECY OF CERTAIN INVENTIONS AND FILING APPLICATIONS IN FOREIGN COUNTRIES[edit | edit source]

Sec. 181 Secrecy of certain inventions and withholding


of patent. 182 Abandonment of invention for unauthorized

disclosure. 183 Right to compensation. 184 Filing of application in foreign country. 185 Patent barred for filing without license. 186 Penalty. 187 Nonapplicability to certain persons. 188 Rules and regulations, delegation of power.

35 U.S.C. 181 Secrecy of certain inventions and withholding of patent.

Whenever publication or disclosure by the publication of an application or by the grant of a patent on an invention in which the Government has a property interest might, in the opinion of the head of the interested Government agency, be detrimental to the national security, the Commissioner of Patents upon being so notified shall order that the invention be kept secret and shall withhold the publication of an application or the grant of a patent therefor under the conditions set forth hereinafter.

Whenever the publication or disclosure of an invention by the publication of an application or by the granting of a patent, in which the Government does not have a property interest, might, in the opinion of the Commissioner of Patents, be detrimental to the national security, he shall make the application for patent in which such invention is disclosed available for inspection to the Atomic Energy Commission, the Secretary of Defense, and the chief officer of any other department or agency of the Government desig-


nated by the President as a defense agency of the United States.

Each individual to whom the application is disclosed shall sign a dated acknowledgment thereof, which acknowledgment shall be entered in the file of the application. If, in the opinion of the Atomic Energy Commission, the Secretary of a Defense Department, or the chief officer of another department or agency so designated, the publication or disclosure of the invention by the publication of an application or by the granting of a patent therefor would be detrimental to the national security, the Atomic Energy Commission, the Secretary of a Defense Department, or such other chief officer shall notify the Commissioner of Patents and the Commissioner of Patents shall order that the invention be kept secret and shall withhold the publication of the application or the grant of a patent for such period as the national interest requires, and notify the applicant thereof. Upon proper showing by the head of the department or agency who caused the secrecy order to be issued that the examination of the application might jeopardize the national interest, the Commissioner of Patents shall thereupon maintain the application in a sealed condition and notify the applicant thereof. The owner of an application which has been placed under a secrecy order shall have a right to appeal from the order to the Secretary of Commerce under rules prescribed by him.

An invention shall not be ordered kept secret and the publication of an application or the grant of a patent withheld for a period of more than one year. The Commissioner of Patents shall renew the order at the end thereof, or at the end of any renewal period, for additional periods of one year upon notification by the head of the department or the chief officer of the agency who caused the order to be issued that an affirmative determination has been made that the national interest continues to so require. An order in effect, or issued, during a time when the United States is at war, shall remain in effect for the duration of hostilities and one year following cessation of hostilities. An order in effect, or issued, during a national emergency declared by the President shall remain in effect for the duration of the national emergency and six months thereafter. The Commissioner of Patents may rescind any order upon notification by the heads of the departments and the chief officers of the agencies who caused the order to be issued that the publication or disclosure of the invention is no longer deemed detrimental to the national security.

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-566, 582 (S. 1948 secs. 4507(7) and 4732(a)(10)(B)).)

35 U.S.C. 182 Abandonment of invention for unauthorized disclosure.

The invention disclosed in an application for patent subject to an order made pursuant to section 181 of this title may be held abandoned upon its being established by the Commissioner of Patents that in violation of said order the invention has been published or disclosed or that an application for a patent therefor has been filed in a foreign country by the inventor, his successors, assigns, or legal representatives, or anyone in privity with him or them, without the consent of the Commissioner of Patents. The abandonment shall be held to have occurred as of the time of violation. The consent of the Commissioner of Patents shall not be given without the concurrence of the heads of the departments and the chief officers of the agencies who caused the order to be issued. A holding of abandonment shall constitute forfeiture by the applicant, his successors, assigns, or legal representatives, or anyone in privity with him or them, of all claims against the United States based upon such invention.

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(B)).)

35 U.S.C. 183 Right to compensation.

An applicant, his successors, assigns, or legal representatives, whose patent is withheld as herein provided, shall have the right, beginning at the date the applicant is notified that, except for such order, his application is otherwise in condition for allowance, or February 1, 1952, whichever is later, and ending six years after a patent is issued thereon, to apply to the head of any department or agency who caused the order to be issued for compensation for the damage caused by the order of secrecy and/or for the use of the invention by the Government, resulting from his disclosure. The right to compensation for use shall begin on the date of the first use of the invention by the Government. The head of the department or agency is authorized, upon the presentation of a


claim, to enter into an agreement with the applicant, his successors, assigns, or legal representatives, in full settlement for the damage and/or use. This settlement agreement shall be conclusive for all purposes notwithstanding any other provision of law to the contrary. If full settlement of the claim cannot be effected, the head of the department or agency may award and pay to such applicant, his successors, assigns, or legal representatives, a sum not exceeding 75 per centum of the sum which the head of the department or agency considers just compensation for the damage and/or use. A claimant may bring suit against the United States in the United States Court of Federal Claims or in the District Court of the United States for the district in which such claimant is a resident for an amount which when added to the award shall constitute just compensation for the damage and/or use of the invention by the Government. The owner of any patent issued upon an application that was subject to a secrecy order issued pursuant to section 181 of this title, who did not apply for compensation as above provided, shall have the right, after the date of issuance of such patent, to bring suit in the United States Court of Federal Claims for just compensation for the damage caused by reason of the order of secrecy and/ or use by the Government of the invention resulting from his disclosure. The right to compensation for use shall begin on the date of the first use of the invention by the Government. In a suit under the provisions of this section the United States may avail itself of all defenses it may plead in an action under section 1498 of title 28. This section shall not confer a right of action on anyone or his successors, assigns, or legal representatives who, while in the full-time employment or service of the United States, discovered, invented, or developed the invention on which the claim is based.

(Amended Apr. 2, 1982, Public Law 97-164, sec. 160(a)(12), 96 Stat. 48; Oct. 29, 1992, Public Law 102-572, sec. 902 (b)(1), 106 Stat. 4516.)

35 U.S.C. 184 Filing of application in foreign country.

Except when authorized by a license obtained from the Commissioner of Patents a person shall not file or cause or authorize to be filed in any foreign country prior to six months after filing in the United States an application for patent or for the registration of a utility model, industrial design, or model in respect of an invention made in this country. A license shall not be granted with respect to an invention subject to an order issued by the Commissioner of Patents pursuant to section 181 of this title without the concurrence of the head of the departments and the chief officers of the agencies who caused the order to be issued. The license may be granted retroactively where an application has been filed abroad through error and without deceptive intent and the application does not disclose an invention within the scope of section 181 of this title.

The term “application” when used in this chapter includes applications and any modifications, amendments, or supplements thereto, or divisions thereof.

The scope of a license shall permit subsequent modifications, amendments, and supplements containing additional subject matter if the application upon which the request for the license is based is not, or was not, required to be made available for inspection under section 181 of this title and if such modifications, amendments, and supplements do not change the general nature of the invention in a manner which would require such application to be made available for inspection under such section 181. In any case in which a license is not, or was not, required in order to file an application in any foreign country, such subsequent modifications, amendments, and supplements may be made, without a license, to the application filed in the foreign country if the United States application was not required to be made available for inspection under section 181 and if such modifications, amendments, and supplements do not, or did not, change the general nature of the invention in a manner which would require the United States application to have been made available for inspection under such section 181.

(Amended Aug. 23, 1988, Public Law 100-418, sec. 9101(b)(1), 102 Stat. 1567; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(B)).)

35 U.S.C. 185 Patent barred for filing without license.

Notwithstanding any other provisions of law any person, and his successors, assigns, or legal representatives, shall not receive a United States patent for an invention if that person, or his successors, assigns, or legal representatives shall, without procuring the license prescribed in section 184 of this title, have


made, or consented to or assisted another’s making, application in a foreign country for a patent or for the registration of a utility model, industrial design, or model in respect of the invention. A United States patent issued to such person, his successors, assigns, or legal representatives shall be invalid, unless the failure to procure such license was through error and without deceptive intent, and the patent does not disclose subject matter within the scope of section 181 of this title.

(Amended Aug. 23, 1988, Public Law 100-418, sec. 9101(b)(2), 102 Stat. 1568; Nov. 2, 2002, Public Law 107273, sec. 13206, 116 Stat. 1904.)

35 U.S.C. 186 Penalty.

Whoever, during the period or periods of time an invention has been ordered to be kept secret and the grant of a patent thereon withheld pursuant to section 181 of this title, shall, with knowledge of such order and without due authorization, willfully publish or disclose or authorize or cause to be published or disclosed the invention, or material information with respect thereto, or whoever willfully, in violation of the provisions of section 184 of this title, shall file or cause or authorize to be filed in any foreign country an application for patent or for the registration of a utility model, industrial design, or model in respect of any invention made in the United States, shall, upon conviction, be fined not more than $10,000 or imprisoned for not more than two years, or both.

(Amended Aug. 23, 1988, Public Law 100-418, sec. 9101(b)(3), 102 Stat. 1568.)

35 U.S.C. 187 Nonapplicability to certain persons.

The prohibitions and penalties of this chapter shall not apply to any officer or agent of the United States acting within the scope of his authority, nor to any person acting upon his written instructions or permission.

35 U.S.C. 188 Rules and regulations, delegation of power.

The Atomic Energy Commission, the Secretary of a defense department, the chief officer of any other department or agency of the Government designated by the President as a defense agency of the United States, and the Secretary of Commerce, may separately issue rules and regulations to enable the respective department or agency to carry out the provisions of this chapter, and may delegate any power conferred by this chapter.

CHAPTER 18 — PATENT RIGHTS IN INVENTIONS MADE WITH FEDERAL ASSISTANCE[edit | edit source]

Sec. 200 Policy and objective. 201 Definitions. 202 Disposition of rights. 203 March-in rights. 204 Preference for United States industry. 205 Confidentiality. 206 Uniform clauses and regulations. 207 Domestic and foreign protection of federally


owned inventions. 208 Regulations governing Federal licensing. 209 Licensing federally owned inventions. 210 Precedence of chapter. 211 Relationship to antitrust laws. 212 Disposition of rights in educational awards.

35 U.S.C. 200 Policy and objective.

It is the policy and objective of the Congress to use the patent system to promote the utilization of inventions arising from federally supported research or development; to encourage maximum participation of small business firms in federally supported research and development efforts; to promote collaboration between commercial concerns and nonprofit organizations, including universities; to ensure that inventions made by nonprofit organizations and small business firms are used in a manner to promote free competition and enterprise without unduly encumbering future research and discovery; to promote the commercialization and public availability of inventions made in the United States by United States industry and labor; to ensure that the Government obtains sufficient rights in federally supported inventions to meet the needs of the Government and protect the public against nonuse or unreasonable use of inventions; and to minimize the costs of administering policies in this area.

(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a), 94 Stat. 3018; amended Nov. 1, 2000, Public Law 106-404, sec. 5, 114 Stat. 1745.)


35 U.S.C. 201 Definitions.

As used in this chapter —

(a) The term “Federal agency” means any executive agency as defined in section 105 of title 5, and the military departments as defined by section 102 of title 5. (b) The term “funding agreement” means any contract, grant, or cooperative agreement entered into between any Federal agency, other than the Tennessee Valley Authority, and any contractor for the performance of experimental, developmental, or research work funded in whole or in part by the Federal Government. Such term includes any assignment, substitution of parties, or subcontract of any type entered into for the performance of experimental, developmental, or research work under a funding agreement as herein defined. (c) The term “contractor” means any person, small business firm, or nonprofit organization that is a party to a funding agreement. (d) The term “invention” means any invention or discovery which is or may be patentable or otherwise protectable under this title or any novel variety of plant which is or may be protectable under the Plant Variety Protection Act (7 U.S.C. 2321, et seq.). (e) The term “subject invention” means any invention of the contractor conceived or first actually reduced to practice in the performance of work under a funding agreement: Provided, That in the case of a variety of plant, the date of determination (as defined in section 41(d) of the Plant Variety Protection Act (7


U.S.C. 2401(d)) must also occur during the period of contract performance.

(f) The term “practical application” means to manufacture in the case of a composition or product, to practice in the case of a process or method, or to operate in the case of a machine or system; and, in each case, under such conditions as to establish that the invention is being utilized and that its benefits are to the extent permitted by law or Government regulations available to the public on reasonable terms. (g) The term “made” when used in relation to any invention means the conception or first actual reduction to practice of such invention. (h) The term “small business firm” means a small business concern as defined at section 2 of Public Law 85-536 (15 U.S.C. 632) and implementing


regulations of the Administrator of the Small Business Administration.

(i) The term “nonprofit organization” means universities and other institutions of higher education or an organization of the type described in section 501(c)(3) of the Internal Revenue Code of 1986 (26

U.S.C. 501(c)) and exempt from taxation under section 501(a) of the Internal Revenue Code (26 U.S.C. 501(a)) or any nonprofit scientific or educational organization qualified under a State nonprofit organization statute.

(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a), 94 Stat. 3019.)

(Subsection (d) amended Nov. 8, 1984, Public Law 98620, sec. 501(1), 98 Stat. 3364.)

(Subsection (e) amended Nov. 8, 1984, Public Law 98620, sec. 501(2), 98 Stat. 3364.)

(Subsection (i) amended Oct. 22, 1986, Public Law 99514, sec. 2, 100 Stat. 2095.)

(Subsection (a) amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1904.)

35 U.S.C. 202 Disposition of rights.

(a) Each nonprofit organization or small business firm may, within a reasonable time after disclosure as required by paragraph (c)(1) of this section, elect to retain title to any subject invention: Provided, however, That a funding agreement may provide otherwise (i) when the contractor is not located in the United States or does not have a place of business located in the United States or is subject to the control of a foreign government, (ii) in exceptional circumstances when it is determined by the agency that restriction or elimination of the right to retain title to any subject invention will better promote the policy and objectives of this chapter, (iii) when it is determined by a Government authority which is authorized by statute or Executive order to conduct foreign intelligence or counterintelligence activities that the restriction or elimination of the right to retain title to any subject invention is necessary to protect the security of such activities, or (iv) when the funding agreement includes the operation of a Government-owned, contractor-operated facility of the Department of Energy primarily dedicated to that Department’s naval nuclear propulsion or weapons related programs and all funding agreement limitations under this subparagraph on the contractor’s right to elect title to a sub-


ject invention are limited to inventions occurring under the above two programs of the Department of Energy. The rights of the nonprofit organization or small business firm shall be subject to the provisions of paragraph (c) of this section and the other provisions of this chapter.

(b)(1) The rights of the Government under subsection (a) shall not be exercised by a Federal agency unless it first determines that at least one of the conditions identified in clauses (i) through (iii) of subsection (a) exists. Except in the case of subsection (a)(iii), the agency shall file with the Secretary of Commerce, within thirty days after the award of the applicable funding agreement, a copy of such determination. In the case of a determination under subsection (a)(ii), the statement shall include an analysis justifying the determination. In the case of determinations applicable to funding agreements with small business firms, copies shall also be sent to the Chief Counsel for Advocacy of the Small Business Administration. If the Secretary of Commerce believes that any individual determination or pattern of determinations is contrary to the policies and objectives of this chapter or otherwise not in conformance with this chapter, the Secretary shall so advise the head of the agency concerned and the Administrator of the Office of Federal Procurement Policy, and recommend corrective actions.

(2) Whenever the Administrator of the Office of Federal Procurement Policy has determined that one or more Federal agencies are utilizing the authority of clause (i) or (ii) of subsection (a) of this section in a manner that is contrary to the policies and objectives of this chapter the Administrator is authorized to issue regulations describing classes of situations in which agencies may not exercise the authorities of those clauses. (3) At least once every 5 years, the Comptroller General shall transmit a report to the Committees on the Judiciary of the Senate and House of Representatives on the manner in which this chapter is being implemented by the agencies and on such other aspects of Government patent policies and practices with respect to federally funded inventions as the Comptroller General believes appropriate. (4) If the contractor believes that a determination is contrary to the policies and objectives of this chapter or constitutes an abuse of discretion by the


agency, the determination shall be subject to the section 203(b).

(c) Each funding agreement with a small business firm or nonprofit organization shall contain appropriate provisions to effectuate the following: (1) That the contractor disclose each subject invention to the Federal agency within a reasonable time after it becomes known to contractor personnel responsible for the administration of patent matters, and that the Federal Government may receive title to any subject invention not disclosed to it within such time. (2) That the contractor make a written election within two years after disclosure to the Federal agency (or such additional time as may be approved by the Federal agency) whether the contractor will retain title to a subject invention: Provided, That in any case where publication, on sale, or public use, has initiated the one year statutory period in which valid patent protection can still be obtained in the United States, the period for election may be shortened by the Federal agency to a date that is not more than sixty days prior to the end of the statutory period: And provided further, That the Federal Government may receive title to any subject invention in which the contractor does not elect to retain rights or fails to elect rights within such times. (3) That a contractor electing rights in a subject invention agrees to file a patent application prior to any statutory bar date that may occur under this title due to publication, on sale, or public use, and shall thereafter file corresponding patent applications in other countries in which it wishes to retain title within reasonable times, and that the Federal Government may receive title to any subject inventions in the United States or other countries in which the contractor has not filed patent applications on the subject invention within such times. (4) With respect to any invention in which the contractor elects rights, the Federal agency shall have a nonexclusive, nontransferable, irrevocable, paid-up license to practice or have practiced for or on behalf of the United States any subject invention throughout the world: Provided, That the funding agreement may provide for such additional rights, including the right to assign or have assigned foreign patent rights in the subject invention, as are determined by the agency as necessary for meeting the



obligations of the United States under any treaty, international agreement, arrangement of cooperation, memorandum of understanding, or similar arrangement, including military agreements relating to weapons development and production.

(5) The right of the Federal agency to require periodic reporting on the utilization or efforts at obtaining utilization that are being made by the contractor or his licensees or assignees: Provided, That any such information, as well as any information on utilization or efforts at obtaining utilization obtained as part of a proceeding under section 203 of this chapter shall be treated by the Federal agency as commercial and financial information obtained from a person and privileged and confidential and not subject to disclosure under section 552 of title 5. (6) An obligation on the part of the contractor, in the event a United States patent application is filed by or on its behalf or by any assignee of the contractor, to include within the specification of such application and any patent issuing thereon, a statement specifying that the invention was made with Government support and that the Government has certain rights in the invention. (7) In the case of a nonprofit organization,


(A) a prohibition upon the assignment of rights to a subject invention in the United States without the approval of the Federal agency, except where such assignment is made to an organization which has as one of its primary functions the management of inventions (provided that such assignee shall be subject to the same provisions as the contractor); (B) a requirement that the contractor share royalties with the inventor; (C) except with respect to a funding agreement for the operation of a Government-ownedcontractor-operated facility, a requirement that the balance of any royalties or income earned by the contractor with respect to subject inventions, after payment of expenses (including payments to inventors) incidental to the administration of subject inventions, be utilized for the support of scientific research, or education; (D) a requirement that, except where it proves infeasible after a reasonable inquiry, in the licensing of subject inventions shall be given to small business firms; and (E) with respect to a funding agreement for the operation of a Government-ownedcontractor-operator facility, requirements (i) that after payment of patenting costs, licensing costs, payments


to inventors, and other expenses incidental to the administration of subject inventions, 100 percent of the balance of any royalties or income earned and retained by the contractor during any fiscal year, up to an amount equal to 5 percent of the annual budget of the facility, shall be used by the contractor for scientific research, development, and education consistent with the research and development mission and objectives of the facility, including activities that increase the licensing potential of other inventions of the facility provided that if said balance exceeds 5 percent of the annual budget of the facility, that 75 percent of such excess shall be paid to the Treasury of the United States and the remaining 25 percent shall be used for the same purposes as described above in this clause (D); and (ii) that, to the extent it provides the most effective technology transfer, the licensing of subject inventions shall be administered by contractor employees on location at the facility.

(8) The requirements of sections 203 and 204 of this chapter. (d) If a contractor does not elect to retain title to a subject invention in cases subject to this section, the Federal agency may consider and after consultation with the contractor grant requests for retention of rights by the inventor subject to the provisions of this Act and regulations promulgated hereunder. (e) In any case when a Federal employee is a coinventor of any invention made with a nonprofit organization, a small business firm, or a non-Federal inventor, the Federal agency employing such coinventor may, for the purpose of consolidating rights in the invention and if it finds that it would expedite the development of the invention— (1) license or assign whatever rights it may acquire in the subject invention to the nonprofit organization, small business firm, or non-Federal inventor in accordance with the provisions of this chapter; or (2) acquire any rights in the subject invention from the nonprofit organization, small business firm, or non-Federal inventor, but only to the extent the party from whom the rights are acquired voluntarily enters into the transaction and no other transaction under this chapter is conditioned on such acquisition.


(f)(1) No funding agreement with a small business firm or nonprofit organization shall contain a provision allowing a Federal agency to require the licensing to third parties of inventions owned by the


contractor that are not subject inventions unless such provision has been approved by the head of the agency and a written justification has been signed by the head of the agency. Any such provision shall clearly state whether the licensing may be required in connection with the practice of a subject invention, a specifically identified work object, or both. The head of the agency may not delegate the authority to approve provisions or sign justifications required by this paragraph.

(2) A Federal agency shall not require the licensing of third parties under any such provision unless the head of the agency determines that the use of the invention by others is necessary for the practice of a subject invention or for the use of a work object of the funding agreement and that such action is necessary to achieve the practical application of the subject invention or work object. Any such determination shall be on the record after an opportunity for an agency hearing. Any action commenced for judicial review of such determination shall be brought within sixty days after notification of such determination.

(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a), 94 Stat. 3020; subsection (b)(4) added and subsections (a), (b)(1), (b)(2), (c)(4), (c)(5), and (c)(7) amended Nov. 8, 1984, Public Law 98-620, sec. 501, 98 Stat. 3364; subsection (b)(3) amended Dec. 10, 1991, Public Law 102-204, sec. 10, 105 Stat. 1641; subsection (a) amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-583 (S. 1948 sec. 4732(a)(12)); subsection (e) amended Nov. 1, 2000, Public Law 106-404, sec. 6(1), 114 Stat. 1745; subsections (b)(4), (c)(4), and (c)(5) amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1905.)

35 U.S.C. 203 March-in rights.

(a) With respect to any subject invention in which a small business firm or nonprofit organization has acquired title under this chapter, the Federal agency under whose funding agreement the subject invention was made shall have the right, in accordance with such procedures as are provided in regulations promulgated hereunder, to require the contractor, an assignee, or exclusive licensee of a subject invention to grant a nonexclusive, partially exclusive, or exclusive license in any field of use to a responsible applicant or applicants, upon terms that are reasonable under the circumstances, and if the contractor, assignee, or exclusive licensee refuses such request, to grant such a license itself, if the Federal agency determines that such —

(1) action is necessary because the contractor or assignee has not taken, or is not expected to take within a reasonable time, effective steps to achieve practical application of the subject invention in such field of use; (2) action is necessary to alleviate health or safety needs which are not reasonably satisfied by the contractor, assignee, or their licensees; (3) action is necessary to meet requirements for public use specified by Federal regulations and such requirements are not reasonably satisfied by the contractor, assignee, or licensees; or (4) action is necessary because the agreement required by section 204 has not been obtained or waived or because a licensee of the exclusive right to use or sell any subject invention in the United States is in breach of its agreement obtained pursuant to section 204. (b) A determination pursuant to this section or section 202(b)(4) shall not be subject to the Contract Disputes Act (41 U.S.C. § 601 et seq.). An administrative appeals procedure shall be established by regulations promulgated in accordance with section 206. Additionally, any contractor, inventor, assignee, or exclusive licensee adversely affected by a determination under this section may, at any time within sixty days after the determination is issued, file a petition in the United States Court of Federal Claims, which shall have jurisdiction to determine the appeal on the record and to affirm, reverse, remand or modify, as appropriate, the determination of the Federal agency. In cases described in paragraphs (1) and (3) of subsection (a), the agency’s determination shall be held in abeyance pending the exhaustion of appeals or petitions filed under the preceding sentence.


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a), 94 Stat. 3022; amended Nov. 8, 1984, Public Law 98-620, sec. 501(9), 98 Stat. 3367; Oct. 29, 1992, Public Law 102572, sec. 902(b)(1), 106 Stat. 4516; amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1905.)

35 U.S.C. 204 Preference for United States industry.

Notwithstanding any other provision of this chapter, no small business firm or nonprofit organization which receives title to any subject invention and no assignee of any such small business firm or nonprofit


organization shall grant to any person the exclusive right to use or sell any subject invention in the United States unless such person agrees that any products embodying the subject invention or produced through the use of the subject invention will be manufactured substantially in the United States. However, in individual cases, the requirement for such an agreement may be waived by the Federal agency under whose funding agreement the invention was made upon a showing by the small business firm, nonprofit organization, or assignee that reasonable but unsuccessful efforts have been made to grant licenses on similar terms to potential licensees that would be likely to manufacture substantially in the United States or that under the circumstances domestic manufacture is not commercially feasible.

(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a), 94 Stat. 3023.)

35 U.S.C. 205 Confidentiality.

Federal agencies are authorized to withhold from disclosure to the public information disclosing any invention in which the Federal Government owns or may own a right, title, or interest (including a nonexclusive license) for a reasonable time in order for a patent application to be filed. Furthermore, Federal agencies shall not be required to release copies of any document which is part of an application for patent filed with the United States Patent and Trademark Office or with any foreign patent office.

(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a), 94 Stat. 3023.)

35 U.S.C. 206 Uniform clauses and regulations.

The Secretary of Commerce may issue regulations which may be made applicable to Federal agencies implementing the provisions of sections 202 through 204 of this chapter and shall establish standard funding agreement provisions required under this chapter. The regulations and the standard funding agreement shall be subject to public comment before their issuance.

(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a), 94 Stat. 3023; amended Nov. 8, 1984, Public Law 98-620, sec. 501(10), 98 Stat. 3367.)

35 U.S.C. 207 Domestic and foreign protection of federally owned inventions.

(a) Each Federal agency is authorized to —

(1) apply for, obtain, and maintain patents or other forms of protection in the United States and in foreign countries on inventions in which the Federal Government owns a right, title, or interest; (2) grant nonexclusive, exclusive, or partially exclusive licenses under federally owned inventions, royalty-free or for royalties or other consideration, and on such terms and conditions, including the grant to the licensee of the right of enforcement pursuant to the provisions of chapter 29 of this title as determined appropriate in the public interest; (3) undertake all other suitable and necessary steps to protect and administer rights to federally owned inventions on behalf of the Federal Government either directly or through contract, including acquiring rights for and administering royalties to the Federal Government in any invention, but only to the extent the party from whom the rights are acquired voluntarily enters into the transaction, to facilitate the licensing of a federally owned invention; and (4) transfer custody and administration, in whole or in part, to another Federal agency, of the right, title, or interest in any federally owned invention. (b) For the purpose of assuring the effective management of Government-owned inventions, the Secretary of Commerce authorized to (1) assist Federal agency efforts to promote the licensing and utilization of Government-owned inventions; (2) assist Federal agencies in seeking protection and maintaining inventions in foreign countries, including the payment of fees and costs connected therewith; and (3) consult with and advise Federal agencies as to areas of science and technology research and development with potential for commercial utilization.


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a), 94 Stat. 3023; amended Nov. 8, 1984, Public Law 98-620, sec. 501(11), 98 Stat. 3367; subsections (a)(2) and (a)(3) amended Nov. 1, 2000, Public Law 106-404, sec. 6(2), 114 Stat. 1745.)


35 U.S.C. 208 Regulations governing Federal licensing.

The Secretary of Commerce is authorized to promulgate regulations specifying the terms and conditions upon which any federally owned invention, other than inventions owned by the Tennessee Valley Authority, may be licensed on a nonexclusive, partially exclusive, or exclusive basis.

(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a), 94 Stat. 3024; amended Nov. 8, 1984, Public Law 98-620, sec. 501(12), 98 Stat. 3367.)

35 U.S.C. 209 Licensing federally owned inventions.

(a) AUTHORITY.—A Federal agency may grant an exclusive or partially exclusive license on a federally owned invention under section 207(a)(2) only if— (1) granting the license is a reasonable and necessary incentive to— (A) call forth the investment capital and expenditures needed to bring the invention to practical application; or (B) otherwise promote the invention’s utilization by the public; (2) the Federal agency finds that the public will be served by the granting of the license, as indicated by the applicant’s intentions, plans, and ability to bring the invention to practical application or otherwise promote the invention’s utilization by the public, and that the proposed scope of exclusivity is not greater than reasonably necessary to provide the incentive for bringing the invention to practical application, as proposed by the applicant, or otherwise to promote the invention’s utilization by the public; (3) the applicant makes a commitment to achieve practical application of the invention within a reasonable time, which time may be extended by the agency upon the applicant’s request and the applicant’s demonstration that the refusal of such extension would be unreasonable; (4) granting the license will not tend to substantially lessen competition or create or maintain a violation of the Federal antitrust laws; and (5) in the case of an invention covered by a foreign patent application or patent, the interests of the Federal Government or United States industry in foreign commerce will be enhanced.


(b) MANUFACTURE IN UNITED STATES.—A Federal agency shall normally grant a license under section 207(a)(2) to use or sell any federally owned invention in the United States only to a licensee who agrees that any products embodying the invention or produced through the use of the invention will be manufactured substantially in the United States. (c) SMALL BUSINESS.—First preference for the granting of any exclusive or partially exclusive licenses under section 207(a)(2) shall be given to small business firms having equal or greater likelihood as other applicants to bring the invention to practical application within a reasonable time. (d) TERMS AND CONDITIONS.—Any licenses granted under section 207(a)(2) shall contain such terms and conditions as the granting agency considers appropriate, and shall include provisions— (1) retaining a nontransferrable, irrevocable, paid-up license for any Federal agency to practice the invention or have the invention practiced throughout the world by or on behalf of the Government of the United States; (2) requiring periodic reporting on utilization of the invention, and utilization efforts, by the licensee, but only to the extent necessary to enable the Federal agency to determine whether the terms of the license are being complied with, except that any such report shall be treated by the Federal agency as commercial and financial information obtained from a person and privileged and confidential and not subject to disclosure under section 552 of title 5; and (3) empowering the Federal agency to terminate the license in whole or in part if the agency determines that— (A) the licensee is not executing its commitment to achieve practical application of the invention, including commitments contained in any plan submitted in support of its request for a license, and the licensee cannot otherwise demonstrate to the satisfaction of the Federal agency that it has taken, or can be expected to take within a reasonable time, effective steps to achieve practical application of the invention; (B) the licensee is in breach of an agreement described in subsection (b); (C) termination is necessary to meet requirements for public use specified by Federal regulations issued after the date of the license, and such



requirements are not reasonably satisfied by the licensee; or

(D) the licensee has been found by a court of competent jurisdiction to have violated the Federal antitrust laws in connection with its performance under the license agreement. (e) PUBLIC NOTICE.—No exclusive or partially exclusive license may be granted under section 207(a)(2) unless public notice of the intention to grant an exclusive or partially exclusive license on a federally owned invention has been provided in an appropriate manner at least 15 days before the license is granted, and the Federal agency has considered all comments received before the end of the comment period in response to that public notice. This subsection shall not apply to the licensing of inventions made under a cooperative research and development agreement entered into under section 12 of the Stevenson-Wydler Technology Innovation Act of 1980 (15 U.S.C. 3710a). (f) PLAN.—No Federal agency shall grant any license under a patent or patent application on a federally owned invention unless the person requesting the license has supplied the agency with a plan for development or marketing of the invention, except that any such plan shall be treated by the Federal agency as commercial and financial information obtained from a person and privileged and confidential and not subject to disclosure under section 552 of title 5.


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a), 94 Stat. 3024; amended Nov. 1, 2000, Public Law 106-404, sec. 4, 114 Stat. 1743; subsections (d)(2) and (f) amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1905.)

35 U.S.C. 210 Precedence of chapter.

(a) This chapter shall take precedence over any other Act which would require a disposition of rights in subject inventions of small business firms or nonprofit organizations contractors in a manner that is inconsistent with this chapter, including but not necessarily limited to the following: (1) section 10(a) of the Act of June 29, 1935, as added by title I of the Act of August 14, 1946 (7


U.S.C. 427i(a); 60 Stat. 1085);

(2) section 205(a) of the Act of August 14, 1946 (7 U.S.C. 1624(a); 60 Stat. 1090);

(3) section 501(c) of the Federal Mine Safety and Health Act of 1977 (30 U.S.C. 951(c); 83 Stat. 742); (4) section 30168(e) of title 49;


(5) section 12 of the National Science Foundation Act of 1950 (42 U.S.C. 1871(a); 82 Stat. 360); (6) section 152 of the Atomic Energy Act of 1954 (42 U.S.C. 2182; 68 Stat. 943); (7) section 305 of the National Aeronautics and Space Act of 1958 (42 U.S.C. 2457); (8) section 6 of the Coal Research Development Act of 1960 (30 U.S.C. 666; 74 Stat. 337); (9) section 4 of the Helium Act Amendments of 1960 (50 U.S.C. 167b; 74 Stat. 920); (10) section 32 of the Arms Control and Disarmament Act of 1961 (22 U.S.C. 2572; 75 Stat. 634); (11) section 9 of the Federal Nonnuclear Energy Research and Development Act of 1974 (42


U.S.C. 5908; 88 Stat. 1878);

(12) section 5(d) of the Consumer Product Safety Act (15 U.S.C. 2054(d); 86 Stat. 1211);

(13) section 3 of the Act of April 5, 1944 (30

U.S.C. 323; 58 Stat. 191);

(14) section 8001(c)(3) of the Solid Waste Disposal Act (42 U.S.C. 6981(c); 90 Stat. 2829); (15) section 219 of the Foreign Assistance Act of 1961 (22 U.S.C. 2179; 83 Stat. 806); (16) section 427(b) of the Federal Mine Health and Safety Act of 1977 (30 U.S.C. 937(b); 86 Stat. 155); (17) section 306(d) of the Surface Mining and Reclamation Act of 1977 (30 U.S.C. 1226(d); 91 Stat. 455); (18) section 21(d) of the Federal Fire Prevention and Control Act of 1974 (15 U.S.C. 2218(d); 88 Stat. 1548); (19) section 6(b) of the Solar Photovoltaic Energy Research Development and Demonstration Act of 1978 (42 U.S.C. 5585(b); 92 Stat. 2516); (20) section 12 of the Native Latex Commercialization and Economic Development Act of 1978 (7 U.S.C. 178j; 92 Stat. 2533); and (21) section 408 of the Water Resources and Development Act of 1978 (42 U.S.C. 7879; 92 Stat. 1360).


The Act creating this chapter shall be construed to take precedence over any future Act unless


that Act specifically cites this Act and provides that it shall take precedence over this Act.

(b) Nothing in this chapter is intended to alter the effect of the laws cited in paragraph (a) of this section or any other laws with respect to the disposition of rights in inventions made in the performance of funding agreements with persons other than nonprofit organizations or small business firms. (c) Nothing in this chapter is intended to limit the authority of agencies to agree to the disposition of rights in inventions made in the performance of work under funding agreements with persons other than nonprofit organizations or small business firms in accordance with the Statement of Government Patent Policy issued on February 18, 1983, agency regulations, or other applicable regulations or to otherwise limit the authority of agencies to allow such persons to retain ownership of inventions, except that all funding agreements, including those with other than small business firms and nonprofit organizations, shall include the requirements established in section 202(c)(4) and section 203 of this title. Any disposition of rights in inventions made in accordance with the Statement or implementing regulations, including any disposition occurring before enactment of this section, are hereby authorized. (d) Nothing in this chapter shall be construed to require the disclosure of intelligence sources or methods or to otherwise affect the authority granted to the Director of Central Intelligence by statute or Executive order for the protection of intelligence sources or methods. (e) The provisions of the Stevenson-Wydler Technology Innovation Act of 1980 shall take precedence over the provisions of this chapter to the extent that they permit or require a disposition of rights in subject inventions which is inconsistent with this chapter.


(Added Dec. 12, 1980, Public Law 96-517, sec. 6(a), 94 Stat. 3026.)

(Subsection (c) amended Nov. 8, 1984, Public Law 98620, sec. 501(13), 98 Stat. 3367.)

(Subsection (e) added Oct. 20, 1986, Public Law 99502, sec. 9(c), 100 Stat. 1796.)

(Subsection (a)(4) amended July 5, 1994, Public Law 103-272, sec. 5(j), 108 Stat. 1375.)

(Subsection (e) amended Mar. 7, 1996, Public Law 104-113, sec. 7, 110 Stat. 779.)

(Subsection (a) amended Nov. 13, 1998, Public Law 105-393, sec. 220(c)(2), 112 Stat. 3625.)

(Subsections (a)(11), (a)(20), and (c) amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1905.)

35 U.S.C. 211 Relationship to antitrust laws.

Nothing in this chapter shall be deemed to convey to any person immunity from civil or criminal liability, or to create any defenses to actions, under any antitrust law.

(Added Dec.12, 1980, Public Law 96-517, sec. 6(a), 94 Stat. 3027.)

35 U.S.C. 212 Disposition of rights in educational awards.

No scholarship, fellowship, training grant, or other funding agreement made by a Federal agency primarily to an awardee for educational purposes will contain any provision giving the Federal agency any rights to inventions made by the awardee.

(Added Nov. 8, 1984, Public Law 98-620, sec. 501(14), 98 Stat. 3368.)

PART III — PATENTS AND PROTECTION OF PATENT RIGHTS[edit | edit source]

CHAPTER 25 — AMENDMENT AND CORRECTION OF PATENTS[edit | edit source]

Sec. 251 Reissue of defective patents. 252 Effect of reissue. 253 Disclaimer. 254 Certificate of correction of Patent and Trade


mark Office mistake. 255 Certificate of correction of applicant’s mistake. 256 Correction of named inventor.

35 U.S.C. 251 Reissue of defective patents.

Whenever any patent is, through error without any deceptive intention, deemed wholly or partly inoperative or invalid, by reason of a defective specification or drawing, or by reason of the patentee claiming more or less than he had a right to claim in the patent, the Director shall, on the surrender of such patent and the payment of the fee required by law, reissue the patent for the invention disclosed in the original


patent, and in accordance with a new and amended application, for the unexpired part of the term of the original patent. No new matter shall be introduced into the application for reissue.

The Director may issue several reissued patents for distinct and separate parts of the thing patented, upon demand of the applicant, and upon payment of the required fee for a reissue for each of such reissued patents.

The provisions of this title relating to applications for patent shall be applicable to applications for reissue of a patent, except that application for reissue may be made and sworn to by the assignee of the entire interest if the application does not seek to enlarge the scope of the claims of the original patent.

No reissued patent shall be granted enlarging the scope of the claims of the original patent unless applied for within two years from the grant of the original patent.

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 252 Effect of reissue.

The surrender of the original patent shall take effect upon the issue of the reissued patent, and every reissued patent shall have the same effect and operation in law, on the trial of actions for causes thereafter arising, as if the same had been originally granted in such amended form, but in so far as the claims of the original and reissued patents are substantially identical, such surrender shall not affect any action then pending nor abate any cause of action then existing, and the reissued patent, to the extent that its claims are substantially identical with the original patent, shall constitute a continuation thereof and have effect continuously from the date of the original patent.

A reissued patent shall not abridge or affect the right of any person or that person’s successors in business who, prior to the grant of a reissue, made, purchased, offered to sell, or used within the United States, or imported into the United States, anything patented by the reissued patent, to continue the use of, to offer to sell, or to sell to others to be used, offered for sale, or sold, the specific thing so made, purchased, offered for sale, used, or imported unless the making, using, offering for sale, or selling of such thing infringes a valid claim of the reissued patent which was in the original patent. The court before which such matter is in question may provide for the continued manufacture, use, offer for sale, or sale of the thing made, purchased, offered for sale, used, or imported as specified, or for the manufacture, use, offer for sale, or sale in the United States of which substantial preparation was made before the grant of the reissue, and the court may also provide for the continued practice of any process patented by the reissue that is practiced, or for the practice of which substantial preparation was made, before the grant of the reissue, to the extent and under such terms as the court deems equitable for the protection of investments made or business commenced before the grant of the reissue.

(Amended Dec. 8, 1994, Public Law 103-465, sec. 533(b)(2), 108 Stat. 4989; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-566 (S. 1948 sec. 4507(8)).)

35 U.S.C. 253 Disclaimer.

Whenever, without any deceptive intention, a claim of a patent is invalid the remaining claims shall not thereby be rendered invalid. A patentee, whether of the whole or any sectional interest therein, may, on payment of the fee required by law, make disclaimer of any complete claim, stating therein the extent of his interest in such patent. Such disclaimer shall be in writing and recorded in the Patent and Trademark Office, and it shall thereafter be considered as part of the original patent to the extent of the interest possessed by the disclaimant and by those claiming under him.

In like manner any patentee or applicant may disclaim or dedicate to the public the entire term, or any terminal part of the term, of the patent granted or to be granted.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949.)

35 U.S.C. 254 Certificate of correction of Patent and Trademark Office mistake.

Whenever a mistake in a patent, incurred through the fault of the Patent and Trademark Office, is clearly disclosed by the records of the Office, the Director may issue a certificate of correction stating the fact and nature of such mistake, under seal, without charge, to be recorded in the records of patents. A printed copy thereof shall be attached to each printed copy of the patent, and such certificate shall be con-


sidered as part of the original patent. Every such patent, together with such certificate, shall have the same effect and operation in law on the trial of actions for causes thereafter arising as if the same had been originally issued in such corrected form. The Director may issue a corrected patent without charge in lieu of and with like effect as a certificate of correction.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 255 Certificate of correction of applicant’s mistake.

Whenever a mistake of a clerical or typographical nature, or of minor character, which was not the fault of the Patent and Trademark Office, appears in a patent and a showing has been made that such mistake occurred in good faith, the Director may, upon payment of the required fee, issue a certificate of correction, if the correction does not involve such changes in the patent as would constitute new matter or would require reexamination. Such patent, together with the certificate, shall have the same effect and operation in law on the trial of actions for causes thereafter arising as if the same had been originally issued in such corrected form.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 256 Correction of named inventor.

Whenever through error a person is named in an issued patent as the inventor, or through error an inventor is not named in an issued patent and such error arose without any deceptive intention on his part, the Director may, on application of all the parties and assignees, with proof of the facts and such other requirements as may be imposed, issue a certificate correcting such error.

The error of omitting inventors or naming persons who are not inventors shall not invalidate the patent in which such error occurred if it can be corrected as provided in this section. The court before which such matter is called in question may order correction of the patent on notice and hearing of all parties concerned and the Director shall issue a certificate accordingly.

(Amended Aug. 27, 1982, Public Law 97-247, sec. 6(b), 96 Stat. 320; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

CHAPTER 26 — OWNERSHIP AND ASSIGNMENT[edit | edit source]

Sec. 261 Ownership; assignment. 262 Joint owners.


35 U.S.C. 261 Ownership; assignment.

Subject to the provisions of this title, patents shall have the attributes of personal property.

Applications for patent, patents, or any interest therein, shall be assignable in law by an instrument in writing. The applicant, patentee, or his assigns or legal representatives may in like manner grant and convey an exclusive right under his application for patent, or patents, to the whole or any specified part of the United States.

A certificate of acknowledgment under the hand and official seal of a person authorized to administer oaths within the United States, or, in a foreign country, of a diplomatic or consular officer of the United States or an officer authorized to administer oaths whose authority is proved by a certificate of a diplomatic or consular officer of the United States, or apostille of an official designated by a foreign country which, by treaty or convention, accords like effect to apostilles of designated officials in the United States, shall be prima facie evidence of the execution of an assignment, grant, or conveyance of a patent or application for patent.

An assignment, grant, or conveyance shall be void as against any subsequent purchaser or mortgagee for a valuable consideration, without notice, unless it is recorded in the Patent and Trademark Office within three months from its date or prior to the date of such subsequent purchase or mortgage.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949; Aug. 27, 1982, Public Law 97-247, sec. 14(b), 96 Stat. 321.)

35 U.S.C. 262 Joint owners.

In the absence of any agreement to the contrary, each of the joint owners of a patent may make, use, offer to sell, or sell the patented invention within the United States, or import the patented invention into


the United States, without the consent of and without accounting to the other owners.

(Amended Dec. 8, 1994, Public Law 103-465, sec. 533(b)(3), 108 Stat. 4989.)

CHAPTER 27 — GOVERNMENT INTERESTS IN PATENTS[edit | edit source]

Sec. 266 [Repealed.] 267 Time for taking action in Government applica


tions.

35 U.S.C. 266 [Repealed.]

(Repealed July 24, 1965, Public Law 89-83, sec. 8, 79 Stat. 261.)

35 U.S.C. 267 Time for taking action in Government applications.

Notwithstanding the provisions of sections 133 and 151 of this title, the Director may extend the time for taking any action to three years, when an application has become the property of the United States and the head of the appropriate department or agency of the Government has certified to the Director that the invention disclosed therein is important to the armament or defense of the United States.

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

CHAPTER 28 — INFRINGEMENT OF PATENTS[edit | edit source]

Sec. 271 Infringement of patent. 272 Temporary presence in the United States. 273 Defense to infringement based on earlier inven


tor.

35 U.S.C. 271 Infringement of patent.

(a) Except as otherwise provided in this title, whoever without authority makes, uses, offers to sell, or sells any patented invention, within the United States, or imports into the United States any patented invention during the term of the patent therefor, infringes the patent. (b) Whoever actively induces infringement of a patent shall be liable as an infringer.


(c) Whoever offers to sell or sells within the United States or imports into the United States a component of a patented machine, manufacture, combination, or composition, or a material or apparatus for use in practicing a patented process, constituting a material part of the invention, knowing the same to be especially made or especially adapted for use in an infringement of such patent, and not a staple article or commodity of commerce suitable for substantial non- infringing use, shall be liable as a contributory infringer. (d) No patent owner otherwise entitled to relief for infringement or contributory infringement of a patent shall be denied relief or deemed guilty of misuse or illegal extension of the patent right by reason of his having done one or more of the following: (1) derived revenue from acts which if performed by another without his consent would constitute contributory infringement of the patent; (2) licensed or authorized another to perform acts which if performed without his consent would constitute contributory infringement of the patent; (3) sought to enforce his patent rights against infringement or contributory infringement; (4) refused to license or use any rights to the patent; or (5) conditioned the license of any rights to the patent or the sale of the patented product on the acquisition of a license to rights in another patent or purchase of a separate product, unless, in view of the circumstances, the patent owner has market power in the relevant market for the patent or patented product on which the license or sale is conditioned. (e)(1) It shall not be an act of infringement to make, use, offer to sell, or sell within the United States or import into the United States a patented invention (other than a new animal drug or veterinary biological product (as those terms are used in the Federal Food, Drug, and Cosmetic Act and the Act of March 4, 1913) which is primarily manufactured using recombinant DNA, recombinant RNA, hybridoma technology, or other processes involving site specific genetic manipulation techniques) solely for uses reasonably related to the development and submission of information under a Federal law which regulates the manufacture, use, or sale of drugs or veterinary biological products.


(2) It shall be an act of infringement to submit —



(A) an application under section 505(j) of the Federal Food, Drug, and Cosmetic Act or described in section 505(b)(2) of such Act for a drug claimed in a patent or the use of which is claimed in a patent, or (B) an application under section 512 of such Act or under the Act of March 4, 1913 (21


U.S.C. 151 - 158) for a drug or veterinary biological product which is not primarily manufactured using recombinant DNA, recombinant RNA, hybridoma technology, or other processes involving site specific genetic manipulation techniques and which is claimed in a patent or the use of which is claimed in a patent, if the purpose of such submission is to obtain approval under such Act to engage in the commercial manufacture, use, or sale of a drug or veterinary biological product claimed in a patent or the use of which is claimed in a patent before the expiration of such patent.

(3) In any action for patent infringement brought under this section, no injunctive or other relief may be granted which would prohibit the making, using, offering to sell, or selling within the United States or importing into the United States of a patented invention under paragraph (1). (4) For an act of infringement described in paragraph (2)— (A) the court shall order the effective date of any approval of the drug or veterinary biological product involved in the infringement to be a date which is not earlier than the date of the expiration of the patent which has been infringed, (B) injunctive relief may be granted against an infringer to prevent the commercial manufacture, use, offer to sell, or sale within the United States or importation into the United States of an approved drug or veterinary biological product, and (C) damages or other monetary relief may be awarded against an infringer only if there has been commercial manufacture, use, offer to sell, or sale within the United States or importation into the United States of an approved drug or veterinary biological product.


The remedies prescribed by subparagraphs (A), (B), and (C) are the only remedies which may be granted by a court for an act of infringement described in paragraph (2), except that a court may award attorney fees under section 285.

(5) Where a person has filed an application described in paragraph (2) that includes a certification under subsection (b)(2)(A)(iv) or (j)(2)(A)(vii)(IV) of section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355), and neither the owner of the patent that is the subject of the certification nor the holder of the approved application under subsection (b) of such section for the drug that is claimed by the patent or a use of which is claimed by the patent brought an action for infringement of such patent before the expiration of 45 days after the date on which the notice given under subsection (b)(3) or (j)(2)(B) of such section was received, the courts of the United States shall, to the extent consistent with the Constitution, have subject matter jurisdiction in any action brought by such person under section 2201 of title 28 for a declaratory judgment that such patent is invalid or not infringed. (f)(1) Whoever without authority supplies or causes to be supplied in or from the United States all or a substantial portion of the components of a patented invention, where such components are uncombined in whole or in part, in such manner as to actively induce the combination of such components outside of the United States in a manner that would infringe the patent if such combination occurred within the United States, shall be liable as an infringer.


(2) Whoever without authority supplies or causes to be supplied in or from the United States any component of a patented invention that is especially made or especially adapted for use in the invention and not a staple article or commodity of commerce suitable for substantial noninfringing use, where such component is uncombined in whole or in part, knowing that such component is so made or adapted and intending that such component will be combined outside of the United States in a manner that would infringe the patent if such combination occurred within the United States, shall be liable as an infringer. (g) Whoever without authority imports into the United States or offers to sell, sells, or uses within the United States a product which is made by a process patented in the United States shall be liable as an infringer, if the importation, offer to sell, sale, or use of the product occurs during the term of such process patent. In an action for infringement of a process



patent, no remedy may be granted for infringement on account of the noncommercial use or retail sale of a product unless there is no adequate remedy under this title for infringement on account of the importation or other use, offer to sell, or sale of that product. A product which is made by a patented process will, for purposes of this title, not be considered to be so made after —

(1) it is materially changed by subsequent processes; or (2) it becomes a trivial and nonessential component of another product. (h) As used in this section, the term “whoever” includes any State, any instrumentality of a State, any officer or employee of a State or instrumentality of a State acting in his official capacity. Any State, and any such instrumentality, officer, or employee, shall be subject to the provisions of this title in the same manner and to the same extent as any nongovernmental entity. (i) As used in this section, an “offer for sale” or an “offer to sell” by a person other than the patentee or any assignee of the patentee, is that in which the sale will occur before the expiration of the term of the patent.


(Subsection (e) added Sept. 24, 1984, Public Law 98417, sec. 202, 98 Stat. 1603.)

(Subsection (f) added Nov. 8, 1984, Public Law 98622, sec. 101(a), 98 Stat. 3383.)

(Subsection (g) added Aug. 23, 1988, Public Law 100418, sec. 9003, 102 Stat. 1564.)

(Subsection (e) amended Nov. 16, 1988, Public Law 100-670, sec. 201(i), 102 Stat. 3988.)

(Subsection (d) amended Nov. 19, 1988, Public Law 100-703, sec. 201, 102 Stat. 4676.)

(Subsection (h) added Oct. 28, 1992, Public Law 102560, sec. 2(a)(1), 106 Stat. 4230.)

(Subsections (a), (c), (e), and (g) amended Dec. 8, 1994, Public Law 103-465, sec. 533(a), 108 Stat. 4988.)

(Subsection (i) added Dec. 8, 1994, Public Law 103465, sec. 533(a), 108 Stat. 4988.)

(Subsection (e)(5) added Dec. 8, 2003, Public Law 108-173, sec. 1101(d), 117 Stat. 2457.)

35 U.S.C. 272 Temporary presence in the United States.

The use of any invention in any vessel, aircraft or vehicle of any country which affords similar privileges to vessels, aircraft, or vehicles of the United States, entering the United States temporarily or accidentally, shall not constitute infringement of any patent, if the invention is used exclusively for the needs of the vessel, aircraft, or vehicle and is not offered for sale or sold in or used for the manufacture of anything to be sold in or exported from the United States.

(Amended Dec. 8, 1994, Public Law 103-465, sec. 533(b)(4), 108 Stat. 4989.)

35 U.S.C. 273 Defense to infringement based on earlier inventor.

(a) DEFINITIONS.— For purposes of this section— (1) the terms “commercially used” and “commercial use” mean use of a method in the United States, so long as such use is in connection with an internal commercial use or an actual arm’s-length sale or other arm’s-length commercial transfer of a useful end result, whether or not the subject matter at issue is accessible to or otherwise known to the public, except that the subject matter for which commercial marketing or use is subject to a premarketing regulatory review period during which the safety or efficacy of the subject matter is established, including any period specified in section 156(g), shall be deemed “commercially used” and in “commercial use” during such regulatory review period; (2) in the case of activities performed by a nonprofit research laboratory, or nonprofit entity such as a university, research center, or hospital, a use for which the public is the intended beneficiary shall be considered to be a use described in paragraph (1), except that the use— (A) may be asserted as a defense under this section only for continued use by and in the laboratory or nonprofit entity; and (B) may not be asserted as a defense with respect to any subsequent commercialization or use outside such laboratory or nonprofit entity; (3) the term “method” means a method of doing or conducting business; and (4) the “effective filing date” of a patent is the earlier of the actual filing date of the application



for the patent or the filing date of any earlier United States, foreign, or international application to which the subject matter at issue is entitled under section 119, 120, or 365 of this title.

(b) DEFENSE TO INFRINGEMENT.—

(1) IN GENERAL.— It shall be a defense to an action for infringement under section 271 of this title with respect to any subject matter that would otherwise infringe one or more claims for a method in the patent being asserted against a person, if such person had, acting in good faith, actually reduced the subject matter to practice at least 1 year before the effective filing date of such patent, and commercially used the subject matter before the effective filing date of such patent. (2) EXHAUSTION OF RIGHT.— The sale or other disposition of a useful end product produced by a patented method, by a person entitled to assert a defense under this section with respect to that useful end result shall exhaust the patent owner’s rights under the patent to the extent such rights would have been exhausted had such sale or other disposition been made by the patent owner. (3) LIMITATIONS AND QUALIFICATIONS OF DEFENSE.— The defense to infringement under this section is subject to the following: (A) PATENT.— A person may not assert the defense under this section unless the invention for which the defense is asserted is for a method. (B) DERIVATION.— A person may not assert the defense under this section if the subject matter on which the defense is based was derived from the patentee or persons in privity with the patentee. (C) NOT A GENERAL LICENSE.— The defense asserted by a person under this section is not a general license under all claims of the patent at issue, but extends only to the specific subject matter claimed in the patent with respect to which the person can assert a defense under this chapter, except that the defense shall also extend to variations in the quantity or volume of use of the claimed subject matter, and to improvements in the claimed subject matter that do not infringe additional specifically claimed subject matter of the patent. (4) BURDEN OF PROOF.— A person asserting the defense under this section shall have the


burden of establishing the defense by clear and convincing evidence.

(5) ABANDONMENT OF USE.— A person who has abandoned commercial use of subject matter may not rely on activities performed before the date of such abandonment in establishing a defense under this section with respect to actions taken after the date of such abandonment. (6) PERSONAL DEFENSE.— The defense under this section may be asserted only by the person who performed the acts necessary to establish the defense and, except for any transfer to the patent owner, the right to assert the defense shall not be licensed or assigned or transferred to another person except as an ancillary and subordinate part of a good faith assignment or transfer for other reasons of the entire enterprise or line of business to which the defense relates. (7) LIMITATION ON SITES.— A defense under this section, when acquired as part of a good faith assignment or transfer of an entire enterprise or line of business to which the defense relates, may only be asserted for uses at sites where the subject matter that would otherwise infringe one or more of the claims is in use before the later of the effective filing date of the patent or the date of the assignment or transfer of such enterprise or line of business. (8) UNSUCCESSFUL ASSERTION OF DEFENSE.— If the defense under this section is pleaded by a person who is found to infringe the patent and who subsequently fails to demonstrate a reasonable basis for asserting the defense, the court shall find the case exceptional for the purpose of awarding attorney fees under section 285 of this title. (9) INVALIDITY.— A patent shall not be deemed to be invalid under section 102 or 103 of this title solely because a defense is raised or established under this section.


(Added Nov. 29, 1999, Public Law 106-113, sec. 

1000(a)(9), 113 Stat. 1501A-555 (S. 1948 sec. 4302).)

CHAPTER 29 — REMEDIES FOR INFRINGEMENT OF PATENT, AND OTHER ACTIONS[edit | edit source]

Sec. 281 Remedy for infringement of patent. 282 Presumption of validity; defenses. 283 Injunction.



284 Damages. 285 Attorney fees. 286 Time limitation on damages. 287 Limitation on damages and other remedies;


marking and notice. 288 Action for infringement of a patent containing an invalid claim. 289 Additional remedy for infringement of design

patent. 290 Notice of patent suits. 291 Interfering patents. 292 False marking. 293 Nonresident patentee; service and notice. 294 Voluntary arbitration. 295 Presumptions: Product made by patented pro

cess. 296 Liability of States, instrumentalities of States, and State officials for infringement of patents. 297 Improper and deceptive invention promotion

35 U.S.C. 281 Remedy for infringement of patent.[edit | edit source]

A patentee shall have remedy by civil action for infringement of his patent.

35 U.S.C. 282 Presumption of validity; defenses.[edit | edit source]

A patent shall be presumed valid. Each claim of a patent (whether in independent, dependent, or multiple dependent form) shall be presumed valid independently of the validity of other claims; dependent or multiple dependent claims shall be presumed valid even though dependent upon an invalid claim. Notwithstanding the preceding sentence, if a claim to a composition of matter is held invalid and that claim was the basis of a determination of nonobviousness under section 103(b)(1), the process shall no longer be considered nonobvious solely on the basis of section 103(b)(1). The burden of establishing invalidity of a patent or any claim thereof shall rest on the party asserting such invalidity.

The following shall be defenses in any action involving the validity or infringement of a patent and shall be pleaded:

(1) Noninfringement, absence of liability for infringement, or unenforceability, (2) Invalidity of the patent or any claim in suit on any ground specified in part II of this title as a condition for patentability,


(3) Invalidity of the patent or any claim in suit for failure to comply with any requirement of sections 112 or 251 of this title, (4) Any other fact or act made a defense by this title.


In actions involving the validity or infringement of a patent the party asserting invalidity or noninfringement shall give notice in the pleadings or otherwise in writing to the adverse party at least thirty days before the trial, of the country, number, date, and name of the patentee of any patent, the title, date, and page numbers of any publication to be relied upon as anticipation of the patent in suit or, except in actions in the United States Court of Federal Claims, as showing the state of the art, and the name and address of any person who may be relied upon as the prior inventor or as having prior knowledge of or as having previously used or offered for sale the invention of the patent in suit. In the absence of such notice proof of the said matters may not be made at the trial except on such terms as the court requires.

Invalidity of the extension of a patent term or any portion thereof under section 154(b) or 156 of this title because of the material failure—

(1) by the applicant for the extension, or

(2) by the Director, to comply with the requirements of such section shall be a defense in any action involving the infringement of a patent during the period of the extension of its term and shall be pleaded. A due diligence determination under section 156(d)(2) is not subject to review in such an action.

(Amended July 24, 1965, Public Law 89-83, sec. 10, 79 Stat. 261; Nov. 14, 1975, Public Law 94-131, sec. 10, 89 Stat. 692; Apr. 2, 1982, Public Law 97-164, sec. 161(7), 96 Stat. 49; Sept. 24, 1984, Public Law 98-417, sec. 203, 98 Stat. 1603; Oct. 29, 1992, Public Law 102-572, sec. 902(b)(1), 106 Stat. 4516; Nov. 1, 1995, Public Law 10441, sec. 2, 109 Stat. 352; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-560, 582 (S. 1948 secs. 4402(b)(1) and 4732(a)(10)(A)).)

35 U.S.C. 283 Injunction.[edit | edit source]

The several courts having jurisdiction of cases under this title may grant injunctions in accordance with the principles of equity to prevent the violation of any right secured by patent, on such terms as the court deems reasonable.

35 U.S.C. 284 Damages.[edit | edit source]

Upon finding for the claimant the court shall award the claimant damages adequate to compensate for the infringement but in no event less that a reasonable royalty for the use made of the invention by the infringer, together with interest and costs as fixed by the court.

When the damages are not found by a jury, the court shall assess them. In either event the court may increase the damages up to three times the amount found or assessed. Increased damages under this paragraph shall not apply to provisional rights under section 154(d) of this title.

The court may receive expert testimony as an aid to the determination of damages or of what royalty would be reasonable under the circumstances.

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-566 (S. 1948 sec. 4507(9)).)

35 U.S.C. 285 Attorney fees.

The court in exceptional cases may award reasonable attorney fees to the prevailing party.

35 U.S.C. 286 Time limitation on damages.[edit | edit source]

Except as otherwise provided by law, no recovery shall be had for any infringement committed more than six years prior to the filing of the complaint or counterclaim for infringement in the action.

In the case of claims against the United States Government for use of a patented invention, the period before bringing suit, up to six years, between the date of receipt of a written claim for compensation by the department or agency of the Government having authority to settle such claim, and the date of mailing by the Government of a notice to the claimant that his claim has been denied shall not be counted as a part of the period referred to in the preceding paragraph.

35 U.S.C. 287 Limitation on damages and other remedies; marking and notice.[edit | edit source]

(a) Patentees, and persons making, offering for sale, or selling within the United States any patented article for or under them, or importing any patented article into the United States, may give notice to the public that the same is patented, either by fixing thereon the word “patent” or the abbreviation “pat.”, together with the number of the patent, or when, from the character of the article, this cannot be done, by fixing to it, or to the package wherein one or more of them is contained, a label containing a like notice. In the event of failure so to mark, no damages shall be recovered by the patentee in any action for infringement, except on proof that the infringer was notified of the infringement and continued to infringe thereafter, in which event damages may be recovered only for infringement occurring after such notice. Filing of an action for infringement shall constitute such notice.

(b)(1) An infringer under section 271(g) shall be subject to all the provisions of this title relating to damages and injunctions except to the extent those remedies are modified by this subsection or section 9006 of the Process Patent Amendments Act of 1988. The modifications of remedies provided in this subsection shall not be available to any person who —

(A) practiced the patented process;

(B) owns or controls, or is owned or controlled by, the person who practiced the patented process; or (C) had knowledge before the infringement that a patented process was used to make the product the importation, use, offer for sale, or sale of which constitutes the infringement. (2) No remedies for infringement under section 271(g) of this title shall be available with respect to any product in the possession of, or in transit to, the person subject to liability under such section before that person had notice of infringement with respect to that product. The person subject to liability shall bear the burden of proving any such possession or transit. (3)(A) In making a determination with respect to the remedy in an action brought for infringement under section 271(g), the court shall consider—


(i) the good faith demonstrated by the defendant with respect to a request for disclosure; (ii) the good faith demonstrated by the plaintiff with respect to a request for disclosure, and


(iii) the need to restore the exclusive rights secured by the patent.

(B) For purposes of subparagraph (A), the following are evidence of good faith: (i) a request for disclosure made by the defendant; (ii) a response within a reasonable time by the person receiving the request for disclosure; and


(iii) the submission of the response by the defendant to the manufacturer, or if the manufacturer is not known, to the supplier, of the product to be purchased by the defendant, together with a request for a written statement that the process claimed in any patent disclosed in the response is not used to produce such product.

The failure to perform any acts described in the preceding sentence is evidence of absence of good faith unless there are mitigating circumstances. Mitigating circumstances include the case in which, due to the nature of the product, the number of sources for the product, or like commercial circumstances, a request for disclosure is not necessary or practicable to avoid infringement.

(4)(A) For purposes of this subsection, a “request for disclosure” means a written request made to a person then engaged in the manufacture of a product to identify all process patents owned by or licensed to that person, as of the time of the request, that the person then reasonably believes could be asserted to be infringed under section 271(g) if that product were imported into, or sold, offered for sale, or used in, the United States by an unauthorized person. A request for disclosure is further limited to a request —

(i) which is made by a person regularly engaged in the United States in the sale of the type of products as those manufactured by the person to whom the request is directed, or which includes facts showing that the person making the request plans to engage in the sale of such products in the United States; (ii) which is made by such person before the person’s first importation, use, offer for sale, or sale of units of the product produced by an infringing process and before the person had notice of infringement with respect to the product; and


(iii) which includes a representation by the person making the request that such person will promptly submit the patents identified pursuant to the request to the manufacturer, or if the manufacturer is not known, to the supplier, of the product to be purchased by the person making the request, and will request from that manufacturer or supplier a written statement that none of the processes claimed in those patents is used in the manufacture of the product.

(B) In the case of a request for disclosure received by a person to whom a patent is licensed, that person shall either identify the patent or promptly notify the licensor of the request for disclosure.

(C) A person who has marked, in the manner prescribed by subsection (a), the number of the process patent on all products made by the patented process which have been offered for sale or sold by that person in the United States, or imported by the person into the United States, before a request for disclosure is received is not required to respond to the request for disclosure. For purposes of the preceding sentence, the term “all products” does not include products made before the effective date of the Process Patent Amendments Act of 1988. (5)(A) For purposes of this subsection, notice of infringement means actual knowledge, or receipt by a person of a written notification, or a combination thereof, of information sufficient to persuade a reasonable person that it is likely that a product was made by a process patented in the United States.

(B) A written notification from the patent holder charging a person with infringement shall specify the patented process alleged to have been used and the reasons for a good faith belief that such process was used. The patent holder shall include in the notification such information as is reasonably necessary to explain fairly the patent holder’s belief, except that the patent holder is not required to disclose any trade secret information. (C) A person who receives a written notification described in subparagraph (B) or a written response to a request for disclosure described in paragraph (4) shall be deemed to have notice of infringement with respect to any patent referred to in such written notification or response unless that person, absent mitigating circumstances— (i) promptly transmits the written notification or response to the manufacturer or, if the manufacturer is not known, to the supplier, of the product purchased or to be purchased by that person; and (ii) receives a written statement from the manufacturer or supplier which on its face sets forth a well grounded factual basis for a belief that the identified patents are not infringed. (D) For purposes of this subsection, a person who obtains a product made by a process patented in the United States in a quantity which is abnormally large in relation to the volume of business of such person or an efficient inventory level shall be rebuttably presumed to have actual knowledge that the product was made by such patented process.

(6) A person who receives a response to a request for disclosure under this subsection shall pay to the person to whom the request was made a reasonable fee to cover actual costs incurred in complying with the request, which may not exceed the cost of a commercially available automated patent search of the matter involved, but in no case more than $500.

(c)(1) With respect to a medical practitioner’s performance of a medical activity that constitutes an infringement under section 271(a) or (b) of this title, the provisions of sections 281, 283, 284, and 285 of this title shall not apply against the medical practitioner or against a related health care entity with respect to such medical activity.

(2) For the purposes of this subsection:

(A) the term “medical activity” means the performance of a medical or surgical procedure on a body, but shall not include (i) the use of a patented machine, manufacture, or composition of matter in violation of such patent, (ii) the practice of a patented use of a composition of matter in violation of such patent, or (iii) the practice of a process in violation of a biotechnology patent. (B) the term “medical practitioner” means any natural person who is licensed by a State to provide the medical activity described in subsection (c)(1) or who is acting under the direction of such person in the performance of the medical activity. (C) the term “related health care entity” shall mean an entity with which a medical practitioner has a professional affiliation under which the medical practitioner performs the medical activity, including but not limited to a nursing home, hospital, university, medical school, health maintenance organization, group medical practice, or a medical clinic. (D) the term “professional affiliation” shall mean staff privileges, medical staff membership, employment or contractual relationship, partnership or ownership interest, academic appointment, or other affiliation under which a medical practitioner provides the medical activity on behalf of, or in association with, the health care entity. (E) the term “body” shall mean a human body, organ or cadaver, or a nonhuman animal used in medical research or instruction directly relating to the treatment of humans.


(F) the term “patented use of a composition of matter” does not include a claim for a method of performing a medical or surgical procedure on a body that recites the use of a composition of matter where the use of that composition of matter does not directly contribute to achievement of the objective of the claimed method. (G) the term “State” shall mean any state or territory of the United States, the District of Columbia, and the Commonwealth of Puerto Rico. (3) This subsection does not apply to the activities of any person, or employee or agent of such person (regardless of whether such person is a tax exempt organization under section 501(c) of the Internal Revenue Code), who is engaged in the commercial development, manufacture, sale, importation, or distribution of a machine, manufacture, or composition of matter or the provision of pharmacy or clinical laboratory services (other than clinical laboratory services provided in a physician’s office), where such activities are: (A) directly related to the commercial development, manufacture, sale, importation, or distribution of a machine, manufacture, or composition of matter or the provision of pharmacy or clinical laboratory services (other than clinical laboratory services provided in a physician’s office), and (B) regulated under the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, or the Clinical Laboratories Improvement Act. (4) This subsection shall not apply to any patent issued based on an application the earliest effective filing date of which is prior to September 30, 1996.


(Amended Aug. 23, 1988, Public Law 100-418, sec. 9004(a), 102 Stat. 1564; Dec. 8, 1994, Public Law 103-465, sec. 533(b)(5), 108 Stat. 4989.)

(Subsection (c) added Sept. 30, 1996, Public Law 104208, sec. 616, 110 Stat. 3009-67.)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-589 (S. 1948 sec. 4803).)

35 U.S.C. 288 Action for infringement of a patent containing an invalid claim.[edit | edit source]

Whenever, without deceptive intention, a claim of a patent is invalid, an action may be maintained for the infringement of a claim of the patent which may be valid. The patentee shall recover no costs unless a dis-


claimer of the invalid claim has been entered at the Patent and Trademark Office before the commencement of the suit.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949.)

35 U.S.C. 289 Additional remedy for infringement of design patent.[edit | edit source]

Whoever during the term of a patent for a design, without license of the owner, (1) applies the patented design, or any colorable imitation thereof, to any article of manufacture for the purpose of sale, or (2) sells or exposes for sale any article of manufacture to which such design or colorable imitation has been applied shall be liable to the owner to the extent of his total profit, but not less than $250, recoverable in any United States district court having jurisdiction of the parties.

Nothing in this section shall prevent, lessen, or impeach any other remedy which an owner of an infringed patent has under the provisions of this title, but he shall not twice recover the profit made from the infringement.

35 U.S.C. 290 Notice of patent suits.[edit | edit source]

The clerks of the courts of the United States, within one month after the filing of an action under this title, shall give notice thereof in writing to the Director, setting forth so far as known the names and addresses of the parties, name of the inventor, and the designating number of the patent upon which the action has been brought. If any other patent is subsequently included in the action he shall give like notice thereof. Within one month after the decision is rendered or a judgment issued the clerk of the court shall give notice thereof to the Director. The Director shall, on receipt of such notices, enter the same in the file of such patent.

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 291 Interfering patents.[edit | edit source]

The owner of an interfering patent may have relief against the owner of another by civil action, and the court may adjudge the question of validity of any of the interfering patents, in whole or in part. The provisions of the second paragraph of section 146 of this title shall apply to actions brought under this section.

35 U.S.C. 292 False marking.[edit | edit source]

(a) Whoever, without the consent of the patentee, marks upon, or affixes to, or uses in advertising in connection with anything made, used, offered for sale, or sold by same person within the United States, or imported by the person into the United States, the name or any imitation of the name of the patentee, the patent number, or the words “patent,” “patentee,” or the like, with the intent of counterfeiting or imitating the mark of the patentee, or of deceiving the public and inducing them to believe that the thing was made, offered for sale, sold, or imported into the United States by or with the consent of the patentee; or

Whoever marks upon, or affixes to, or uses in advertising in connection with any unpatented article the word “patent” or any word or number importing the same is patented, for the purpose of deceiving the public; or

Whoever marks upon, or affixes to, or uses in advertising in connection with any article the words “patent applied for,” “patent pending,” or any word importing that an application for patent has been made, when no application for patent has been made, or if made, is not pending, for the purpose of deceiving the public —

Shall be fined not more than $500 for every such offense.

(b) Any person may sue for the penalty, in which event one-half shall go to the person suing and the other to the use of the United States.

(Subsection (a) amended Dec. 8, 1994, Public Law 103-465, sec. 533(b)(6), 108 Stat. 4990.)

35 U.S.C. 293 Nonresident patentee; service and notice.[edit | edit source]

Every patentee not residing in the United States may file in the Patent and Trademark Office a written designation stating the name and address of a person residing within the United States on whom may be served process or notice of proceedings affecting the patent or rights thereunder. If the person designated cannot be found at the address given in the last designation, or if no person has been designated, the United States District Court for the District of Columbia shall have jurisdiction and summons shall be served by publication or otherwise as the court directs. The court shall have the same jurisdiction to take any action respecting the patent or rights thereunder that it would have if the patentee were personally within the jurisdiction of the court.

(Amended Jan. 2, 1975, Public Law 93-596, sec. 1, 88 Stat. 1949.)

35 U.S.C. 294 Voluntary arbitration.[edit | edit source]

(a) A contract involving a patent or any right under a patent may contain a provision requiring arbitration of any dispute relating to patent validity or infringement arising under the contract. In the absence of such a provision, the parties to an existing patent validity or infringement dispute may agree in writing to settle such dispute by arbitration. Any such provision or agreement shall be valid, irrevocable, and enforceable, except for any grounds that exist at law or in equity for revocation of a contract. (b) Arbitration of such disputes, awards by arbitrators, and confirmation of awards shall be governed by title 9, to the extent such title is not inconsistent with this section. In any such arbitration proceeding, the defenses provided for under section 282 of this title shall be considered by the arbitrator if raised by any party to the proceeding. (c) An award by an arbitrator shall be final and binding between the parties to the arbitration but shall have no force or effect on any other person. The parties to an arbitration may agree that in the event a patent which is the subject matter of an award is subsequently determined to be invalid or unenforceable in a judgment rendered by a court of competent jurisdiction from which no appeal can or has been taken, such award may be modified by any court of competent jurisdiction upon application by any party to the arbitration. Any such modification shall govern the rights and obligations between such parties from the date of such modification. (d) When an award is made by an arbitrator, the patentee, his assignee or licensee shall give notice thereof in writing to the Director. There shall be a separate notice prepared for each patent involved in such proceeding. Such notice shall set forth the names and addresses of the parties, the name of the inventor, and the name of the patent owner, shall designate the number of the patent, and shall contain a copy of the award. If an award is modified by a court, the party requesting such modification shall give notice of such modification to the Director. The Director shall, upon receipt of either notice, enter the same in the record of the prosecution of such patent. If the required notice is


not filed with the Director, any party to the proceeding may provide such notice to the Director.

(e) The award shall be unenforceable until the notice required by subsection (d) is received by the Director.

(Added Aug. 27, 1982, Public Law 97-247, sec. 17(b)(1), 96 Stat. 322; amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)); subsections (b) and (c) amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1905.)

35 U.S.C. 295 Presumption: Product made by patented process.[edit | edit source]

In actions alleging infringement of a process patent based on the importation, sale, offered for sale, or use of a product which is made from a process patented in the United States, if the court finds—

(1) that a substantial likelihood exists that the product was made by the patented process, and (2) that the plaintiff has made a reasonable effort to determine the process actually used in the production of the product and was unable so to determine, the product shall be presumed to have been so made, and the burden of establishing that the product was not made by the process shall be on the party asserting that it was not so made.


(Added Aug. 23, 1988, Public Law 100-418, sec. 9005(a), 102 Stat. 1566; amended Dec. 8, 1994, Public Law 103-465, sec. 533(b)(7), 108 Stat. 4990.)

35 U.S.C. 296 Liability of States, instrumentalities of States, and State officials for infringement of patents.[edit | edit source]

(a) IN GENERAL. - Any State, any instrumentality of a State, and any officer or employee of a State or instrumentality of a State, acting in his official capacity, shall not be immune, under the eleventh amendment of the Constitution of the United States or under any other doctrine of sovereign immunity, from suit in Federal court by any person, including any governmental or nongovernmental entity, for infringement of a patent under section 271, or for any other violation under this title. (b) REMEDIES. - In a suit described in subsection (a) for a violation described in that subsection, remedies (including remedies both at law and in equity) are available for the violation to the same extent as such remedies are available for such a violation in a suit against any private entity. Such remedies include damages, interest, costs, and treble damages under section 284, attorney fees under section 285, and the additional remedy for infringement of design patents under section 289.

(Added Oct. 28, 1992, Public Law 102-560, sec. 2(a)(2), 106 Stat. 4230.)

35 U.S.C. 297 Improper and deceptive invention promotion.

(a) IN GENERAL.— An invention promoter shall have a duty to disclose the following information to a customer in writing, prior to entering into a contract for invention promotion services: (1) the total number of inventions evaluated by the invention promoter for commercial potential in the past 5 years, as well as the number of those inventions that received positive evaluations, and the number of those inventions that received negative evaluations; (2) the total number of customers who have contracted with the invention promoter in the past 5 years, not including customers who have purchased trade show services, research, advertising, or other nonmarketing services from the invention promoter, or who have defaulted in their payment to the invention promoter; (3) the total number of customers known by the invention promoter to have received a net financial profit as a direct result of the invention promotion services provided by such invention promoter; (4) the total number of customers known by the invention promoter to have received license agreements for their inventions as a direct result of the invention promotion services provided by such invention promoter; and (5) the names and addresses of all previous invention promotion companies with which the invention promoter or its officers have collectively or individually been affiliated in the previous 10 years. (b) CIVIL ACTION.—


(1) Any customer who enters into a contract with an invention promoter and who is found by a court to have been injured by any material false or fraudulent statement or representation, or any omission of material fact, by that invention promoter (or any agent, employee, director, officer, partner, or independent contractor of such invention promoter), or by the failure of that invention promoter to disclose such information as required under subsection (a),


may recover in a civil action against the invention promoter (or the officers, directors, or partners of such invention promoter), in addition to reasonable costs and attorneys’ fees-

(A) the amount of actual damages incurred by the customer; or (B) at the election of the customer at any time before final judgment is rendered, statutory damages in a sum of not more than $5,000, as the court considers just. (2) Notwithstanding paragraph (1), in a case where the customer sustains the burden of proof, and the court finds, that the invention promoter intentionally misrepresented or omitted a material fact to such customer, or willfully failed to disclose such information as required under subsection (a), with the purpose of deceiving that customer, the court may increase damages to not more than three times the amount awarded, taking into account past complaints made against the invention promoter that resulted in regulatory sanctions or other corrective actions based on those records compiled by the Commissioner of Patents under subsection (d). (c) DEFINITIONS.— For purposes of this section— (1) a “contract for invention promotion services” means a contract by which an invention promoter undertakes invention promotion services for a customer; (2) a “customer” is any individual who enters into a contract with an invention promoter for invention promotion services; (3) the term “invention promoter” means any person, firm, partnership, corporation, or other entity who offers to perform or performs invention promotion services for, or on behalf of, a customer, and who holds itself out through advertising in any mass media as providing such services, but does not include— (A) any department or agency of the Federal Government or of a State or local government; (B) any nonprofit, charitable, scientific, or educational organization, qualified under applicable State law or described under section 170(b)(1)(A) of the Internal Revenue Code of 1986; (C) any person or entity involved in the evaluation to determine commercial potential of, or offering to license or sell, a utility patent or a previously filed nonprovisional utility patent application; (D) any party participating in a transaction involving the sale of the stock or assets of a business; or (E) any party who directly engages in the business of retail sales of products or the distribution of products; and (4) the term “invention promotion services” means the procurement or attempted procurement for a customer of a firm, corporation, or other entity to develop and market products or services that include the invention of the customer. (d) RECORDS OF COMPLAINTS.—


(1) RELEASE OF COMPLAINTS.— The Commissioner of Patents shall make all complaints received by the Patent and Trademark Office involving invention promoters publicly available, together with any response of the invention promoters. The Commissioner of Patents shall notify the invention promoter of a complaint and provide a reasonable opportunity to reply prior to making such complaint publicly available. (2) REQUEST FOR COMPLAINTS.— The Commissioner of Patents may request complaints relating to invention promotion services from any Federal or State agency and include such complaints in the records maintained under paragraph (1), together with any response of the invention promoters.


(Added Nov. 29, 1999, Public Law 106-113, sec. 

1000(a)(9), 113 Stat. 1501A-552 (S. 1948 sec. 4102(a)).)

CHAPTER 30 — PRIOR ART CITATIONS TO OFFICE AND EX PARTE REEXAMINATION OF PATENTS[edit | edit source]

Sec.

301 Citation of prior art.

302 Request for reexamination.

303 Determination of issue by Director.

304 Reexamination order by Director.

305 Conduct of reexamination proceedings.

306 Appeal.

307 Certificate of patentability, unpatentability, and claim cancellation.

35 U.S.C. 301 Citation of prior art.[edit | edit source]

Any person at any time may cite to the Office in writing prior art consisting of patents or printed publications which that person believes to have a bearing on the patentability of any claim of a particular patent. If the person explains in writing the pertinency and manner of applying such prior art to at least one claim of the patent, the citation of such prior art and the explanation thereof will become a part of the official file of the patent. At the written request of the person citing the prior art, his or her identity will be excluded from the patent file and kept confidential.

(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94 Stat. 3015.)

35 U.S.C. 302 Request for reexamination.[edit | edit source]

Any person at any time may file a request for reexamination by the Office of any claim of a patent on the basis of any prior art cited under the provisions of section 301 of this title. The request must be in writing and must be accompanied by payment of a reexamination fee established by the Director pursuant to the provisions of section 41 of this title. The request must set forth the pertinency and manner of applying cited prior art to every claim for which reexamination is requested. Unless the requesting person is the owner of the patent, the Director promptly will send a copy of the request to the owner of record of the patent.

(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94 Stat. 3015; amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 secs. 4732(a)(8) and 4732(a)(10)(A)).)

35 U.S.C. 303 Determination of issue by Director.[edit | edit source]

(a) Within three months following the filing of a request for reexamination under the provisions of section 302 of this title, the Director will determine whether a substantial new question of patentability affecting any claim of the patent concerned is raised by the request, with or without consideration of other patents or printed publications. On his own initiative, and any time, the Director may determine whether a substantial new question of patentability is raised by patents and publications discovered by him or cited under the provisions of section 301 of this title. The existence of a substantial new question of patentability is not precluded by the fact that a patent or printed publication was previously cited by or to the Office or considered by the Office. (b) A record of the Director’s determination under subsection (a) of this section will be placed in the official file of the patent, and a copy promptly will be given or mailed to the owner of record of the patent and to the person requesting reexamination, if any.

(c) A determination by the Director pursuant to subsection (a) of this section that no substantial new question of patentability has been raised will be final and nonappealable. Upon such a determination, the Director may refund a portion of the reexamination fee required under section 302 of this title.

(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94 Stat. 3015; amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-581, 582 (S. 1948 secs. 4732(a)(9) and (4732(a)(10)(A)); subsection (a) amended Nov. 2, 2002, Public Law 107-273, sec. 13105, 116 Stat. 1900.)

35 U.S.C. 304 Reexamination order by Director.[edit | edit source]

If, in a determination made under the provisions of subsection 303(a) of this title, the Director finds that a substantial new question of patentability affecting any claim of a patent is raised, the determination will include an order for reexamination of the patent for resolution of the question. The patent owner will be given a reasonable period, not less than two months from the date a copy of the determination is given or mailed to him, within which he may file a statement on such question, including any amendment to his patent and new claim or claims he may wish to propose, for consideration in the reexamination. If the patent owner files such a statement, he promptly will serve a copy of it on the person who has requested reexamination under the provisions of section 302 of this title. Within a period of two months from the date of service, that person may file and have considered in the reexamination a reply to any statement filed by the patent owner. That person promptly will serve on the patent owner a copy of any reply filed.

(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94 Stat. 3016; amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 305 Conduct of reexamination proceedings.[edit | edit source]

After the times for filing the statement and reply provided for by section 304 of this title have expired, reexamination will be conducted according to the procedures established for initial examination under the provisions of sections 132 and 133 of this title. In any reexamination proceeding under this chapter, the patent owner will be permitted to propose any amendment to his patent and a new claim or claims thereto, in order to distinguish the invention as claimed from the prior art cited under the provisions of section 301 of this title, or in response to a decision adverse to the patentability of a claim of a patent. No proposed amended or new claim enlarging the scope of a claim of the patent will be permitted in a reexamination proceeding under this chapter. All reexamination proceedings under this section, including any appeal to the Board of Patent Appeals and Interferences, will be conducted with special dispatch within the Office.

(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94 Stat. 3016; amended Nov. 8, 1984, Public Law 98-622, sec. 204(c), 98 Stat. 3388.)

35 U.S.C. 306 Appeal.[edit | edit source]

The patent owner involved in a reexamination proceeding under this chapter may appeal under the provisions of section 134 of this title, and may seek court review under the provisions of sections 141 to 145 of this title, with respect to any decision adverse to the patentability of any original or proposed amended or new claim of the patent.

(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94 Stat. 3016.)

35 U.S.C. 307 Certificate of patentability, unpatentability, and claim cancellation.[edit | edit source]

(a) In a reexamination proceeding under this chapter, when the time for appeal has expired or any appeal proceeding has terminated, the Director will issue and publish a certificate canceling any claim of the patent finally determined to be unpatentable, confirming any claim of the patent determined to be patentable, and incorporating in the patent any proposed amended or new claim determined to be patentable. (b) Any proposed amended or new claim determined to be patentable and incorporated into a patent following a reexamination proceeding will have the same effect as that specified in section 252 of this title for reissued patents on the right of any person who made, purchased, or used within the United States, or imported into the United States, anything patented by such proposed amended or new claim, or who made substantial preparation for the same, prior to issuance of a certificate under the provisions of subsection (a) of this section.

(Added Dec. 12, 1980, Public Law 96-517, sec. 1, 94 Stat. 3016; amended Dec. 8, 1994, Public Law 103-465, sec. 533(b)(8), 108 Stat. 4990; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

CHAPTER 31 — OPTIONAL INTER PARTES REEXAMINATION PROCEDURES[edit | edit source]

Sec. 311 Request for inter partes reexamination. 312 Determination of issue by Director. 313 Inter partes reexamination order by Director. 314 Conduct of inter partes reexamination proceed


ings. 315 Appeal. 316 Certificate of patentability, unpatentability, and

claim cancellation. 317 Inter partes reexamination prohibited. 318 Stay of litigation.

35 U.S.C. 311 Request for inter partes reexamination[edit | edit source]

(a) IN GENERAL.— Any third-party requester at any time may file a request for inter partes reexamination by the Office of a patent on the basis of any prior art cited under the provisions of section 301. (b) REQUIREMENTS.— The request shall—


(1) be in writing, include the identity of the real party in interest, and be accompanied by payment of an inter partes reexamination fee established by the Director under section 41; and (2) set forth the pertinency and manner of applying cited prior art to every claim for which reexamination is requested. (c) COPY.— The Director promptly shall send a copy of the request to the owner of record of the patent.


(Added Nov. 29, 1999, Public Law 106-113, sec. 

1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)); subsections (a) and (c) amended Nov. 2, 2002, Public Law 107-273, sec. 13202, 116 Stat. 1901.)

35 U.S.C. 312 Determination of issue by Director[edit | edit source]

(a) REEXAMINATION.— Not later than 3 months after the filing of a request for inter partes reexamination under section 311, the Director shall determine whether a substantial new question of patentability affecting any claim of the patent concerned is raised by the request, with or without consideration of other patents or printed publications. The existence of a substantial new question of patentability is not precluded by the fact that a patent or printed publication was previously cited by or to the Office or considered by the Office.

(b) RECORD.— A record of the Director’s determination under subsection (a) shall be placed in the official file of the patent, and a copy shall be promptly given or mailed to the owner of record of the patent and to the third-party requester. (c) FINAL DECISION.— A determination by the Director under subsection (a) shall be final and non-appealable. Upon a determination that no substantial new question of patentability has been raised, the Director may refund a portion of the inter partes reexamination fee required under section 311.


(Added Nov. 29, 1999, Public Law 106-113, sec. 

1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)); subsections (a) and (b) amended Nov. 2, 2002, Public Law 107-273, secs. 13105 and 13202, 116 Stat.1900-1901.)

35 U.S.C. 313 Inter partes reexamination order by Director[edit | edit source]

If, in a determination made under section 312(a), the Director finds that a substantial new question of patentability affecting a claim of a patent is raised, the determination shall include an order for inter partes reexamination of the patent for resolution of the question. The order may be accompanied by the initial action of the Patent and Trademark Office on the merits of the inter partes reexamination conducted in accordance with section 314.

(Added Nov. 29, 1999, Public Law 106-113, sec. 

1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)).)

35 U.S.C. 314 Conduct of inter partes reexamination proceedings[edit | edit source]

(a) IN GENERAL.— Except as otherwise provided in this section, reexamination shall be conducted according to the procedures established for initial examination under the provisions of sections 132 and 133. In any inter partes reexamination proceeding under this chapter, the patent owner shall be permitted to propose any amendment to the patent and a new claim or claims, except that no proposed amended or new claim enlarging the scope of the claims of the patent shall be permitted.


(b) RESPONSE.—

(1) With the exception of the inter partes reexamination request, any document filed by either the patent owner or the third-party requester shall be served on the other party. In addition, the Office shall send to the third-party requester a copy of any communication sent by the Office to the patent owner concerning the patent subject to the inter partes reexamination proceeding. (2) Each time that the patent owner files a response to an action on the merits from the Patent and Trademark Office, the third-party requester shall have one opportunity to file written comments addressing issues raised by the action of the Office or the patent owner’s response thereto, if those written comments are received by the Office within 30 days after the date of service of the patent owner’s response. (c) SPECIAL DISPATCH.— Unless otherwise provided by the Director for good cause, all inter partes reexamination proceedings under this section, including any appeal to the Board of Patent Appeals and Interferences, shall be conducted with special dispatch within the Office.


(Added Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)); subsection (b)(1) amended Nov. 2, 2002, Public Law 107273, sec. 13202, 116 Stat. 1901.)

35 U.S.C. 315 Appeal[edit | edit source]

(a) PATENT OWNER.— The patent owner involved in an inter partes reexamination proceeding under this chapter— (1) may appeal under the provisions of section 134 and may appeal under the provisions of sections 141 through 144, with respect to any decision adverse to the patentability of any original or proposed amended or new claim of the patent; and (2) may be a party to any appeal taken by a third-party requester under subsection (b). (b) THIRD-PARTY REQUESTER.— A third- party requester— (1) may appeal under the provisions of section 134, and may appeal under the provisions of sections 141 through 144, with respect to any final decision favorable to the patentability of any original or proposed amended or new claim of the patent; and


(2) may, subject to subsection (c), be a party to any appeal taken by the patent owner under the provisions of section 134 or sections 141 through 144. (c) CIVIL ACTION.— A third-party requester whose request for an inter partes reexamination results in an order under section 313 is estopped from asserting at a later time, in any civil action arising in whole or in part under section 1338 of title 28, the invalidity of any claim finally determined to be valid and patentable on any ground which the third-party requester raised or could have raised during the inter partes reexamination proceedings. This subsection does not prevent the assertion of invalidity based on newly discovered prior art unavailable to the third- party requester and the Patent and Trademark Office at the time of the inter partes reexamination proceedings.


(Added Nov. 29, 1999, Public Law 106-113, sec. 

1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)); subsection (b) amended Nov. 2, 2002, Public Law 107-273, sec. 13106, 116 Stat. 1900; subsection (c) amended Nov. 2, 2002, Public Law 107-273, sec. 13202, 116 Stat. 1901.)

35 U.S.C. 316 Certificate of patentability, unpatentability and claim cancellation[edit | edit source]

(a) IN GENERAL.— In an inter partes reexamination proceeding under this chapter, when the time for appeal has expired or any appeal proceeding has terminated, the Director shall issue and publish a certificate canceling any claim of the patent finally determined to be unpatentable, confirming any claim of the patent determined to be patentable, and incorporating in the patent any proposed amended or new claim determined to be patentable. (b) AMENDED OR NEW CLAIM.— Any proposed amended or new claim determined to be patentable and incorporated into a patent following an inter partes reexamination proceeding shall have the same effect as that specified in section 252 of this title for reissued patents on the right of any person who made, purchased, or used within the United States, or imported into the United States, anything patented by such proposed amended or new claim, or who made substantial preparation therefor, prior to issuance of a certificate under the provisions of subsection (a) of this section.


(Added Nov. 29, 1999, Public Law 106-113, sec. 

1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)).)


35 U.S.C. 317 Inter partes reexamination prohibited[edit | edit source]

(a) ORDER FOR REEXAMINATION.— Notwithstanding any provision of this chapter, once an order for inter partes reexamination of a patent has been issued under section 313, neither the third-party requester nor its privies may file a subsequent request for inter partes reexamination of the patent until an inter partes reexamination certificate is issued and published under section 316, unless authorized by the Director. (b) FINAL DECISION.— Once a final decision has been entered against a party in a civil action arising in whole or in part under section 1338 of title 28, that the party has not sustained its burden of proving the invalidity of any patent claim in suit or if a final decision in an inter partes reexamination proceeding instituted by a third-party requester is favorable to the patentability of any original or proposed amended or new claim of the patent, then neither that party nor its privies may thereafter request an inter partes reexamination of any such patent claim on the basis of issues which that party or its privies raised or could have raised in such civil action or inter partes reexamination proceeding, and an inter partes reexamination requested by that party or its privies on the basis of such issues may not thereafter be maintained by the Office, notwithstanding any other provision of this chapter. This subsection does not prevent the assertion of invalidity based on newly discovered prior art unavailable to the third-party requester and the Patent and Trademark Office at the time of the inter partes reexamination proceedings.


(Added Nov. 29, 1999, Public Law 106-113, sec. 

1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)); subsections (a) and (b) amended Nov. 2, 2002, Public Law 107-273, sec. 13202, 116 Stat. 1901.)

35 U.S.C. 318 Stay of litigation[edit | edit source]

Once an order for inter partes reexamination of a 

patent has been issued under section 313, the patent owner may obtain a stay of any pending litigation which involves an issue of patentability of any claims of the patent which are the subject of the inter partes reexamination order, unless the court before which such litigation is pending determines that a stay would not serve the interests of justice.

(Added Nov. 29, 1999, Public Law 106-113, sec. 

1000(a)(9), 113 Stat. 1501A-570 (S. 1948 sec. 4604(a)).)

PART IV — PATENT COOPERATION TREATY[edit | edit source]

CHAPTER 35 — DEFINITIONS[edit | edit source]

Sec. 351 Definitions.

35 U.S.C. 351 Definitions.

When used in this part unless the context otherwise indicates—

(a) The term “treaty” means the Patent Cooperation Treaty done at Washington, on June 19, 1970. (b) The term “Regulations,” when capitalized, means the Regulations under the treaty, done at Washington on the same date as the treaty. The term “regulations,” when not capitalized, means the regulations established by the Director under this title. (c) The term “international application” means an application filed under the treaty. (d) The term “international application originating in the United States” means an international application filed in the Patent and Trademark Office when it is acting as a Receiving Office under the treaty, irrespective of whether or not the United States has been designated in that international application. (e) The term “international application designating the United States” means an international application specifying the United States as a country in which a patent is sought, regardless where such international application is filed. (f) The term “Receiving Office” means a national patent office or intergovernmental organization which receives and processes international applications as prescribed by the treaty and the Regulations. (g) The terms “International Searching Authority” and “International Preliminary Examining Authority” mean a national patent office or intergovernmental organization as appointed under the treaty which processes international applications as prescribed by the treaty and the Regulations. (h) The term “International Bureau” means the inter national intergovernmental organization which is recognized as the coordinating body under the treaty and the Regulations.

(i) Terms and expressions not defined in this part are to be taken in the sense indicated by the treaty and the Regulations.

(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 685; amended Nov. 8, 1984, Public Law 98-622, sec. 403(a), 98 Stat. 3392; Nov. 6, 1986, Public Law 99616, sec. 2 (a)-(c), 100 Stat. 3485; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582

(S. 1948 sec. 4732(a)(10)(A)).)

CHAPTER 36 — INTERNATIONAL STAGE[edit | edit source]

Sec.

361 Receiving Office.

362 International Searching Authority and International Preliminary Examining Authority.

363 International application designating the United States: Effect.

364 International stage: Procedure.

365 Right of priority; benefit of the filing date of a prior application.

366 Withdrawn international application.

367 Actions of other authorities: Review.

368 Secrecy of certain inventions; filing international applications in foreign countries.

35 U.S.C. 361 Receiving Office.[edit | edit source]

(a) The Patent and Trademark Office shall act as a Receiving Office for international applications filed by nationals or residents of the United States. In accordance with any agreement made between the United States and another country, the Patent and Trademark Office may also act as a Receiving Office for international applications filed by residents or nationals of such country who are entitled to file international applications. (b) The Patent and Trademark Office shall perform all acts connected with the discharge of duties required of a Receiving Office, including the collection of international fees and their transmittal to the International Bureau. (c) International applications filed in the Patent and Trademark Office shall be in the English language. (d) The international fee, and the transmittal and search fees prescribed under section 376(a) of this part, shall either be paid on filing of an international application or within such later time as may be fixed by the Director.


(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622, sec. 401(a), 403(a), 98 Stat. 3391-3392; Nov. 6, 1986, Public Law 99-616, sec. 2(d), 100 Stat. 3485; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582

(S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 362 International Searching Authority and International Preliminary Examining Authority.[edit | edit source]

(a) The Patent and Trademark Office may act as an International Searching Authority and International Preliminary Examining Authority with respect to international applications in accordance with the terms and conditions of an agreement which may be concluded with the International Bureau, and may discharge all duties required of such Authorities, including the collection of handling fees and their transmittal to the International Bureau. (b) The handling fee, preliminary examination fee, and any additional fees due for international preliminary examination shall be paid within such time as may be fixed by the Director.


(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622, sec. 403 (a), 98 Stat. 3392; Nov. 6, 1986, Public Law 99616, sec. 4, 100 Stat. 3485; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 363 International application designating the United States: Effect.[edit | edit source]

An international application designating the United States shall have the effect, from its international filing date under article 11 of the treaty, of a national application for patent regularly filed in the Patent and Trademark Office except as otherwise provided in section 102(e) of this title.

(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622, sec. 403(a), 98 Stat. 3392.)

35 U.S.C. 364 International stage: Procedure.[edit | edit source]

(a) International applications shall be processed by the Patent and Trademark Office when acting as a Receiving Office, International Searching Authority, or International Preliminary Examining Authority, in accordance with the applicable provisions of the treaty, the Regulations, and this title.

(b) An applicant’s failure to act within prescribed time limits in connection with requirements pertaining to a pending international application may be excused upon a showing satisfactory to the Director of unavoidable delay, to the extent not precluded by the treaty and the Regulations, and provided the conditions imposed by the treaty and the Regulations regarding the excuse of such failure to act are complied with.

(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622, sec. 403(a), 98 Stat. 3392.)

(Subsection (a) amended Nov. 6, 1986, Public Law 99616, sec. 5, 100 Stat. 3485.)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 365 Right of priority; benefit of the filing date of a prior application.[edit | edit source]

(a) In accordance with the conditions and requirements of subsections (a) through (d) of section 119 of this title, a national application shall be entitled to the right of priority based on a prior filed international application which designated at least one country other than the United States. (b) In accordance with the conditions and requirements of section 119(a) of this title and the treaty and the Regulations, an international application designating the United States shall be entitled to the right of priority based on a prior foreign application, or a prior international application designating at least one country other than the United States. (c) In accordance with the conditions and requirements of section 120 of this title, an international application designating the United States shall be entitled to the benefit of the filing date of a prior national application or a prior international application designating the United States, and a national application shall be entitled to the benefit of the filing date of a prior international application designating the United States. If any claim for the benefit of an earlier filing date is based on a prior international application which designated but did not originate in the United States, the Director may require the filing in the Patent and Trademark Office of a certified copy of such application together with a translation thereof into the English language, if it was filed in another language.

(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 686; amended Nov. 8, 1984, Public Law 98-622, sec. 403(a), 98 Stat. 3392; Dec. 8, 1994, Public Law 103465, sec. 532(c)(4), 108 Stat. 4987; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 366 Withdrawn international application.[edit | edit source]

Subject to section 367 of this part, if an international application designating the United States is withdrawn or considered withdrawn, either generally or as to the United States, under the conditions of the treaty and the Regulations, before the applicant has complied with the applicable requirements prescribed by section 371(c) of this part, the designation of the United States shall have no effect after the date of withdrawal and shall be considered as not having been made, unless a claim for benefit of a prior filing date under section 365(c) of this section was made in a national application, or an international application designating the United States, filed before the date of such withdrawal. However, such withdrawn international application may serve as the basis for a claim of priority under section 365 (a) and (b) of this part, if it designated a country other than the United States.

(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 687; amended Nov. 8, 1984, Public Law 98-622, sec. 401(b), 98 Stat. 3391.)

35 U.S.C. 367 Actions of other authorities: Review.[edit | edit source]

(a) Where a Receiving Office other than the Patent and Trademark Office has refused to accord an international filing date to an international application designating the United States or where it has held such application to be withdrawn either generally or as to the United States, the applicant may request review of the matter by the Director, on compliance with the requirements of and within the time limits specified by the treaty and the Regulations. Such review may result in a determination that such application be considered as pending in the national stage. (b) The review under subsection (a) of this section, subject to the same requirements and conditions, may also be requested in those instances where an international application designating the United States is considered withdrawn due to a finding by the International Bureau under article 12 (3) of the treaty.

(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 687; amended Nov. 8, 1984, Public Law 98-622, sec. 403(a), 98 Stat 3392; Nov. 29, 1999, Public Law 106113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 368 Secrecy of certain inventions; filing international applications in foreign countries.[edit | edit source]

(a) International applications filed in the Patent and Trademark Office shall be subject to the provisions of chapter 17 of this title. (b) In accordance with article 27 (8) of the treaty, the filing of an international application in a country other than the United States on the invention made in this country shall be considered to constitute the filing of an application in a foreign country within the meaning of chapter 17 of this title, whether or not the United States is designated in that international application. (c) If a license to file in a foreign country is refused or if an international application is ordered to be kept secret and a permit refused, the Patent and Trademark Office when acting as a Receiving Office, International Searching Authority, or International Preliminary Examining Authority, may not disclose the contents of such application to anyone not authorized to receive such disclosure.


(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 687; amended Nov. 8, 1984, Public Law 98-622, sec. 403(a), 98 Stat. 3392; Nov. 6, 1986, Public Law 99616, sec. 6, 100 Stat. 3486.)

CHAPTER 37 — NATIONAL STAGE[edit | edit source]

Sec. 371 National stage: Commencement. 372 National stage: Requirements and procedure. 373 Improper applicant. 374 Publication of international application: Effect. 375 Patent issued on international application:


Effect. 376 Fees.

35 U.S.C. 371 National stage: Commencement.[edit | edit source]

(a) Receipt from the International Bureau of copies of international applications with any amendments to the claims, international search reports, and international preliminary examination reports including any annexes thereto may be required in the case of international applications designating or electing the United States.

(b) Subject to subsection (f) of this section, the national stage shall commence with the expiration of the applicable time limit under article 22 (1) or (2), or under article 39 (1)(a) of the treaty.

(c) The applicant shall file in the Patent and Trademark Office — (1) the national fee provided in section 41(a) of this title; (2) a copy of the international application, unless not required under subsection (a) of this section or already communicated by the International Bureau, and a translation into the English language of the international application, if it was filed in another language; (3) amendments, if any, to the claims in the international application, made under article 19 of the treaty, unless such amendments have been communicated to the Patent and Trademark Office by the International Bureau, and a translation into the English language if such amendments were made in another language; (4) an oath or declaration of the inventor (or other person authorized under chapter 11 of this title) complying with the requirements of section 115 of this title and with regulations prescribed for oaths or declarations of applicants; (5) a translation into the English language of any annexes to the international preliminary examination report, if such annexes were made in another language.

(d) The requirement with respect to the national fee referred to in subsection (c)(1), the translation referred to in subsection (c)(2), and the oath or declaration referred to in subsection (c)(4) of this section shall be complied with by the date of the commencement of the national stage or by such later time as may be fixed by the Director. The copy of the international application referred to in subsection (c)(2) shall be submitted by the date of the commencement of the national stage. Failure to comply with these requirements shall be regarded as abandonment of the application by the parties thereof, unless it be shown to the satisfaction of the Director that such failure to comply was unavoidable. The payment of a surcharge may be required as a condition of accepting the national fee referred to in subsection (c)(1) or the oath or declaration referred to in subsection (c)(4) of this section if these requirements are not met by the date of the commencement of the national stage. The requirements of subsection (c)(3) of this section shall be complied with by the date of the commencement of the national stage, and failure to do so shall be regarded as a cancellation of the amendments to the claims in the international application made under article 19 of the treaty. The requirement of subsection (c)(5) shall be complied with at such time as may be fixed by the Director and failure to do so shall be regarded as cancellation of the amendments made under article 34 (2)(b) of the treaty.

(e) After an international application has entered the national stage, no patent may be granted or refused thereon before the expiration of the applicable time limit under article 28 or article 41 of the treaty, except with the express consent of the applicant. The applicant may present amendments to the specification, claims, and drawings of the application after the national stage has commenced.

(f) At the express request of the applicant, the national stage of processing may be commenced at any time at which the application is in order for such purpose and the applicable requirements of subsection (c) of this section have been complied with.


(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 688; amended Nov. 8, 1984, Public Law 98-622, sec. 402(a)-(d), 403(a), 98 Stat. 3391, 3392.)

(Subsections (a), (b), (c), (d), and (e) amended Nov. 6, 1986, Public Law, 99-616, sec. 7, 100 Stat. 3486.)

(Subsection (c)(1) amended Dec. 10, 1991, Public Law 102-204, sec. 5(g)(2), 105 Stat. 1641.)

(Amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

(Subsection (d) amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1905.)

35 U.S.C. 372 National stage: Requirements and procedure.[edit | edit source]

(a) All questions of substance and, within the scope of the requirements of the treaty and Regulations, procedure in an international application designating the United States shall be determined as in the case of national applications regularly filed in the Patent and Trademark Office.

(b) In case of international applications designating but not originating in, the United States (1) the Director may cause to be reexamined questions relating to form and contents of the application in accordance with the requirements of the treaty and the Regulations; (2) the Director may cause the question of unity of invention to be reexamined under section 121 of this title, within the scope of the requirements of the treaty and the Regulations; and (3) the Director may require a verification of the translation of the international application or any other document pertaining to the application if the application or other document was filed in a language other than English.


(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 689; amended Nov. 8, 1984, Public Law 98-622, sec. 402(e), (f), 403(a), 98 Stat. 3392; Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582

(S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 373 Improper applicant.[edit | edit source]

An international application designating the United States, shall not be accepted by the Patent and Trademark Office for the national stage if it was filed by anyone not qualified under chapter 11 of this title to be an applicant for the purpose of filing a national application in the United States. Such international applications shall not serve as the basis for the benefit of an earlier filing date under section 120 of this title in a subsequently filed application, but may serve as the basis for a claim of the right of priority under subsections (a) through (d) of section 119 of this title, if the United States was not the sole country designated in such international application.

(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 689; amended Nov. 8, 1984, Public Law 98-622, sec. 403(a), 98 Stat. 3392; Dec. 8, 1994, Public Law 103465, sec. 532(c)(5), 108 Stat. 4987.)

35 U.S.C. 374 Publication of international application.[edit | edit source]

The publication under the treaty defined in section 351(a) of this title, of an international application designating the United States shall be deemed a publication under section 122(b), except as provided in sections 102(e) and 154(d) of this title.


(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 689; amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-566 (S. 1948 sec. 4507(10)); amended Nov. 2, 2002, Public Law 107-273, sec.13205, 116 Stat. 1903.)

35 U.S.C. 375 Patent issued on international application: Effect.[edit | edit source]

(a) A patent may be issued by the Director based on an international application designating the United States, in accordance with the provisions of this title. Subject to section 102(e) of this title, such patent shall have the force and effect of a patent issued on a national application filed under the provisions of chapter 11 of this title. (b) Where due to an incorrect translation the scope of a patent granted on an international application designating the United States, which was not originally filed in the English language, exceeds the scope of the international application in its original language, a court of competent jurisdiction may retroactively limit the scope of the patent, by declaring it unenforceable to the extent that it exceeds the scope of the international application in its original language.


(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 689; amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501A-582 (S. 1948 sec. 4732(a)(10)(A)).)

35 U.S.C. 376 Fees.[edit | edit source]

(a) The required payment of the international fee and the handling fee, which amounts are specified in the Regulations, shall be paid in United States currency. The Patent and Trademark Office shall charge a national fee as provided in section 41(a), and may also charge the following fees: (1) A transmittal fee (see section 361(d)). (2) A search fee (see section 361(d)).



(3) A supplemental search fee (to be paid when required). (4) A preliminary examination fee and any additional fees (see section 362(b)). (5) Such other fees as established by the Director. (b) The amounts of fees specified in subsection


(a) of this section, except the international fee and the handling fee, shall be prescribed by the Director. He may refund any sum paid by mistake or in excess of the fees so specified, or if required under the treaty


and the Regulations. The Director may also refund any part of the search fee, the national fee, the preliminary examination fee and any additional fees, where he determines such refund to be warranted.

(Added Nov. 14, 1975, Public Law 94-131, sec. 1, 89 Stat. 690, amended Nov. 8, 1984, Public Law 98-622, sec. 402(g), 403(a), 98 Stat. 3392; Nov. 6, 1986, Public Law 99-616, sec. 8(a) & (b), 100 Stat. 3486; Dec. 10, 1991, Public Law 102-204, sec. 5(g)(1), 105 Stat. 1640; amended Nov. 29, 1999, Public Law 106-113, sec. 1000(a)(9), 113 Stat. 1501-582 (S. 1948 sec. 4732(a)(10)(A)); subsections (a)(1)-(a)(3) amended Nov. 2, 2002, Public Law 107-273, sec. 13206, 116 Stat. 1905.)

LAWS NOT IN TITLE 35, UNITED STATES CODE[edit | edit source]

18 U.S.C. 1001 Statements or entries generally.[edit | edit source]

(a) Except as otherwise provided in this section, whoever, in any matter within the jurisdiction of the executive, legislative, or judicial branch of the Government of the United States, knowingly and willfully — (1) falsifies, conceals, or covers up by any trick, scheme, or device a material fact; (2) makes any materially false, fictitious, or fraudulent statement or representation; or (3) makes or uses any false writing or document knowing the same to contain any materially false, fictitious, or fraudulent statement or entry; shall be fined under this title or imprisoned not more than 5 years, or both. (b) Subsection (a) does not apply to a party to a judicial proceeding, or that party’s counsel, for statements, representations, writings or documents submitted by such party or counsel to a judge or magistrate in that proceeding. (c) With respect to any matter within the jurisdiction of the legislative branch, subsection (a) shall apply only to — (1) administrative matters, including a claim for payment, a matter related to the procurement of property or services, personnel or employment practices, or support services, or a document required by law, rule, or regulation to be submitted to the Congress or any office or officer within the legislative branch; or (2) any investigation or review, conducted pursuant to the authority of any committee, subcommittee, commission or office of the Congress, consistent with applicable rules of the House or Senate.

(Amended Sept. 13, 1994, Public Law 103-322, sec. 330016(1)(L), 108 Stat. 2147; Oct. 11, 1996, Public Law 104-292, Sec. 2, 110 Stat. 3459.)

18 U.S.C. 2071 Concealment, removal, or mutilation generally.[edit | edit source]

(a) Whoever willfully and unlawfully conceals, removes, mutilates, obliterates, or destroys, or attempts to do so, or, with intent to do so takes and carries away any record, proceeding, map, book, paper, document, or other thing, filed or deposited with any clerk or officer of any court of the United States, or in any public office, or with any judicial or public officer of the United States, shall be fined under this title or imprisoned not more than three years, or both.

(b) Whoever, having the custody of any such record, proceeding, map, book, document, paper, or other thing, willfully and unlawfully conceals, removes, mutilates, obliterates, falsifies, or destroys the same, shall be fined under this title or imprisoned not more than three years, or both; and shall forfeit his office and be disqualified from holding any office under the United States. As used in this subsection, the term “office” does not include the office held by any person as a retired officer of the Armed Forces of the United States.

(Amended Nov. 5, 1990, Public Law 101-510, sec. 552(a), 104 Stat. 1566; Sept. 13, 1994, Public Law 103322, sec. 330016(1)(I), 108 Stat. 2147.)